[
  {
    "text": "The efficacy of remote ischemic conditioning in improving neurological function",
    "entities": []
  },
  {
    "text": "and short-term prognosis in acute ischemic stroke: a prospective controlled",
    "entities": []
  },
  {
    "text": "Author information:",
    "entities": []
  },
  {
    "text": "(1)Department of Rehabilitation, The First Affiliated Hospital of Shantou",
    "entities": [
      {
        "text": "Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital of Shantou\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical College, Shantou, Guangdong Province, China.",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Shantou",
        "label": "GPE"
      },
      {
        "text": "Guangdong Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Endocrinology, The First Affiliated Hospital of Shantou",
    "entities": [
      {
        "text": "The First Affiliated Hospital of Shantou\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Neurology, The First Affiliated Hospital of Shantou University",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "The First Affiliated Hospital of Shantou University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical College, Shantou, Guangdong Province, China.",
    "entities": [
      {
        "text": "Medical College",
        "label": "ORG"
      },
      {
        "text": "Shantou",
        "label": "GPE"
      },
      {
        "text": "Guangdong Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To evaluate the efficacy of remote ischemic conditioning (RIC) in",
    "entities": []
  },
  {
    "text": "improving neurological function and short-term prognosis in patients with acute",
    "entities": []
  },
  {
    "text": "METHODS: This randomized, controlled, single-blind study aimed to evaluate the",
    "entities": []
  },
  {
    "text": "short-term (7-day) effects of RIC on neurological function in patients with AIS.",
    "entities": [
      {
        "text": "7-day",
        "label": "DATE"
      },
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "264 AIS patients (median age 65 years, 63.3% male) with ischemic symptoms <72 h",
    "entities": [
      {
        "text": "264",
        "label": "CARDINAL"
      },
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "age 65 years",
        "label": "DATE"
      },
      {
        "text": "63.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "post-onset were randomly assigned to either the RIC group (n = 65) or the",
    "entities": [
      {
        "text": "RIC",
        "label": "ORG"
      },
      {
        "text": "65",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "control group (n = 199). RIC was administered manually using a cuff",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      },
      {
        "text": "199",
        "label": "CARDINAL"
      },
      {
        "text": "RIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sphygmomanometer, while the control group received a sham RIC treatment.",
    "entities": []
  },
  {
    "text": "Patients with cardioembolic sources or a history of prior stroke were excluded",
    "entities": []
  },
  {
    "text": "from the study. Primary outcomes were the proportion of patients with an mRS",
    "entities": []
  },
  {
    "text": "score of \u22642 at 7 days, as well as changes in the National Institutes of Health",
    "entities": [
      {
        "text": "7 days",
        "label": "DATE"
      },
      {
        "text": "the National Institutes of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Stroke Scale (NIHSS), modified Rankin Scale (mRS), Activities of Daily Living",
    "entities": [
      {
        "text": "Stroke Scale",
        "label": "PERSON"
      },
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      },
      {
        "text": "Activities of Daily Living",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(ADL), and Rancho Los Amigos (RLA) scores. Data were collected at baseline and",
    "entities": [
      {
        "text": "ADL",
        "label": "ORG"
      },
      {
        "text": "Rancho Los Amigos",
        "label": "ORG"
      },
      {
        "text": "RLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "7 days post-enrollment, with in-person follow-up visits conducted by blinded",
    "entities": [
      {
        "text": "7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: At 7 days, the RIC group showed a significantly higher proportion of",
    "entities": [
      {
        "text": "7 days",
        "label": "DATE"
      },
      {
        "text": "RIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with an mRS score of \u22642 compared to the control group (41.5% vs. 28.1%,",
    "entities": [
      {
        "text": "41.5%",
        "label": "PERCENT"
      },
      {
        "text": "28.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p = 0.043). Significant improvements were observed in the RIC group compared to",
    "entities": [
      {
        "text": "0.043",
        "label": "CARDINAL"
      },
      {
        "text": "RIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the control group in NIHSS (p = 0.004) and ADL scores (p = 0.005), but not in",
    "entities": [
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "0.004",
        "label": "CARDINAL"
      },
      {
        "text": "ADL",
        "label": "LAW"
      },
      {
        "text": "0.005",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RLA scores (p > 0.05). Binary Logistic Regression Analysis indicated that, after",
    "entities": [
      {
        "text": "RLA",
        "label": "ORG"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "Binary Logistic Regression Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "adjusting for baseline factors, the treatment effect of RIC remained",
    "entities": [
      {
        "text": "RIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "statistically significant.",
    "entities": []
  },
  {
    "text": "CONCLUSION: RIC treatment enhances neurological function and improves short-term",
    "entities": []
  },
  {
    "text": "prognosis in AIS patients. These findings support the potential clinical",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "application of RIC in AIS management.",
    "entities": [
      {
        "text": "RIC",
        "label": "ORG"
      },
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that the research was",
    "entities": []
  },
  {
    "text": "conducted in the absence of any commercial or financial relationships that could",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest.",
    "entities": []
  },
  {
    "text": "Serum ferritin and risk of stroke: a meta-analysis of observation studies.",
    "entities": []
  },
  {
    "text": "(1)School of Preclinical Medicine, Zunyi Medical University, Zunyi, China.",
    "entities": [
      {
        "text": "1)School of Preclinical Medicine",
        "label": "ORG"
      },
      {
        "text": "Zunyi Medical University",
        "label": "ORG"
      },
      {
        "text": "Zunyi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurosurgery, Sichuan Provincial People's Hospital, University",
    "entities": [
      {
        "text": "Neurosurgery, Sichuan Provincial People's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Electronic Science and Technology of China, Chengdu, China.",
    "entities": [
      {
        "text": "Electronic Science and Technology of China",
        "label": "ORG"
      },
      {
        "text": "Chengdu",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Gastrointestinal Surgery, Chongqing Jiulongpo People's",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "Jiulongpo People's",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department of General Surgery, Xipeng Town Health Center of Jiulongpo",
    "entities": [
      {
        "text": "Surgery",
        "label": "PERSON"
      },
      {
        "text": "Xipeng Town Health Center of Jiulongpo\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "District, Chongqing, China.",
    "entities": [
      {
        "text": "Chongqing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(#)Contributed equally",
    "entities": []
  },
  {
    "text": "BACKGROUND AND PURPOSE: Serum ferritin, a well-established biomarker of iron",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      },
      {
        "text": "Serum ferritin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "status, has been inconsistently linked to stroke risk in previous studies. This",
    "entities": []
  },
  {
    "text": "meta-analysis aims to systematically evaluate the association between serum",
    "entities": []
  },
  {
    "text": "ferritin levels and the risk of stroke.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a systematic literature search across the PubMed and",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "eligibility criteria were selected, and relevant data were extracted.",
    "entities": []
  },
  {
    "text": "Statistical analysis was performed using Stata 12.0.",
    "entities": [
      {
        "text": "Stata 12.0",
        "label": "LAW"
      }
    ]
  },
  {
    "text": "RESULTS: Ten studies, including eight longitudinal and three cross-sectional,",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      },
      {
        "text": "eight",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were included in our meta-analysis. Cross-sectional studies showed that stroke",
    "entities": []
  },
  {
    "text": "patients had significantly higher serum ferritin levels than controls.",
    "entities": []
  },
  {
    "text": "Longitudinal studies suggested a 22% increase in stroke risk in individuals with",
    "entities": [
      {
        "text": "22%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "higher serum ferritin. Subgroup analysis indicated that further high-quality",
    "entities": []
  },
  {
    "text": "population-based cohort studies are warranted to validate these findings.",
    "entities": []
  },
  {
    "text": "Dose-response meta-analysis confirmed a positive association between serum",
    "entities": []
  },
  {
    "text": "CONCLUSION: This meta-analysis provides evidence of a positive association",
    "entities": []
  },
  {
    "text": "between increased serum ferritin levels and stroke incidence. While these",
    "entities": []
  },
  {
    "text": "results are promising, definitive conclusions cannot be drawn at this time.",
    "entities": []
  },
  {
    "text": "Therefore, additional robust, prospective cohort studies are imperative to",
    "entities": []
  },
  {
    "text": "substantiate this relationship.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Zheng, Wang, Xia and Liu.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Zheng",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "PERSON"
      },
      {
        "text": "Xia",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Is helicopter transferal in the \"drip-and-ship\" approach for endovascular",
    "entities": []
  },
  {
    "text": "treatment the better choice? A retrospective analysis of transfer times.",
    "entities": []
  },
  {
    "text": "V(5), Macke C(5), Worthmann H(1).",
    "entities": [
      {
        "text": "Macke C(5)",
        "label": "PERSON"
      },
      {
        "text": "Worthmann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Hannover Medical School, Hannover, Germany.",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Hannover Medical School",
        "label": "ORG"
      },
      {
        "text": "Hannover",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Interdisciplinary Emergency and Disaster Medicine, Hannover Medical School,",
    "entities": [
      {
        "text": "2)Interdisciplinary",
        "label": "CARDINAL"
      },
      {
        "text": "Hannover Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hannover, Germany.",
    "entities": [
      {
        "text": "Hannover",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Anesthesiology and Surgical Intensive Care Medicine, KRH",
    "entities": [
      {
        "text": "Anesthesiology and Surgical Intensive Care Medicine",
        "label": "ORG"
      },
      {
        "text": "KRH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital Siloah, Hannover, Germany.",
    "entities": [
      {
        "text": "Hannover",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical",
    "entities": [
      {
        "text": "Diagnostic and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Hannover Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Hannover, Germany.",
    "entities": [
      {
        "text": "Hannover",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Trauma Surgery, Hannover Medical School, Hannover, Germany.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Trauma Surgery",
        "label": "PERSON"
      },
      {
        "text": "Hannover Medical School",
        "label": "ORG"
      },
      {
        "text": "Hannover",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: For patients with large vessel occlusion (LVO) admitted to primary",
    "entities": [
      {
        "text": "LVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke centers (PSC) without neuro-interventional capabilities, timely transfer",
    "entities": []
  },
  {
    "text": "to comprehensive stroke centers (CSC) is crucial. In this study, we compared the",
    "entities": [
      {
        "text": "CSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transport time of ground- and air-based transfer for patients receiving",
    "entities": []
  },
  {
    "text": "METHODS: In a retrospective cohort study, consecutive ischemic stroke patients",
    "entities": []
  },
  {
    "text": "with LVO who were transferred ground- or air-based to our CSC between October",
    "entities": [
      {
        "text": "LVO",
        "label": "ORG"
      },
      {
        "text": "CSC",
        "label": "ORG"
      },
      {
        "text": "between October\n",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2018 and December 2022 were examined. 170 patients with LVO from five PSCs",
    "entities": [
      {
        "text": "2018",
        "label": "DATE"
      },
      {
        "text": "December 2022",
        "label": "DATE"
      },
      {
        "text": "170",
        "label": "CARDINAL"
      },
      {
        "text": "LVO",
        "label": "ORG"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "within a radius of 55 to 85 km to the CSC were included. Patients were",
    "entities": [
      {
        "text": "55 to 85 km",
        "label": "QUANTITY"
      },
      {
        "text": "CSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transported either with an emergency rescue helicopter (ERH), a ground ambulance",
    "entities": []
  },
  {
    "text": "(GA), GA accompanied by an emergency physician vehicle (EPV), or in a mobile",
    "entities": [
      {
        "text": "EPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "intensive care unit (MICU) and were accordingly divided into air-based (61",
    "entities": [
      {
        "text": "MICU",
        "label": "ORG"
      },
      {
        "text": "61",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients) and ground-based (109 patients) main transport groups.",
    "entities": [
      {
        "text": "109",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: The analysis revealed a significant difference between air- and",
    "entities": []
  },
  {
    "text": "ground-based transport groups (75 vs. 82 min, p = 0.01). After calculating the",
    "entities": [
      {
        "text": "75",
        "label": "CARDINAL"
      },
      {
        "text": "82",
        "label": "CARDINAL"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "transport time in relation to the covered ground distance, air-based transport",
    "entities": []
  },
  {
    "text": "was shorter by a median of 0.15 min per kilometer. In a comparison of the",
    "entities": [
      {
        "text": "0.15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "individual means, ERH was faster than GA and EPV (both p < 0.001). Only few",
    "entities": [
      {
        "text": "EPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "transports were done by MICU and they mainly showed very long transfer times.",
    "entities": [
      {
        "text": "MICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The complication rates were generally low with only minor complications and no",
    "entities": []
  },
  {
    "text": "deaths reported in both groups. However, they were more frequently observed in",
    "entities": []
  },
  {
    "text": "the land-based transport group (20.2% vs. 8.2%, p = 0.04).",
    "entities": [
      {
        "text": "20.2%",
        "label": "PERCENT"
      },
      {
        "text": "8.2%",
        "label": "PERCENT"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: In the present analysis, air-based transport was faster than",
    "entities": []
  },
  {
    "text": "ground-based transport for the secondary transfer of patients with stroke due to",
    "entities": []
  },
  {
    "text": "LVO in the observed regional conditions. Both air- and land-based transport",
    "entities": [
      {
        "text": "LVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "appear to be safe. No serious complications occurred during transport, while",
    "entities": []
  },
  {
    "text": "complications were more frequent in the ground-based transport group.",
    "entities": []
  },
  {
    "text": "Worthmann.",
    "entities": [
      {
        "text": "Worthmann",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Metabolic syndrome is associated with prognosis in patients with acute ischemic",
    "entities": []
  },
  {
    "text": "stroke after intravenous thrombolysis: a prospective cohort study.",
    "entities": []
  },
  {
    "text": "(1)Department of Geriatric Medicine, Shanxi Bethune Hospital, Shanxi Academy of",
    "entities": [
      {
        "text": "Geriatric Medicine",
        "label": "ORG"
      },
      {
        "text": "Bethune Hospital",
        "label": "ORG"
      },
      {
        "text": "Shanxi Academy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi",
    "entities": [
      {
        "text": "Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Third Hospital of Shanxi Medical University",
        "label": "ORG"
      },
      {
        "text": "Tongji Shanxi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Linfen People's Hospital, Linfen, China.",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Linfen People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Linfen",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurology, Beijing Yanhua Hospital, Beijing, China.",
    "entities": [
      {
        "text": "Neurology",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Metabolic syndrome (MetS) is a known risk factor for stroke, but its",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "impact on prognosis after intravenous thrombolysis (IVT) in acute ischemic",
    "entities": [
      {
        "text": "IVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke (AIS) remains unclear. This study aimed to evaluate the association",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "between MetS and prognosis in AIS patients treated with IVT.",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      },
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "IVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a prospective cohort study including AIS patients who",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received IVT at Shanxi Bethune Hospital between January 2022 and December 2023.",
    "entities": [
      {
        "text": "IVT",
        "label": "ORG"
      },
      {
        "text": "Shanxi Bethune Hospital",
        "label": "FAC"
      },
      {
        "text": "between January 2022",
        "label": "DATE"
      },
      {
        "text": "December 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Propensity score matching (PSM) was applied to balance baseline characteristics",
    "entities": []
  },
  {
    "text": "between MetS and non-MetS groups. The primary outcome was 3-month all-cause",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      },
      {
        "text": "3-month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mortality. Secondary outcomes included good functional outcome (modified Rankin",
    "entities": [
      {
        "text": "Secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "Scale [mRS] 0-2) and symptomatic intracranial hemorrhage (SICH).",
    "entities": [
      {
        "text": "0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: After PSM, 292 patients (146 pairs) were enrolled in the analysis. The",
    "entities": [
      {
        "text": "PSM",
        "label": "ORG"
      },
      {
        "text": "292",
        "label": "CARDINAL"
      },
      {
        "text": "146",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "all-cause mortality rate within 3 months was significantly higher in the MetS",
    "entities": [
      {
        "text": "3 months",
        "label": "DATE"
      },
      {
        "text": "MetS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group compared to the non-MetS group (24.0% vs. 11.6%; p < 0.01). Multivariate",
    "entities": [
      {
        "text": "non-MetS",
        "label": "ORG"
      },
      {
        "text": "24.0%",
        "label": "PERCENT"
      },
      {
        "text": "11.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Cox regression analysis indicated that MetS was independently associated with",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increased 3-month mortality (adjusted hazard ratio [HR] = 2.50, 95% CI:",
    "entities": [
      {
        "text": "3-month",
        "label": "DATE"
      },
      {
        "text": "2.50",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "1.35-4.60; p < 0.01). A dose-response relationship was observed between the",
    "entities": [
      {
        "text": "1.35",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "number of MetS components and mortality. Additionally, patients with MetS were",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      },
      {
        "text": "MetS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "less likely to achieve good functional outcomes (adjusted odds ratio",
    "entities": []
  },
  {
    "text": "[OR] = 0.47, 95% CI: 0.28-0.77; p < 0.01) and had a higher risk of SICH",
    "entities": [
      {
        "text": "0.47",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.28",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(adjusted OR = 2.40, 95% CI: 1.17-4.92; p = 0.02).",
    "entities": [
      {
        "text": "2.40",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.17-4.92",
        "label": "CARDINAL"
      },
      {
        "text": "0.02",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: MetS is an independent predictor of increased mortality, poorer",
    "entities": [
      {
        "text": "MetS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "functional recovery, and higher risk of SICH in AIS patients treated with IVT.",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "IVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Early identification and management of metabolic risk factors may improve",
    "entities": []
  },
  {
    "text": "outcomes in this population.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Chen, Liu, Li and Zhang.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Chen",
        "label": "PERSON"
      },
      {
        "text": "Liu",
        "label": "PERSON"
      },
      {
        "text": "Li",
        "label": "PERSON"
      },
      {
        "text": "Zhang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Association between triglyceride glucose-waist-adjusted waist index and incident",
    "entities": []
  },
  {
    "text": "stroke in Chinese adults: a prospective cohort study.",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Department of General Practice Medicine, The First Affiliated Hospital, Sun",
    "entities": [
      {
        "text": "General Practice Medicine",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Sun",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Yat-sen University, Guangzhou, China.",
    "entities": [
      {
        "text": "Yat-sen University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Current literature lacks evidence on the association between the",
    "entities": []
  },
  {
    "text": "triglyceride glucose-weight-adjusted waist index (TyG-WWI) and incident stroke.",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therefore, this study aims to elucidate the relationship between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk in a nationally representative cohort of middle-aged and elderly",
    "entities": []
  },
  {
    "text": "Chinese adults by: (1) Quantitatively assessing its prospective association with",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "incident stroke, and (2) Investigating potential nonlinear relationships and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "inflection points.",
    "entities": []
  },
  {
    "text": "METHODS: This national longitudinal study examined data from five waves of the",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CHARLS (2011-2020). TyG-WWI served as the key exposure variable, while stroke",
    "entities": [
      {
        "text": "CHARLS",
        "label": "ORG"
      },
      {
        "text": "2011-2020",
        "label": "DATE"
      },
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "incidence, as determined by physician diagnosis, was the principal outcome of",
    "entities": []
  },
  {
    "text": "interest. Associations were evaluated using Cox proportional hazards models",
    "entities": [
      {
        "text": "Cox",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alongside nonlinear analyses, with careful adjustment for a range of covariates.",
    "entities": []
  },
  {
    "text": "To further ensure the reliability of our findings, we performed a series of",
    "entities": []
  },
  {
    "text": "sensitivity and subgroup analyses.",
    "entities": []
  },
  {
    "text": "RESULTS: In this study, we investigated the association between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk. The results demonstrated a significant positive correlation between",
    "entities": []
  },
  {
    "text": "TyG-WWI quartiles and stroke risk, with HRs of 1.35 (95% CI 1.08-1.69,",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "1.35",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "p = 0.0094), 1.38 (95% CI 1.09-1.73, p = 0.0069), and 1.42 (95% CI 1.09-1.85,",
    "entities": [
      {
        "text": "0.0094",
        "label": "CARDINAL"
      },
      {
        "text": "1.38",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09-1.73",
        "label": "PRODUCT"
      },
      {
        "text": "0.0069",
        "label": "CARDINAL"
      },
      {
        "text": "1.42",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09-1.85",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "p = 0.0086) for Q2, Q3, and Q4, respectively, compared to Q1 in Model III (P for",
    "entities": [
      {
        "text": "0.0086",
        "label": "CARDINAL"
      },
      {
        "text": "Q2",
        "label": "CARDINAL"
      },
      {
        "text": "Q3",
        "label": "PRODUCT"
      },
      {
        "text": "Q4",
        "label": "PRODUCT"
      },
      {
        "text": "Q1 in Model III",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "trend = 0.0158). A two-piecewise linear regression model revealed an inflection",
    "entities": [
      {
        "text": "0.0158",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "point of TyG-WWI at 43.32, with a significant association between TyG-WWI and",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "43.32",
        "label": "CARDINAL"
      },
      {
        "text": "TyG-WWI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke risk only above this point (HR = 1.03, 95% CI 1.01-1.05, p = 0.0008).",
    "entities": [
      {
        "text": "1.03",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01-1.05",
        "label": "CARDINAL"
      },
      {
        "text": "0.0008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Stratified analysis indicated a more robust association in non-hypertensive",
    "entities": []
  },
  {
    "text": "individuals (HR = 1.94, 95% CI 1.29-2.91, p = 0.0014 in Q4) and a significant",
    "entities": [
      {
        "text": "1.94",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.29-2.91",
        "label": "CARDINAL"
      },
      {
        "text": "0.0014",
        "label": "CARDINAL"
      },
      {
        "text": "Q4",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "interaction for hypertension status (P for interaction = 0.0493).",
    "entities": [
      {
        "text": "0.0493",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: In conclusion, our study reveals a significant association between",
    "entities": []
  },
  {
    "text": "TyG-WWI and stroke risk in the middle-aged and elderly population in China, with",
    "entities": [
      {
        "text": "TyG-WWI",
        "label": "ORG"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "stroke risk increasing progressively across higher TyG-WWI quartiles. Notably,",
    "entities": []
  },
  {
    "text": "this association was significantly more pronounced in non-hypertensive",
    "entities": []
  },
  {
    "text": "individuals. Furthermore, an inflection point indicates a stronger association",
    "entities": []
  },
  {
    "text": "beyond this threshold.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Ye, He, Wu, Wu and Liang.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      },
      {
        "text": "Wu",
        "label": "PERSON"
      },
      {
        "text": "Liang",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "How does academic self-efficacy influence learning anxiety and academic burnout",
    "entities": []
  },
  {
    "text": "in Chinese characters learning among international students in China?",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Faculty of Humanities and Foreign Languages, Xi'an University of Technology,",
    "entities": [
      {
        "text": "Humanities and Foreign Languages",
        "label": "ORG"
      },
      {
        "text": "Xi'an University of Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: The interplay between learning self-efficacy, anxiety, and burnout",
    "entities": []
  },
  {
    "text": "has been extensively documented in English as a Second Language (ESL) education.",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "However, Chinese character learning-a uniquely complex task involving",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "visual-spatial processing, stroke order mastery, and radical",
    "entities": []
  },
  {
    "text": "decomposition-presents distinct cognitive and affective challenges. The dynamics",
    "entities": []
  },
  {
    "text": "of self-efficacy, anxiety, and burnout in Chinese character acquisition remain",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "under-explored, creating a critical gap in understanding how these constructs",
    "entities": []
  },
  {
    "text": "operate in non-alphabetic language contexts.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: The purpose of this study was to investigate how learning anxiety",
    "entities": []
  },
  {
    "text": "(LA) affects academic burnout (AB) and explores the role of academic",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "self-efficacy (ASE) in the relationship between the two.",
    "entities": [
      {
        "text": "ASE",
        "label": "ORG"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "METHODS: A study of 537 international students (50.4% males, mean",
    "entities": [
      {
        "text": "537",
        "label": "CARDINAL"
      },
      {
        "text": "50.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "age = 20.96 years, SD = 1.36) was conducted using the Academic Self-Efficacy",
    "entities": [
      {
        "text": "20.96 years",
        "label": "DATE"
      },
      {
        "text": "1.36",
        "label": "CARDINAL"
      },
      {
        "text": "the Academic Self-Efficacy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Scale (ASES), Foreign Language Learning Anxiety Scale (FLLAS), Academic Burnout",
    "entities": [
      {
        "text": "Foreign Language Learning Anxiety Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: \u2460 LA was significantly and positively correlated with AB, and",
    "entities": [
      {
        "text": "\u2460",
        "label": "CARDINAL"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "AB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly and negatively correlated with ASE. \u2461 ASE mediated the",
    "entities": [
      {
        "text": "ASE",
        "label": "ORG"
      },
      {
        "text": "\u2461",
        "label": "CARDINAL"
      },
      {
        "text": "ASE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relationship between LA and AB. \u2462 Grade level, sleep quality, and parental",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "AB",
        "label": "GPE"
      },
      {
        "text": "\u2462",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "education level have a significant effect on ASE, LA and AB; and \u2463 Extroversion",
    "entities": [
      {
        "text": "ASE",
        "label": "ORG"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "\u2463 Extroversion",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "has a significant effect on ASE, but not on LA and AB.",
    "entities": [
      {
        "text": "ASE",
        "label": "ORG"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "AB",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "CONCLUSION: The chain mediation model validated by this study provides valuable",
    "entities": []
  },
  {
    "text": "insights into the effects of international students' learning anxiety (LA) on",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "academic burnout (AB) in China, alongside practical implications for preventing",
    "entities": [
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "and intervening in LA and AB among other current students.",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Lin.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Lin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The author declares that the research was",
    "entities": []
  },
  {
    "text": "EF-G Mutations Reveal Correlation between Power Stroke and Translocation",
    "entities": []
  },
  {
    "text": "Fidelity in Protein Synthesis.",
    "entities": []
  },
  {
    "text": "The ribosome translocates on the mRNA by primarily three nucleotides per step",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "during protein synthesis, a process catalyzed by elongation factor G (EF-G). The",
    "entities": []
  },
  {
    "text": "large conformational changes of EF-G in this process generate significant",
    "entities": []
  },
  {
    "text": "mechanical force, referred to as power stroke. Quantification of power stroke",
    "entities": []
  },
  {
    "text": "remains under debate and its potential correlation with translocation fidelity",
    "entities": []
  },
  {
    "text": "has not been observed. In this work, we present a unique application of quantum",
    "entities": [
      {
        "text": "quantum",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sensing in combined measurements of the power strokes of mutated EF-G and their",
    "entities": []
  },
  {
    "text": "influence on ribosome translocation steps. Two EF-G mutants, H584K and Q508K,",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      },
      {
        "text": "H584K",
        "label": "ORG"
      },
      {
        "text": "Q508K",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "were expressed, with the mutated residues directly interacting with tRNA. H584K,",
    "entities": [
      {
        "text": "mutated",
        "label": "ORDINAL"
      },
      {
        "text": "H584K",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "which interacts on codon-anticodon minihelix, produced a much reduced power",
    "entities": []
  },
  {
    "text": "stroke of 60 \u00b1 6 pN and induced -1 frameshifting, wherein the ribosome",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "translocated only two nucleotides on both sides of the mRNA. In contrast, Q508K,",
    "entities": [
      {
        "text": "only two",
        "label": "CARDINAL"
      },
      {
        "text": "Q508K",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "which interacts with tRNA residue 37 immediately outside the codon-anticodon",
    "entities": [
      {
        "text": "37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "minihelix, exhibited a power stroke of 89 \u00b1 11 pN and maintained canonical 3-nt",
    "entities": [
      {
        "text": "89",
        "label": "CARDINAL"
      },
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "3-nt\n",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "translocation, similar to wild-type EF-G. These findings provide direct",
    "entities": []
  },
  {
    "text": "mechanistic evidence that the pivotal point and force projection exerted by EF-G",
    "entities": []
  },
  {
    "text": "are critical for maintaining translocation fidelity, likely via lowering the",
    "entities": []
  },
  {
    "text": "Multimodal Analysis of Sepsis-induced Cardiomyopathy in a Baboon Model.",
    "entities": [
      {
        "text": "Multimodal Analysis of Sepsis",
        "label": "ORG"
      },
      {
        "text": "Cardiomyopathy",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sepsis-induced cardiomyopathy (SIC) significantly contributes to sepsis-related",
    "entities": []
  },
  {
    "text": "morbidity and mortality, necessitating a deeper understanding of its mechanisms.",
    "entities": []
  },
  {
    "text": "This study used a post-hoc, multimodal approach-including single-nucleus RNA",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sequencing (snRNA-seq), echocardiography, mitochondrial function, and",
    "entities": []
  },
  {
    "text": "histopathology-to characterize SIC in a non-human primate model. Archived data",
    "entities": [
      {
        "text": "SIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and samples from six baboons challenged with 37.5 mg/kg of purified",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "37.5 mg/kg",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "peptidoglycan were analyzed. Vital signs and echocardiography were monitored for",
    "entities": []
  },
  {
    "text": "8 hours; the endpoint was survival at 168 hours or euthanasia for irreversible",
    "entities": [
      {
        "text": "8 hours",
        "label": "TIME"
      },
      {
        "text": "168 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "organ failure. Septic shock-defined by hypotension, tachycardia, and elevated",
    "entities": []
  },
  {
    "text": "lactate-was associated with poor outcomes. Echocardiography showed reduced",
    "entities": []
  },
  {
    "text": "revealed distinct transcriptomic profiles: non-survivors exhibited inflammation,",
    "entities": []
  },
  {
    "text": "mitochondrial dysfunction, and maladaptive remodeling; survivors showed",
    "entities": []
  },
  {
    "text": "activation of pathways supporting contraction, metabolism, and repair. Cell-type",
    "entities": []
  },
  {
    "text": "analysis highlighted metabolic dysfunction in cardiomyocytes, TNF/NF-\u03baB-driven",
    "entities": [
      {
        "text": "TNF/NF-\u03baB-driven\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inflammation in endothelial cells, and stress responses in fibroblasts and",
    "entities": []
  },
  {
    "text": "pericytes. Mitochondrial analysis showed impaired electron transport and",
    "entities": []
  },
  {
    "text": "disrupted metabolism. Histopathology revealed inflammation and myofibrillar",
    "entities": []
  },
  {
    "text": "damage, more severe in non-survivors. This model recapitulates key SIC features",
    "entities": []
  },
  {
    "text": "and supports mechanistic and therapeutic discovery.",
    "entities": []
  },
  {
    "text": "Competition between tool and hand motion impairs movement planning in limb",
    "entities": []
  },
  {
    "text": "Thibault S, Yates JB, Buxbaum LJ, Wong AL.",
    "entities": [
      {
        "text": "Thibault S",
        "label": "PERSON"
      },
      {
        "text": "Yates JB",
        "label": "GPE"
      },
      {
        "text": "Buxbaum LJ",
        "label": "ORG"
      },
      {
        "text": "Wong AL",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Tool use is a complex motor planning problem. Prior research suggests that",
    "entities": []
  },
  {
    "text": "planning to use tools involves resolving competition between different",
    "entities": []
  },
  {
    "text": "tool-related action representations. We therefore reasoned that competition may",
    "entities": []
  },
  {
    "text": "also be exacerbated with tools for which the motions of the tool and the hand",
    "entities": []
  },
  {
    "text": "are incongruent (e.g., pinching the fingers to open a clothespin). If this",
    "entities": []
  },
  {
    "text": "hypothesis is correct, we should observe marked deficits in planning the use of",
    "entities": []
  },
  {
    "text": "incongruent as compared to congruent tools in individuals with limb apraxia",
    "entities": []
  },
  {
    "text": "following left-hemisphere stroke (LCVA), a disorder associated with abnormal",
    "entities": []
  },
  {
    "text": "action competition. We asked 34 individuals with chronic LCVA (14 females) and",
    "entities": [
      {
        "text": "34",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "16 matched neurotypical controls (8 females) to use novel tools in which the",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "correspondence between the motions of the hand and tool-tip were either",
    "entities": []
  },
  {
    "text": "congruent or incongruent. Individuals with LCVA also completed background",
    "entities": [
      {
        "text": "LCVA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "assessments to quantify apraxia severity. We observed increased planning time",
    "entities": []
  },
  {
    "text": "for incongruent as compared to congruent tools as a function of apraxia",
    "entities": []
  },
  {
    "text": "severity. Further analysis revealed that this impairment predominantly occurred",
    "entities": []
  },
  {
    "text": "early in the task when the tools were first introduced. Lesion-symptom mapping",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "analyses revealed that lesions to posterior temporal and inferior parietal areas",
    "entities": []
  },
  {
    "text": "were associated with impaired planning for incongruent tools. A second",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "experiment on the same individuals with LCVA revealed that the ability to",
    "entities": [
      {
        "text": "LCVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gesture the use of conventional tools was impaired for tools rated as more",
    "entities": []
  },
  {
    "text": "incongruent by a normative sample. These findings suggest that tool-hand",
    "entities": []
  },
  {
    "text": "incongruence evokes action competition and influences the tool-use difficulties",
    "entities": []
  },
  {
    "text": "experienced by people with apraxia.",
    "entities": []
  },
  {
    "text": "SIGNIFICANCE STATEMENT: Prior research indicates that competition between",
    "entities": [
      {
        "text": "SIGNIFICANCE STATEMENT",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "different representations associated with moving or using tools must be resolved",
    "entities": []
  },
  {
    "text": "to enable tool use. We demonstrated that competition may be exacerbated when",
    "entities": []
  },
  {
    "text": "tool and hand motions are incongruent (e.g., pinching the hand opens a",
    "entities": []
  },
  {
    "text": "clothespin), resulting in tool-use impairments particularly for individuals with",
    "entities": []
  },
  {
    "text": "greater severity of limb apraxia, a disorder known to be associated with action",
    "entities": []
  },
  {
    "text": "competition abnormalities. Lesions in posterior portions of the brain's tool use",
    "entities": []
  },
  {
    "text": "network were associated with impairments in planning incongruent tool actions.",
    "entities": []
  },
  {
    "text": "This study thus demonstrates that tool-hand incongruence may invoke competition",
    "entities": []
  },
  {
    "text": "between motions of the hand and tool-tip, which individuals with limb apraxia",
    "entities": []
  },
  {
    "text": "have difficulty resolving to properly use tools.",
    "entities": []
  },
  {
    "text": "Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in",
    "entities": [
      {
        "text": "Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and Complement.",
    "entities": []
  },
  {
    "text": "Chen H, Frank JA, Tan C, Lee AG, Kopchock R, Chiang T, Kim A, Galvan M, Fraser",
    "entities": [
      {
        "text": "Chen H",
        "label": "PERSON"
      },
      {
        "text": "Frank JA",
        "label": "PERSON"
      },
      {
        "text": "Tan C",
        "label": "PERSON"
      },
      {
        "text": "Lee AG",
        "label": "PERSON"
      },
      {
        "text": "Kim A",
        "label": "PERSON"
      },
      {
        "text": "Galvan M",
        "label": "PERSON"
      },
      {
        "text": "Fraser",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "JF, Dornbos D, Aboul-Nour H, Millson N, Tomlinson S, McCullough LD, Pennypacker",
    "entities": [
      {
        "text": "JF",
        "label": "ORG"
      },
      {
        "text": "Dornbos D",
        "label": "PERSON"
      },
      {
        "text": "Aboul-Nour H",
        "label": "ORG"
      },
      {
        "text": "Millson N",
        "label": "PERSON"
      },
      {
        "text": "Tomlinson S",
        "label": "PERSON"
      },
      {
        "text": "McCullough LD",
        "label": "PERSON"
      },
      {
        "text": "Pennypacker",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Acute hyperglycemia affects approximately 40% of stroke patients and",
    "entities": [
      {
        "text": "approximately 40%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "is associated with worse outcomes. The underlying mechanisms linking this",
    "entities": []
  },
  {
    "text": "metabolic stress to stroke-induced brain injury remains unclear, and effective",
    "entities": []
  },
  {
    "text": "therapies are lacking.",
    "entities": []
  },
  {
    "text": "METHODS: In a mouse model of acute hyperglycemic stroke, luminal disruption,",
    "entities": []
  },
  {
    "text": "blood-brain barrier (BBB) leakage, neurological deficit, motor function, and",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "mortality were evaluated. Vascular luminal glycocalyx and complement activation",
    "entities": []
  },
  {
    "text": "were assessed by immunostaining, with glycocalyx loss confirmed by electron",
    "entities": [
      {
        "text": "glycocalyx",
        "label": "ORG"
      },
      {
        "text": "electron\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "microscopy. Complement C3's causal role was tested using C3 knockout mice and",
    "entities": [
      {
        "text": "Complement C3's",
        "label": "PERSON"
      },
      {
        "text": "C3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "site-targeted inhibition with CR2-Crry. To enhance translational relevance,",
    "entities": [
      {
        "text": "CR2-Crry",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "post-mortem human stroke and control brains were immunostained to assess the",
    "entities": []
  },
  {
    "text": "association between endothelial glycocalyx loss and vascular complement",
    "entities": [
      {
        "text": "glycocalyx",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "activation. In a separate stroke patient cohort, soluble complement activation",
    "entities": []
  },
  {
    "text": "products were measured in pre-thrombectomy plasma, and their predictive value",
    "entities": []
  },
  {
    "text": "for modified Rankin Scale (mRS) outcomes evaluated using elastic net regression.",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: Hyperglycemic stroke mice exhibited accelerated and more severe BBB",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "breakdown, greater functional deficits, and higher mortality than normoglycemic",
    "entities": []
  },
  {
    "text": "controls, mirroring clinical observations. Acute hyperglycemia triggered rapid",
    "entities": []
  },
  {
    "text": "vascular luminal injury characterized by loss of endothelial luminal glycocalyx,",
    "entities": []
  },
  {
    "text": "luminal IgM/IgG deposition, and vascular complement C3 activation, leading to",
    "entities": [
      {
        "text": "C3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "BBB disruption. This vascular luminal injury was corroborated in human stroke",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "brain tissue. These luminal changes persisted despite glucose normalization and",
    "entities": []
  },
  {
    "text": "were exacerbated by reperfusion, driving injury into the brain parenchyma.",
    "entities": []
  },
  {
    "text": "Genetic and pharmacological approaches confirmed vascular complement activation",
    "entities": []
  },
  {
    "text": "as a causal driver of severe BBB disruption and poor outcomes. Importantly,",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "site-targeted pharmacological inhibition of complement after reperfusion",
    "entities": []
  },
  {
    "text": "preserved BBB integrity and improved outcomes, defining a time-specific,",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "luminal-directed strategy as a promising adjunct to thrombectomy. Notably,",
    "entities": []
  },
  {
    "text": "soluble complement activation markers in pre-thrombectomy stroke plasma",
    "entities": []
  },
  {
    "text": "predicted clinical outcomes, highlighting their potential as pre-intervention",
    "entities": []
  },
  {
    "text": "markers for patient stratification and tailored therapy.",
    "entities": []
  },
  {
    "text": "CONCLUSION: This study reframes acute hyperglycemic stroke as a vascular luminal",
    "entities": []
  },
  {
    "text": "disorder, establishing a novel Metabolic-Complement-Vascular (MCV) axis linking",
    "entities": [
      {
        "text": "Metabolic-Complement-Vascular",
        "label": "ORG"
      },
      {
        "text": "MCV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "metabolic stress to endothelial luminal glycocalyx loss, vascular complement",
    "entities": []
  },
  {
    "text": "activation, and BBB breakdown in both mice and humans. This new mechanistic",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "understanding transforms the therapeutic landscape of hyperglycemic stroke,",
    "entities": []
  },
  {
    "text": "offering a potential time-defined, luminal-focused adjunct therapy alongside",
    "entities": []
  },
  {
    "text": "thrombectomy.",
    "entities": []
  },
  {
    "text": "CLINICAL PERSPECTIVE: What Is New?: - This study reframes hyperglycemic stroke",
    "entities": []
  },
  {
    "text": "as an acute vascular luminal problem, marked by rapid loss of endothelial",
    "entities": []
  },
  {
    "text": "luminal glycocalyx and complement C3 activation at the vascular luminal surface.",
    "entities": [
      {
        "text": "C3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "- The rapid luminal changes, identified in both rodent and human stroke brain",
    "entities": []
  },
  {
    "text": "tissues, establish a novel Metabolic-Complement-Vascular (MCV) axis linking",
    "entities": [
      {
        "text": "Metabolic-Complement-Vascular",
        "label": "ORG"
      },
      {
        "text": "MCV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "metabolic stress to luminal damage, blood-brain barrier (BBB) breakdown, and",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "injury progression into the brain parenchyma. - The first clinical evidence that",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "pre-thrombectomy plasma complement activation markers independently predict",
    "entities": []
  },
  {
    "text": "stroke outcomes - laying the foundation for risk stratification before",
    "entities": []
  },
  {
    "text": "reperfusion and precision adjunct therapies.What Are the Clinical Implications?:",
    "entities": []
  },
  {
    "text": "- The rapidity and persistence of the MCV axis activation-even after glucose",
    "entities": [
      {
        "text": "MCV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "normalization-help explain the limited efficacy of insulin therapy, shifting the",
    "entities": []
  },
  {
    "text": "therapeutic focus from glycemic control to luminal-targeted interventions.-",
    "entities": []
  },
  {
    "text": "Identification of a narrow but actionable window following reperfusion where",
    "entities": []
  },
  {
    "text": "complement C3 inhibition preserves the BBB and limits injury progression to the",
    "entities": [
      {
        "text": "C3",
        "label": "PRODUCT"
      },
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "parenchyma, offers a promising adjunct to thrombectomy in metabolically",
    "entities": []
  },
  {
    "text": "vulnerable stroke patients.- Targeting the vascular luminal surface reshapes the",
    "entities": []
  },
  {
    "text": "therapeutic landscape for hyperglycemic stroke by enabling systemic",
    "entities": []
  },
  {
    "text": "interventions-bypassing the challenge of BBB penetration, supporting rapid",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical translation using existing FDA-approved C3 inhibitors, and framing the",
    "entities": [
      {
        "text": "FDA",
        "label": "ORG"
      },
      {
        "text": "C3",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "endothelial glycocalyx as a promising area for therapeutic and diagnostic",
    "entities": []
  },
  {
    "text": "exploration in hyperglycemic stroke and broader cerebrovascular disease.",
    "entities": []
  },
  {
    "text": "Cross-sectional Cranial CT Imaging Findings and Patterns in Clinically Diagnosed",
    "entities": [
      {
        "text": "Cranial CT Imaging Findings",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "COVID-19 Cases in a Tertiary Referral Center.",
    "entities": [
      {
        "text": "COVID-19 Cases",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Vascular and Interventional Radiology Section, Department of Radiology,",
    "entities": [
      {
        "text": "Interventional Radiology Section,",
        "label": "ORG"
      },
      {
        "text": "Department of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Philippine General Hospital, University of the Philippines Manila.",
    "entities": [
      {
        "text": "Philippine General Hospital, University of the Philippines",
        "label": "ORG"
      },
      {
        "text": "Manila",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus,",
    "entities": [
      {
        "text": "2019",
        "label": "DATE"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presents not only as a respiratory ailment but also poses risks of neurological",
    "entities": []
  },
  {
    "text": "complications whose underlying mechanisms remain unclear. These complications",
    "entities": []
  },
  {
    "text": "range from mild to severe and may involve direct invasion of the central nervous",
    "entities": []
  },
  {
    "text": "system (CNS), disruption of the blood-brain barrier, or systemic cytokine",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effects. Diagnostic challenges persist due to the suboptimal sensitivity of",
    "entities": []
  },
  {
    "text": "RT-PCR assays.",
    "entities": [
      {
        "text": "RT-PCR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: The present study aimed to review the contrast and non-contrast",
    "entities": []
  },
  {
    "text": "enhanced cranial CT images of all diagnosed COVID-19 patients in a tertiary",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "referral center with the clinical impression of non-traumatic and nonoperative",
    "entities": []
  },
  {
    "text": "CNS pathologies.",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We conducted a cross-sectional study analyzing CT images of COVID-19",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with neurological symptoms. Among 51 included patients, plain CT scans",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were predominantly used, revealing no acute infarcts or hemorrhages in the",
    "entities": []
  },
  {
    "text": "majority, while frontal lobe involvement was notable in cases with pathology.",
    "entities": []
  },
  {
    "text": "Chronic infarcts or ischemic changes were observed in over half of the cases,",
    "entities": [
      {
        "text": "over half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "primarily affecting the anterior circulation. Only one case of meningitis was",
    "entities": [
      {
        "text": "Only one",
        "label": "CARDINAL"
      },
      {
        "text": "meningitis",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "RESULTS: In the final analysis, 51 patients met the inclusion criteria out of",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the initial 64 enrolled. The study population, predominantly male with a mean",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "age of 58.02 \u00b1 20.87 years, mainly comprised patients solely diagnosed with",
    "entities": [
      {
        "text": "58.02",
        "label": "CARDINAL"
      },
      {
        "text": "20.87 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "COVID-19. Plain CT scans were favored over contrast-enhanced scans (76.50%, n =",
    "entities": [
      {
        "text": "76.50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "39). While most patients had no acute infarcts or hemorrhages, the frontal lobe",
    "entities": [
      {
        "text": "39",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "was commonly affected among stroke patients (9.8%, n = 5). Additionally, a",
    "entities": [
      {
        "text": "9.8%",
        "label": "PERCENT"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant portion of patients without acute stroke findings exhibited chronic",
    "entities": []
  },
  {
    "text": "infarcts or ischemic changes (57.69%, n = 15).",
    "entities": [
      {
        "text": "57.69%",
        "label": "PERCENT"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: This study sheds light on the radiological patterns of CNS",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "involvement in COVID-19 patients, highlighting frequent frontal lobe involvement",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "possibly attributed to hypercoagulability and endotheliitis. Further research",
    "entities": []
  },
  {
    "text": "with larger sample sizes and MRI utilization is recommended to enhance our",
    "entities": []
  },
  {
    "text": "understanding of CNS manifestations in COVID-19. This study contributes to",
    "entities": [
      {
        "text": "CNS",
        "label": "ORG"
      },
      {
        "text": "COVID-19",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "understanding COVID-19 neurological sequelae, particularly in terms of",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "radiological patterns, among patients presenting with neurological symptoms. The",
    "entities": []
  },
  {
    "text": "findings highlight the need for comprehensive evaluation and management of",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: All authors declared no conflicts of interest.",
    "entities": []
  },
  {
    "text": "Dependence of mitochondrial dysfunction in peripheral blood mononuclear cells on",
    "entities": []
  },
  {
    "text": "cervicocephalic atherosclerotic burden in acute ischemic stroke.",
    "entities": [
      {
        "text": "cervicocephalic atherosclerotic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Xuanwu Hospital, Capital Medical University,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Xuanwu Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)National Clinical Research Center for Geriatric Disorders, Beijing, China.",
    "entities": [
      {
        "text": "Clinical Research Center for Geriatric Disorders",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Radiology, Xuanwu Hospital, Capital Medical University,",
    "entities": [
      {
        "text": "Xuanwu Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Center for Evidence-Based Medicine, Xuanwu Hospital, Capital Medical",
    "entities": [
      {
        "text": "Xuanwu Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Beijing, China.",
    "entities": [
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurobiology, Xuanwu Hospital, Capital Medical University,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Xuanwu Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Clinical Biobank, Xuanwu Hospital, Capital Medical University,",
    "entities": [
      {
        "text": "Clinical Biobank",
        "label": "ORG"
      },
      {
        "text": "Xuanwu Hospital",
        "label": "ORG"
      },
      {
        "text": "Capital Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "As an inflammatory disease, atherosclerosis is associated with acute ischemic",
    "entities": []
  },
  {
    "text": "stroke (AIS), but its early identification and intervention efficacy remain",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "suboptimal. A new research direction may be to explore peripheral",
    "entities": []
  },
  {
    "text": "atherosclerotic biomarkers from the perspective of mitochondrial dysfunction,",
    "entities": []
  },
  {
    "text": "which can induce inflammatory cell activation. Moreover, the degree of overall",
    "entities": []
  },
  {
    "text": "cervicocephalic atherosclerosis (namely, atherosclerotic burden) is more closely",
    "entities": []
  },
  {
    "text": "related to AIS prognosis than local atherosclerotic lesions. Therefore, this",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "study investigated the relationship between mitochondrial dysfunction in",
    "entities": []
  },
  {
    "text": "peripheral blood mononuclear cells (PBMCs), including monocytes and lymphocytes,",
    "entities": []
  },
  {
    "text": "and overall cervicocephalic atherosclerotic burden and AIS outcome. Patients",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with AIS and cervicocephalic atherosclerosis were enrolled and followed up for",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "90 days. The reactive oxygen species (ROS) and the mitochondrial",
    "entities": [
      {
        "text": "90 days",
        "label": "DATE"
      },
      {
        "text": "ROS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "deoxyribonucleic acid copy number (mtDNA-CN) in PBMCs were measured respectively",
    "entities": [
      {
        "text": "deoxyribonucleic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "through a fluorescence probe and a droplet digital polymerase chain reaction to",
    "entities": []
  },
  {
    "text": "evaluate mitochondrial function. The overall intracranial and cervical",
    "entities": []
  },
  {
    "text": "atherosclerotic burden (ICAB) was quantified by summing up the atherosclerosis",
    "entities": []
  },
  {
    "text": "degree points in each arterial segment as assessed by computed tomography",
    "entities": []
  },
  {
    "text": "angiography. A modified Rankin Scale (mRS) score >2 was considered a 90-day",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "unfavorable functional outcome. Five (4.9%) of the 103 patients with AIS were",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      },
      {
        "text": "4.9%",
        "label": "PERCENT"
      },
      {
        "text": "103",
        "label": "CARDINAL"
      },
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "lost to follow-up. mtDNA-CN [adjusted \u03b2 = -0.099, 95% confidence intervals (CIs)",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "= -0.153 \u223c -0.044, p < 0.001] and ROS content (adjusted \u03b2 = 1.275, 95%CI = 0.885",
    "entities": [
      {
        "text": "ROS",
        "label": "ORG"
      },
      {
        "text": "1.275",
        "label": "CARDINAL"
      },
      {
        "text": "0.885",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u223c 1.665, p < 0.001) were correlated with ICAB. The risk of a 90-day unfavorable",
    "entities": [
      {
        "text": "1.665",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "ICAB",
        "label": "ORG"
      },
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "functional outcome increased with higher ROS content [adjusted odds ratio (OR) =",
    "entities": [
      {
        "text": "ROS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.523, 95%CI = 1.172 \u223c 1.981, p = 0.002] and decreased with higher mtDNA-CN",
    "entities": [
      {
        "text": "1.523",
        "label": "CARDINAL"
      },
      {
        "text": "1.172",
        "label": "CARDINAL"
      },
      {
        "text": "1.981",
        "label": "CARDINAL"
      },
      {
        "text": "0.002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(adjusted OR = 0.911, 95%CI = 0.850 \u223c 0.976, p = 0.008). PBMC mitochondrial",
    "entities": [
      {
        "text": "0.911",
        "label": "CARDINAL"
      },
      {
        "text": "0.850",
        "label": "CARDINAL"
      },
      {
        "text": "0.976",
        "label": "CARDINAL"
      },
      {
        "text": "0.008",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "dysfunction was found to be independently associated with extensive and severe",
    "entities": []
  },
  {
    "text": "cervicocephalic atherosclerosis and a 90-day unfavorable functional outcome in",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients with AIS, which may provide a novel approach to improving the early",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "identification and risk stratification of cervicocephalic atherosclerosis, along",
    "entities": []
  },
  {
    "text": "with the prediction of the outcome of atherosclerotic AIS.",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025 Zhao, Yang, Du, Li, Hou, Cai and Ma.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Zhao",
        "label": "PERSON"
      },
      {
        "text": "Yang, Du",
        "label": "PERSON"
      },
      {
        "text": "Cai",
        "label": "PERSON"
      },
      {
        "text": "Ma",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The author(s) declared no potential conflicts of",
    "entities": []
  },
  {
    "text": "interest with respect to the research, authorship, and/or publication of this",
    "entities": []
  },
  {
    "text": "13. Brain Netw Disord. 2025 Jun;1(2):98-108. doi: 10.1016/j.bnd.2024.08.001. Epub",
    "entities": [
      {
        "text": "13",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1016/j.bnd.2024.08.001",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "Acute temporal lesions are associated with phonological word verification",
    "entities": []
  },
  {
    "text": "(1)Department of Neurology, Johns Hopkins University School of Medicine,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Otolaryngology, Loma Linda University School of Medicine, Loma",
    "entities": [
      {
        "text": "Otolaryngology",
        "label": "ORG"
      },
      {
        "text": "Loma Linda University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Loma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Radiology and Radiological Science, Johns Hopkins University",
    "entities": [
      {
        "text": "Radiology and Radiological Science",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Baltimore, MD, 21287, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "21287",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Speech-Language Pathology & Audiology, Towson University,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Speech-Language Pathology & Audiology",
        "label": "ORG"
      },
      {
        "text": "Towson University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Towson, MD, 21252, USA.",
    "entities": [
      {
        "text": "Towson",
        "label": "ORG"
      },
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "21252",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Communication Sciences and Disorders, University of South",
    "entities": [
      {
        "text": "Communication Sciences",
        "label": "ORG"
      },
      {
        "text": "Disorders, University of South\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Carolina Arnold School of Public Health, Columbia, SC, 29208, USA.",
    "entities": [
      {
        "text": "Carolina Arnold School of Public Health",
        "label": "ORG"
      },
      {
        "text": "Columbia",
        "label": "ORG"
      },
      {
        "text": "SC",
        "label": "ORG"
      },
      {
        "text": "29208",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Cognitive Sciences, Department of Language Science, University",
    "entities": [
      {
        "text": "Cognitive Sciences",
        "label": "ORG"
      },
      {
        "text": "Department of Language Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of California, Irvine, CA, 92697, USA.",
    "entities": [
      {
        "text": "California",
        "label": "GPE"
      },
      {
        "text": "Irvine",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "92697",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Within the dual stream model for language, the bilateral dorsal",
    "entities": []
  },
  {
    "text": "superior temporal gyrus (STG) is associated with spectro-temporal analysis while",
    "entities": []
  },
  {
    "text": "the mid-post superior temporal sulcus is associated with processing of",
    "entities": []
  },
  {
    "text": "higher-level phonological codes. However, the true lateralization of functions",
    "entities": []
  },
  {
    "text": "needed for phonological discrimination at the word level remains unsettled. The",
    "entities": []
  },
  {
    "text": "aim of the present work was to determine if individuals with acute stroke",
    "entities": []
  },
  {
    "text": "primarily involving the left STG and middle temporal gyrus (MTG) demonstrated",
    "entities": [
      {
        "text": "STG",
        "label": "ORG"
      },
      {
        "text": "MTG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "poorer discrimination (d') between phonologically related words in a",
    "entities": []
  },
  {
    "text": "word-picture verification task than those with left hemisphere lesions outside",
    "entities": []
  },
  {
    "text": "the temporal lobe and compared to those with right hemisphere stroke. The latter",
    "entities": []
  },
  {
    "text": "would support a left bias and provide an estimate of the magnitude.",
    "entities": []
  },
  {
    "text": "METHODS: One hundred fourteen individuals with acute stroke completed both acute",
    "entities": [
      {
        "text": "One hundred fourteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "magnetic resonance imaging and a word-picture verification task with",
    "entities": []
  },
  {
    "text": "phonological and semantic foils. Eighty-nine participants had left hemisphere",
    "entities": [
      {
        "text": "Eighty-nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stroke (51 included the temporal lobe). Twenty participants had right hemisphere",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      },
      {
        "text": "Twenty",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stroke (14 included the temporal lobe). Five participants with bilateral stroke",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "Five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were included (3 included the bilateral temporal lobes). Quantile regression was",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "performed controlling for overall lesion volume, age, and sex.",
    "entities": []
  },
  {
    "text": "RESULTS: While more than half of patients performed the task well, patients with",
    "entities": [
      {
        "text": "more than half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "left temporal lobe lesions were more likely to perform poorly.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: These results confirm a role for the left superior temporal lobe,",
    "entities": []
  },
  {
    "text": "including the STG, in phonological processing during word recognition, and",
    "entities": [
      {
        "text": "STG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "indicate that a subset of individuals (<50%) have varying degrees of left bias",
    "entities": [
      {
        "text": "50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "in discrimination of phonologically similar words in the STG.",
    "entities": [
      {
        "text": "STG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest The authors",
    "entities": []
  },
  {
    "text": "declare that they have no known competing financial interests or personal",
    "entities": []
  },
  {
    "text": "relationships that could have appeared to influence the work reported in this",
    "entities": []
  },
  {
    "text": "Editorial: Women in radiology: neuroimaging and neurotechnology.",
    "entities": []
  },
  {
    "text": "(1)College of Health and Life Sciences, London South Bank University, London,",
    "entities": [
      {
        "text": "Health and Life Sciences",
        "label": "ORG"
      },
      {
        "text": "London South Bank University",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "United Kingdom.",
    "entities": [
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Translational Neuroscience and Stroke, Queen Square Institute",
    "entities": [
      {
        "text": "Translational Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Stroke, Queen Square Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Neurology, University College London, London, United Kingdom.",
    "entities": [
      {
        "text": "Neurology, University College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)TU London, Teesside University London, London, United Kingdom.",
    "entities": [
      {
        "text": "3)TU",
        "label": "CARDINAL"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "Teesside University London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Lysholm Department of Neuroradiology, National Hospital for Neurology and",
    "entities": [
      {
        "text": "Department of Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "National Hospital for Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Neurosurgery, University College London Hospitals NHS Foundation Trust, London,",
    "entities": [
      {
        "text": "University College London Hospitals NHS Foundation Trust",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Late-onset ornithine transcarbamylase deficiency mimicking cognitive, behavioral",
    "entities": []
  },
  {
    "text": "and gait disorders: a case report and literature review.",
    "entities": []
  },
  {
    "text": "(1)Neurology and Stroke Department, St. Adalbert Hospital, Gdansk, Poland.",
    "entities": [
      {
        "text": "Stroke Department",
        "label": "ORG"
      },
      {
        "text": "St. Adalbert Hospital",
        "label": "ORG"
      },
      {
        "text": "Gdansk",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Intensive Care Unit, St. Adalbert Hospital, Gdansk, Poland.",
    "entities": [
      {
        "text": "Care Unit",
        "label": "ORG"
      },
      {
        "text": "St. Adalbert Hospital",
        "label": "ORG"
      },
      {
        "text": "Gdansk",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurological-Psychiatric Nursing, Faculty of Health Sciences,",
    "entities": [
      {
        "text": "Faculty of Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical University of Gdansk, Poland.",
    "entities": [
      {
        "text": "Medical University of Gdansk",
        "label": "ORG"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Progressive cognitive disorders are not always caused primarily by",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurodegenerative diseases. This case report emphasizes the importance of taking",
    "entities": []
  },
  {
    "text": "rare metabolic disorders into consideration in the differential diagnosis in",
    "entities": [
      {
        "text": "rare metabolic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "patients of all ages. It also shows the possible risk of corticosteroids in the",
    "entities": []
  },
  {
    "text": "treatment of unexplained neurological symptoms.",
    "entities": []
  },
  {
    "text": "CASE DESCRIPTION: We report on the case of a 60-year-old female who presented",
    "entities": [
      {
        "text": "DESCRIPTION",
        "label": "PERSON"
      },
      {
        "text": "60-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mild dementia with progression and fluctuations for the last 5 years, scanning",
    "entities": [
      {
        "text": "the last 5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "speech and wide-base gait. Due to a significantly elevated level of anti-thyroid",
    "entities": []
  },
  {
    "text": "thyroiditis (STREAT) was suspected and steroids were administered. This was a",
    "entities": [
      {
        "text": "thyroiditis",
        "label": "PERSON"
      },
      {
        "text": "STREAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "trigger factor for the patient developing coma with severe hyperammonemia.",
    "entities": []
  },
  {
    "text": "Consequent genetic testing identified a pathogenic variant of the OTC (ornithine",
    "entities": []
  },
  {
    "text": "COMMENT: Late-onset ornithine transcarbamylase deficiency can be a rare cause of",
    "entities": []
  },
  {
    "text": "cognitive impairment. It is reasonable to determine the level of ammonia in",
    "entities": []
  },
  {
    "text": "patients with non-specific symptoms, as hyperammonemia can cause permanent brain",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Institute of Psychiatry and Neurology.",
    "entities": [
      {
        "text": "Institute of Psychiatry and Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Absent.",
    "entities": []
  },
  {
    "text": "Anti-LGI1-antibody autoimmune encephalitis as a neurological paraneoplastic",
    "entities": [
      {
        "text": "Anti-LGI1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "syndrome associated with gastrointestinal stromal tumour: a case report.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurology and Stroke, University Clinical Hospital 2 of Medical",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Stroke, University Clinical Hospital 2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Lodz, Poland.",
    "entities": [
      {
        "text": "University of Lodz",
        "label": "ORG"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology and Faculty of Health Science, Mazovian \"Br\u00f3dnowski\"",
    "entities": [
      {
        "text": "Neurology and Faculty of Health Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Warsaw, Poland.",
    "entities": [
      {
        "text": "Warsaw",
        "label": "GPE"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Medical University of Warsaw, Poland.",
    "entities": [
      {
        "text": "University of Warsaw",
        "label": "ORG"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Extrapyramidal Diseases, Central Teaching Hospital of Medical",
    "entities": [
      {
        "text": "Extrapyramidal Diseases",
        "label": "ORG"
      },
      {
        "text": "Central Teaching Hospital of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Medical University of Lodz, Poland.",
    "entities": [
      {
        "text": "University of Lodz",
        "label": "ORG"
      },
      {
        "text": "Poland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: The aim of the case is to present the significance of a thorough",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "analysis of the cases of patients with newly developed memory disorders",
    "entities": []
  },
  {
    "text": "accompanied by epileptic seizures.",
    "entities": []
  },
  {
    "text": "CASE DESCRIPTION: We present a case of a 61-year-old male patient who was",
    "entities": [
      {
        "text": "DESCRIPTION",
        "label": "PERSON"
      },
      {
        "text": "61-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "admitted to the hospital due to unexplained memory disorders and seizures.",
    "entities": []
  },
  {
    "text": "Further examination showed the presence of anti-LGI1 (leucine-rich",
    "entities": [
      {
        "text": "anti-LGI1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "glioma-inactivated 1) antibodies. Computed tomography of the abdominal cavity",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "revealed a mass located between the stomach and the spleen. Histopathological",
    "entities": []
  },
  {
    "text": "examination identified the mass as a gastrointestinal tumour (GIST). After the",
    "entities": []
  },
  {
    "text": "surgical removal of the tumour the symptoms were significantly reduced. The",
    "entities": []
  },
  {
    "text": "early diagnosis and treatment of the tumour contributed to favourable",
    "entities": []
  },
  {
    "text": "neurological and oncological outcomes for the patient.",
    "entities": []
  },
  {
    "text": "COMMENT: Paraneoplastic neurological syndrome is a clinical condition in which",
    "entities": []
  },
  {
    "text": "the functioning of the nervous system is impaired, not resulting from local",
    "entities": []
  },
  {
    "text": "tumour growth or metastases. The currently recognized underlaying mechanism of",
    "entities": []
  },
  {
    "text": "this condition is an autoimmune reaction occurring in the patient's body. In",
    "entities": []
  },
  {
    "text": "response to the presence of tumour, the antibodies called onconeural antibodies",
    "entities": []
  },
  {
    "text": "are produced, which are then directed against antigens present on the nervous",
    "entities": []
  },
  {
    "text": "system cells. To the best of our knowledge this is the first and so far only",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "syndrome associated with GIST.",
    "entities": [
      {
        "text": "GIST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.1016/j.ijcha.2025.101736. eCollection 2025 Aug.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      },
      {
        "text": "2025 Aug.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Can TAVI be performed without on-site cardiac surgery?",
    "entities": []
  },
  {
    "text": "(1)Department of Cardiac Surgery, Azienda Ospedaliera Ordine Mauriziano, Turin,",
    "entities": [
      {
        "text": "Cardiac Surgery",
        "label": "ORG"
      },
      {
        "text": "Ordine Mauriziano",
        "label": "PERSON"
      },
      {
        "text": "Turin",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Italy.",
    "entities": [
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)University of Turin, Department of Cardiovascular and Thoracic Surgery,",
    "entities": [
      {
        "text": "Turin, Department of Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Thoracic Surgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Turin, Italy.",
    "entities": [
      {
        "text": "Turin",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Aim of this analysis in to assess the prevalence and",
    "entities": [
      {
        "text": "Aim",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "post-procedural outcomes of surgical bailout during transcatheter aortic valve",
    "entities": []
  },
  {
    "text": "implantation (TAVI).",
    "entities": []
  },
  {
    "text": "METHODS: Patients undergoing TAVI from September 2017 to March 2023 were",
    "entities": [
      {
        "text": "September 2017 to March 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "enrolled from two high volume centers. All the procedures were performed with",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "on-site cardiac surgery, but especially the scrubbed cardiac surgeon. The",
    "entities": []
  },
  {
    "text": "primary endpoint was in-hospital mortality of TAVI patients after emergent",
    "entities": []
  },
  {
    "text": "cardiac surgery (ECS). Secondary endpoints were intra-operative and 1-year",
    "entities": [
      {
        "text": "ECS",
        "label": "ORG"
      },
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mortality, and post-procedural complications such as acute kidney injury (AKI),",
    "entities": []
  },
  {
    "text": "stroke, myocardial infarction (MI), conduction abnormalities, need for inotropic",
    "entities": []
  },
  {
    "text": "support and intensive care unit (ICU) and in- hospital length of stay.",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 1347 consecutive patients underwent transfemoral TAVI. Ten",
    "entities": [
      {
        "text": "1347",
        "label": "DATE"
      },
      {
        "text": "Ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients (0.74 %), representing the study population, reported intra-procedural",
    "entities": [
      {
        "text": "0.74 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "complications requiring ECS: seven patients received a self-expandable",
    "entities": [
      {
        "text": "ECS",
        "label": "ORG"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "prosthesis; three patients received a balloon expandable prosthesis. Indications",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for ECS included: type A dissection (n = 2), aortic annulus rupture (n = 1),",
    "entities": [
      {
        "text": "ECS",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "left(n = 1) and right (n = 2) ventricle perforation, mitral valve apparatus",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "damage (n = 2), prosthesis embolization (n = 2). Four patients required",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "Four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "post-operative inotropic support. One case of minor stroke and one case of AKI",
    "entities": [
      {
        "text": "One",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "AKI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(grade III) were reported. Three patients developed a post procedural left",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "bundle branch block (LBBB). Median ICU and hospital length-of-stay were 4.5",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "4.5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(2-7.75) days and 14 (8-22) days, respectively. One case of in-hospital",
    "entities": [
      {
        "text": "2-7.75",
        "label": "DATE"
      },
      {
        "text": "days",
        "label": "DATE"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "8-22) days",
        "label": "DATE"
      },
      {
        "text": "One",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mortality was reported.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The on-site cardiac surgery, with the scrubbed heart surgeon,",
    "entities": []
  },
  {
    "text": "represents a life-saving resource for TAVI centers in case of ECS, and it is",
    "entities": [
      {
        "text": "ECS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "essential to achieve low-rate in-hospital mortality.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Authors.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no known",
    "entities": []
  },
  {
    "text": "competing financial interests or personal relationships that could have appeared",
    "entities": []
  },
  {
    "text": "to influence the work reported in this paper.",
    "entities": []
  },
  {
    "text": "Enhancing Patient Care Through Improved Escalation Planning and Documentation: A",
    "entities": []
  },
  {
    "text": "Quality Improvement Project at a District General Hospital.",
    "entities": [
      {
        "text": "Quality Improvement Project",
        "label": "ORG"
      },
      {
        "text": "District General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Maqsood R(1), Aziz M(2), Hartley K(2), Hassan T(3), Ijaz S(4), Ahmad H(2), Sreh",
    "entities": [
      {
        "text": "Maqsood R(1",
        "label": "PRODUCT"
      },
      {
        "text": "Aziz",
        "label": "PERSON"
      },
      {
        "text": "M(2",
        "label": "CARDINAL"
      },
      {
        "text": "Hartley K(2",
        "label": "PERSON"
      },
      {
        "text": "Hassan T(3",
        "label": "PERSON"
      },
      {
        "text": "Ahmad",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Internal Medicine, Doncaster & Bassetlaw Teaching Hospitals NHS Foundation",
    "entities": [
      {
        "text": "Medicine, Doncaster & Bassetlaw Teaching Hospitals NHS Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Trust, Doncaster, GBR.",
    "entities": []
  },
  {
    "text": "(2)Stroke, Doncaster Royal Infirmary, Doncaster, GBR.",
    "entities": [
      {
        "text": "Doncaster Royal",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Gastroenterology and Hepatology, Sheffield Teaching Hospital, Sheffield, GBR.",
    "entities": [
      {
        "text": "Hepatology",
        "label": "ORG"
      },
      {
        "text": "Sheffield Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "Sheffield",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Emergency Medicine, Sheffield Teaching Hospital, Sheffield, GBR.",
    "entities": [
      {
        "text": "Medicine, Sheffield Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "Sheffield",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Gastroenterology, Sheffield Teaching Hospital, Sheffield, GBR.",
    "entities": [
      {
        "text": "Sheffield Teaching Hospital",
        "label": "ORG"
      },
      {
        "text": "Sheffield",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Introduction Clear escalation plans are critical to patient safety, particularly",
    "entities": []
  },
  {
    "text": "during periods of out-of-hours work. This is supported by guidance developed by",
    "entities": []
  },
  {
    "text": "the Royal College of Physicians, which states that all patients should have an",
    "entities": [
      {
        "text": "the Royal College of Physicians",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "escalation plan documented. Despite this, documentation is often inconsistent",
    "entities": []
  },
  {
    "text": "due to the complexity and time-consuming nature of these decisions.",
    "entities": []
  },
  {
    "text": "Nevertheless, accessibility to this information is imperative for effective",
    "entities": []
  },
  {
    "text": "handover between clinical teams and contributes towards delivering safe patient",
    "entities": []
  },
  {
    "text": "care. Methods The Plan-Do-Study-Act (PDSA) cycle methodology was used. Thirty",
    "entities": [
      {
        "text": "Thirty",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patient notes were reviewed to assess the clarity of documentation regarding do",
    "entities": []
  },
  {
    "text": "not attempt cardiopulmonary resuscitation (DNAR) decisions, escalation planning,",
    "entities": []
  },
  {
    "text": "and weekend handover. Based on these findings, a standardised proforma was",
    "entities": []
  },
  {
    "text": "developed to evaluate the impact of the intervention on clinical practice.",
    "entities": []
  },
  {
    "text": "Subsequent PDSA cycles were implemented across the Gastroenterology ward.",
    "entities": []
  },
  {
    "text": "Results Following the introduction of the proforma, there were significant",
    "entities": []
  },
  {
    "text": "improvements in the quality of documentation. DNAR documentation increased from",
    "entities": []
  },
  {
    "text": "47% to 90%, escalation planning improved from 23% to 81%, and weekend handover",
    "entities": [
      {
        "text": "47% to 90%",
        "label": "PERCENT"
      },
      {
        "text": "23% to 81%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "documentation rose from 47% to 100%. Conclusion The use of a standardised",
    "entities": [
      {
        "text": "47% to 100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "proforma improved the documentation and handover of patients in the",
    "entities": []
  },
  {
    "text": "Gastroenterology ward. This project demonstrated the positive impact of using a",
    "entities": []
  },
  {
    "text": "structured format to record key clinical information, thereby contributing to",
    "entities": []
  },
  {
    "text": "safer patient care. As a result, the proforma has been adopted by other wards",
    "entities": []
  },
  {
    "text": "within the hospital.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025, Maqsood et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Maqsood et al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: All authors have confirmed that",
    "entities": []
  },
  {
    "text": "this study did not involve human participants or tissue. Animal subjects: All",
    "entities": []
  },
  {
    "text": "authors have confirmed that this study did not involve animal subjects or",
    "entities": []
  },
  {
    "text": "tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "form, all authors declare the following: Payment/services info: All authors have",
    "entities": []
  },
  {
    "text": "declared that no financial support was received from any organization for the",
    "entities": []
  },
  {
    "text": "submitted work. Financial relationships: All authors have declared that they",
    "entities": []
  },
  {
    "text": "have no financial relationships at present or within the previous three years",
    "entities": [
      {
        "text": "the previous three years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with any organizations that might have an interest in the submitted work. Other",
    "entities": []
  },
  {
    "text": "relationships: All authors have declared that there are no other relationships",
    "entities": []
  },
  {
    "text": "or activities that could appear to have influenced the submitted work.",
    "entities": []
  },
  {
    "text": "Cerebellar Infarction Diagnosed by the 'Hyperdense Sign' on Plain CT.",
    "entities": [
      {
        "text": "Cerebellar Infarction Diagnosed",
        "label": "ORG"
      },
      {
        "text": "Plain CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Emergency and Critical Care Medicine, Wakayama Medical",
    "entities": [
      {
        "text": "Emergency and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "Wakayama Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Wakayama, JPN.",
    "entities": [
      {
        "text": "Wakayama",
        "label": "GPE"
      },
      {
        "text": "JPN",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "We hereby present a case of thrombus or possible vertebral artery dissection",
    "entities": []
  },
  {
    "text": "(VAD), but no confirmatory evidence in a young adult male, diagnosed using an",
    "entities": []
  },
  {
    "text": "unusual but pivotal imaging clue, the \"dense vertebral artery sign\" observed on",
    "entities": []
  },
  {
    "text": "non-contrast computed tomography (CT). This finding led to the initial suspicion",
    "entities": []
  },
  {
    "text": "and subsequent confirmation of VAD. This report underscores the diagnostic value",
    "entities": [
      {
        "text": "VAD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of subtle vascular signs on plain CT imaging that are frequently overlooked but",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "can result in prompt and life-saving intervention. This report is of particular",
    "entities": []
  },
  {
    "text": "significance in emergency settings, where advanced imaging modalities such as",
    "entities": []
  },
  {
    "text": "MRI and CT angiography may not be readily available.",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Human subjects: Informed consent for treatment",
    "entities": []
  },
  {
    "text": "and open access publication was obtained or waived by all participants in this",
    "entities": []
  },
  {
    "text": "study. Conflicts of interest: In compliance with the ICMJE uniform disclosure",
    "entities": [
      {
        "text": "ICMJE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "STRAUMA Code: The Systematic Approach to Simultaneous Stroke and Trauma",
    "entities": [
      {
        "text": "Simultaneous Stroke",
        "label": "PERSON"
      },
      {
        "text": "Trauma\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Assessment - Strengthening the \"Stroke-Trauma\" Chain of Survival.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency Medicine, Singapore General Hospital, Singapore.",
    "entities": [
      {
        "text": "Emergency Medicine",
        "label": "ORG"
      },
      {
        "text": "Singapore General Hospital",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Florida State University College of Medicine Emergency Medicine Residency",
    "entities": [
      {
        "text": "2)Florida State University College of Medicine Emergency Medicine Residency",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: In clinical practice, it is common to see stroke and trauma",
    "entities": []
  },
  {
    "text": "simultaneously in the same patient. When such a patient presents to the",
    "entities": []
  },
  {
    "text": "emergency department (ED), rapid assessment must be done to adequately manage",
    "entities": []
  },
  {
    "text": "both conditions. As the assessment will cover a significant number of steps and",
    "entities": []
  },
  {
    "text": "tasks to be accomplished, it may prove challenging, especially for a novice",
    "entities": []
  },
  {
    "text": "practitioner. As a result, key diagnostic signs may be missed or overlooked.",
    "entities": []
  },
  {
    "text": "This may cause nondiagnosis, misdiagnosis, or delay in the handling of",
    "entities": []
  },
  {
    "text": "time-dependent diagnoses (e.g. thrombolytic therapy decision for stroke and",
    "entities": []
  },
  {
    "text": "recognition of early shock in trauma). Therefore, the need for a comprehensive",
    "entities": []
  },
  {
    "text": "approach to the management of the patient who has simultaneous acute stroke and",
    "entities": []
  },
  {
    "text": "trauma is needed.",
    "entities": []
  },
  {
    "text": "METHODS: We propose the Stroke-Trauma (STRAUMA) Code framework for use in the ED",
    "entities": [
      {
        "text": "the Stroke-Trauma (STRAUMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and by first-line healthcare staff. We used a trans-continental approach by",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "testing our proposed STRAUMA framework at two centers: in the Department of",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "the Department of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Emergency Medicine at Singapore General Hospital in Singapore and in the",
    "entities": [
      {
        "text": "Singapore General Hospital",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Emergency Care Center at Sarasota Memorial Hospital in Sarasota, Florida, USA.",
    "entities": [
      {
        "text": "Emergency Care Center",
        "label": "ORG"
      },
      {
        "text": "Sarasota Memorial Hospital",
        "label": "FAC"
      },
      {
        "text": "Sarasota",
        "label": "GPE"
      },
      {
        "text": "Florida",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: Both teams agreed that the new proposed STRAUMA Code framework is",
    "entities": []
  },
  {
    "text": "systematic, structured, and organized thus making it easier to apply in the",
    "entities": []
  },
  {
    "text": "CONCLUSION: A structured approach to manage the more complex cases presenting to",
    "entities": []
  },
  {
    "text": "the ED is useful so as not to miss important and often critical information and",
    "entities": [
      {
        "text": "ED",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "steps which will affect patient management as well as outcomes.",
    "entities": []
  },
  {
    "text": "Copyright: \u00a9 2025 Journal of Emergencies, Trauma, and Shock.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Journal of Emergencies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There are no conflicts of interest.",
    "entities": []
  },
  {
    "text": "Clinical characteristics and risk factors for perinatal arterial ischemic and",
    "entities": []
  },
  {
    "text": "hemorrhagic stroke: a comparative study.",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Neonatology, Maternal and Child Health Hospital of Hubei",
    "entities": [
      {
        "text": "Neonatology",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Province, Tongji Medical College, Huazhong University of Science and Technology,",
    "entities": [
      {
        "text": "Tongji Medical College",
        "label": "ORG"
      },
      {
        "text": "Huazhong University of Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatric Neurology, Maternal and Child Health Hospital of",
    "entities": [
      {
        "text": "Pediatric Neurology",
        "label": "ORG"
      },
      {
        "text": "Maternal and Child Health Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hubei Province, Tongji Medical College, Huazhong University of Science and",
    "entities": [
      {
        "text": "Hubei Province",
        "label": "GPE"
      },
      {
        "text": "Tongji Medical College",
        "label": "ORG"
      },
      {
        "text": "Huazhong University of Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Technology, Wuhan, China.",
    "entities": [
      {
        "text": "Wuhan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Perinatal cerebral infarction (PCI) is a common cause of",
    "entities": []
  },
  {
    "text": "neurological complications in neonates. This study aimed to compare the clinical",
    "entities": []
  },
  {
    "text": "characteristics and risk factors of perinatal arterial ischemic stroke (PAIS)",
    "entities": []
  },
  {
    "text": "and perinatal hemorrhagic stroke (PHS) to inform early recognition and",
    "entities": []
  },
  {
    "text": "intervention strategies.",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a retrospective analysis of 124 neonates diagnosed with",
    "entities": [
      {
        "text": "124",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PCI, admitted to the neonatal intensive care unit (NICU) between June 2015 and",
    "entities": [
      {
        "text": "PCI",
        "label": "ORG"
      },
      {
        "text": "NICU",
        "label": "ORG"
      },
      {
        "text": "between June 2015",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "December 2023. The neonates were divided into two groups-PAIS and PHS-based on",
    "entities": [
      {
        "text": "December 2023",
        "label": "DATE"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "PHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clinical symptoms and cranial imaging findings.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the 124 patients, 87 (70.2%) were diagnosed with PAIS, while 37",
    "entities": [
      {
        "text": "124",
        "label": "CARDINAL"
      },
      {
        "text": "87",
        "label": "DATE"
      },
      {
        "text": "70.2%",
        "label": "PERCENT"
      },
      {
        "text": "PAIS",
        "label": "ORG"
      },
      {
        "text": "37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(29.8%) had PHS. Clonic seizures were observed in 78 cases (62.9%), with apnoea",
    "entities": [
      {
        "text": "29.8%",
        "label": "PERCENT"
      },
      {
        "text": "78",
        "label": "CARDINAL"
      },
      {
        "text": "62.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "noted in 11 cases (12.6%) within the PAIS group and jaundice in 8 cases (21.6%)",
    "entities": [
      {
        "text": "11",
        "label": "CARDINAL"
      },
      {
        "text": "12.6%",
        "label": "PERCENT"
      },
      {
        "text": "PAIS",
        "label": "ORG"
      },
      {
        "text": "8",
        "label": "CARDINAL"
      },
      {
        "text": "21.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "within the PHS group. Lesions were primarily located in the left cerebral",
    "entities": [
      {
        "text": "PHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hemisphere in 53 cases (41.4%), whereas PHS lesions frequently involved the",
    "entities": [
      {
        "text": "53",
        "label": "CARDINAL"
      },
      {
        "text": "41.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "thalamus and basal ganglia (12 cases, 32.4%). Statistical analysis revealed",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "32.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "significant differences in risk factors between the PAIS and PHS groups. The",
    "entities": [
      {
        "text": "PAIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PAIS group had a higher rate of conversion from failed trial of labor to",
    "entities": []
  },
  {
    "text": "cesarean section compared to the PHS group (P = 0.012). Additionally, postnatal",
    "entities": [
      {
        "text": "PHS",
        "label": "ORG"
      },
      {
        "text": "0.012",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "thrombocytopenia was more commonly associated with the PHS group than the PAIS",
    "entities": [
      {
        "text": "PHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group (P = 0.034).",
    "entities": [
      {
        "text": "0.034",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our findings indicate that PAIS is more prevalent within the",
    "entities": [
      {
        "text": "PAIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "studied population, with a notable correlation between failed labor trials",
    "entities": []
  },
  {
    "text": "resulting in cesarean sections and the incidence of PAIS. This suggests a",
    "entities": [
      {
        "text": "PAIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potential link between complications during labor and the occurrence of ischemic",
    "entities": []
  },
  {
    "text": "strokes. In contrast, postnatal thrombocytopenia was found to be significantly",
    "entities": []
  },
  {
    "text": "more common in the PHS group, indicating a possible association between low",
    "entities": [
      {
        "text": "PHS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "platelet counts and hemorrhagic strokes.",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DOI: 10.3389/fped.2025.1540173",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "2025 Jan-Dec.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Jan-Dec.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Subclavian Artery-Internal Carotid Artery Bypass Using a Radial Artery Graft for",
    "entities": [
      {
        "text": "Subclavian Artery-Internal Carotid Artery Bypass Using a Radial Artery Graft",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Common Carotid Artery Occlusion with Immediate Improvement of Cognitive",
    "entities": [
      {
        "text": "Immediate Improvement of Cognitive",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Function: A Case Report.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurosurgery, Graduate School of Medical Science, Kanazawa",
    "entities": [
      {
        "text": "Neurosurgery, Graduate School of Medical Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Kanazawa, Japan.",
    "entities": [
      {
        "text": "Kanazawa",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Although rare, common carotid artery occlusion (CCAO) causes",
    "entities": [
      {
        "text": "CCAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ischemic neurological dysfunction, which can be treated by revascularization.",
    "entities": []
  },
  {
    "text": "Although several bypass approaches for CCAO have been suggested, no consensus on",
    "entities": [
      {
        "text": "CCAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the surgical revascularization approach and its functional outcome have been",
    "entities": []
  },
  {
    "text": "reached. Herein, we present a case of Rile's type 1A CCAO in which a subclavian",
    "entities": [
      {
        "text": "Rile",
        "label": "PERSON"
      },
      {
        "text": "CCAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "artery (SclA)-internal carotid artery (ICA) bypass using a radial artery graft",
    "entities": [
      {
        "text": "ICA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(RAG) resulted in immediate recovery of cognitive function and successfully",
    "entities": []
  },
  {
    "text": "prevented ischemic stroke.",
    "entities": []
  },
  {
    "text": "CASE DESCRIPTION: A 58-year-old man presented with recurrent episodes of",
    "entities": [
      {
        "text": "DESCRIPTION",
        "label": "PERSON"
      },
      {
        "text": "58-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "right-sided weakness. Brain magnetic resonance imaging revealed multiple",
    "entities": []
  },
  {
    "text": "cerebral infarcts. Digital subtraction angiography confirmed left CCAO and no",
    "entities": [
      {
        "text": "CCAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anterograde blood flow in the left ICA and ipsilateral external carotid artery.",
    "entities": [
      {
        "text": "ICA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "A bypass was performed from the left SclA to the left cervical ICA using a left",
    "entities": [
      {
        "text": "ICA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RAG, and supraclavicular anastomosis between the SclA and ICA was performed",
    "entities": [
      {
        "text": "RAG",
        "label": "ORG"
      },
      {
        "text": "SclA",
        "label": "ORG"
      },
      {
        "text": "ICA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "without graft-vessel kinking. Postoperatively, no neurological deficits were",
    "entities": []
  },
  {
    "text": "observed, and his cognitive function was successfully improved.",
    "entities": []
  },
  {
    "text": "CONCLUSION: SclA-ICA bypass using an RAG can be a reasonable treatment option",
    "entities": []
  },
  {
    "text": "for CCAO. CCAO revascularization can prevent ischemic stroke and improve",
    "entities": [
      {
        "text": "CCAO",
        "label": "ORG"
      },
      {
        "text": "CCAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). Published by S. Karger AG, Basel.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "S. Karger AG",
        "label": "ORG"
      },
      {
        "text": "Basel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors have no conflicts of interest to",
    "entities": []
  },
  {
    "text": "Gaps in Artificial Intelligence Research for Rural Health in the United States:",
    "entities": [
      {
        "text": "Artificial Intelligence Research for Rural Health",
        "label": "ORG"
      },
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "A Scoping Review.",
    "entities": []
  },
  {
    "text": "Brown KE, Davis SE.",
    "entities": [
      {
        "text": "Davis SE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Artificial intelligence (AI) has impacted healthcare at urban and",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "academic medical centers globally. The current focus on AI deployments in urban",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "areas and the history of US urban-rural digital divides raises concerns that the",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "promise of AI may not be realized in rural communities. This may exacerbate",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "well-documented health disparities. Without the benefits of AI-driven",
    "entities": []
  },
  {
    "text": "improvements in patient outcomes and increased efficiency, rural healthcare",
    "entities": []
  },
  {
    "text": "facilities may fall farther behind their urban counterparts and rural hospital",
    "entities": []
  },
  {
    "text": "METHODS: We conducted a scoping review following the PRISMA guidelines. We",
    "entities": [
      {
        "text": "PRISMA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "included peer-reviewed, original research studies indexed in PubMed, Embase, and",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "WebOfScience after January 1, 2010 and through April 29, 2025. Studies were",
    "entities": [
      {
        "text": "January 1, 2010",
        "label": "DATE"
      },
      {
        "text": "April 29, 2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "required to discuss the development, implementation, or evaluation of AI tools",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in rural US healthcare, including frameworks that help facilitate AI development",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "FINDINGS: Our search strategy found 26 studies meeting inclusion criteria after",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "full text screening with 14 papers discussing predictive AI models and 12 papers",
    "entities": [
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "discussing data or research infrastructure. AI models most commonly targeted",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resource allocation and distribution. Few studies explored model deployment and",
    "entities": []
  },
  {
    "text": "impact. Half noted the lack of data and analytic resources as a limitation to",
    "entities": [
      {
        "text": "Half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "both development and validation. None of the studies discussed examples of",
    "entities": []
  },
  {
    "text": "generative AI being trained, evaluated, or deployed in a rural setting.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTERPRETATION: Practical limitations may be influencing and limiting the types",
    "entities": []
  },
  {
    "text": "of AI models evaluated in the rural US. We noted validation of tools in the",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "rural US was underwhelming, and ultimately, neglected. With few studies moving",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "beyond AI model design and development stages, there is a clear gap in our",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "understanding of how to reliably validate, deploy, and sustain AI models in",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rural settings to advance health in all communities.",
    "entities": []
  },
  {
    "text": "FUNDING: National Library of Medicine.",
    "entities": []
  },
  {
    "text": "RESEARCH IN CONTEXT: Evidence before this study: Clinical artificial",
    "entities": []
  },
  {
    "text": "intelligence (AI)-both for prediction modeling and generative tools- tools",
    "entities": []
  },
  {
    "text": "promise to reduce care delays, improve diagnosis and treatment decision-making,",
    "entities": []
  },
  {
    "text": "reduce care costs, and improve efficiency to reduce provider workload and",
    "entities": []
  },
  {
    "text": "enhance practice management. Unfortunately, efforts to deploy artificial",
    "entities": []
  },
  {
    "text": "intelligence (AI)-both for prediction modeling and generative tools-in",
    "entities": []
  },
  {
    "text": "healthcare are advancing, primarily at large academic medical centers and in",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "urban areas. An emerging new digital divide in the use of clinical AI could",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exacerbate the well-documented health disparities between urban and rural",
    "entities": []
  },
  {
    "text": "communities in the United States. A better understanding of if and how AI is",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "being developed, deployed, and evaluated across rural US communities is",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "necessary to identify resources gaps and challenges to broad AI use in all",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "communities.Added value of this study: This study analyzes the current state of",
    "entities": []
  },
  {
    "text": "artificial intelligence research in the rural United States. For predictive AI",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      },
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "models, applications most commonly targeted resource allocation and",
    "entities": []
  },
  {
    "text": "distribution. We noted several attempts to predict resource utilization of",
    "entities": []
  },
  {
    "text": "patients who were either tested or tested positive to COVID-19. However, we",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "noted few AI solutions for acute medical events faced by rural patients, such as",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "trauma and stroke, despite worse outcomes for rural patients suffering from",
    "entities": []
  },
  {
    "text": "these acute events. The limited availability of time-critical specialties such",
    "entities": []
  },
  {
    "text": "as trauma/emergency medicine, neurology, and cardiology in rural areas often",
    "entities": []
  },
  {
    "text": "necessitates patients with such conditions be transferred to larger, more",
    "entities": []
  },
  {
    "text": "resourced hospitals. Practical limitations may be influencing and limiting the",
    "entities": []
  },
  {
    "text": "types of AI models evaluated in rural US medical facilities. The most frequent",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      },
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "model employed were tree-based ensembles, such as random forests and",
    "entities": []
  },
  {
    "text": "gradient-boosting trees. Our review also highlighted few studies of AI models",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "moving beyond the design and develop stages, leaving a clear gap in our",
    "entities": []
  },
  {
    "text": "understanding of how to deploy and sustain predictive AI models in rural",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "settings. Several challenges noted in the reviewed studies may provide insight",
    "entities": []
  },
  {
    "text": "into this lack of translation from research to implementation. We note that",
    "entities": []
  },
  {
    "text": "validation of A tools in the rural US was underwhelming, and ultimately,",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "neglected. The most common form of model validation employed was a single random",
    "entities": []
  },
  {
    "text": "holdout test set. Half of the included papers mentioned a lack of reliable data",
    "entities": [
      {
        "text": "Half",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "sources or limited data volume as a potential challenge in developing and",
    "entities": []
  },
  {
    "text": "adopting AI/ML tools. The use of patient-level EHR data was often limited to",
    "entities": [
      {
        "text": "AI/ML",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "what was available to the authors or at a specific medical center.Implications",
    "entities": []
  },
  {
    "text": "of all the available evidence: Our review indicates a gap and highlights",
    "entities": []
  },
  {
    "text": "opportunity for innovation in leveraging AI tools to predict and support",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients in rural communities. Further research is needed to enhance the",
    "entities": []
  },
  {
    "text": "translation of state-of-the-art modeling techniques into effective AI tools for",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "use in the rural US, including exploring partnerships between academic medical",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "centers and rural communities and solutions to logistic challenges of such",
    "entities": []
  },
  {
    "text": "partnerships, including data and resource sharing.",
    "entities": []
  },
  {
    "text": "Wearable Myoelectric Interface for Neurorehabilitation (MINT) to Recover Arm",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      },
      {
        "text": "Recover Arm\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Function: a Randomized Controlled Trial.",
    "entities": []
  },
  {
    "text": "S, Seo G, Houskamp EJ, Lanis J, Hunzeker M, King E, Chappel A, Jampol A, Patel",
    "entities": [
      {
        "text": "Seo G",
        "label": "PERSON"
      },
      {
        "text": "Houskamp EJ",
        "label": "ORG"
      },
      {
        "text": "Lanis J",
        "label": "PERSON"
      },
      {
        "text": "Hunzeker M",
        "label": "ORG"
      },
      {
        "text": "Chappel A",
        "label": "ORG"
      },
      {
        "text": "Jampol A",
        "label": "ORG"
      },
      {
        "text": "Patel",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "BACKGROUND: Abnormal muscle co-activation contributes to arm impairment after",
    "entities": []
  },
  {
    "text": "stroke. This single-blind, randomized, sham-controlled trial evaluated the",
    "entities": []
  },
  {
    "text": "feasibility and efficacy of home-based, personalized myoelectric interface for",
    "entities": []
  },
  {
    "text": "neurorehabilitation (MINT) conditioning to reduce abnormal co-activation and",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "enhance arm function and determine the optimal number of abnormally",
    "entities": []
  },
  {
    "text": "co-activating muscles to target during training.",
    "entities": []
  },
  {
    "text": "METHODS: Moderately to severely impaired chronic stroke survivors were",
    "entities": []
  },
  {
    "text": "randomized to one of three MINT groups (who played customized games requiring",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "independent activation of 2 or 3 abnormally co-activating muscles) or a sham",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "control group (played using one muscle). All groups trained 90 minutes/day, 5",
    "entities": [
      {
        "text": "control group",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "90 minutes/day",
        "label": "TIME"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "days/week at home and 1 day/week in lab, for 6 weeks, and changed trained muscle",
    "entities": [
      {
        "text": "days/week",
        "label": "DATE"
      },
      {
        "text": "1 day/week",
        "label": "DATE"
      },
      {
        "text": "6 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "sets every 2-3 weeks. The primary outcome was the Wolf Motor Function Test",
    "entities": [
      {
        "text": "every 2-3 weeks",
        "label": "DATE"
      },
      {
        "text": "the Wolf Motor Function Test",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Fifty-nine participants completed the training. Participants performed",
    "entities": [
      {
        "text": "Fifty-nine",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "315 \u00b1 85 (mean \u00b1 SD) repetitions daily. At week 6, participants in all MINT",
    "entities": [
      {
        "text": "315",
        "label": "CARDINAL"
      },
      {
        "text": "daily",
        "label": "DATE"
      },
      {
        "text": "week 6",
        "label": "DATE"
      },
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups combined improved by 4 s on WMFT (p=0.0008), exceeding the minimal",
    "entities": [
      {
        "text": "4 s",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "clinically important difference (1.5 s). Participants who trained 3 muscles",
    "entities": [
      {
        "text": "1.5",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "simultaneously improved by 6.8 s (p=0.001), while the 2-muscle and sham groups",
    "entities": [
      {
        "text": "6.8",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "did not change significantly. In per-protocol analysis, the 3-muscle group, but",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "not 2-muscle groups, improved significantly more than sham (p=0.046), though not",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in intention-to-treat analysis. All MINT groups continued improving at 4 weeks",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      },
      {
        "text": "4 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "post-training. Importantly, severely impaired participants in combined MINT",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups improved more than those in sham (p=0.02). Importantly, combined MINT",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "groups also improved their reaching range of motion significantly more than",
    "entities": []
  },
  {
    "text": "sham. Co-activation decreased by 76% in MINT groups during training. Notably,",
    "entities": [
      {
        "text": "sham",
        "label": "ORG"
      },
      {
        "text": "76%",
        "label": "PERCENT"
      },
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduction in co-activation during reaching correlated significantly with",
    "entities": []
  },
  {
    "text": "improved arm function and range of motion. Other secondary outcomes did not show",
    "entities": []
  },
  {
    "text": "clinically important improvement. Stroke involving the posterior limb of the",
    "entities": []
  },
  {
    "text": "internal capsule negatively predicted response to MINT.",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Home-based MINT conditioning, especially the 3-muscle variant, is",
    "entities": [
      {
        "text": "MINT",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "feasible, reduces co-activation, and improves arm movement and function.",
    "entities": []
  },
  {
    "text": "Predicting Post-Stroke Gait and Balance Function with Simple Neuromotor",
    "entities": [
      {
        "text": "Predicting Post-Stroke Gait",
        "label": "ORG"
      },
      {
        "text": "Simple Neuromotor",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Measures.",
    "entities": []
  },
  {
    "text": "BACKGROUND: Stroke commonly results in permanent damage to central neural",
    "entities": []
  },
  {
    "text": "circuits. At a physiological level, this damage manifests as neuromotor",
    "entities": []
  },
  {
    "text": "impairments like reduced muscle strength, altered coordination, and delayed",
    "entities": []
  },
  {
    "text": "reaction time. At a functional level, this damage results in reduced gait speed,",
    "entities": []
  },
  {
    "text": "endurance, and balance ability, which leads to long-term disability and loss of",
    "entities": []
  },
  {
    "text": "independence. However, the interplay between these neuromotor impairments and",
    "entities": []
  },
  {
    "text": "functional disability is not well understood. An understanding of these",
    "entities": []
  },
  {
    "text": "relationships is critical to tailoring rehabilitation approaches for post-stroke",
    "entities": []
  },
  {
    "text": "recovery.",
    "entities": []
  },
  {
    "text": "METHODS: We measured upper extremity neuromotor capacities as well as mobility",
    "entities": []
  },
  {
    "text": "and balance measures in 20 chronic stroke survivors and 20 age- and sex-matched",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "controls for this cross-sectional, case-control study. The upper extremity",
    "entities": []
  },
  {
    "text": "neuromotor capacities included grip strength and various reaction time measures",
    "entities": []
  },
  {
    "text": "(simple reaction time [SRT], reaction accuracy [All Accuracy], and All",
    "entities": []
  },
  {
    "text": "Accuracy/SRT) derived using the ReacStick-a novel instrumented ruler-drop test",
    "entities": [
      {
        "text": "Accuracy/SRT",
        "label": "PERSON"
      },
      {
        "text": "ReacStick",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "that provides greater ecological validity than computer-based measures. The",
    "entities": []
  },
  {
    "text": "mobility and balance measures included preferred gait speed, 6-minute walking",
    "entities": [
      {
        "text": "6-minute",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "distance, timed up-and-go test, and single leg balance ability. ANOVAs were used",
    "entities": []
  },
  {
    "text": "to make between-limb and between-group comparisons, and linear and logistic",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "regression analyses were used to evaluate the neuromotor capacities as",
    "entities": []
  },
  {
    "text": "predictors of mobility and balance.",
    "entities": []
  },
  {
    "text": "RESULTS: All neuromotor capacities except All Accuracy and all mobility and",
    "entities": [
      {
        "text": "All Accuracy",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "balance measures were negatively affected by stroke (all p <0.02). We observed",
    "entities": []
  },
  {
    "text": "that grip strength symmetry (the ratio of grip strength in the paretic limb to",
    "entities": []
  },
  {
    "text": "the nonparetic limb) was the primary predictor of all mobility measures (all p",
    "entities": []
  },
  {
    "text": "\u22640.014), and SRT symmetry and paretic All Accuracy/SRT were the primary",
    "entities": [
      {
        "text": "SRT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "predictors of balance (all p \u22640.002).",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: These results serve as foundational evidence for the relationship",
    "entities": []
  },
  {
    "text": "between neuromotor performance and functional ability following a stroke and may",
    "entities": []
  },
  {
    "text": "present an accessible clinical tool for safe measurement of post-stroke mobility",
    "entities": []
  },
  {
    "text": "and balance.",
    "entities": []
  },
  {
    "text": "26. Front Sports Act Living. 2025 Jul 1;7:1613661. doi:",
    "entities": [
      {
        "text": "26",
        "label": "CARDINAL"
      },
      {
        "text": "Front Sports Act Living",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "10.3389/fspor.2025.1613661. eCollection 2025.",
    "entities": [
      {
        "text": "10.3389",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "External training load and rating of perceived exertion comparison between",
    "entities": []
  },
  {
    "text": "different playing styles and winning vs. losing matches in elite tennis.",
    "entities": []
  },
  {
    "text": "(1)Department of Sport Games, Hungarian University of Sports Science, Budapest,",
    "entities": [
      {
        "text": "Sport Games",
        "label": "ORG"
      },
      {
        "text": "Hungarian University of Sports Science",
        "label": "ORG"
      },
      {
        "text": "Budapest",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Doctoral Studies, Hungarian University of Sports Science, Budapest,",
    "entities": [
      {
        "text": "Hungarian University of Sports Science",
        "label": "ORG"
      },
      {
        "text": "Budapest",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Kinesiology, Hungarian University of Sports Science, Budapest,",
    "entities": [
      {
        "text": "Kinesiology, Hungarian University of Sports Science",
        "label": "ORG"
      },
      {
        "text": "Budapest",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Neurocognitive Research Center, Ny\u00edr\u0151 Gyula National Institute of Psychiatry,",
    "entities": [
      {
        "text": "Research Center",
        "label": "ORG"
      },
      {
        "text": "Ny\u00edr\u0151 Gyula National Institute of Psychiatry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Addictology, Budapest, Hungary.",
    "entities": [
      {
        "text": "Budapest",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Institute of Health Development and Sport Sciences, E\u00f6tv\u00f6s Lor\u00e1nd University",
    "entities": [
      {
        "text": "Health Development and Sport Sciences",
        "label": "ORG"
      },
      {
        "text": "E\u00f6tv\u00f6s Lor\u00e1nd University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Faculty of Education and Psychology, Budapest, Hungary.",
    "entities": [
      {
        "text": "Faculty of Education",
        "label": "ORG"
      },
      {
        "text": "Budapest",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Training Theory and Methodology Research Center, Hungarian University of",
    "entities": [
      {
        "text": "Theory and Methodology Research Center",
        "label": "ORG"
      },
      {
        "text": "Hungarian University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sports Science, Budapest, Hungary.",
    "entities": [
      {
        "text": "Sports Science",
        "label": "ORG"
      },
      {
        "text": "Budapest",
        "label": "GPE"
      },
      {
        "text": "Hungary",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: This study aims to compare different playing styles on external",
    "entities": []
  },
  {
    "text": "training load and rating of perceived exertion (RPE) in elite Hungarian junior",
    "entities": [
      {
        "text": "Hungarian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "tennis players during the off-season in winning vs. losing matches.",
    "entities": [
      {
        "text": "the off-season",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: Sixteen elite male junior tennis players from the same club",
    "entities": [
      {
        "text": "Sixteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participated in this study (aggressive baseliner: n = 9; counterpuncher: n = 7),",
    "entities": [
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "7",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and each player was required to play three simulated matches. We measured eleven",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "eleven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "activity profiles, fourteen external training load variables, and the subjective",
    "entities": [
      {
        "text": "fourteen",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RPE parameter for all matches. For the activity profile measure, we used video",
    "entities": []
  },
  {
    "text": "cameras, and for the external training load, we used a 10 Hz global navigation",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "satellite system (GNSS) with integrated 100 Hz inertial measurement units (IMU).",
    "entities": [
      {
        "text": "GNSS",
        "label": "ORG"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: For the different playing styles, we found that aggressive baseliner",
    "entities": []
  },
  {
    "text": "players produce more high-intensity (\u2264-2 m/s2) decelerations (p = 0.015;",
    "entities": [
      {
        "text": "0.015",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "r = 0.35), and higher other stroke load values (p = 0.009; r = 0.38), than",
    "entities": [
      {
        "text": "0.35",
        "label": "CARDINAL"
      },
      {
        "text": "0.009",
        "label": "CARDINAL"
      },
      {
        "text": "0.38",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "counterpuncher players. However, in the other external training load and RPE",
    "entities": []
  },
  {
    "text": "variables we did not find any significance differences (p > 0.05). For the match",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcomes, we found that the running load (p = 0.013; r = 0.50) values were",
    "entities": [
      {
        "text": "0.013",
        "label": "CARDINAL"
      },
      {
        "text": "0.50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "higher in winning situations, while the RPE (p = 0.000; r = 0.79) values were",
    "entities": [
      {
        "text": "RPE",
        "label": "ORG"
      },
      {
        "text": "0.000",
        "label": "CARDINAL"
      },
      {
        "text": "0.79",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "greater in losing matches. However, apart from this, we did not find any",
    "entities": []
  },
  {
    "text": "significant differences in the other parameters (p > 0.05).",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DISCUSSION: In conclusion, aggressive baseliner players must develop more",
    "entities": []
  },
  {
    "text": "movements toward the net and the necessary adjustment steps for volleys.",
    "entities": []
  },
  {
    "text": "Furthermore, running activities do not necessarily influence match outcomes,",
    "entities": []
  },
  {
    "text": "therefore, it is important to place more emphasis on the development and",
    "entities": []
  },
  {
    "text": "monitoring of technical and tactical situations. Based on these points, we",
    "entities": []
  },
  {
    "text": "recommend that coaches integrate the development of specific footwork and",
    "entities": []
  },
  {
    "text": "dominant technical-tactical actions simultaneously on the court, so that players",
    "entities": []
  },
  {
    "text": "can better incorporate these elements into their game.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: JN was employed by CRU Hungary Ltd. The",
    "entities": [
      {
        "text": "JN",
        "label": "PERSON"
      },
      {
        "text": "CRU Hungary Ltd.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "remaining authors declare that the research was conducted in the absence of any",
    "entities": []
  },
  {
    "text": "commercial or financial relationships that could be construed as a potential",
    "entities": []
  },
  {
    "text": "conflict of interest.",
    "entities": []
  },
  {
    "text": "Early corticospinal tract sub-pathway lesion load and integrity predict",
    "entities": []
  },
  {
    "text": "(1)Department of Medical Imaging, The First Affiliated Hospital of Xi'an",
    "entities": [
      {
        "text": "Medical Imaging",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Jiaotong University, Xi'an, Shaanxi, China.",
    "entities": [
      {
        "text": "Jiaotong University",
        "label": "ORG"
      },
      {
        "text": "Xi'an",
        "label": "GPE"
      },
      {
        "text": "Shaanxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Xi'an Academy of Fine Arts, Xi'an, Shaanxi, China.",
    "entities": [
      {
        "text": "2)Xi'an Academy of Fine Arts",
        "label": "MONEY"
      },
      {
        "text": "Xi'an",
        "label": "GPE"
      },
      {
        "text": "Shaanxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Radiology, Xi'an Daxing Hospital, Xi'an, Shaanxi, China.",
    "entities": [
      {
        "text": "Radiology",
        "label": "GPE"
      },
      {
        "text": "Xi'an",
        "label": "GPE"
      },
      {
        "text": "Shaanxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi'an",
    "entities": [
      {
        "text": "Rehabilitation Medicine",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Growing evidence suggests that corticospinal tract (CST) damage",
    "entities": [
      {
        "text": "CST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and microstructural integrity are key predictors of post-stroke motor",
    "entities": []
  },
  {
    "text": "impairment. However, their combined clinical utility-particularly in CST",
    "entities": [
      {
        "text": "CST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sub-pathways originating from non-primary motor cortical areas-remains",
    "entities": []
  },
  {
    "text": "underexplored. This study aimed to determine whether microstructural integrity",
    "entities": []
  },
  {
    "text": "and lesion load (LL) of each CST sub-pathway at 2 weeks predict motor outcomes",
    "entities": [
      {
        "text": "LL",
        "label": "ORG"
      },
      {
        "text": "CST",
        "label": "ORG"
      },
      {
        "text": "2 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "METHODS: Fifty seven participants completed motor and neuroimaging evaluations",
    "entities": [
      {
        "text": "Fifty seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at 2 weeks post-stroke and underwent follow-up motor assessments at 6 (n = 37)",
    "entities": [
      {
        "text": "2 weeks",
        "label": "DATE"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "37",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 12 weeks (n = 34). The integrity of the CSTs was quantified using diffusion",
    "entities": [
      {
        "text": "12 weeks",
        "label": "DATE"
      },
      {
        "text": "34",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "spectrum imaging (DSI), while CST-LL was measured using structural magnetic",
    "entities": [
      {
        "text": "CST-LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resonance imaging, both based on the sensorimotor area tract template atlas.",
    "entities": []
  },
  {
    "text": "Stepwise multiple linear regression models were used to assess the predictive",
    "entities": [
      {
        "text": "linear",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "value of CST microstructural integrity and CST-LL in each sub-pathway at 2 weeks",
    "entities": [
      {
        "text": "CST",
        "label": "ORG"
      },
      {
        "text": "CST-LL",
        "label": "ORG"
      },
      {
        "text": "2 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "for motor function at 2, 6, and 12 weeks post-stroke.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "DATE"
      },
      {
        "text": "12 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: The results indicated CST integrity and CST-LL were both the main",
    "entities": [
      {
        "text": "CST",
        "label": "ORG"
      },
      {
        "text": "CST-LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "determinants of motor deficit at 2 weeks post-stroke. Specifically, the",
    "entities": [
      {
        "text": "determinants of motor",
        "label": "ORG"
      },
      {
        "text": "2 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "integrity of CSTs from the primary motor cortex (M1), reflected by fractional",
    "entities": [
      {
        "text": "M1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "anisotropy, emerged as a significant predictor of post-stroke motor deficit at 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "weeks, whereas CST integrity from the dorsal premotor cortex (PMd), reflected by",
    "entities": [
      {
        "text": "weeks",
        "label": "DATE"
      },
      {
        "text": "CST",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "diffusivity. CST-LL originating from non-M1 motor areas, such as primary sensory",
    "entities": [
      {
        "text": "CST-LL",
        "label": "ORG"
      },
      {
        "text": "non-M1 motor",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "cortex (S1), were also the main determinants for motor impairment at 2 weeks",
    "entities": [
      {
        "text": "S1",
        "label": "PRODUCT"
      },
      {
        "text": "2 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "post-stroke. However, compared to CST integrity, CST-LL from non-M1 motor areas,",
    "entities": [
      {
        "text": "CST",
        "label": "ORG"
      },
      {
        "text": "CST-LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "including both the PMd and S1, were more dominant predictors, explaining 68.3%",
    "entities": [
      {
        "text": "S1",
        "label": "PRODUCT"
      },
      {
        "text": "68.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(R 2 adjusted = 0.683, p < 0.001) and 79.5% (R 2 adjusted = 0.795, p < 0.001) of",
    "entities": [
      {
        "text": "0.683",
        "label": "CARDINAL"
      },
      {
        "text": "79.5%",
        "label": "PERCENT"
      },
      {
        "text": "0.795",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the variance in motor outcomes at 6 and 12 weeks.",
    "entities": [
      {
        "text": "6 and 12 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: The microstructural integrity of the PMd tracts and CST-LL from the",
    "entities": [
      {
        "text": "CST-LL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "non-M1 motor areas may be promising biomarker for post-stroke motor impairment.",
    "entities": [
      {
        "text": "non-M1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "These findings highlight the pivotal role of non-M1 tracts in post-stroke motor",
    "entities": [
      {
        "text": "non-M1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "function, particularly the PMd tracts, as a potential intervention target to",
    "entities": []
  },
  {
    "text": "enhance motor recovery.",
    "entities": []
  },
  {
    "text": "be construed as a potential conflict of interest. The reviewer LG declared a",
    "entities": [
      {
        "text": "LG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "past co-authorship with the author(s) MZ and WD to the handling editor.",
    "entities": []
  },
  {
    "text": "A Case of Stanford Type A Aortic Dissection Presenting as Syncope and Neurologic",
    "entities": [
      {
        "text": "Stanford Type A Aortic Dissection Presenting as Syncope",
        "label": "ORG"
      },
      {
        "text": "Neurologic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Deficits Without Pain: Diagnostic Pitfalls and a Therapeutic Dilemma.",
    "entities": []
  },
  {
    "text": "(1)Medicine, NHS Wales, Wales, GBR.",
    "entities": [
      {
        "text": "1)Medicine",
        "label": "CARDINAL"
      },
      {
        "text": "NHS Wales",
        "label": "ORG"
      },
      {
        "text": "Wales",
        "label": "GPE"
      },
      {
        "text": "GBR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Acute aortic dissection (AAD) is a true medical emergency that classically",
    "entities": []
  },
  {
    "text": "presents with sudden severe tearing chest pain that may radiate to the back or",
    "entities": []
  },
  {
    "text": "with tearing abdominal pain. When it presents atypically without pain,",
    "entities": []
  },
  {
    "text": "diagnostic delays or misdiagnosis are common, often with devastating",
    "entities": []
  },
  {
    "text": "consequences. We report the case of a 59-year-old male with uncontrolled",
    "entities": [
      {
        "text": "59-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hypertension who first presented to an outside emergency department (ED) with",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "multiple collapses and was discharged after assessment. He presented 48 hours",
    "entities": [
      {
        "text": "48 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "later to our ED following collapse and loss of consciousness. The patient was in",
    "entities": []
  },
  {
    "text": "shock upon arrival. Transient right upper limb weakness and slurring of speech",
    "entities": []
  },
  {
    "text": "were noted on initial assessment. Acute coronary syndrome (ACS) with cardiogenic",
    "entities": []
  },
  {
    "text": "shock was suspected on the basis of electrocardiographic (ECG) changes and",
    "entities": [
      {
        "text": "ECG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "raised troponin, and ACS treatment was administered. However, bedside",
    "entities": [
      {
        "text": "ACS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "echocardiogram performed to assess left ventricular function as part of the ACS",
    "entities": [
      {
        "text": "ACS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "work-up suggested Stanford type A AAD, which was confirmed by computed tomogram",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(CT) of the aorta. Emergency surgical repair of the aorta was performed after",
    "entities": []
  },
  {
    "text": "transfer to a tertiary hospital, with good postoperative recovery. This case",
    "entities": [
      {
        "text": "tertiary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "highlights the importance of maintaining a high index of suspicion for aortic",
    "entities": []
  },
  {
    "text": "dissection in patients presenting with syncope and neurological deficits even in",
    "entities": []
  },
  {
    "text": "the absence of classical symptoms. Simulation training specifically tailored to",
    "entities": []
  },
  {
    "text": "scenarios of atypical presentations of AAD may be of benefit to emergency",
    "entities": []
  },
  {
    "text": "clinicians and help reduce the unacceptably high rate of misdiagnosis.",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Copyright \u00a9 2025, Ismail et al.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Ismail et al.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "eCollection 2025 Aug.",
    "entities": [
      {
        "text": "2025 Aug.",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Analysis of social determinants of health and extreme climate events:",
    "entities": []
  },
  {
    "text": "Identifying vulnerable populations and health outcomes in Jacksonville.",
    "entities": [
      {
        "text": "Jacksonville",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Division of Nephrology, Hypertension, and Renal Transplantation, Department",
    "entities": [
      {
        "text": "Nephrology, Hypertension",
        "label": "ORG"
      },
      {
        "text": "Renal Transplantation, Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine, College of Medicine, University of Florida, Gainesville, Florida.",
    "entities": [
      {
        "text": "Medicine, College of Medicine, University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      },
      {
        "text": "Florida",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Intelligent Clinical Care Center, University of Florida, Gainesville,",
    "entities": [
      {
        "text": "Clinical Care Center,",
        "label": "ORG"
      },
      {
        "text": "University of Florida",
        "label": "ORG"
      },
      {
        "text": "Gainesville",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Environmental Engineering Sciences, University of Florida,",
    "entities": [
      {
        "text": "Environmental Engineering Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Florida",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Heatwaves and hurricanes pose risks to public health, especially for",
    "entities": []
  },
  {
    "text": "METHODS: We assessed the impact of extreme weather events on health outcomes in",
    "entities": []
  },
  {
    "text": "socially vulnerable groups. We analyzed hospital mortality, acute stroke,",
    "entities": []
  },
  {
    "text": "myocardial infarction, and nonelective intensive care unit (ICU) admissions for",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "24,814 patients admitted to two hospitals in Jacksonville (2015-2017). We fitted",
    "entities": [
      {
        "text": "24,814",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Jacksonville",
        "label": "GPE"
      },
      {
        "text": "2015-2017",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "modified Poisson regression models to assess differences relative to the",
    "entities": [
      {
        "text": "Poisson",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "heatwave and Hurricane Irma, presenting impacts with relative risks (RR) and 95%",
    "entities": [
      {
        "text": "Hurricane Irma",
        "label": "EVENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "confidence intervals (CI).",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: There was no significant change in the rate of acute stroke or",
    "entities": []
  },
  {
    "text": "myocardial infarction during both the heatwave and Hurricane Irma. The rate of",
    "entities": [
      {
        "text": "Hurricane Irma",
        "label": "EVENT"
      }
    ]
  },
  {
    "text": "nonelective ICU admission showed no significant change during the heatwave and",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "immediate posthurricane period (0-14 days after the hurricane) but increased",
    "entities": [
      {
        "text": "0-14 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "during the extended posthurricane period (15-74 days after the hurricane) with",
    "entities": [
      {
        "text": "15-74 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "an RR of 6.19 (95% CI = 1.25, 30.54) compared with the control period. Extreme",
    "entities": [
      {
        "text": "6.19",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      },
      {
        "text": "30.54",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "During heatwave and extended posthurricane periods, the rate of acute stroke or",
    "entities": []
  },
  {
    "text": "myocardial infarction increased for elderly patients relative to younger",
    "entities": []
  },
  {
    "text": "patients with RRs of 1.43 (95% CI = 1.05, 1.94) and 1.53 (95% CI = 1.14, 2.07),",
    "entities": [
      {
        "text": "1.43",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.94",
        "label": "CARDINAL"
      },
      {
        "text": "1.53",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      },
      {
        "text": "2.07",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and uninsured or Medicaid-insured patients relative to those with Medicare or",
    "entities": [
      {
        "text": "Medicaid",
        "label": "ORG"
      },
      {
        "text": "Medicare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "private insurance with RRs of 1.71 (95% CI = 1.26, 2.33) and 1.88 (95% CI =",
    "entities": [
      {
        "text": "1.71",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.26",
        "label": "CARDINAL"
      },
      {
        "text": "2.33",
        "label": "CARDINAL"
      },
      {
        "text": "1.88",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "1.38, 2.59). Social vulnerability and air quality further impacted health",
    "entities": [
      {
        "text": "1.38",
        "label": "CARDINAL"
      },
      {
        "text": "2.59",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcomes during the extended posthurricane period, with a 0.1-unit increase in",
    "entities": [
      {
        "text": "0.1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the Social Vulnerability Index score associated with a 65% decrease in risk of",
    "entities": [
      {
        "text": "65%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "acute stroke or myocardial infarction with RR of 0.35 (95% CI = 0.16, 0.75) and",
    "entities": [
      {
        "text": "0.35",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      },
      {
        "text": "0.75",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "a 69% decrease in risk of nonelective ICU admissions with RR of 0.31 (95% CI =",
    "entities": [
      {
        "text": "69%",
        "label": "PERCENT"
      },
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "RR of 0.31",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "0.15-0.65), and a 1-unit increase in Air Quality Index value indicated a 2%",
    "entities": [
      {
        "text": "0.15-0.65",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "Air Quality",
        "label": "ORG"
      },
      {
        "text": "2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "increase in risk of acute stroke or myocardial infarction with RR of 1.02 (95%",
    "entities": [
      {
        "text": "RR of 1.02",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 1.01, 1.03).",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "1.03",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Our findings suggest extreme climate events exacerbate negative",
    "entities": []
  },
  {
    "text": "health outcomes in socioeconomically vulnerable populations, underscoring the",
    "entities": []
  },
  {
    "text": "need for targeted public health interventions, improved healthcare access, and",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of The Environmental Epidemiology. All rights reserved.",
    "entities": [
      {
        "text": "The Environmental Epidemiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no conflicts",
    "entities": []
  },
  {
    "text": "of interest with regard to the content of this report.",
    "entities": []
  },
  {
    "text": "30. Stroke. 2025 Jul 16. doi: 10.1161/STROKEAHA.124.048584. Online ahead of",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PPAR\u03b3 Agonists Accelerate MRI Signal Resolution Mediated by Resting-State",
    "entities": []
  },
  {
    "text": "Astroglia in Acute Intracerebral Hemorrhage.",
    "entities": [
      {
        "text": "Astroglia",
        "label": "ORG"
      },
      {
        "text": "Acute Intracerebral Hemorrhage",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CD(1)(2)(5)(6)(7).",
    "entities": []
  },
  {
    "text": "(1)Graduate Institute of Biomedical Science, China Medical University, Taichung,",
    "entities": [
      {
        "text": "1)Graduate Institute of Biomedical Science",
        "label": "ORG"
      },
      {
        "text": "China Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)School of Medicine, China Medical University, Taichung, Taiwan. (Y.-P.C.,",
    "entities": [
      {
        "text": "Medicine, China Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      },
      {
        "text": "Y.-P.C.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "H.-R.J., C.-D.C.).",
    "entities": []
  },
  {
    "text": "(3)Department of Neurosurgery, Neurological Institute, Taichung Veterans General",
    "entities": [
      {
        "text": "Neurosurgery, Neurological Institute",
        "label": "ORG"
      },
      {
        "text": "Taichung Veterans General",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan (D.W.H.).",
    "entities": [
      {
        "text": "Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Academia Sinica",
        "label": "ORG"
      },
      {
        "text": "Taipei",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      },
      {
        "text": "D.W.H.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosurgery, China Medical University Hospital, Taichung,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "China Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Spine Center, China Medical University Hospital, Taichung, Taiwan. (C.-D.C.).",
    "entities": [
      {
        "text": "Center",
        "label": "GPE"
      },
      {
        "text": "China Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Graduate Institute of Medical Sciences, National Defense Medical Center,",
    "entities": [
      {
        "text": "Institute of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "National Defense Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: In the aftermath of intracerebral hemorrhage (ICH), the clearance of",
    "entities": []
  },
  {
    "text": "harmful substances from the hematoma helps to mitigate brain edema and reduce",
    "entities": []
  },
  {
    "text": "the risk of subsequent neurological damage. This study aimed to investigate the",
    "entities": []
  },
  {
    "text": "mechanism underlying early hematoma processing following ICH and to explore the",
    "entities": [
      {
        "text": "ICH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "potential of modulating this process via astrocyte regulation.",
    "entities": [
      {
        "text": "astrocyte",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: ICH was induced by intrastriatal injection of bacterial collagenase. A",
    "entities": []
  },
  {
    "text": "calcium channel blocker, pyr3, was used to suppress astrocyte activity, or",
    "entities": [
      {
        "text": "astrocyte",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "combined with PPAR\u03b3 (peroxisome proliferator-activated receptor gamma) agonists",
    "entities": []
  },
  {
    "text": "(rosiglitazone and pioglitazone) as the intervention approach. The rats were",
    "entities": []
  },
  {
    "text": "randomly assigned to the following groups: ICH with vehicle treatment, ICH with",
    "entities": []
  },
  {
    "text": "pyr3 treatment, ICH with rosiglitazone treatment, ICH with pioglitazone",
    "entities": []
  },
  {
    "text": "treatment, ICH with pyr3 and rosiglitazone treatment, and ICH with pyr3 and",
    "entities": [
      {
        "text": "ICH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "pioglitazone treatment. Drugs were administered via the intraventricular route",
    "entities": []
  },
  {
    "text": "into the contralateral ventricle 10 minutes after ICH induction. The evolution",
    "entities": [
      {
        "text": "10 minutes",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "of hematoma within the first 21 hours was meticulously examined using",
    "entities": [
      {
        "text": "the first 21 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "T2-weighted magnetic resonance imaging. Motor behavioral testing and",
    "entities": [
      {
        "text": "T2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diffusion-weighted imaging were used to assess longer-lasting functional",
    "entities": []
  },
  {
    "text": "outcomes and edema. To assess astrocyte-specific responses, an astrocyte cell",
    "entities": [
      {
        "text": "astrocyte",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "line was incubated with hemin followed by different drug treatments. An",
    "entities": []
  },
  {
    "text": "intracellular hemin assay was used to quantify the hemin uptake capacity of",
    "entities": [
      {
        "text": "intracellular hemin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "astrocytes.",
    "entities": []
  },
  {
    "text": "RESULTS: Delayed signaling transitions of the hematoma were observed in the ICH",
    "entities": [
      {
        "text": "ICH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with pyr3 treatment group in T2-weighted images, manifesting in different ICH",
    "entities": [
      {
        "text": "T2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "models (ANOVA; P<0.001). The additional treatment of rosiglitazone rescued the",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "delayed signaling transition (ANOVA; P<0.01) with a slight reduction in hematoma",
    "entities": [
      {
        "text": "hematoma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "volume (ANOVA; P<0.001). ICH with pyr3 and pioglitazone treatment group",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exhibited improved motor behavior (ANOVA; P<0.001), gait (ANOVA; P<0.001), and",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      },
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced brain water content (ANOVA; P<0.01) than ICH with the vehicle treatment",
    "entities": [
      {
        "text": "ANOVA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group. In cultured astrocytes, the combined treatment group showed increased",
    "entities": []
  },
  {
    "text": "HCP-1 (heme carrier protein-1) expression and hemin uptake within a few hours",
    "entities": [
      {
        "text": "a few hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Combined treatment with the calcium channel blocker, pyr3, and the",
    "entities": []
  },
  {
    "text": "PPAR\u03b3 agonist accelerated the early absorption of heme iron by resting-state",
    "entities": []
  },
  {
    "text": "astrocytes, leading to improved functional performance and reduced edema in",
    "entities": []
  },
  {
    "text": "10.1161/CIRCIMAGING.125.018124. Online ahead of print.",
    "entities": [
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Long-Term Follow-Up in Severe Mitral Stenosis With Low Transmitral Diastolic",
    "entities": []
  },
  {
    "text": "Pressure Gradient: From MASTER Registry.",
    "entities": []
  },
  {
    "text": "(1)Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University",
    "entities": [
      {
        "text": "Yonsei University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Seoul, South Korea (I.C., H.J. Lim, K.K., S.-Y.G., H.-J.L.,",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "I.C.",
        "label": "GPE"
      },
      {
        "text": "H.J. Lim",
        "label": "ORG"
      },
      {
        "text": "K.K.",
        "label": "ORG"
      },
      {
        "text": "S.-Y.G.",
        "label": "ORG"
      },
      {
        "text": "H.-J.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Division of Cardiology, Department of Internal Medicine, Inha University",
    "entities": [
      {
        "text": "Cardiology, Department of Internal Medicine, Inha University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Incheon, South Korea (D.-Y.K.).",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Incheon",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "D.-Y.K.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Statistical Analysis, Zarathu Co., Ltd, Seoul, South Korea",
    "entities": [
      {
        "text": "Statistical Analysis",
        "label": "ORG"
      },
      {
        "text": "Zarathu Co., Ltd",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei",
    "entities": [
      {
        "text": "Yonsei",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University College of Medicine, Seoul, South Korea (J.S.).",
    "entities": [
      {
        "text": "University College of Medicine,",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "J.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Cardiology, Department of Internal Medicine, Cardiovascular",
    "entities": [
      {
        "text": "Cardiology, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Keimyung University Dongsan Hospital, Keimyung University School of",
    "entities": [
      {
        "text": "Center, Keimyung University Dongsan Hospital",
        "label": "ORG"
      },
      {
        "text": "Keimyung University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Daegu, South Korea (H.J. Lee, S.L., I.-C.K.).",
    "entities": [
      {
        "text": "Daegu",
        "label": "PERSON"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "H.J. Lee",
        "label": "PERSON"
      },
      {
        "text": "I.-C.K.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Division of Cardiology, Department of Internal Medicine, Inje University",
    "entities": [
      {
        "text": "Cardiology, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Inje University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College of Medicine, Ilsan Paik Hospital, Goyang, South Korea (K.-Y.K.).",
    "entities": [
      {
        "text": "College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Ilsan Paik Hospital",
        "label": "ORG"
      },
      {
        "text": "Goyang",
        "label": "PERSON"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "K.-Y.K.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(7)Division of Cardiology, Department of Internal Medicine, Yeungnam University",
    "entities": [
      {
        "text": "Cardiology, Department of Internal Medicine",
        "label": "ORG"
      },
      {
        "text": "Yeungnam University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Center, Daegu, South Korea (K.-U.C., J.-W.S.).",
    "entities": [
      {
        "text": "Daegu",
        "label": "PERSON"
      },
      {
        "text": "South Korea",
        "label": "GPE"
      },
      {
        "text": "K.-U.C.",
        "label": "GPE"
      },
      {
        "text": "J.-W.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Medicine, Eulji University College of Medicine, Daejeon, South",
    "entities": [
      {
        "text": "Eulji University College of Medicine, Daejeon",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)University of Texas Health, Houston (J.N.).",
    "entities": [
      {
        "text": "9)University",
        "label": "CARDINAL"
      },
      {
        "text": "Texas Health",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "J.N.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Long-term follow-up studies in severe mitral stenosis (MS) with low",
    "entities": []
  },
  {
    "text": "evaluated the prognostic implications of severe MS with low MDPG in our MASTER",
    "entities": [
      {
        "text": "MS",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(Multicenter Mitral Stenosis with Rheumatic Etiology) registry.",
    "entities": []
  },
  {
    "text": "METHODS: We included patients with severe rheumatic MS (mitral valve area \u22641.5",
    "entities": [
      {
        "text": "MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cm2) from the long-term MASTER registry. Patients were categorized into high (\u22655",
    "entities": []
  },
  {
    "text": "mm Hg) or low (<5 mm Hg) MDPG groups. The primary outcome was a composite of",
    "entities": [
      {
        "text": "mm Hg",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "all-cause mortality and stroke.",
    "entities": []
  },
  {
    "text": "RESULTS: Among 1248 patients with severe MS, 322 (25.8%) had low MDPG and 926",
    "entities": [
      {
        "text": "1248",
        "label": "DATE"
      },
      {
        "text": "MS",
        "label": "ORG"
      },
      {
        "text": "322",
        "label": "CARDINAL"
      },
      {
        "text": "25.8%",
        "label": "PERCENT"
      },
      {
        "text": "926",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(74.2%) had high MDPG. Their mean age was 59\u00b113 years, 25% were men, and 74% had",
    "entities": [
      {
        "text": "74.2%",
        "label": "PERCENT"
      },
      {
        "text": "59\u00b113 years",
        "label": "DATE"
      },
      {
        "text": "25%",
        "label": "PERCENT"
      },
      {
        "text": "74%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "atrial fibrillation. Patients with low MDPG were older and had a higher",
    "entities": []
  },
  {
    "text": "prevalence of atrial fibrillation. During a mean follow-up of 6.8\u00b15.9 years, 194",
    "entities": [
      {
        "text": "6.8\u00b15.9 years",
        "label": "DATE"
      },
      {
        "text": "194",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(15.5%) patients experienced major adverse events. Patients who had low MDPG",
    "entities": [
      {
        "text": "15.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "sustained more events than those with high MDPG (hazard ratio, 1.56 [95% CI,",
    "entities": [
      {
        "text": "1.56",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.15-2.12]; P=0.004), and low MDPG was independently associated with poor",
    "entities": [
      {
        "text": "1.15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcome (hazard ratio, 1.42 [95% CI, 1.02-1.97]; P=0.038) in the multivariable",
    "entities": [
      {
        "text": "1.42",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.02",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "model. In the subgroup analysis of patients with low MDPG, decreased LA",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "reservoir strain was independently associated with poor outcome (hazard ratio,",
    "entities": []
  },
  {
    "text": "3.22 [95% CI, 1.25-8.31]; P=0.016).",
    "entities": [
      {
        "text": "3.22",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Severe patients with MS and low MDPG carried a greater risk of",
    "entities": [
      {
        "text": "MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "adverse events than those with high MDPG and had less frequent and delayed",
    "entities": []
  },
  {
    "text": "mitral valve intervention. Also, it is not necessarily indicative of milder",
    "entities": []
  },
  {
    "text": "hemodynamic encumbrance. LA reservoir strain could help identify a subgroup",
    "entities": [
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "associated with poor prognosis in patients with low MDPG.",
    "entities": []
  },
  {
    "text": "10.1161/CIRCIMAGING.125.018370. Online ahead of print.",
    "entities": [
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Assessing LV Contractility Identifies Populations With Preserved Ejection",
    "entities": []
  },
  {
    "text": "Fraction at Risk of Adverse Heart Failure Outcomes.",
    "entities": []
  },
  {
    "text": "Straw S(1), Brown OI(1), Cole CA(2), Lowry JE(2), Conning-Rowland M(1),",
    "entities": [
      {
        "text": "Straw S(1",
        "label": "PRODUCT"
      },
      {
        "text": "Brown OI(1",
        "label": "PERSON"
      },
      {
        "text": "Cole CA(2",
        "label": "PERSON"
      },
      {
        "text": "Lowry JE(2",
        "label": "PERSON"
      },
      {
        "text": "Conning-Rowland",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TA(1), Relton SD(4), Levelt E(1)(5), Witte KK(1), Kearney MT(1), Cubbon RM(1),",
    "entities": [
      {
        "text": "TA(1",
        "label": "PERSON"
      },
      {
        "text": "Relton",
        "label": "PERSON"
      },
      {
        "text": "Levelt",
        "label": "GPE"
      },
      {
        "text": "Witte KK(1",
        "label": "PERSON"
      },
      {
        "text": "Kearney MT(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Leeds Institute of Cardiovascular and Metabolic Medicine, University of",
    "entities": [
      {
        "text": "Institute of Cardiovascular",
        "label": "ORG"
      },
      {
        "text": "Metabolic Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Leeds, United Kingdom. (S.S., O.I.B., M.C.-R., M.F.P., M.D., T.A.S., E.L.,",
    "entities": [
      {
        "text": "Leeds",
        "label": "PERSON"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      },
      {
        "text": "S.S.",
        "label": "GPE"
      },
      {
        "text": "O.I.B.",
        "label": "ORG"
      },
      {
        "text": "M.C.-R.",
        "label": "PERSON"
      },
      {
        "text": "M.F.P.",
        "label": "ORG"
      },
      {
        "text": "M.D.",
        "label": "GPE"
      },
      {
        "text": "T.A.S.",
        "label": "GPE"
      },
      {
        "text": "E.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Leeds Teaching Hospitals NHS Trust, United Kingdom (C.A.C., J.E.L., S.K.,",
    "entities": [
      {
        "text": "Teaching Hospitals NHS Trust",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      },
      {
        "text": "J.E.L.",
        "label": "GPE"
      },
      {
        "text": "S.K.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)York and Scarborough Teaching Hospitals, United Kingdom (S.D.).",
    "entities": [
      {
        "text": "Scarborough Teaching Hospitals",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Leeds Institute for Data Analytics, University of Leeds, United Kingdom.",
    "entities": [
      {
        "text": "Institute for Data Analytics,",
        "label": "ORG"
      },
      {
        "text": "University of Leeds",
        "label": "ORG"
      },
      {
        "text": "United Kingdom",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Baker Heart and Diabetes Institute, Melbourne, Australia (E.L.).",
    "entities": [
      {
        "text": "5)Baker",
        "label": "CARDINAL"
      },
      {
        "text": "Diabetes Institute",
        "label": "ORG"
      },
      {
        "text": "Melbourne",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      },
      {
        "text": "E.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Left ventricular ejection fraction (LVEF) is an essential tool for",
    "entities": []
  },
  {
    "text": "heart failure (HF) assessment but is limited by load dependence. Additional",
    "entities": []
  },
  {
    "text": "tools are needed to risk-stratify normal LVEF populations. We aimed to assess",
    "entities": []
  },
  {
    "text": "the prognostic value of systolic blood pressure-indexed left ventricular",
    "entities": []
  },
  {
    "text": "end-systolic volume ratio, or cardiac contractility index (CCI).",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: In a prospective observational cohort study of people newly diagnosed",
    "entities": []
  },
  {
    "text": "with HF, we defined characteristics and outcomes associated with LVEF and CCI,",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "LVEF",
        "label": "GPE"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "including after stratification into HF with reduced ejection fraction or HF with",
    "entities": [
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "preserved ejection fraction. We used UK Biobank to assess whether CCI is",
    "entities": [
      {
        "text": "UK Biobank",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with subclinical myocardial dysfunction and incident HF.",
    "entities": []
  },
  {
    "text": "RESULTS: In people with HF, mortality increased over tertiles of declining CCI",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(P<0.001). Within the HF preserved ejection fraction group, below-median CCI was",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "associated with distinct clinical characteristics and an all-cause mortality",
    "entities": []
  },
  {
    "text": "risk approximately twice that of those with above median CCI (observed event",
    "entities": []
  },
  {
    "text": "rate 17.3/100 patient-years versus 8.8/100 patient-years; P<0.001), similar to",
    "entities": [
      {
        "text": "17.3/100",
        "label": "CARDINAL"
      },
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "8.8/100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "those with HF with reduced ejection fraction. Modeled as continuous variables,",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "there was a curvilinear relationship between mortality across the detected range",
    "entities": []
  },
  {
    "text": "of CCI, while there was no clear association with mortality risk across a wide",
    "entities": [
      {
        "text": "CCI",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "range of LVEF (20%-55%). In UK Biobank for participants without HF and normal",
    "entities": [
      {
        "text": "LVEF",
        "label": "ORG"
      },
      {
        "text": "20%-55%",
        "label": "PERCENT"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "Biobank",
        "label": "ORG"
      },
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "LVEF, below-median CCI was associated with \u224833% increased risk of incident heart",
    "entities": [
      {
        "text": "LVEF",
        "label": "GPE"
      },
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "failure (adjusted hazard ratio, 1.33 [1.01-1.75]; P=0.043). Decreasing CCI was",
    "entities": [
      {
        "text": "1.33",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "also associated with lower myocardial contractility defined using global radial",
    "entities": []
  },
  {
    "text": "and circumferential strain.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: CCI is a simple, noninvasive, relatively afterload-independent",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "method to stratify HF risk in populations with normal LVEF. Its simplicity means",
    "entities": []
  },
  {
    "text": "CCI could be applied to existing clinical trial data sets or used be as an",
    "entities": [
      {
        "text": "CCI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "inclusion criterion in future randomized controlled trials.",
    "entities": []
  },
  {
    "text": "33. Stroke. 2025 Jul 16. doi: 10.1161/STROKEAHA.125.051237. Online ahead of",
    "entities": [
      {
        "text": "33",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Medication Administration in Poststroke Dysphagia: Evaluating Swallowing Safety",
    "entities": []
  },
  {
    "text": "of Solid Dosage Forms.",
    "entities": [
      {
        "text": "Solid Dosage Forms",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Karl Landsteiner University of Health Sciences, Krems, Austria (M.T.-G.,",
    "entities": [
      {
        "text": "Landsteiner University of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Krems",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      },
      {
        "text": "M.T.-G.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Division of Neurology, University Hospital Tulln, Austria (M.T.-G., W.S.).",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "University Hospital Tulln",
        "label": "ORG"
      },
      {
        "text": "Austria",
        "label": "GPE"
      },
      {
        "text": "M.T.-G.",
        "label": "GPE"
      },
      {
        "text": "W.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Doctor of Philosophy (Ph.D.) Program, Institute for Nursing Science and",
    "entities": [
      {
        "text": "Institute for Nursing Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Practice, Paracelsus Medical University, Salzburg, Austria (M.T.-G., J.O.).",
    "entities": [
      {
        "text": "Paracelsus Medical University",
        "label": "ORG"
      },
      {
        "text": "Salzburg",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "PERSON"
      },
      {
        "text": "M.T.-G.",
        "label": "PERSON"
      },
      {
        "text": "J.O.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(4)Department for Clinical Neurosciences and Preventive Medicine, University for",
    "entities": [
      {
        "text": "Clinical Neurosciences",
        "label": "ORG"
      },
      {
        "text": "Preventive Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Continuing Education Krems, Austria (Y.T.).",
    "entities": [
      {
        "text": "Austria",
        "label": "GPE"
      },
      {
        "text": "Y.T.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)EUFH Campus Rostock, University of Applied Sciences, Rostock, Germany (S.",
    "entities": [
      {
        "text": "5)EUFH",
        "label": "CARDINAL"
      },
      {
        "text": "University of Applied Sciences",
        "label": "ORG"
      },
      {
        "text": "Rostock",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division for Rehabilitation and Recovery, VASCage Center on Clinical Stroke",
    "entities": []
  },
  {
    "text": "BACKGROUND: International guidelines recommend standardized dysphagia screening",
    "entities": [
      {
        "text": "dysphagia screening",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "in acute stroke, as up to 75% of patients develop poststroke dysphagia. While",
    "entities": [
      {
        "text": "up to 75%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "medication swallowing is also advised for assessment, no validated screening",
    "entities": []
  },
  {
    "text": "tools or instrumental evidence exist on solid dosage form (SDF) management.",
    "entities": [
      {
        "text": "SDF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Whole tablets are often crushed to reduce aspiration risk, yet the actual risk",
    "entities": []
  },
  {
    "text": "of aspiration for both forms remains unknown. Despite its widespread clinical",
    "entities": []
  },
  {
    "text": "use, crushed medication swallowing has never been evaluated using fiberoptic",
    "entities": []
  },
  {
    "text": "endoscopic evaluation of swallowing. Closing this evidence gap is essential for",
    "entities": []
  },
  {
    "text": "guiding safe medication administration in patients with dysphagic stroke.",
    "entities": []
  },
  {
    "text": "METHODS: A prospective, single-center, cross-sectional study with an",
    "entities": []
  },
  {
    "text": "experimental design was conducted on 60 patients with acute stroke (<7 days).",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "The swallowing safety and efficiency of 1 crushed placebo tablet and 3 different",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "types of whole placebo tablets, each administered with an accompanying",
    "entities": []
  },
  {
    "text": "applesauce bolus, were compared using fiberoptic endoscopic evaluation of",
    "entities": []
  },
  {
    "text": "swallowing. The primary outcome was the incidence of unsafe swallowing, as",
    "entities": []
  },
  {
    "text": "determined by the Penetration-Aspiration Scale. Secondary outcomes included the",
    "entities": [
      {
        "text": "the Penetration-Aspiration Scale",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "presence and location of pharyngeal residue associated with each SDF condition.",
    "entities": [
      {
        "text": "SDF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Of 60 patients with stroke (mean age, 73.4\u00b110.7 years; 55% male) with a",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "73.4\u00b110.7 years",
        "label": "DATE"
      },
      {
        "text": "55%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "median Gugging Swallowing Screen score of 14 indicating moderate dysphagia, 58",
    "entities": [
      {
        "text": "Gugging Swallowing Screen",
        "label": "PERSON"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "dysphagia",
        "label": "GPE"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients completed the crushed SDFs trial. Whole SDFs were not swallowed",
    "entities": []
  },
  {
    "text": "(chewed, spit out, and stopped) in 20 of the 174 trials. All fully swallowed",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "174",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "tablets (n=154) were safe, with no penetration or aspiration observed. In",
    "entities": []
  },
  {
    "text": "contrast, 22 of 154 accompanying boli (14.3%) and 7 of 58 crushed SDFs (12.1%)",
    "entities": [
      {
        "text": "22",
        "label": "CARDINAL"
      },
      {
        "text": "154",
        "label": "CARDINAL"
      },
      {
        "text": "14.3%",
        "label": "PERCENT"
      },
      {
        "text": "7",
        "label": "CARDINAL"
      },
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "12.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "were rated unsafe, without a significant difference. Crushed SDFs caused",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: These findings highlight the need to reconsider the routine",
    "entities": []
  },
  {
    "text": "practice of crushing SDFs for patients with dysphagic stroke. A paradigm shift",
    "entities": []
  },
  {
    "text": "towards using whole SDFs, guided by fiberoptic endoscopic evaluation of",
    "entities": []
  },
  {
    "text": "swallowing, could enable more frequent administration, reduce errors, and",
    "entities": []
  },
  {
    "text": "enhance medication efficacy.",
    "entities": []
  },
  {
    "text": "34. Stroke. 2025 Jul 16. doi: 10.1161/STROKEAHA.125.052347. Online ahead of",
    "entities": [
      {
        "text": "34",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "TET3-Interacting LncRNA TILR Is Essential for DNA Hydroxymethylation-Mediated",
    "entities": []
  },
  {
    "text": "Neuroprotection After Ischemic Stroke.",
    "entities": [
      {
        "text": "Ischemic Stroke",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Neurological Surgery, University of Wisconsin-Madison (V.A.,",
    "entities": [
      {
        "text": "Neurological Surgery",
        "label": "ORG"
      },
      {
        "text": "University of Wisconsin-Madison",
        "label": "ORG"
      },
      {
        "text": "V.A.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)William S. Middleton Veterans Administration Hospital, Madison, WI (R.V.).",
    "entities": [
      {
        "text": "2)William",
        "label": "CARDINAL"
      },
      {
        "text": "S. Middleton Veterans Administration Hospital",
        "label": "ORG"
      },
      {
        "text": "Madison",
        "label": "PERSON"
      },
      {
        "text": "WI",
        "label": "ORG"
      },
      {
        "text": "R.V.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Epigenetic modifications 5-methylcytosine and",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "5-hydroxymethylcytosine in DNA regulate neuronal survival under ischemic stress.",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "We previously showed that TET3 (ten-eleven translocation 3)-mediated",
    "entities": [
      {
        "text": "ten-eleven",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "5-methylcytosine to 5-hydroxymethylcytosine conversion induces neuroprotective",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "gene transcription after stroke. As TET3 neuronal isoform lacks the DNA-binding",
    "entities": []
  },
  {
    "text": "domain, how TET3 drives 5-hydroxymethylcytosine-mediated transcriptional",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "induction in the ischemic brain remains unclear. Long noncoding RNAs (lncRNAs)",
    "entities": []
  },
  {
    "text": "act as structural scaffolds to recruit chromatin-modifying proteins and other",
    "entities": []
  },
  {
    "text": "RNAs to specific genomic loci. However, whether TET3 requires an lncRNA to drive",
    "entities": []
  },
  {
    "text": "DNA hydroxymethylation in the ischemic brain is unknown.",
    "entities": []
  },
  {
    "text": "METHODS: Adult male and female mice were subjected to transient middle cerebral",
    "entities": []
  },
  {
    "text": "artery occlusion. TET3-bound lncRNAs were immunoprecipitated from peri-infarct",
    "entities": []
  },
  {
    "text": "cortex, and TILR (TET3-interacting lncRNA; AK020504) identified was inhibited",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      },
      {
        "text": "AK020504",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "with small interfering RNA injected at 5 minutes of reperfusion. Ascorbate was",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      },
      {
        "text": "5 minutes",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "administered at 30 minutes of reperfusion to induce TET3 activity. Poststroke",
    "entities": [
      {
        "text": "30 minutes",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "DNA hydroxymethylation was assessed with hydroxymethylation DNA",
    "entities": []
  },
  {
    "text": "immunoprecipitation sequencing, and sensorimotor deficits, and infarct volume",
    "entities": []
  },
  {
    "text": "were evaluated between days 1 and 7 of reperfusion.",
    "entities": [
      {
        "text": "between days 1 and 7",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: TILR binds to TET3 with high affinity and was significantly upregulated",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in the peri-infarct cortex at 12 hours of reperfusion. Knockdown of TILR",
    "entities": [
      {
        "text": "12 hours",
        "label": "TIME"
      },
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "increased the infarct volume and reduced the motor function recovery after",
    "entities": []
  },
  {
    "text": "transient middle cerebral artery occlusion, in a TET3-dependent manner. On",
    "entities": []
  },
  {
    "text": "contrary, TET3 activation by ascorbate decreased brain damage and improved motor",
    "entities": []
  },
  {
    "text": "function recovery after ischemia. However, ascorbate-induced postischemic",
    "entities": []
  },
  {
    "text": "protection was abrogated by TILR knockdown. Genome-wide profiling showed that",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ascorbate increases the number of differentially hydroxymethylated regions in",
    "entities": []
  },
  {
    "text": "the poststroke genome, a neuroprotective effect that is reversed by TILR",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "knockdown. Moreover, TILR inhibition significantly reduced the DNA",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hydroxymethylation in the intergenic regions associated with enhancers, super",
    "entities": []
  },
  {
    "text": "enhancers, and the promoters of other lncRNAs, microRNAs, and PIWI-interacting",
    "entities": []
  },
  {
    "text": "RNAs.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: These findings highlight the essential role of TILR in",
    "entities": [
      {
        "text": "TILR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "TET3-mediated 5-hydroxymethylcytosine-dependent epigenetic reprogramming in the",
    "entities": [
      {
        "text": "5-hydroxymethylcytosine-dependent",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "ischemic brain.",
    "entities": []
  },
  {
    "text": "10.1161/CIRCINTERVENTIONS.125.015196. Online ahead of print.",
    "entities": [
      {
        "text": "10.1161",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve",
    "entities": []
  },
  {
    "text": "Morray BH(1), Gillespie MJ(2), Cheatham JP(3), Salavitabar A(4), Peng L(5),",
    "entities": [
      {
        "text": "Gillespie MJ(2",
        "label": "PERSON"
      },
      {
        "text": "Cheatham JP(3",
        "label": "PERSON"
      },
      {
        "text": "Salavitabar",
        "label": "GPE"
      },
      {
        "text": "Peng L(5",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Division of Pediatric Cardiology, Seattle Children's Hospital, WA (B.H.M.,",
    "entities": [
      {
        "text": "Seattle Children's Hospital",
        "label": "ORG"
      },
      {
        "text": "B.H.M.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Division of Cardiology, Children's Hospital of Philadelphia, PA (M.J.G.).",
    "entities": [
      {
        "text": "Cardiology, Children's Hospital of Philadelphia",
        "label": "ORG"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "M.J.G.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Pediatrics and Cardiology, The Ohio State University, Columbus (J.P.C.).",
    "entities": [
      {
        "text": "3)Pediatrics and",
        "label": "ORG"
      },
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "The Ohio State University",
        "label": "ORG"
      },
      {
        "text": "Columbus",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Nationwide Children's Hospital, Columbus, OH (A.S.).",
    "entities": [
      {
        "text": "Children's Hospital",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Columbus",
        "label": "GPE"
      },
      {
        "text": "OH",
        "label": "GPE"
      },
      {
        "text": "A.S.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Pediatrics, Stanford University, Lucile Packard Children's",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Pediatrics, David Geffen School of Medicine at UCLA,",
    "entities": [
      {
        "text": "Pediatrics",
        "label": "ORG"
      },
      {
        "text": "David Geffen School of Medicine",
        "label": "PERSON"
      },
      {
        "text": "UCLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, CA (D.S.L.).",
    "entities": [
      {
        "text": "Ahmanson/UCLA Adult Congenital Heart Disease Center",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      },
      {
        "text": "D.S.L.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Division of Pediatric Cardiology, University of Utah at Primary Children's",
    "entities": [
      {
        "text": "Pediatric Cardiology",
        "label": "ORG"
      },
      {
        "text": "University of Utah at Primary Children's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital, Salt Lake City (R.G.G.).",
    "entities": [
      {
        "text": "Salt Lake City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Section of Pediatric Cardiology, Yale University, New Haven, CT (J.A.).",
    "entities": [
      {
        "text": "Pediatric Cardiology",
        "label": "ORG"
      },
      {
        "text": "Yale University",
        "label": "ORG"
      },
      {
        "text": "New Haven",
        "label": "GPE"
      },
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "J.A.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Pediatric Cardiology/Structural Heart Disease, Mayo Clinic,",
    "entities": [
      {
        "text": "Pediatric Cardiology/Structural Heart Disease",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)National Cerebral and Cardiovascular Center, Osaka, Japan (K.F.).",
    "entities": [
      {
        "text": "10)National",
        "label": "CARDINAL"
      },
      {
        "text": "Cerebral and Cardiovascular Center",
        "label": "ORG"
      },
      {
        "text": "Osaka",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Section of Cardiology, Texas Children's Hospital/Baylor College of Medicine,",
    "entities": [
      {
        "text": "11)Section",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology",
        "label": "GPE"
      },
      {
        "text": "Texas Children's",
        "label": "ORG"
      },
      {
        "text": "Hospital/Baylor College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Houston, TX (A.M.Q.).",
    "entities": [
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "A.M.Q.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Department of Cardiology, Boston Children's Hospital, MA (L.B.).",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Boston Children's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13)Labatt Family Heart Center, Hospital for Sick Children, Toronto, Ontario,",
    "entities": [
      {
        "text": "13)Labatt",
        "label": "CARDINAL"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "Ontario",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Medtronic, Minneapolis, MN (D.H.).",
    "entities": [
      {
        "text": "14)Medtronic",
        "label": "DATE"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      },
      {
        "text": "D.H.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)Department of Cardiothoracic Surgery, Stanford University Medical Center, CA",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stanford University Medical Center",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "BACKGROUND: The Harmony transcatheter pulmonary valve (TPV) is designed to treat",
    "entities": [
      {
        "text": "Harmony",
        "label": "ORG"
      },
      {
        "text": "TPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "severe pulmonary regurgitation in the native or surgically repaired right",
    "entities": []
  },
  {
    "text": "ventricular (RV) outflow tract. Early outcomes after TPV replacement with the",
    "entities": [
      {
        "text": "ventricular",
        "label": "PERSON"
      },
      {
        "text": "RV",
        "label": "ORG"
      },
      {
        "text": "TPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Harmony valve have been positive, but longer-term data are limited.",
    "entities": []
  },
  {
    "text": "METHODS: The study included patients who received a commercially available TPV22",
    "entities": []
  },
  {
    "text": "or TPV25 device as part of the nonrandomized, prospective Native Outflow Tract",
    "entities": [
      {
        "text": "Native Outflow Tract",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study.",
    "entities": [
      {
        "text": "Continued Access Study",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Patients completed at least 3 years of follow-up, and outcomes to 5 years were",
    "entities": [
      {
        "text": "at least 3 years",
        "label": "DATE"
      },
      {
        "text": "5 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "reported when available.",
    "entities": []
  },
  {
    "text": "RESULTS: Eighty-nine patients were catheterized, and 86 were successfully",
    "entities": [
      {
        "text": "Eighty-nine",
        "label": "CARDINAL"
      },
      {
        "text": "86",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "implanted with a Harmony TPV. Median duration of follow-up was 5 (range 0-6)",
    "entities": [
      {
        "text": "5",
        "label": "DATE"
      },
      {
        "text": "0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years in the TPV22 group and 3 (1-4) years in the TPV25 group. At 3 years, all",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "1-4) years",
        "label": "DATE"
      },
      {
        "text": "TPV25",
        "label": "GPE"
      },
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients with a TPV22 and 96% of those with a TPV25 had \u2264mild pulmonary",
    "entities": [
      {
        "text": "96%",
        "label": "PERCENT"
      },
      {
        "text": "\u2264mild pulmonary\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "regurgitation. By magnetic resonance imaging, significant improvements from",
    "entities": []
  },
  {
    "text": "preimplant to 2 years were observed in RV end-diastolic volume index, RV to left",
    "entities": [
      {
        "text": "2 years",
        "label": "DATE"
      },
      {
        "text": "RV",
        "label": "GPE"
      },
      {
        "text": "RV",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "P<0.001). SF-36 quality-of-life scores improved after Harmony implantation and",
    "entities": [
      {
        "text": "Harmony",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "were sustained over 3 years. Early cases of ventricular tachycardia resolved,",
    "entities": [
      {
        "text": "3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and there were no new arrhythmias. Adverse events up to 5 years included 3",
    "entities": [
      {
        "text": "up to 5 years",
        "label": "DATE"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "deaths unrelated to the device or procedure, 2 cases of endocarditis that were",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "treated (1 medically, 1 transcatheter debulking of a vegetation) and resolved, 6",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients with RV outflow tract obstruction and thrombosis resulting in valve-in",
    "entities": [
      {
        "text": "RV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "valve procedures, and 1 major stent fracture resulting in surgical explant.",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: At 3 to 5 years, Harmony TPV replacement resulted in sustained",
    "entities": [
      {
        "text": "3 to 5 years",
        "label": "DATE"
      },
      {
        "text": "Harmony TPV",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "valve competence, beneficial cardiac remodeling, and improved quality of life.",
    "entities": []
  },
  {
    "text": "Continued monitoring is needed to assess long-term outcomes and valve",
    "entities": []
  },
  {
    "text": "performance.",
    "entities": []
  },
  {
    "text": "ahead of print.",
    "entities": []
  },
  {
    "text": "Comparative efficacy and safety of prourokinase versus alteplase for acute",
    "entities": []
  },
  {
    "text": "ischemic stroke within 4.5 hours: a systematic review and meta-analysis of",
    "entities": [
      {
        "text": "4.5 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "randomized controlled trials.",
    "entities": []
  },
  {
    "text": "Mohammed HE(1), Haseeb ME(2), Bady Z(1)(3), Arafeh Y(4).",
    "entities": [
      {
        "text": "Mohammed HE(1",
        "label": "PERSON"
      },
      {
        "text": "Haseeb ME(2",
        "label": "PERSON"
      },
      {
        "text": "Arafeh Y(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Faculty of Medicine, Assiut University, Assiut, Egypt.",
    "entities": [
      {
        "text": "Medicine, Assiut University",
        "label": "ORG"
      },
      {
        "text": "Assiut",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Faculty of Medicine, Minia University, Minia, Egypt.",
    "entities": [
      {
        "text": "2)Faculty",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine, Minia University",
        "label": "ORG"
      },
      {
        "text": "Minia",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Medical Research Group of Egypt (MRGE), Cairo, Egypt.",
    "entities": [
      {
        "text": "Research Group",
        "label": "ORG"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      },
      {
        "text": "MRGE",
        "label": "ORG"
      },
      {
        "text": "Cairo",
        "label": "GPE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Faculty of Medicine, Jordan University of Science and Technology, Irbid,",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Jordan University of Science and Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Intravenous thrombolysis with recombinant tissue plasminogen",
    "entities": []
  },
  {
    "text": "activator, such as alteplase, is the standard treatment for acute ischemic",
    "entities": []
  },
  {
    "text": "stroke (AIS). However, concerns about cost and safety have led to an interest in",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "alternative thrombolytics like prourokinase (rhPro-UK). This meta-analysis",
    "entities": [
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "evaluated the efficacy and safety of prourokinase compared to alteplase for AIS",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "treatment within 4.5 hours of symptom onset.",
    "entities": [
      {
        "text": "4.5 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "METHODS: A literature search was conducted across PubMed, Web of Science, and",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Scopus up to January 2025. The outcome measures included functional outcomes",
    "entities": [
      {
        "text": "up to January 2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(modified Rankin Scale [mRS]), early neurological improvement (NIHSS reduction),",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      },
      {
        "text": "NIHSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and safety outcomes, involving symptomatic intracranial hemorrhage (sICH).",
    "entities": []
  },
  {
    "text": "PROSPERO registration is CRD42025632210.",
    "entities": [
      {
        "text": "CRD42025632210",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RESULTS: Three RCTs with a total of 2,289 patients were included. The proportion",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "2,289",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of patients achieving excellent functional outcomes (mRS 0-1 at 90 days) did not",
    "entities": [
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "differ significantly between groups (risk ratio (RR): 1.04, 95% confidence",
    "entities": [
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "interval (CI): 0.98-1.10, p = 0.17). Similarly, good functional outcomes (mRS",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.98-1.10",
        "label": "CARDINAL"
      },
      {
        "text": "0.17",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0-2) were comparable (p = 0.86). Early neurological improvement at 24 hours was",
    "entities": [
      {
        "text": "0",
        "label": "CARDINAL"
      },
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "also similar (p = 0.32). However, prourokinase showed a slight but statistically",
    "entities": [
      {
        "text": "0.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significant advantage in NIHSS score reduction at 24 hours (mean difference",
    "entities": [
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "(MD): -0.43, 95% CI: -0.85 to -0.02, p = 0.04). The risk of sICH, defined by",
    "entities": [
      {
        "text": "MD",
        "label": "GPE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ECASS III (p = 0.16) and SITS-MOST (p = 0.07), showed insignificant difference.",
    "entities": [
      {
        "text": "0.16",
        "label": "CARDINAL"
      },
      {
        "text": "0.07",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: Prourokinase is a safe and effective thrombolytic agent for AIS",
    "entities": [
      {
        "text": "Prourokinase",
        "label": "PERSON"
      },
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "within 4.5 hours, demonstrating non-inferiority to alteplase in both efficacy",
    "entities": [
      {
        "text": "4.5 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "and safety. Its advantages, including lower cost and ease of administration,",
    "entities": []
  },
  {
    "text": "make it a viable alternative. Future large-scale trials are recommended.",
    "entities": []
  },
  {
    "text": "10.1177/15910199251342841. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/15910199251342841",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Baseline predictors of poor clinical outcome despite recanalization of distal",
    "entities": []
  },
  {
    "text": "middle cerebral artery occlusions.",
    "entities": []
  },
  {
    "text": "Sheth SA(20), Essibayi MA(21), Puri AS(8), Dyzmann C(22), Colasurdo M(23),",
    "entities": [
      {
        "text": "Sheth",
        "label": "PERSON"
      },
      {
        "text": "Puri AS(8",
        "label": "PERSON"
      },
      {
        "text": "Dyzmann C(22",
        "label": "PERSON"
      },
      {
        "text": "Colasurdo M(23",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "TR(16), Spears J(16), Ota T(29), Mowla A(30), Jabbour P(5), Biswas A(31),",
    "entities": [
      {
        "text": "Mowla A(30",
        "label": "PERSON"
      },
      {
        "text": "Jabbour P(5",
        "label": "PERSON"
      },
      {
        "text": "Biswas A(31",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Pedicelli A(43), Alexandre AM(43), Tancredi I(44), Faizy TD(45), Kalsoum E(11),",
    "entities": [
      {
        "text": "Pedicelli A(43",
        "label": "PERSON"
      },
      {
        "text": "Alexandre",
        "label": "PERSON"
      },
      {
        "text": "Faizy",
        "label": "PERSON"
      },
      {
        "text": "Kalsoum E(11",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Patel AB(3), Fahed R(46), Wang M(1), Pereira VM(16), Lubicz B(1), Dmytriw",
    "entities": [
      {
        "text": "Patel AB(3",
        "label": "PERSON"
      },
      {
        "text": "Wang",
        "label": "ORG"
      },
      {
        "text": "Pereira VM(16",
        "label": "GPE"
      },
      {
        "text": "Lubicz B(1",
        "label": "PERSON"
      },
      {
        "text": "Dmytriw",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Diagnostic and Interventional Neuroradiology, Erasme University",
    "entities": [
      {
        "text": "Diagnostic and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Erasme University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical",
    "entities": [
      {
        "text": "Radiology, Division of Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Center, Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University, Boston, MA, USA.",
    "entities": [
      {
        "text": "University,",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery and Interventional Neuroradiology, Louisiana State",
    "entities": [
      {
        "text": "Neurosurgery and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Louisiana State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Shreveport, LA, USA.",
    "entities": [
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "Shreveport",
        "label": "GPE"
      },
      {
        "text": "LA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "Thomas Jefferson University",
        "label": "PERSON"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Neurology, University of Massachusetts Chan Medical School,",
    "entities": [
      {
        "text": "Neurology, University of Massachusetts Chan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Worcester, MA, USA.",
    "entities": [
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Endovascular Neurosurgery and Neuroradiology, Rutgers Health",
    "entities": [
      {
        "text": "Endovascular Neurosurgery and Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Rutgers Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "New Jersey Medical School (NJMS), Newark, NJ, USA.",
    "entities": [
      {
        "text": "New Jersey Medical School (NJMS",
        "label": "ORG"
      },
      {
        "text": "Newark",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Division of Neurointerventional Radiology, Department of Radiology,",
    "entities": [
      {
        "text": "Neurointerventional Radiology,",
        "label": "ORG"
      },
      {
        "text": "Department of Radiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Massachusetts Medical Center, Worcester, MA, USA.",
    "entities": [
      {
        "text": "University of Massachusetts Medical Center",
        "label": "ORG"
      },
      {
        "text": "Worcester",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Cooper Neurological Institute, Cooper University Hospital, Cooper Medical",
    "entities": [
      {
        "text": "Neurological Institute",
        "label": "ORG"
      },
      {
        "text": "Cooper University Hospital",
        "label": "ORG"
      },
      {
        "text": "Cooper Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Rowan University, Camden, NJ, USA.",
    "entities": [
      {
        "text": "School of Rowan University",
        "label": "ORG"
      },
      {
        "text": "Camden",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Departments of Neurological Surgery & Radiology, Mayo Clinic, Rochester, MN,",
    "entities": [
      {
        "text": "10)Departments",
        "label": "CARDINAL"
      },
      {
        "text": "Neurological Surgery & Radiology",
        "label": "ORG"
      },
      {
        "text": "Mayo Clinic",
        "label": "ORG"
      },
      {
        "text": "Rochester",
        "label": "GPE"
      },
      {
        "text": "MN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Neurology, University of Chicago, Chicago, IL, USA.",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, University of Chicago",
        "label": "ORG"
      },
      {
        "text": "Chicago",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Medicine, Yong Loo Lin School of Medicine, National University",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Yong Loo Lin School of Medicine",
        "label": "ORG"
      },
      {
        "text": "National University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(14)Division of Neurology, Department of Medicine, National University Hospital,",
    "entities": [
      {
        "text": "14)Division",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, Department of Medicine,",
        "label": "ORG"
      },
      {
        "text": "National University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Department of Interventional Neuroradiology, Stanford Medical Center, Palo",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Stanford Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(16)Neurovascular Centre, Divisions of Therapeutic Neuroradiology and",
    "entities": []
  },
  {
    "text": "Neurosurgery, St Michael's Hospital, Toronto, ON, Canada.",
    "entities": [
      {
        "text": "St Michael's",
        "label": "PERSON"
      },
      {
        "text": "Toronto",
        "label": "GPE"
      },
      {
        "text": "ON",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery, Brigham and Women's Hospital",
        "label": "ORG"
      },
      {
        "text": "Harvard Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Boston, MA, USA.",
    "entities": [
      {
        "text": "School",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)University Hospital of Limoges, Neuroradiology Department, Dupuytren,",
    "entities": [
      {
        "text": "Neuroradiology Department",
        "label": "ORG"
      },
      {
        "text": "Dupuytren",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(19)Department of Diagnostic and Interventional Neuroradiology, University",
    "entities": [
      {
        "text": "19)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical Center Hamburg-Eppendorf, Hamburg, Germany.",
    "entities": [
      {
        "text": "Hamburg",
        "label": "GPE"
      },
      {
        "text": "Germany",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Department of Neurology, UTHealth McGovern Medical School, Houston, TX, USA.",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "UTHealth McGovern Medical School",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(21)Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Montefiore-Einstein Cerebrovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine,",
    "entities": [
      {
        "text": "Montefiore Medical Center",
        "label": "ORG"
      },
      {
        "text": "Albert Einstein College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bronx, NY, USA.",
    "entities": [
      {
        "text": "Bronx",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Interventional Radiology, Oregon Health and Science",
    "entities": [
      {
        "text": "23)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Radiology",
        "label": "ORG"
      },
      {
        "text": "Oregon Health and Science\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Portland, OR, USA.",
    "entities": [
      {
        "text": "Portland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Interventional Neuroradiology Department, Bordeaux University Hospital,",
    "entities": [
      {
        "text": "24)Interventional Neuroradiology Department",
        "label": "ORG"
      },
      {
        "text": "Bordeaux University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(26)Department of Diagnostic and Interventional Neuroradiology, Centro",
    "entities": [
      {
        "text": "26)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Diagnostic and Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Centro",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(27)Department of Neurology, University of Cincinnati Medical Center,",
    "entities": [
      {
        "text": "27)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology, University of Cincinnati Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical Center, Montpellier, France.",
    "entities": [
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Montpellier",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Tokyo,",
    "entities": [
      {
        "text": "29)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Tokyo Metropolitan Tama Medical Center",
        "label": "ORG"
      },
      {
        "text": "Tokyo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(30)Division of Stroke and Endovascular Neurosurgery, Department of Neurological",
    "entities": [
      {
        "text": "Department of Neurological",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Surgery, Keck School of Medicine, University of Southern California (USC), Los",
    "entities": [
      {
        "text": "Keck School of Medicine, University of Southern California",
        "label": "ORG"
      },
      {
        "text": "USC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(31)Department of Neurosurgery, Westchester Medical Center at New York Medical",
    "entities": [
      {
        "text": "31)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery, Westchester Medical Center",
        "label": "ORG"
      },
      {
        "text": "New York Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(33)GRC BioFast. Sorbonne University Paris VI, Paris, France.",
    "entities": [
      {
        "text": "BioFast",
        "label": "ORG"
      },
      {
        "text": "Sorbonne University",
        "label": "ORG"
      },
      {
        "text": "Paris VI",
        "label": "PERSON"
      },
      {
        "text": "Paris",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Departments of Radiology & Neurology, Boston Medical Center, Boston, MA,",
    "entities": [
      {
        "text": "34)Departments of Radiology & Neurology",
        "label": "ORG"
      },
      {
        "text": "Boston Medical Center",
        "label": "ORG"
      },
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "MA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(36)Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA,",
    "entities": [
      {
        "text": "36)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery",
        "label": "PRODUCT"
      },
      {
        "text": "Cedars-Sinai Medical Center",
        "label": "ORG"
      },
      {
        "text": "Los Angeles",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(38)Department of Interventional Neuroradiology, Nancy University Hospital,",
    "entities": [
      {
        "text": "38)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "Nancy University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Nancy, France.",
    "entities": [
      {
        "text": "Nancy",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(39)INSERM U1254, Laboratory of Adaptive Diagnostic and Interventional Imaging",
    "entities": [
      {
        "text": "39)INSERM",
        "label": "CARDINAL"
      },
      {
        "text": "U1254, Laboratory of Adaptive Diagnostic",
        "label": "ORG"
      },
      {
        "text": "Interventional Imaging",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(40)Department of Radiology, Interventional Neuroradiology Section, University",
    "entities": [
      {
        "text": "40)Department of Radiology, Interventional Neuroradiology Section",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(41)Departments of Neurology & Neurosurgery, Christian Doppler Clinic,",
    "entities": [
      {
        "text": "41)Departments",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology & Neurosurgery",
        "label": "ORG"
      },
      {
        "text": "Christian Doppler Clinic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Paracelsus Medical University Salzburg, Salzburg, Austria.",
    "entities": [
      {
        "text": "Paracelsus Medical University Salzburg",
        "label": "ORG"
      },
      {
        "text": "Salzburg",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)UCLA Stroke Center and Department of Neurology Department, UCLA, Los",
    "entities": [
      {
        "text": "42)UCLA Stroke Center and Department of Neurology Department",
        "label": "WORK_OF_ART"
      },
      {
        "text": "UCLA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(44)Department of Neurology, H\u00f4pital Civil Marie Curie, Charleroi, Belgium.",
    "entities": [
      {
        "text": "Marie Curie",
        "label": "PERSON"
      },
      {
        "text": "Charleroi",
        "label": "GPE"
      },
      {
        "text": "Belgium",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)Department of Radiology, Neuroendovascular Program, University Medical",
    "entities": [
      {
        "text": "Radiology, Neuroendovascular Program",
        "label": "ORG"
      },
      {
        "text": "University Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(46)Department of Medicine - Division of Neurology; The Ottawa Hospital, Ottawa",
    "entities": [
      {
        "text": "46)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Medicine - Division of Neurology",
        "label": "ORG"
      },
      {
        "text": "The Ottawa Hospital",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hospital Research Institute and University of Ottawa, Ottawa-Ontario, Canada.",
    "entities": [
      {
        "text": "Hospital Research Institute",
        "label": "ORG"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ObjectiveMechanical thrombectomy (MT) is well-established for the treatment of",
    "entities": [
      {
        "text": "ObjectiveMechanical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "acute ischemic stroke (AIS) from large vessel occlusion (LVO), with growing data",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "LVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "supporting the expansion to distal and medium vessel occlusions (DMVO). Despite",
    "entities": []
  },
  {
    "text": "successful recanalization in DMVO, certain patients still experience poor",
    "entities": [
      {
        "text": "DMVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long-term clinical outcomes, prompting our study to comprehensively explore",
    "entities": []
  },
  {
    "text": "pre-MT factors influencing outcome despite excellent recanalization (final",
    "entities": []
  },
  {
    "text": "modified Thrombolysis in Cerebral Infarction [mTICI] score \u22652c).MethodsWe",
    "entities": [
      {
        "text": "\u22652c).MethodsWe",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "retrospectively examined data from patients who consecutively underwent MT for a",
    "entities": []
  },
  {
    "text": "primary middle cerebral artery (MCA) DMVO across 37 centers in North America,",
    "entities": [
      {
        "text": "MCA",
        "label": "ORG"
      },
      {
        "text": "DMVO",
        "label": "ORG"
      },
      {
        "text": "37",
        "label": "CARDINAL"
      },
      {
        "text": "North America",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Asia, and Europe. We identified baseline clinical and imaging factors associated",
    "entities": [
      {
        "text": "Asia",
        "label": "LOC"
      },
      {
        "text": "Europe",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "with poor clinical outcome (defined as a modified Rankin Scale [mRS] score of",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "3-6) at 3 months, despite excellent recanalization using a multivariable",
    "entities": [
      {
        "text": "3-6",
        "label": "CARDINAL"
      },
      {
        "text": "3 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "model.ResultsBetween September 2017 and July 2021, 623 patients achieved",
    "entities": [
      {
        "text": "ResultsBetween September 2017 and July 2021",
        "label": "EVENT"
      },
      {
        "text": "623",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mTICI > 2b and they were included in our study. Among them, 198 (32%)",
    "entities": [
      {
        "text": "2b",
        "label": "CARDINAL"
      },
      {
        "text": "198",
        "label": "CARDINAL"
      },
      {
        "text": "32%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "experienced a poor clinical outcome (mRS 3-6). Predictors of poor clinical",
    "entities": [
      {
        "text": "3-6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "outcome included higher age (OR 1.05 [1.03-1.07], p < 0.001), higher NIHSS at",
    "entities": [
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.03",
        "label": "CARDINAL"
      },
      {
        "text": "NIHSS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "admission (OR 1.12 [1.08-1.15], p < 0.001), higher baseline mRS (OR 1.77",
    "entities": [
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      },
      {
        "text": "1.77",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[0.96-3.26], p = 0.067), and diabetes (OR 1.59 [1.01-2.48], p = 0.044). Higher",
    "entities": [
      {
        "text": "0.96",
        "label": "CARDINAL"
      },
      {
        "text": "3.26",
        "label": "CARDINAL"
      },
      {
        "text": "0.067",
        "label": "CARDINAL"
      },
      {
        "text": "1.59",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "0.044",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ASPECTS was associated with a decreased risk of poor clinical outcome (OR 0.82",
    "entities": [
      {
        "text": "0.82",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[0.71-0.94], p = 0.006).ConclusionOlder age, diabetes, higher baseline mRS, and",
    "entities": [
      {
        "text": "0.71",
        "label": "CARDINAL"
      },
      {
        "text": "0.006).ConclusionOlder age",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "NIHSS were associated with poor clinical outcome in MCA DMVO despite excellent",
    "entities": [
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "MCA DMVO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recanalization. Conversely, a higher ASPECTS decreased the probability of such",
    "entities": [
      {
        "text": "ASPECTS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "an outcome.",
    "entities": []
  },
  {
    "text": "of print.",
    "entities": []
  },
  {
    "text": "Complications of Carotid Artery Stenting: A Real-World Cohort Study in Canada",
    "entities": [
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "before and during the COVID-19 Pandemic.",
    "entities": []
  },
  {
    "text": "S(1), Singh N(5)(6), Chakraborty S(2)(7), Portela de Oliveira E(2)(7),",
    "entities": [
      {
        "text": "Singh N(5)(6",
        "label": "GPE"
      },
      {
        "text": "Chakraborty",
        "label": "ORG"
      },
      {
        "text": "Portela de Oliveira",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Medicine, University of Ottawa, Ottawa, Canada.",
    "entities": [
      {
        "text": "Medicine, University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Ottawa Hospital Research Institute, Ottawa, Canada.",
    "entities": [
      {
        "text": "2)Ottawa Hospital Research Institute",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Medical Imaging, Division of Radiology, University of Ottawa,",
    "entities": [
      {
        "text": "Medical Imaging",
        "label": "ORG"
      },
      {
        "text": "Division of Radiology",
        "label": "ORG"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Surgery and School of Epidemiology and Public Health, Division",
    "entities": [
      {
        "text": "Surgery and School of Epidemiology and Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Vascular and Endovascular Surgery, University of Ottawa, Ottawa, Canada.",
    "entities": [
      {
        "text": "Vascular",
        "label": "LOC"
      },
      {
        "text": "University of Ottawa",
        "label": "ORG"
      },
      {
        "text": "Ottawa",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosciences, Radiology and Community Health Sciences,",
    "entities": [
      {
        "text": "Neurosciences, Radiology and Community Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Calgary, Calgary, Canada.",
    "entities": [
      {
        "text": "University of Calgary",
        "label": "ORG"
      },
      {
        "text": "Calgary",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Internal Medicine (Neurology Division), Rady Faculty of Health",
    "entities": [
      {
        "text": "Internal Medicine (Neurology Division",
        "label": "ORG"
      },
      {
        "text": "Rady Faculty of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Manitoba, Winnipeg, Canada.",
    "entities": [
      {
        "text": "University of Manitoba",
        "label": "ORG"
      },
      {
        "text": "Winnipeg",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Radiology, Radiation Oncology and Medical Physics, University",
    "entities": [
      {
        "text": "Radiology, Radiation Oncology and Medical Physics",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND AND OBJECTIVES: Although carotid endarterectomy (CEA) or carotid",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      },
      {
        "text": "CEA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "artery stenting (CAS) is recommended for symptomatic extracranial carotid",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stenosis of 50-99%, the COVID-19 pandemic significantly impacted resources. CAS",
    "entities": [
      {
        "text": "50-99%",
        "label": "PERCENT"
      },
      {
        "text": "COVID-19",
        "label": "ORG"
      },
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "therefore offered potential advantages as access to the angiosuite was seemingly",
    "entities": []
  },
  {
    "text": "easier than access to operating rooms. The primary objective was to determine",
    "entities": []
  },
  {
    "text": "the frequency of serious and non-serious complications following CAS before and",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "during the COVID-19 pandemic.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We performed a retrospective cohort study of consecutive patients who",
    "entities": []
  },
  {
    "text": "received CAS at the Ottawa Hospital, Canada, from June 2019 to May 2021. We",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      },
      {
        "text": "the Ottawa Hospital",
        "label": "FAC"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "June 2019",
        "label": "DATE"
      },
      {
        "text": "May 2021",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "reviewed baseline demographics, imaging, as well as intraprocedural and",
    "entities": []
  },
  {
    "text": "postprocedural complications based on chart review. We performed multivariable",
    "entities": []
  },
  {
    "text": "logistic regression to determine associations between clinical and safety",
    "entities": []
  },
  {
    "text": "RESULTS: We included 47 patients in the pre-pandemic period and 93 patients in",
    "entities": [
      {
        "text": "47",
        "label": "CARDINAL"
      },
      {
        "text": "93",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the pandemic period (mean age = 70.4 years; 54% female; P = 0.287 for age and P",
    "entities": [
      {
        "text": "70.4 years",
        "label": "DATE"
      },
      {
        "text": "54%",
        "label": "PERCENT"
      },
      {
        "text": "0.287",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "= 0.962 for sex, respectively). The combined rate of intraprocedural and",
    "entities": [
      {
        "text": "0.962",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "postprocedural serious complications (ischemic stroke, intracerebral hemorrhage,",
    "entities": []
  },
  {
    "text": "myocardial infarction or death) was 7.1%. Eight strokes occurred, and one",
    "entities": [
      {
        "text": "7.1%",
        "label": "PERCENT"
      },
      {
        "text": "Eight",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patient with a postprocedural ischemic stroke died 11 days after stenting.",
    "entities": [
      {
        "text": "11 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Complication rates were similar before and during the pandemic (aOR 1.040, 95%",
    "entities": [
      {
        "text": "1.040",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI 0.466-2.321). The number of referrals for CEA during the pandemic period",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.466-2.321",
        "label": "CARDINAL"
      },
      {
        "text": "CEA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "decreased by 50%.",
    "entities": [
      {
        "text": "50%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSION: In this cohort of consecutive patients undergoing CAS at a Canadian",
    "entities": [
      {
        "text": "CAS",
        "label": "ORG"
      },
      {
        "text": "Canadian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "comprehensive stroke center before and during the COVID-19 pandemic, the rates",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of stroke and death were similar to pre-pandemic conditions and were generally",
    "entities": []
  },
  {
    "text": "consistent with the published literature.",
    "entities": []
  },
  {
    "text": "39. J Cereb Blood Flow Metab. 2025 Jul 15:271678X251358979. doi:",
    "entities": [
      {
        "text": "39",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15:271678X251358979",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1177/0271678X251358979. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/0271678X251358979",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Characterizing pre- and post-operative cerebral blood flow and transit time in",
    "entities": []
  },
  {
    "text": "pediatric moyamoya patients using multi-delay ASL and DSC MRI.",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "DSC MRI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Neurosurgery and Stanford Stroke Center, Stanford University,",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "PRODUCT"
      },
      {
        "text": "Stanford Stroke Center",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Stanford, CA, USA.",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Maternal and Child Health Research Institute, Stanford University, Stanford,",
    "entities": [
      {
        "text": "Child Health Research Institute",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Radiology, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurology, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Cerebral blood flow (CBF) and transit time are essential biomarkers for",
    "entities": [
      {
        "text": "CBF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "assessing brain health. While dynamic susceptibility contrast (DSC) MRI has been",
    "entities": []
  },
  {
    "text": "widely applied to measure these metrics, it is limited in the pediatric",
    "entities": []
  },
  {
    "text": "population due to the need for contrast agents. Arterial spin labeling is a",
    "entities": []
  },
  {
    "text": "non-invasive and quantitative MR modality, and multi-delay ASL can measure CBF",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "CBF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and transit time simultaneously. Although multi-delay ASL has been used in adult",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neuroimaging studies, its application in children requires investigation.",
    "entities": []
  },
  {
    "text": "Moyamoya disease, a progressive steno-occlusive cerebrovascular disorder, often",
    "entities": []
  },
  {
    "text": "manifests in childhood. In this work, we present a cohort study that examines",
    "entities": []
  },
  {
    "text": "multi-delay ASL and DSC MRI to characterize vascular hemodynamics in 22",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "DSC",
        "label": "ORG"
      },
      {
        "text": "22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pediatric patients. We evaluate CBF and transit time in different brain regions",
    "entities": [
      {
        "text": "CBF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "before and after revascularization surgeries. Results show that",
    "entities": []
  },
  {
    "text": "revascularization significantly increased CBF by 24% and 7.6%, respectively, as",
    "entities": [
      {
        "text": "CBF",
        "label": "ORG"
      },
      {
        "text": "24%",
        "label": "PERCENT"
      },
      {
        "text": "7.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "measured by ASL and DSC; it also significantly decreased transit time by 12% and",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "DSC",
        "label": "ORG"
      },
      {
        "text": "12%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "15%, indicating improved hemodynamics and metabolism. ASL and DSC results also",
    "entities": [
      {
        "text": "15%",
        "label": "PERCENT"
      },
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "DSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "showed significantly positive correlations in all brain regions. Thus,",
    "entities": []
  },
  {
    "text": "revascularization improved hemodynamics in pediatric moyamoya patients and shows",
    "entities": []
  },
  {
    "text": "that multi-delay ASL can effectively characterize CBF and transit time in the",
    "entities": [
      {
        "text": "ASL",
        "label": "ORG"
      },
      {
        "text": "CBF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "40. J Med Econ. 2025 Jul 15:1-16. doi: 10.1080/13696998.2025.2535236. Online",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Projected clinical and economic benefits of improved patent foramen ovale",
    "entities": []
  },
  {
    "text": "testing among cryptogenic stroke patients in the United States.",
    "entities": [
      {
        "text": "the United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Volpi JJ(1), Kasner SE(2), Looman T(3), Tiozzo G(3)(4), Louwsma T(3)(4), Imhoff",
    "entities": [
      {
        "text": "Kasner SE(2",
        "label": "PERSON"
      },
      {
        "text": "Looman T(3",
        "label": "PERSON"
      },
      {
        "text": "Tiozzo",
        "label": "PERSON"
      },
      {
        "text": "Louwsma",
        "label": "PERSON"
      },
      {
        "text": "Imhoff",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)The Houston Methodist Institute for Academic Medicine, Houston, TX, USA.",
    "entities": [
      {
        "text": "Houston Methodist Institute for Academic Medicine",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.",
    "entities": [
      {
        "text": "Neurology, University of Pennsylvania",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "PA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Asc Academics B.V, Groningen, Netherlands.",
    "entities": [
      {
        "text": "3)Asc",
        "label": "CARDINAL"
      },
      {
        "text": "Groningen",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Health Sciences, University Medical Centre Groningen,",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University Medical Centre Groningen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)W. L. Gore & Associates, Newark, DE, USA.",
    "entities": [
      {
        "text": "5)W.",
        "label": "CARDINAL"
      },
      {
        "text": "L. Gore & Associates",
        "label": "ORG"
      },
      {
        "text": "Newark",
        "label": "GPE"
      },
      {
        "text": "DE",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Accurate determination of stroke etiology is essential for effective",
    "entities": []
  },
  {
    "text": "secondary stroke prevention, yet 25% to 40% of ischemic strokes are classified",
    "entities": [
      {
        "text": "25% to 40%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "as cryptogenic. Patent foramen ovale (PFO), a common finding in cryptogenic",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke, elevates the risk of strokes. However, underuse of diagnostic practices",
    "entities": []
  },
  {
    "text": "may lead to underdiagnosis of PFO, missing opportunities for",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "guideline-recommended PFO closures and preventable recurrent strokes. This study",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "estimates the value of improving testing for PFO among patients with cryptogenic",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke in the US.",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "METHODS: A cost-effectiveness analysis was conducted, employing a hybrid model",
    "entities": []
  },
  {
    "text": "including a decision tree and a Markov model to assess health outcomes and",
    "entities": [
      {
        "text": "Markov",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "economic impacts from a US payor perspective over a life-time horizon. The model",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "compared two PFO testing scenarios: the Current Diagnostic Scenario (54%",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "PFO",
        "label": "ORG"
      },
      {
        "text": "the Current Diagnostic Scenario",
        "label": "ORG"
      },
      {
        "text": "54%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "testing) and Optimal PFO Diagnostics (100% testing). The decision tree evaluated",
    "entities": [
      {
        "text": "Optimal PFO Diagnostics",
        "label": "ORG"
      },
      {
        "text": "100%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "diagnostic pathways for PFO (TTE, TEE, TCD), while the Markov model simulated",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      },
      {
        "text": "TTE",
        "label": "ORG"
      },
      {
        "text": "TEE",
        "label": "ORG"
      },
      {
        "text": "TCD",
        "label": "GPE"
      },
      {
        "text": "Markov",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "patient progression through various health states (recurrent ischemic stroke,",
    "entities": []
  },
  {
    "text": "TIA, and death). Cost-effectiveness was determined using the incremental",
    "entities": [
      {
        "text": "TIA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cost-effectiveness ratio (ICER) with a willingness-to-pay threshold of $75,000",
    "entities": [
      {
        "text": "75,000",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "per Quality-Adjusted Life Year (QALY).",
    "entities": [
      {
        "text": "Quality-Adjusted Life Year",
        "label": "ORG"
      },
      {
        "text": "QALY",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "RESULTS: In a simulated cohort of 1,000 patients, increasing the diagnostic",
    "entities": [
      {
        "text": "1,000",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "testing rate for PFO from 54% to 100% is expected to prevent 63 recurrent",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      },
      {
        "text": "54% to 100%",
        "label": "PERCENT"
      },
      {
        "text": "63",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strokes, resulting in 23 life years saved and 286 QALYs gained. This led to",
    "entities": [
      {
        "text": "23 life years",
        "label": "DATE"
      },
      {
        "text": "286",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cost-savings of $1.9 million for payors, indicating a dominant economic position",
    "entities": [
      {
        "text": "$1.9 million",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "(ICER = -$6,770/QALY). The model estimated screening four patients would lead to",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "identifying and closing one PFO, while screening seven would prevent one",
    "entities": [
      {
        "text": "one",
        "label": "CARDINAL"
      },
      {
        "text": "PFO",
        "label": "ORG"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recurrent stroke. Thorough sensitivity analyses confirmed the robustness of",
    "entities": []
  },
  {
    "text": "these findings.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Improving PFO diagnostic testing among patients with cryptogenic",
    "entities": [
      {
        "text": "PFO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke is projected to result in improved health outcomes for patients, while",
    "entities": []
  },
  {
    "text": "yielding cost-savings for US payors, underscoring the importance of adhering to",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Vessel Wall Imaging for Identifying Symptomatic Atherosclerotic Plaque in",
    "entities": [
      {
        "text": "Vessel Wall Imaging for Identifying Symptomatic Atherosclerotic Plaque",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Perforating Artery Stroke.",
    "entities": []
  },
  {
    "text": "42. Ann Clin Transl Neurol. 2025 Jul 15. doi: 10.1002/acn3.70144. Online ahead of",
    "entities": [
      {
        "text": "42",
        "label": "CARDINAL"
      },
      {
        "text": "Ann Clin Transl Neurol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Associations of Stroke With Risk of Epilepsy: Results From the Atherosclerosis",
    "entities": [
      {
        "text": "Associations of Stroke With Risk of Epilepsy",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Risk in Communities (ARIC) Study.",
    "entities": []
  },
  {
    "text": "Zhou J(1), Ladak AA(1), Law CA(1), Johansen MC(2), Reyes A(3), Koton S(4)(5),",
    "entities": [
      {
        "text": "Ladak AA(1",
        "label": "PERSON"
      },
      {
        "text": "Law CA(1",
        "label": "PERSON"
      },
      {
        "text": "Johansen MC(2",
        "label": "PERSON"
      },
      {
        "text": "Reyes A(3",
        "label": "PRODUCT"
      },
      {
        "text": "Koton",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, University of Pennsylvania Perelman School of",
    "entities": [
      {
        "text": "Neurology, University of Pennsylvania Perelman School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Johns Hopkins University School of Medicine,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baltimore, Maryland, USA.",
    "entities": [
      {
        "text": "Baltimore",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Neurological Institute and Epilepsy Center, Cleveland Clinic, Cleveland,",
    "entities": [
      {
        "text": "Institute",
        "label": "ORG"
      },
      {
        "text": "Epilepsy Center",
        "label": "PERSON"
      },
      {
        "text": "Cleveland Clinic",
        "label": "ORG"
      },
      {
        "text": "Cleveland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Nursing, Tel Aviv University, Tel Aviv-Yafo, Israel.",
    "entities": [
      {
        "text": "Nursing",
        "label": "GPE"
      },
      {
        "text": "Tel Aviv University",
        "label": "ORG"
      },
      {
        "text": "Tel Aviv-Yafo",
        "label": "GPE"
      },
      {
        "text": "Israel",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Johns Hopkins Bloomberg School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Neurology, New York University Grossman School of Medicine, New",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "New York University Grossman School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "York, New York, USA.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Neurology, University of Mississippi Medical Center, Jackson,",
    "entities": [
      {
        "text": "Neurology, University of Mississippi Medical Center",
        "label": "ORG"
      },
      {
        "text": "Jackson",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Division of Epidemiology and Community Health, School of Public Health,",
    "entities": [
      {
        "text": "Epidemiology and Community Health, School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Minnesota, Minneapolis, Minnesota, USA.",
    "entities": [
      {
        "text": "University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "Minnesota",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)National Institute of Neurological Disorders and Stroke, Intramural Research",
    "entities": [
      {
        "text": "Institute of Neurological Disorders and Stroke",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Program, Bethesda, Maryland, USA.",
    "entities": [
      {
        "text": "Bethesda",
        "label": "GPE"
      },
      {
        "text": "Maryland",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Biostatics, Epidemiology, and Informatics, University of",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatics, Epidemiology",
        "label": "ORG"
      },
      {
        "text": "Informatics, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.",
    "entities": [
      {
        "text": "Pennsylvania Perelman School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Philadelphia",
        "label": "GPE"
      },
      {
        "text": "Pennsylvania",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To estimate the risk of epilepsy associated with stroke in a",
    "entities": []
  },
  {
    "text": "community-based cohort, with consideration of stroke type, number, and severity.",
    "entities": []
  },
  {
    "text": "METHODS: Data from 15,100 Atherosclerosis Risk in Communities (ARIC) Study",
    "entities": [
      {
        "text": "15,100 Atherosclerosis Risk",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "participants without stroke at baseline (1987-1989) were analyzed through",
    "entities": [
      {
        "text": "1987-1989",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "12/31/2022. Adjudicated stroke events were modeled as time-varying exposures.",
    "entities": [
      {
        "text": "12/31/2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Epilepsy was defined using International Classification of Diseases Ninth/Tenth",
    "entities": [
      {
        "text": "Epilepsy",
        "label": "PERSON"
      },
      {
        "text": "International Classification of Diseases Ninth/Tenth",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Revisions codes. Adjusted Fine and Gray proportional hazards models were used to",
    "entities": []
  },
  {
    "text": "estimate the risk of epilepsy associated with stroke.",
    "entities": []
  },
  {
    "text": "RESULTS: At baseline, the mean age of participants was 54 years, 55% were",
    "entities": [
      {
        "text": "54 years",
        "label": "DATE"
      },
      {
        "text": "55%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "female, and 26% were of Black race. Over a median of 27 years, 1553 incident",
    "entities": [
      {
        "text": "26%",
        "label": "PERCENT"
      },
      {
        "text": "27 years",
        "label": "DATE"
      },
      {
        "text": "1553",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "all-cause strokes occurred. The risk of epilepsy was higher among individuals",
    "entities": []
  },
  {
    "text": "with versus without incident stroke (HR = 1.75, 95% CI = 1.50-2.04). There was",
    "entities": [
      {
        "text": "1.75",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.50",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "evidence for interaction by age (p-interaction = 0.03) whereby the risk of",
    "entities": [
      {
        "text": "0.03",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "epilepsy associated with stroke was higher among individuals with younger versus",
    "entities": []
  },
  {
    "text": "older baseline age. Compared to no stroke, the point estimate for the risk of",
    "entities": []
  },
  {
    "text": "epilepsy associated with subarachnoid hemorrhage (HR = 2.94, 95% CI = 1.67-5.17)",
    "entities": [
      {
        "text": "2.94",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.67-5.17",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "was higher than that for the risk of epilepsy associated with ischemic stroke",
    "entities": []
  },
  {
    "text": "(HR = 1.65, 95% CI = 1.40-1.94) and hemorrhagic stroke (HR = 1.47, 95%",
    "entities": [
      {
        "text": "1.65",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.40",
        "label": "CARDINAL"
      },
      {
        "text": "1.47",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 0.95, 2.27). The risk of epilepsy was similar by the number of incident",
    "entities": [
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "0.95",
        "label": "CARDINAL"
      },
      {
        "text": "2.27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "strokes but was greater with increasing ischemic stroke severity.",
    "entities": []
  },
  {
    "text": "INTERPRETATION: The risk of epilepsy was increased after an incident stroke.",
    "entities": []
  },
  {
    "text": "This work identifies high-risk subgroups, including younger individuals,",
    "entities": []
  },
  {
    "text": "individuals with subarachnoid hemorrhage, and individuals with more severe",
    "entities": []
  },
  {
    "text": "ischemic strokes, who may benefit from closer clinical monitoring for",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). Annals of Clinical and Translational Neurology published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "by Wiley Periodicals LLC on behalf of American Neurological Association.",
    "entities": [
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "American Neurological Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "43. Glia. 2025 Jul 15. doi: 10.1002/glia.70055. Online ahead of print.",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1002",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Microglial Activation and Inflammatory Responses in Parkinson's Disease Models",
    "entities": [
      {
        "text": "Microglial Activation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Are Attenuated by TRPM2 Depletion.",
    "entities": [
      {
        "text": "TRPM2 Depletion",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Physiology and Biophysics, Institute of Biomedical Sciences,",
    "entities": [
      {
        "text": "Physiology and Biophysics, Institute of Biomedical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Physiology, Temerty Faculty of Medicine, University of Toronto,",
    "entities": [
      {
        "text": "University of Toronto",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Surgery, Temerty Faculty of Medicine, University of Toronto,",
    "entities": [
      {
        "text": "University of Toronto",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Inflammation, and particularly microglial cells, has become a central feature in",
    "entities": []
  },
  {
    "text": "Parkinson's disease (PD) pathology. The transient receptor potential melastatin",
    "entities": []
  },
  {
    "text": "2 (TRPM2) is a calcium-permeable nonselective channel involved in the",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pathological mechanism of several inflammatory and neurodegenerative diseases.",
    "entities": []
  },
  {
    "text": "However, the role of TRPM2 in inflammation and microglial activation in the",
    "entities": [
      {
        "text": "TRPM2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "context of PD remains unclear. Here, we combined both in vivo and in vitro PD",
    "entities": [
      {
        "text": "PD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "models to investigate that question. Male and female TRPM2 partial and complete",
    "entities": [
      {
        "text": "TRPM2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "knockout mice were submitted to the 6-hydroxidopamine mouse model of PD. We",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "PD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "assessed microglia and lysosome-associated protein (CD68) density levels,",
    "entities": []
  },
  {
    "text": "microglial morphology and cluster classification, CD68 area in individual",
    "entities": []
  },
  {
    "text": "microglial cells, and the protein levels of six different cytokines in the",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "substantia nigra pars compacta and the striatum. Our results indicate that TRPM2",
    "entities": [
      {
        "text": "TRPM2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "deletion reduced microglial density, rescued its morphology, decreased CD68",
    "entities": []
  },
  {
    "text": "staining area within microglia, and lowered pro-inflammatory cytokines levels in",
    "entities": []
  },
  {
    "text": "both male and female mice. To better understand TRPM2 involvement in PD",
    "entities": [
      {
        "text": "TRPM2",
        "label": "PERSON"
      },
      {
        "text": "PD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "pathology, we selectively knocked-down TRPM2 in neurons, microglia, or both",
    "entities": [
      {
        "text": "TRPM2",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "viability and a decrease in cell death were observed across the different",
    "entities": []
  },
  {
    "text": "experimental approaches. Lastly, TRPM2 deletion revealed reduced microglial",
    "entities": []
  },
  {
    "text": "phagocytosis and decreased expression of inflammation-related molecules. For the",
    "entities": []
  },
  {
    "text": "first time, we demonstrated that TRPM2 is a critical mediator of microglial",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "TRPM2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "function in the context of PD. Thus, this study suggests that TRPM2 inhibition",
    "entities": [
      {
        "text": "PD",
        "label": "GPE"
      },
      {
        "text": "TRPM2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "may offer a novel therapeutic target for PD modification.",
    "entities": [
      {
        "text": "PD",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "\u00a9 2025 The Author(s). GLIA published by Wiley Periodicals LLC.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wiley Periodicals",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "10.3724/zdxbyxb-2024-0532. Online ahead of print.",
    "entities": [
      {
        "text": "10.3724/",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Experience of the use of Sentinel cerebral embolic protection device during",
    "entities": [
      {
        "text": "Sentinel",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "transcatheter aortic valve replacement.",
    "entities": []
  },
  {
    "text": "[Article in Chinese, English; Abstract available in Chinese from the publisher]",
    "entities": [
      {
        "text": "Article in Chinese, English",
        "label": "LAW"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)Center for Valvular Heart Disease Intervention, Beijing Anzhen Hospital,",
    "entities": [
      {
        "text": "1)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Valvular Heart Disease Intervention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Capital Medical University, National Clinical Research Center for Cardiovascular",
    "entities": [
      {
        "text": "Capital Medical University",
        "label": "ORG"
      },
      {
        "text": "National Clinical Research Center for Cardiovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diseases, Beijing 100029, China. zhanglan0621@sina.com.",
    "entities": [
      {
        "text": "Beijing 100029",
        "label": "EVENT"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiovascular Medicine, Zhengzhou Central Hospital Affiliated",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou Central Hospital Affiliated",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to Zhengzhou University, Zhengzhou 450007, China. zhanglan0621@sina.com.",
    "entities": [
      {
        "text": "Zhengzhou University",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      },
      {
        "text": "450007",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Center for Valvular Heart Disease Intervention, Beijing Anzhen Hospital,",
    "entities": []
  },
  {
    "text": "Diseases, Beijing 100029, China. anzhenliuxinmin@163.com.",
    "entities": [
      {
        "text": "Beijing 100029",
        "label": "EVENT"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Center for Valvular Heart Disease Intervention, Beijing Anzhen Hospital,",
    "entities": [
      {
        "text": "Valvular Heart Disease Intervention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diseases, Beijing 100029, China.",
    "entities": [
      {
        "text": "Beijing 100029",
        "label": "EVENT"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Center for Valvular Heart Disease Intervention, Beijing Anzhen Hospital,",
    "entities": [
      {
        "text": "5)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Valvular Heart Disease Intervention",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Diseases, Beijing 100029, China. songgy_anzhen@vip.163.com.",
    "entities": [
      {
        "text": "Beijing 100029",
        "label": "EVENT"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To evaluate the feasibility, efficacy and safety of the Sentinel",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cerebral Embolic Protection Device (CEPD) during transcatheter aortic valve",
    "entities": [
      {
        "text": "Cerebral Embolic Protection Device",
        "label": "ORG"
      },
      {
        "text": "CEPD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "replacement (TAVR). This study is a subgroup analysis of the Chinese Registry of",
    "entities": [
      {
        "text": "TAVR",
        "label": "ORG"
      },
      {
        "text": "the Chinese Registry of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "moderate to severe valvular heart disease (CREDIT), which has been registered at",
    "entities": []
  },
  {
    "text": "the Chinese Clinical Trial Registry (ChiCTR2300075006).",
    "entities": [
      {
        "text": "the Chinese Clinical Trial Registry (ChiCTR2300075006",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Patients undergoing TAVR with the Sentinel CEPD from October 2023 to",
    "entities": [
      {
        "text": "the Sentinel CEPD",
        "label": "ORG"
      },
      {
        "text": "October 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "September 2024 were retrospectively enrolled. A total of 80 patients were",
    "entities": [
      {
        "text": "September 2024",
        "label": "DATE"
      },
      {
        "text": "80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included, with a median age of 72 (68, 76) years, including 52 males (65.0%) and",
    "entities": [
      {
        "text": "68",
        "label": "DATE"
      },
      {
        "text": "76) years",
        "label": "DATE"
      },
      {
        "text": "52",
        "label": "CARDINAL"
      },
      {
        "text": "65.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "28 females (35.0%), 62 patients (77.5%) with tricuspid valves, and 18 (22.5%)",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "35.0%",
        "label": "PERCENT"
      },
      {
        "text": "62",
        "label": "CARDINAL"
      },
      {
        "text": "77.5%",
        "label": "PERCENT"
      },
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "22.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with bicuspid valves; 34 patients (42.5%) with type \u2160 aortic arch, 24 patients",
    "entities": [
      {
        "text": "34",
        "label": "CARDINAL"
      },
      {
        "text": "42.5%",
        "label": "PERCENT"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(30.0%) with type \u2161 aortic arch, 12 patients (15.0%) with type \u2162 aortic arch,",
    "entities": [
      {
        "text": "30.0%",
        "label": "PERCENT"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "15.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and 10 patients (12.5%) with bovine-type aortic arch. Clinical data of the",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      },
      {
        "text": "12.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients were summarized and analyzed. The primary endpoints were success rate",
    "entities": []
  },
  {
    "text": "of Sentinel CEPD implantation, as well as all-cause death, symptomatic stroke,",
    "entities": [
      {
        "text": "Sentinel",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "transient ischemic attack, and Sentinel CEPD access vessel complications during",
    "entities": [
      {
        "text": "Sentinel CEPD",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "hospitalization and within 30 days postoperatively.",
    "entities": [
      {
        "text": "30 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: In the 80 patients, Self-expanding valves were used in 68 cases (85.0%)",
    "entities": [
      {
        "text": "80",
        "label": "CARDINAL"
      },
      {
        "text": "68",
        "label": "CARDINAL"
      },
      {
        "text": "85.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and balloon-expandable valves in 12 cases (15.0%). Seventy-nine patients (98.8%)",
    "entities": [
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "15.0%",
        "label": "PERCENT"
      },
      {
        "text": "Seventy-nine",
        "label": "CARDINAL"
      },
      {
        "text": "98.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "successfully underwent TAVR with Sentinel CEPD deployment. 98.8% (79/80)",
    "entities": [
      {
        "text": "Sentinel",
        "label": "NORP"
      },
      {
        "text": "98.8%",
        "label": "PERCENT"
      },
      {
        "text": "79/80",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "successful CEPD deployment. Macroscopically visible debris was captured in 93.8%",
    "entities": [
      {
        "text": "CEPD",
        "label": "ORG"
      },
      {
        "text": "93.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(75/80) by filters of Sentinel CEPD. Although the procedure time for Sentinel",
    "entities": [
      {
        "text": "Sentinel CEPD",
        "label": "PERSON"
      },
      {
        "text": "Sentinel",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "CEPD placement was slightly longer in patients with bovine aortic arch, there",
    "entities": [
      {
        "text": "CEPD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was no statistically significant difference in deployment time among different",
    "entities": []
  },
  {
    "text": "aortic arch types (P>0.05). During hospitalization and within 30 days",
    "entities": [
      {
        "text": "P>0.05",
        "label": "ORG"
      },
      {
        "text": "30 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "postoperatively, only one case of transient ischemic attack occurred, there was",
    "entities": [
      {
        "text": "only one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "no all-cause mortality, symptomatic stroke, or access-site vascular",
    "entities": []
  },
  {
    "text": "complications related to the Sentinel CEPD observed.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: The Sentinel CEPD demonstrates high feasibility across aortic arch",
    "entities": []
  },
  {
    "text": "types, potential efficacy in embolic capture, and excellent safety in TAVR.",
    "entities": [
      {
        "text": "TAVR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Existing evidence of self-management interventions in acquired brain injuries",
    "entities": []
  },
  {
    "text": "and traumatic injuries: a scoping review.",
    "entities": []
  },
  {
    "text": "(1)Department of Psychology, University of Oslo, Oslo, Norway.",
    "entities": [
      {
        "text": "Psychology, University of Oslo, Oslo",
        "label": "ORG"
      },
      {
        "text": "Norway",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pain Management and Research, Oslo University Hospital, Oslo,",
    "entities": [
      {
        "text": "Pain Management and Research",
        "label": "ORG"
      },
      {
        "text": "Oslo University Hospital",
        "label": "ORG"
      },
      {
        "text": "Oslo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The Mind Body Lab, Department of Psychology, University of Oslo, Oslo,",
    "entities": [
      {
        "text": "Mind Body Lab",
        "label": "PERSON"
      },
      {
        "text": "Department of Psychology",
        "label": "ORG"
      },
      {
        "text": "University of Oslo",
        "label": "ORG"
      },
      {
        "text": "Oslo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Physical Medicine and Rehabilitation, Oslo University Hospital,",
    "entities": [
      {
        "text": "Physical Medicine and Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "Oslo University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Rehabilitation Science and Health Technology, Faculty of Health",
    "entities": [
      {
        "text": "Rehabilitation Science and Health Technology, Faculty of Health\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Oslo Metropolitan University, Oslo, Norway.",
    "entities": [
      {
        "text": "Oslo Metropolitan University",
        "label": "ORG"
      },
      {
        "text": "Oslo",
        "label": "GPE"
      },
      {
        "text": "Norway",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Research and Innovation, Sunnaas Rehabilitation Hospital,",
    "entities": [
      {
        "text": "Research and Innovation, Sunnaas Rehabilitation Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PURPOSE: Patients with acquired brain injuries (ABI) and severe traumatic",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "injuries face many persisting and overlapping injury-related consequences.",
    "entities": []
  },
  {
    "text": "Despite a growing number of self-management (SM) interventions targeting these",
    "entities": [
      {
        "text": "SM",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "conditions, no comprehensive reviews exist. This scoping review aims to map the",
    "entities": []
  },
  {
    "text": "existing SM interventions across these injury populations.",
    "entities": [
      {
        "text": "SM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: Five databases (MEDLINE, EMBASE, PsycINFO, CINAHL,",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      },
      {
        "text": "MEDLINE",
        "label": "ORG"
      },
      {
        "text": "EMBASE",
        "label": "ORG"
      },
      {
        "text": "PsycINFO, CINAHL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PubMed) were systematically searched. Studies were included if they adhered to",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the operational definition by Jonkman et al. and targeted adults with ABI and",
    "entities": [
      {
        "text": "Jonkman",
        "label": "PERSON"
      },
      {
        "text": "al.",
        "label": "GPE"
      },
      {
        "text": "ABI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 43 studies were included. Most interventions targeted stroke",
    "entities": [
      {
        "text": "43",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and spinal cord injuries. The key ingredients were psychoeducation, goal",
    "entities": []
  },
  {
    "text": "setting, and training in self-management skills. Most interventions were",
    "entities": []
  },
  {
    "text": "conducted in hospitals by healthcare personnel in the chronic post-injury phase.",
    "entities": []
  },
  {
    "text": "A considerable variation of reported effects was observed. Additionally,",
    "entities": []
  },
  {
    "text": "Bandura's social cognitive theory was frequently applied as a theoretical",
    "entities": [
      {
        "text": "Bandura",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "background.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: A significant lack of SM interventions for multiple/major trauma",
    "entities": [
      {
        "text": "SM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and burns was identified. Many studies were poorly described and did not",
    "entities": []
  },
  {
    "text": "indicate how the interventions were tailored to the patients, and the effects",
    "entities": []
  },
  {
    "text": "were inconsistent. However, the findings suggest that SM ingredients are",
    "entities": [
      {
        "text": "SM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "applicable to both ABI and traumatic injury populations in clinical settings.",
    "entities": [
      {
        "text": "ABI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Plain Language Summary: Patients with acquired brain injuries and traumatic",
    "entities": []
  },
  {
    "text": "injuries to other parts of the body face long-lasting health issues and have",
    "entities": []
  },
  {
    "text": "many unmet healthcare needs requiring day-to-day self-management.There is",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "evidence supporting the implementation of self-management interventions at all",
    "entities": []
  },
  {
    "text": "stages post-injury.Despite evidence supporting the use of goal setting, action",
    "entities": []
  },
  {
    "text": "planning, and tailoring interventions to patients\u2019 needs as cornerstones of",
    "entities": []
  },
  {
    "text": "self-management programmes, a significant proportion of the reviewed",
    "entities": []
  },
  {
    "text": "interventions did not include these elements.We recommend that clinicians tailor",
    "entities": [
      {
        "text": "clinicians",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "self-management interventions to meet condition-specific needs and incorporate",
    "entities": []
  },
  {
    "text": "goal setting and action planning to empower patients to manage their conditions",
    "entities": []
  },
  {
    "text": "effectively.",
    "entities": []
  },
  {
    "text": "Association of temporal MASLD with type 2 diabetes, cardiovascular disease and",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "mortality.",
    "entities": []
  },
  {
    "text": "Fatty LiverResearch Group of the Korean Diabetes Association.",
    "entities": [
      {
        "text": "Fatty LiverResearch Group",
        "label": "ORG"
      },
      {
        "text": "the Korean Diabetes Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Keimyung University School of Medicine, Daegu, Korea.",
    "entities": [
      {
        "text": "Keimyung University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Daegu",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Statistics and Actuarial Science, Soongsil University, Seoul,",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Soongsil University",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Yonsei University College of Medicine, Seoul, Korea.",
    "entities": [
      {
        "text": "Yonsei University College of Medicine, Seoul,",
        "label": "ORG"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.",
    "entities": [
      {
        "text": "CHA Bundang Medical Center",
        "label": "ORG"
      },
      {
        "text": "CHA University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seongnam",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hanyang Guri Hospital, Hanyang University College of Medicine, Guri, Korea.",
    "entities": [
      {
        "text": "Hanyang Guri Hospital",
        "label": "PERSON"
      },
      {
        "text": "Hanyang University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Guri",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hanyang University College of Medicine, Seoul, Korea.",
    "entities": [
      {
        "text": "Hanyang University College of Medicine",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of Endocrinology and Metabolism, Department of Internal Medicine,",
    "entities": [
      {
        "text": "Endocrinology and Metabolism, Department of Internal Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29",
    "entities": [
      {
        "text": "Kangbuk Samsung Hospital",
        "label": "ORG"
      },
      {
        "text": "Sungkyunkwan University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "29",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BACKGROUND: We investigated the risk of type 2 diabetes (T2DM) and related",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "comorbidities including cardiovascular disease (CVD), and mortality, based on",
    "entities": []
  },
  {
    "text": "changes in metabolic dysfunction associated steatotic liver disease (MASLD).",
    "entities": []
  },
  {
    "text": "METHODS: We analyzed data from the Korean National Health Insurance Service for",
    "entities": [
      {
        "text": "the Korean National Health Insurance Service",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "individuals aged \u2265 20 years. MASLD was defined as a fatty liver index (FLI), a",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "20 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "prediction formula based on metabolic parameters, with a cutoff of \u2265 60. FLI",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "measurements were compared within each individual over a 2 years period. Based",
    "entities": [
      {
        "text": "2 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "on changes in FLI between two health checkups, individuals were classified into",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "four categories; never MASLD (FLI consistently < 60), incident MASLD (FLI < 60",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "to \u2265 60), regressed MASLD (\u2265 60 to < 60), and persistent MASLD (FLI",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "consistently \u2265 60). The primary outcome was T2DM occurrence in the general",
    "entities": [
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "population and myocardial infarction (MI), ischemic stroke, heart failure (HF)",
    "entities": []
  },
  {
    "text": "and mortality events in individuals with preexisting T2DM with adjustment for",
    "entities": []
  },
  {
    "text": "age, sex, smoking, alcohol drinking, and regular exercise.",
    "entities": []
  },
  {
    "text": "RESULTS: In 4,397,808 individuals without T2DM, 229,475 (5.2%) developed T2DM",
    "entities": [
      {
        "text": "4,397,808",
        "label": "CARDINAL"
      },
      {
        "text": "229,475",
        "label": "CARDINAL"
      },
      {
        "text": "5.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "during a median follow-up period of 7.3 years. The risk of incident T2DM was the",
    "entities": [
      {
        "text": "7.3 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "highest in individuals with persistent MASLD compared to those who never had",
    "entities": []
  },
  {
    "text": "MASLD (HR = 5.28, 95% CI = 5.22-5.34). Individuals with incident or regressed",
    "entities": [
      {
        "text": "5.28",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "5.22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "MASLD also had increased risk of developing T2DM (HR = 3.30, 95% CI = 3.25-3.35",
    "entities": [
      {
        "text": "MASLD",
        "label": "ORG"
      },
      {
        "text": "3.30",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.25",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "for incident MASLD, HR = 2.87, 95% CI = 2.82-2.92 for regressed MASLD). In a",
    "entities": [
      {
        "text": "2.87",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "2.82-2.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cohort of 636,520 individuals with preexisting T2DM followed for a median of 6.2",
    "entities": [
      {
        "text": "636,520",
        "label": "CARDINAL"
      },
      {
        "text": "6.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years, those with persistent MASLD had a higher risk of HF (HR = 1.28, 95%",
    "entities": [
      {
        "text": "HF",
        "label": "ORG"
      },
      {
        "text": "1.28",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI = 1.25 to 1.32), MI (HR = 1.15, 95% CI = 1.10 to 1.20), stroke (HR = 1.14,",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.25",
        "label": "CARDINAL"
      },
      {
        "text": "1.32",
        "label": "CARDINAL"
      },
      {
        "text": "1.15",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.10 to 1.20",
        "label": "CARDINAL"
      },
      {
        "text": "1.14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "95% CI = 1.09 to 1.19) and all-cause mortality (HR = 1.11, 95% CI = 1.09-1.14)",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      },
      {
        "text": "1.19",
        "label": "CARDINAL"
      },
      {
        "text": "1.11",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.09",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared to individuals who never had MASLD. Similarly, both incident and",
    "entities": []
  },
  {
    "text": "regressed MASLD were associated with an increased risk for HF, MI, stroke and",
    "entities": [
      {
        "text": "HF",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "all-cause mortality.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Persistent MASLD is associated with an increased risk of incident",
    "entities": []
  },
  {
    "text": "T2DM, and further elevates the risk of CVD, and mortality among individuals with",
    "entities": [
      {
        "text": "CVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "T2DM. Even individuals with incident or regressed MASLD exhibit an increased",
    "entities": []
  },
  {
    "text": "risk of these adverse outcomes compared to those who never had MASLD.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s).",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOI: 10.1186/s12933-025-02824-3",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665356 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665356",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval: This study",
    "entities": []
  },
  {
    "text": "complied with the Declaration of Helsinki; the study protocol was approved by",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "the institutional review board (Soongsil University, SSU-202007-HR-236-01).",
    "entities": [
      {
        "text": "Soongsil University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Written informed consent was waived, as this study was based on deidentified",
    "entities": []
  },
  {
    "text": "administrative data. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Design and validation of a comprehensive educational program for stroke nursing",
    "entities": []
  },
  {
    "text": "care: a mixed methods study.",
    "entities": []
  },
  {
    "text": "(1)Master's Student in Medical-Surgical Nursing, Student Research Committee,",
    "entities": [
      {
        "text": "1)Master",
        "label": "DATE"
      },
      {
        "text": "Student in Medical-Surgical Nursing",
        "label": "ORG"
      },
      {
        "text": "Student Research Committee",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences,",
    "entities": [
      {
        "text": "School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Medical-Surgical Nursing, School of Nursing and Midwifery,",
    "entities": [
      {
        "text": "Medical-Surgical Nursing, School of Nursing and Midwifery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shahid Beheshti University of Medical Sciences, Tehran, Iran.",
    "entities": [
      {
        "text": "Shahid Beheshti University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Tehran",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Tabassom Stroke Rehabilitation Clinic, Tehran, Iran.",
    "entities": [
      {
        "text": "Stroke Rehabilitation Clinic",
        "label": "ORG"
      },
      {
        "text": "Tehran",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Basic Sciences, School of Nursing and Midwifery, Shahid",
    "entities": [
      {
        "text": "Basic Sciences, School of Nursing and Midwifery",
        "label": "ORG"
      },
      {
        "text": "Shahid",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Beheshti University of Medical Sciences, Tehran, Iran.",
    "entities": [
      {
        "text": "Beheshti University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Tehran",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical-Surgical Nursing, School of Nursing and Midwifery,",
    "entities": [
      {
        "text": "Medical-Surgical Nursing, School of Nursing and Midwifery",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Nurse education can assist in developing comprehensive stroke care.",
    "entities": []
  },
  {
    "text": "This study aimed to design and validate a comprehensive educational program for",
    "entities": []
  },
  {
    "text": "stroke nursing care.",
    "entities": []
  },
  {
    "text": "METHODS: This study employed a mixed-methods approach, emphasizing four of the",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "six steps in Kern's model of educational program development (needs assessment,",
    "entities": [
      {
        "text": "six",
        "label": "CARDINAL"
      },
      {
        "text": "Kern",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "initial design, goals and specific objectives, and educational strategy). It was",
    "entities": []
  },
  {
    "text": "conducted at Shohadaye Tajrish, Loghman-e Hakim, and Imam Hossein Hospitals in",
    "entities": [
      {
        "text": "Shohadaye Tajrish",
        "label": "PERSON"
      },
      {
        "text": "Loghman-e Hakim",
        "label": "PERSON"
      },
      {
        "text": "Imam Hossein Hospitals",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Tehran during 2023-2024. The initial phase consisted of a comprehensive needs",
    "entities": [
      {
        "text": "Tehran",
        "label": "GPE"
      },
      {
        "text": "2023-2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "assessment, a literature review, in-depth interviews with twenty nurses and",
    "entities": [
      {
        "text": "twenty",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients, a careful review of patient documents and medical records, as well as",
    "entities": []
  },
  {
    "text": "direct observations of patient care. The interviews were analyzed with MAXQDA 20",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "software using the conventional content analysis method. Validation was",
    "entities": []
  },
  {
    "text": "conducted through two Delphi rounds, with an agreement level of more than 70%",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "Delphi",
        "label": "ORG"
      },
      {
        "text": "more than 70%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "based on the frequency of responses in each round.",
    "entities": []
  },
  {
    "text": "RESULTS: Through the Delphi method, twenty experts participated in the",
    "entities": [
      {
        "text": "Delphi",
        "label": "ORG"
      },
      {
        "text": "twenty",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "evaluation and validation process. In the first round of Delphi, 30 learning",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "Delphi",
        "label": "ORG"
      },
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "topics achieved appropriate consensus (mean scores ranging from 2.33 to 3.55),",
    "entities": [
      {
        "text": "2.33",
        "label": "CARDINAL"
      },
      {
        "text": "3.55",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "while 2 topics (applying basic nursing concepts in patient care and providing",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "nursing care based on the nursing process) were eliminated due to inappropriate",
    "entities": []
  },
  {
    "text": "consensus (mean scores ranging from 1 to 2.32). In the second Delphi round, the",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "2.32",
        "label": "CARDINAL"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      },
      {
        "text": "Delphi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "validation of the remaining 30 items was reexamined, which obtained an",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "appropriate consensus. In the first round of the Delphi study, a significant",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      },
      {
        "text": "Delphi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Kendall's coefficient of concordance was observed (Kendall's W = 0.735,",
    "entities": [
      {
        "text": "Kendall",
        "label": "GPE"
      },
      {
        "text": "0.735",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u03c7\u00b2=30.524, p < 0.01); however, after removing two items in the second round,",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "this coefficient improved, indicating stronger agreement among the participants",
    "entities": []
  },
  {
    "text": "CONCLUSION: This study developed and validated an educational program focused on",
    "entities": []
  },
  {
    "text": "professional nursing care for stroke patients, recognizing the critical need for",
    "entities": []
  },
  {
    "text": "continuous education in the neurology department to update nurses' knowledge and",
    "entities": []
  },
  {
    "text": "skills with the most current care methods and information.",
    "entities": []
  },
  {
    "text": "CLINICAL TRIAL NUMBER: Not applicable.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12909-025-07623-8",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665313 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Ethics approval and consent to",
    "entities": []
  },
  {
    "text": "participate: In alignment with the ethical principles of the Helsinki",
    "entities": [
      {
        "text": "Helsinki",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Declaration and under the approval of the Review Board of Shahid Beheshti",
    "entities": [
      {
        "text": "the Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Medical Sciences (IR.SBMU.PHARMACY.REC.1402.178), the participants",
    "entities": [
      {
        "text": "University of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "at all stages of the study have explained of the purpose of the study, and they",
    "entities": []
  },
  {
    "text": "were assured of their privacy and confidentiality of their personal information.",
    "entities": []
  },
  {
    "text": "They were informed regarding the voluntary nature of the study, and they could",
    "entities": []
  },
  {
    "text": "leave the study at any time. They signed the informed consent form before",
    "entities": []
  },
  {
    "text": "participating in the study. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "48. BMC Psychiatry. 2025 Jul 15;25(1):697. doi: 10.1186/s12888-025-07151-1.",
    "entities": [
      {
        "text": "48",
        "label": "CARDINAL"
      },
      {
        "text": "BMC Psychiatry",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15;25(1):697",
        "label": "CARDINAL"
      },
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Repetitive transcranial magnetic stimulation for treating post-stroke",
    "entities": []
  },
  {
    "text": "depression: a systematic review and network meta-analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Medicine, Shandong Xiandai University, Jinan, China.",
    "entities": [
      {
        "text": "Medicine",
        "label": "GPE"
      },
      {
        "text": "Shandong Xiandai University",
        "label": "ORG"
      },
      {
        "text": "Jinan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Rehabilitation Medicine, The Second Affiliated Hospital of",
    "entities": [
      {
        "text": "Rehabilitation Medicine",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Shandong University of Traditional Chinese Medicine, Jinan, China.",
    "entities": [
      {
        "text": "Shandong University of Traditional Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Jinan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To systematically evaluate the effects of different modes of",
    "entities": []
  },
  {
    "text": "repetitive transcranial magnetic stimulation (rTMS) on depression in post-stroke",
    "entities": []
  },
  {
    "text": "depression (PSD) patients using the network meta-analysis method.",
    "entities": []
  },
  {
    "text": "METHODS: PubMed, Web of Science, Cochrane Library, Embase, Wanfang Data, CNKI,",
    "entities": [
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      },
      {
        "text": "Wanfang Data",
        "label": "ORG"
      },
      {
        "text": "CNKI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "VIP, and CBM were searched for randomized controlled trials on rTMS for PSD from",
    "entities": [
      {
        "text": "CBM",
        "label": "ORG"
      },
      {
        "text": "PSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the time the database was constructed until April 20th, 2024. Two researchers",
    "entities": [
      {
        "text": "April 20th, 2024",
        "label": "DATE"
      },
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "independently conducted screenings to extract the relevant literature. The",
    "entities": []
  },
  {
    "text": "meta-analysis was performed using RevMan 5.4.1 software. Network meta-analysis",
    "entities": [
      {
        "text": "RevMan 5.4.1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "of depression scores was performed using Stata 17.0 software and R 4.4.1",
    "entities": [
      {
        "text": "Stata 17.0",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "software.",
    "entities": []
  },
  {
    "text": "RESULTS: Twelve studies involving four different rTMS modalities were included.",
    "entities": [
      {
        "text": "Twelve",
        "label": "CARDINAL"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The results of the meta-analysis revealed that rTMS significantly improved",
    "entities": []
  },
  {
    "text": "depression (SMD = -1.47, 95% CI [-1.97, -0.97]) and activity of daily living",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(ADL) (SMD = 0.78, 95% CI [0.52, 1.04]) in patients with PSD. The follow-up",
    "entities": [
      {
        "text": "ADL",
        "label": "ORG"
      },
      {
        "text": "0.78",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.52",
        "label": "CARDINAL"
      },
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "PSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "results revealed that rTMS significantly improved depression in the long term",
    "entities": []
  },
  {
    "text": "(SMD = -1.74, 95% CI [-2.32, -1.17]). The results of the network meta-analysis",
    "entities": [
      {
        "text": "-1.74",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "revealed that dual-rTMS (SMD = -2.33, 95% CI [-3.16, -1.50]), HF-rTMS (SMD =",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "-3.16",
        "label": "PERSON"
      },
      {
        "text": "HF-rTMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "-1.62, 95% CI [-2.11, -1.13]), iTBS (SMD = -1.57, 95% CI [-2.56, -0.57]), and",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "-1.57",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "PERSON"
      },
      {
        "text": "-2.56",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "LF-rTMS (SMD = -0.80, 95% CI [-1.36, -0.23]) significantly improved depression",
    "entities": [
      {
        "text": "LF-rTMS",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "-1.36",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "compared with sham stimulation. The SUCRA values in descending order were",
    "entities": [
      {
        "text": "sham stimulation",
        "label": "ORG"
      },
      {
        "text": "SUCRA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "dual-rTMS (95.9%) > HF-rTMS (65.0%) > iTBS (61.9%) > LF-rTMS (27.1%).",
    "entities": [
      {
        "text": "95.9%",
        "label": "PERCENT"
      },
      {
        "text": "65.0%",
        "label": "PERCENT"
      },
      {
        "text": "61.9%",
        "label": "PERCENT"
      },
      {
        "text": "27.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Twenty minutes of 4-week dual-rTMS on the DLPFC of PSD patients may",
    "entities": [
      {
        "text": "Twenty minutes",
        "label": "TIME"
      },
      {
        "text": "4-week",
        "label": "DATE"
      },
      {
        "text": "PSD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "produce better therapeutic effects. High-quality, large-sample, standardized RCT",
    "entities": []
  },
  {
    "text": "trials can be conducted to further test the scientific validity of the findings.",
    "entities": []
  },
  {
    "text": "DOI: 10.1186/s12888-025-07151-1",
    "entities": [
      {
        "text": "10.1186",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40665248 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40665248",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: Not applicable. Consent for publication: Not applicable. Competing",
    "entities": []
  },
  {
    "text": "49. Acta Neurol Belg. 2025 Jul 16. doi: 10.1007/s13760-025-02842-8. Online ahead",
    "entities": [
      {
        "text": "49",
        "label": "CARDINAL"
      },
      {
        "text": "Acta Neurol Belg",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bilateral middle cerebellar peduncle infarcts in a patient with systemic lupus",
    "entities": []
  },
  {
    "text": "erythematosus.",
    "entities": []
  },
  {
    "text": "(1)Department of Emergency and Urgent Medicine, Stroke Unit, Santa Maria Delle",
    "entities": [
      {
        "text": "Emergency and Urgent Medicine",
        "label": "ORG"
      },
      {
        "text": "Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Santa Maria Delle",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Grazie Hospital, Naples, Italy. perillosandra@gmail.com.",
    "entities": [
      {
        "text": "Grazie Hospital",
        "label": "ORG"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Emergency and Urgent Medicine, Stroke Unit, Santa Maria Delle",
    "entities": [
      {
        "text": "Emergency and Urgent Medicine",
        "label": "ORG"
      },
      {
        "text": "Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Santa Maria Delle",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Grazie Hospital, Naples, Italy.",
    "entities": [
      {
        "text": "Grazie Hospital",
        "label": "ORG"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Radiology, Santa Maria Delle Grazie Hospital, Naples, Italy.",
    "entities": [
      {
        "text": "Radiology",
        "label": "GPE"
      },
      {
        "text": "Santa Maria Delle Grazie Hospital",
        "label": "ORG"
      },
      {
        "text": "Naples",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "multiorgan involvement, including the central nervous system. Neuropsychiatric",
    "entities": [
      {
        "text": "multiorgan involvement",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "manifestations (NPSLE) are observed in a significant proportion of patients and",
    "entities": []
  },
  {
    "text": "may include ischemic strokes, often related to antiphospholipid syndrome (APS)",
    "entities": [
      {
        "text": "APS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "or small vessel vasculitis. We report the case of a 38-year-old woman who",
    "entities": [
      {
        "text": "38-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "presented to the emergency department with acute dysarthria and a history of",
    "entities": []
  },
  {
    "text": "fever. Brain imaging demonstrated multiple subacute ischemic lesions affecting",
    "entities": []
  },
  {
    "text": "the bilateral middle cerebellar peduncles and frontal regions, and diffuse",
    "entities": []
  },
  {
    "text": "leukoencephalopathy. Laboratory investigations revealed high-titer antinuclear,",
    "entities": []
  },
  {
    "text": "anti-dsDNA, anticardiolipin antibodies, and lupus anticoagulant. The overall",
    "entities": []
  },
  {
    "text": "clinical, radiological, and immunological profile was consistent with",
    "entities": []
  },
  {
    "text": "neuropsychiatric SLE. The possible underlying causes of ischemic events were",
    "entities": [
      {
        "text": "SLE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "antiphospholipid syndrome and small vessel vasculitis. This case highlights the",
    "entities": []
  },
  {
    "text": "importance of considering NPSLE in the differential diagnosis of diseases",
    "entities": []
  },
  {
    "text": "involving bilateral middle cerebellar peduncles. Early recognition and therapy",
    "entities": []
  },
  {
    "text": "of NPSLE are crucial for improving outcomes in this complex clinical scenario.",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s) under exclusive licence to Belgian Neurological Society.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Belgian Neurological Society",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: The authors",
    "entities": []
  },
  {
    "text": "declare no competing interests. Ethical guidelines: All relevant ethical",
    "entities": []
  },
  {
    "text": "guidelines have been followed. Consent to participate: Not applicable. Informed",
    "entities": []
  },
  {
    "text": "Consent: Written informed consent was obtained from the patient for the",
    "entities": []
  },
  {
    "text": "publication of this case report and accompanying images.Written informed consent",
    "entities": []
  },
  {
    "text": "was obtained from the patient for the publication of this case report and",
    "entities": []
  },
  {
    "text": "accompanying images.",
    "entities": []
  },
  {
    "text": "50. Nat Med. 2025 Jul 15. doi: 10.1038/s41591-025-03831-3. Online ahead of print.",
    "entities": [
      {
        "text": "50",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Med",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Disruption of the cerebrospinal fluid-plasma protein balance in cognitive",
    "entities": []
  },
  {
    "text": "impairment and aging.",
    "entities": []
  },
  {
    "text": "Farinas A(1)(2)(3), Rutledge J(2)(3), Bot VA(2)(3)(4), Western D(5)(6)(7), Ying",
    "entities": [
      {
        "text": "Farinas",
        "label": "PERSON"
      },
      {
        "text": "Rutledge",
        "label": "GPE"
      },
      {
        "text": "Ying\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "K(2)(3)(8)(9), Lawrence KA(10), Oh HS(2)(3)(11)(12)(13)(14), Yoon S(2)(3), Ding",
    "entities": [
      {
        "text": "Lawrence KA(10",
        "label": "PERSON"
      },
      {
        "text": "Yoon",
        "label": "PERSON"
      },
      {
        "text": "Ding",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Global Neurodegeneration Proteomics Consortium (GNPC); Montgomery",
    "entities": [
      {
        "text": "Global Neurodegeneration Proteomics Consortium",
        "label": "ORG"
      },
      {
        "text": "GNPC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mormino E(19), Cruchaga C(5)(6)(21)(22)(23)(24), Wyss-Coray T(25)(26)(27).",
    "entities": [
      {
        "text": "Mormino E(19",
        "label": "PERSON"
      },
      {
        "text": "Cruchaga",
        "label": "PERSON"
      },
      {
        "text": "Wyss-Coray",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Graduate Program in Neuroscience, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "GPE"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The Phil and Penny Knight Initiative for Brain Resilience, Stanford",
    "entities": [
      {
        "text": "2)The",
        "label": "CARDINAL"
      },
      {
        "text": "Penny Knight",
        "label": "PERSON"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "3)Wu Tsai Neurosciences Institute",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Graduate Program in Biomedical Engineering, Stanford University, Stanford,",
    "entities": [
      {
        "text": "4)Graduate Program in Biomedical Engineering",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Psychiatry, Washington University School of Medicine, St.",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Psychiatry",
        "label": "ORG"
      },
      {
        "text": "Washington University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)NeuroGenomics and Informatics Center, Washington University School of",
    "entities": [
      {
        "text": "6)NeuroGenomics",
        "label": "CARDINAL"
      },
      {
        "text": "Informatics Center",
        "label": "ORG"
      },
      {
        "text": "Washington University School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, St. Louis, MO, USA.",
    "entities": [
      {
        "text": "St. Louis",
        "label": "GPE"
      },
      {
        "text": "MO",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of Biology and Biomedical Sciences, Washington University School of",
    "entities": [
      {
        "text": "Biology and Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Washington University School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Department of Biochemistry, University of Washington, Seattle, WA, USA.",
    "entities": [
      {
        "text": "Biochemistry, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Institute for Protein Design, University of Washington, Seattle, WA, USA.",
    "entities": [
      {
        "text": "Protein Design, University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Genetics, Stanford University School of Medicine, Stanford,",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Genetics",
        "label": "ORG"
      },
      {
        "text": "Stanford University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Nash Family Department of Neuroscience, Icahn School of Medicine at Mount",
    "entities": [
      {
        "text": "Family Department of Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Mount\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Brain and Body Research Center of the Friedman Brain Institute, Icahn School",
    "entities": [
      {
        "text": "12)Brain",
        "label": "CARDINAL"
      },
      {
        "text": "Body Research Center",
        "label": "ORG"
      },
      {
        "text": "the Friedman Brain Institute",
        "label": "ORG"
      },
      {
        "text": "Icahn School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine at Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "FAC"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Genetics and Genomic Sciences, Icahn School of Medicine at",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Genetics and Genomic Sciences",
        "label": "ORG"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Mount Sinai, New York, NY, USA.",
    "entities": [
      {
        "text": "Mount Sinai",
        "label": "GPE"
      },
      {
        "text": "New York",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at",
    "entities": [
      {
        "text": "14)Ronald",
        "label": "CARDINAL"
      },
      {
        "text": "Icahn School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Quantitative Services Unit, Department of Medicine, Stanford University",
    "entities": [
      {
        "text": "15)Quantitative Services Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Stanford, CA, USA.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Department of Pathology, Stanford University School of Medicine, Stanford,",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stanford University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(17)Department of Biomedical Data Science, Stanford University School of",
    "entities": [
      {
        "text": "17)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biomedical Data Science",
        "label": "ORG"
      },
      {
        "text": "Stanford University School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Stanford, CA, USA.",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.",
    "entities": [
      {
        "text": "18)Howard",
        "label": "CARDINAL"
      },
      {
        "text": "Hughes Medical Institute",
        "label": "ORG"
      },
      {
        "text": "University of Washington",
        "label": "ORG"
      },
      {
        "text": "Seattle",
        "label": "GPE"
      },
      {
        "text": "WA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Department of Neurology and Neurological Sciences, Stanford University",
    "entities": [
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(20)Department of Psychology, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "20)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(21)Department of Neurology, Washington University School of Medicine, St.",
    "entities": [
      {
        "text": "21)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Washington University School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(22)Department of Genetics, Washington University School of Medicine, St. Louis,",
    "entities": [
      {
        "text": "22)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Genetics",
        "label": "ORG"
      },
      {
        "text": "Washington University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "St. Louis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Hope Center for Neurologic Diseases, Washington University, St. Louis, MO,",
    "entities": [
      {
        "text": "Center for Neurologic Diseases",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Washington University",
        "label": "ORG"
      },
      {
        "text": "St. Louis",
        "label": "GPE"
      },
      {
        "text": "MO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)Knight Alzheimer Disease Research Center, Washington University School of",
    "entities": [
      {
        "text": "24)Knight",
        "label": "CARDINAL"
      },
      {
        "text": "Alzheimer Disease Research Center",
        "label": "ORG"
      },
      {
        "text": "Washington University School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(25)The Phil and Penny Knight Initiative for Brain Resilience, Stanford",
    "entities": [
      {
        "text": "25)The",
        "label": "CARDINAL"
      },
      {
        "text": "Penny Knight",
        "label": "PERSON"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Stanford, CA, USA. twc@stanford.edu.",
    "entities": [
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.",
    "entities": [
      {
        "text": "26)Wu",
        "label": "CARDINAL"
      },
      {
        "text": "Tsai Neurosciences Institute",
        "label": "ORG"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Department of Neurology and Neurological Sciences, Stanford University",
    "entities": [
      {
        "text": "27)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stanford University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School of Medicine, Stanford, CA, USA. twc@stanford.edu.",
    "entities": [
      {
        "text": "School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "The brain barrier system, including the choroid plexus, meninges and brain",
    "entities": []
  },
  {
    "text": "concentrations between blood and cerebrospinal fluid (CSF). Aging and",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurodegeneration disrupt brain barrier function, but proteomic studies of the",
    "entities": []
  },
  {
    "text": "effects on blood-CSF protein balance are limited. Here we used SomaScan",
    "entities": [
      {
        "text": "SomaScan",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "proteomics to characterize paired CSF and plasma samples from 2,171 healthy or",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      },
      {
        "text": "2,171",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cognitively impaired older individuals from multiple cohorts, including the",
    "entities": []
  },
  {
    "text": "Global Neurodegeneration Proteomics Consortium. We identified proteins with",
    "entities": [
      {
        "text": "Global Neurodegeneration Proteomics Consortium",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "correlated CSF and plasma levels that are produced primarily outside the brain",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and are enriched for structural domains that may enable their transport across",
    "entities": []
  },
  {
    "text": "brain barriers. CSF to plasma ratios of 848 proteins increased with aging in",
    "entities": [
      {
        "text": "848",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "healthy control individuals, including complement and coagulation proteins,",
    "entities": []
  },
  {
    "text": "chemokines and proteins linked to neurodegeneration, whereas 64 protein ratios",
    "entities": [
      {
        "text": "64",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "decreased with age, suggesting substrate-specific barrier regulation. Notably,",
    "entities": []
  },
  {
    "text": "elevated CSF to plasma ratios of peripherally derived or vascular-associated",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "proteins, including DCUN1D1, MFGE8 and VEGFA, were associated with preserved",
    "entities": [
      {
        "text": "MFGE8",
        "label": "PERSON"
      },
      {
        "text": "VEGFA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cognitive function. Genome-wide association studies identified genetic loci",
    "entities": []
  },
  {
    "text": "associated with CSF to plasma ratios of 241 proteins, many of which have known",
    "entities": [
      {
        "text": "CSF",
        "label": "ORG"
      },
      {
        "text": "241",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disease associations, including FCN2, the collagen-like domain of which may",
    "entities": [
      {
        "text": "FCN2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "facilitate blood-CSF transport. Overall, this work provides molecular insight",
    "entities": []
  },
  {
    "text": "into the human brain barrier system and its disruption with age and disease,",
    "entities": []
  },
  {
    "text": "with implications for the development of brain-permeable therapeutics.",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41591-025-03831-3",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: T.W.-C., J.R. and H.S.O.",
    "entities": [
      {
        "text": "J.R.",
        "label": "PERSON"
      },
      {
        "text": "H.S.O.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "are co-founders and scientific advisors of Teal Omics Inc. and have received",
    "entities": [
      {
        "text": "Teal Omics Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "equity stakes. T.W.-C. is a co-founder and scientific advisor of Alkahest Inc.",
    "entities": [
      {
        "text": "T.W.-C.",
        "label": "PERSON"
      },
      {
        "text": "Alkahest Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Qinotto Inc. and has received equity stakes in these companies. C.C. has",
    "entities": [
      {
        "text": "Qinotto Inc.",
        "label": "ORG"
      },
      {
        "text": "C.C.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "received research support from GSK and EISAI. C.C. is a member of the scientific",
    "entities": [
      {
        "text": "GSK",
        "label": "ORG"
      },
      {
        "text": "EISAI",
        "label": "ORG"
      },
      {
        "text": "C.C.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "advisory board of Circular Genomics and owns stock and a member of the",
    "entities": [
      {
        "text": "advisory board of Circular Genomics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Scientific Advisory Board of ADmit. K.L.P. is on the Scientific Advisory Board",
    "entities": [
      {
        "text": "Scientific Advisory Board of ADmit",
        "label": "ORG"
      },
      {
        "text": "K.L.P.",
        "label": "ORG"
      },
      {
        "text": "the Scientific Advisory Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for Amprion and is a consultant for Novartis, Biohaven, Curasen and Neuron23,",
    "entities": [
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Biohaven",
        "label": "PERSON"
      },
      {
        "text": "Curasen",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "where she receives consulting fees. S.B.M. is an advisor to MyOme, PhiTech and",
    "entities": [
      {
        "text": "S.B.M.",
        "label": "ORG"
      },
      {
        "text": "MyOme",
        "label": "ORG"
      },
      {
        "text": "PhiTech",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Valinor Discovery. The remaining authors declare no competing interests.",
    "entities": [
      {
        "text": "Valinor Discovery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "51. Nat Neurosci. 2025 Jul 15. doi: 10.1038/s41593-025-02009-x. Online ahead of",
    "entities": [
      {
        "text": "51",
        "label": "CARDINAL"
      },
      {
        "text": "Nat Neurosci",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Mapping human thalamocortical connectivity with electrical stimulation and",
    "entities": []
  },
  {
    "text": "recording.",
    "entities": []
  },
  {
    "text": "(1)Laboratory of Behavioral and Cognitive Neuroscience, Department of Neurology",
    "entities": [
      {
        "text": "Behavioral",
        "label": "ORG"
      },
      {
        "text": "Department of Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Neurological Sciences, Stanford University School of Medicine, Stanford, CA,",
    "entities": [
      {
        "text": "Neurological Sciences",
        "label": "ORG"
      },
      {
        "text": "Stanford University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      },
      {
        "text": "CA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Neurosurgery, Stanford University School of Medicine, Stanford,",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "ORG"
      },
      {
        "text": "Stanford University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Laboratory of Behavioral and Cognitive Neuroscience, Department of Neurology",
    "entities": [
      {
        "text": "Behavioral",
        "label": "ORG"
      },
      {
        "text": "Department of Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery, Stanford University School of Medicine, Stanford,",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Stanford University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Stanford",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The brain's functional architecture is shaped by electrophysiological",
    "entities": []
  },
  {
    "text": "interactions between its components, encompassing both cortical and subcortical",
    "entities": []
  },
  {
    "text": "structures. In this study, we provide an atlas of electrophysiological causal",
    "entities": []
  },
  {
    "text": "connections across 4,864 brain sites in 27 human participants using repeated",
    "entities": [
      {
        "text": "4,864",
        "label": "CARDINAL"
      },
      {
        "text": "27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "single-pulse electrical stimulations and recordings with intracranial electrodes",
    "entities": []
  },
  {
    "text": "implanted in cortical regions and multiple thalamic nuclei. We show distinct",
    "entities": []
  },
  {
    "text": "spectral signatures elicited by perturbations of specific brain areas.",
    "entities": []
  },
  {
    "text": "Identified features of causal connectivity exhibited highly organized yet",
    "entities": []
  },
  {
    "text": "distinct patterns, indicating that each feature may correspond to a separate",
    "entities": []
  },
  {
    "text": "mode of information transmission across brain regions. Notably, we report a new",
    "entities": []
  },
  {
    "text": "waveform with unique temporal and spatial characteristics specifically linked to",
    "entities": []
  },
  {
    "text": "thalamic stimulations, namely delayed-onset theta oscillations in both",
    "entities": []
  },
  {
    "text": "ipsilateral and contralateral cortical regions. These findings contribute to a",
    "entities": []
  },
  {
    "text": "more detailed understanding of the human brain's functional architecture and",
    "entities": []
  },
  {
    "text": "offer valuable data for the development of biologically informed computational",
    "entities": []
  },
  {
    "text": "\u00a9 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer Nature America, Inc.",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: The authors declare no",
    "entities": []
  },
  {
    "text": "competing interests.",
    "entities": []
  },
  {
    "text": "52. Hypertens Res. 2025 Jul 15. doi: 10.1038/s41440-025-02286-w. Online ahead of",
    "entities": [
      {
        "text": "52",
        "label": "CARDINAL"
      },
      {
        "text": "Hypertens Res",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1038/s41440-025-02286-w. Online",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "Re: Comment on: Optimal blood pressure target for patients with prior stroke: a",
    "entities": []
  },
  {
    "text": "systematic review and meta-analysis.",
    "entities": []
  },
  {
    "text": "(1)Department of Preventive Medicine and Public Health, Faculty of Medicine,",
    "entities": [
      {
        "text": "Preventive Medicine and Public Health, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Preventive Medicine and Public Health, Faculty of Medicine,",
    "entities": [
      {
        "text": "Preventive Medicine and Public Health, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Compliance with ethical standards. Conflict of",
    "entities": []
  },
  {
    "text": "interest: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "Vestibular event monitoring in acute posterior circulation stroke: from",
    "entities": []
  },
  {
    "text": "emergency room to stroke unit and beyond.",
    "entities": []
  },
  {
    "text": "(1)Neurology Department, Dokuz Eyl\u00fcl University Hospital, Izmir, Turkey.",
    "entities": [
      {
        "text": "1)Neurology Department",
        "label": "ORG"
      },
      {
        "text": "Dokuz Eyl\u00fcl University Hospital",
        "label": "ORG"
      },
      {
        "text": "Izmir",
        "label": "PERSON"
      },
      {
        "text": "Turkey",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Royal Prince Alfred Hospital Medical Centre, Sydney, Australia.",
    "entities": [
      {
        "text": "2)Royal",
        "label": "CARDINAL"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia.",
    "entities": [
      {
        "text": "Royal Prince Alfred Hospital",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia.",
    "entities": [
      {
        "text": "4)Neurology Department",
        "label": "ORG"
      },
      {
        "text": "Royal Prince Alfred Hospital",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.1007/s00415-025-13163-4",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflicts of interest: All the",
    "entities": []
  },
  {
    "text": "authors of \u201cVestibular event monitoring in acute posterior circulation stroke",
    "entities": []
  },
  {
    "text": "from emergency room to stroke unit and beyond\u201d declare that they have no",
    "entities": []
  },
  {
    "text": "conflicts of interest. Ethical approval: The study complied with good clinical",
    "entities": []
  },
  {
    "text": "practice guidelines and with the declaration of Helsinki.",
    "entities": [
      {
        "text": "Helsinki",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Investigation of spark ignition engine performance in ethanol-petrol blended",
    "entities": []
  },
  {
    "text": "fuels using artificial neural network.",
    "entities": []
  },
  {
    "text": "(1)Department of Motor Vehicle Engineering, College of Engineering, Ethiopian",
    "entities": [
      {
        "text": "Motor Vehicle Engineering",
        "label": "ORG"
      },
      {
        "text": "College of Engineering",
        "label": "ORG"
      },
      {
        "text": "Ethiopian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Defence University, P.O. Box 1041, Bishoftu, Ethiopia.",
    "entities": [
      {
        "text": "Defence University",
        "label": "ORG"
      },
      {
        "text": "P.O. Box 1041",
        "label": "ORG"
      },
      {
        "text": "Bishoftu",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Motor Vehicle Engineering, College of Engineering, Ethiopian",
    "entities": [
      {
        "text": "Motor Vehicle Engineering",
        "label": "ORG"
      },
      {
        "text": "College of Engineering",
        "label": "ORG"
      },
      {
        "text": "Ethiopian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Defence University, P.O. Box 1041, Bishoftu, Ethiopia. kumynnh2023@gmail.com.",
    "entities": [
      {
        "text": "Defence University",
        "label": "ORG"
      },
      {
        "text": "P.O. Box 1041",
        "label": "ORG"
      },
      {
        "text": "Bishoftu",
        "label": "GPE"
      },
      {
        "text": "Ethiopia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Faculty of Mechanical Engineering, Wroc\u0142aw University of Science and",
    "entities": [
      {
        "text": "Mechanical Engineering",
        "label": "ORG"
      },
      {
        "text": "Wroc\u0142aw University of Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The increasing global cost of fossil fuels and growing environmental concerns",
    "entities": []
  },
  {
    "text": "have accelerated the search for sustainable energy alternatives, positioning",
    "entities": []
  },
  {
    "text": "bioethanol as a promising renewable fuel for spark-ignition (SI) engines. This",
    "entities": []
  },
  {
    "text": "study uniquely integrates ethanol-petrol blends (E0, E10, E20, and E30) with",
    "entities": [
      {
        "text": "E0",
        "label": "PRODUCT"
      },
      {
        "text": "E10",
        "label": "ORG"
      },
      {
        "text": "E20",
        "label": "ORG"
      },
      {
        "text": "E30",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Artificial Neural Networks (ANNs) to address critical gaps in predictive",
    "entities": [
      {
        "text": "Artificial Neural Networks",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "modeling and fuel optimization. Experimental tests were conducted on a",
    "entities": []
  },
  {
    "text": "single-cylinder, four-stroke SI engine under constant load conditions, capturing",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "SI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "data on engine speed, mass flow rate, combustion efficiency, peak cylinder",
    "entities": []
  },
  {
    "text": "pressure, brake-specific fuel consumption (BSFC), and exhaust gas temperature. A",
    "entities": []
  },
  {
    "text": "feed-forward backpropagation ANN model was developed using 75% of the collected",
    "entities": [
      {
        "text": "ANN",
        "label": "ORG"
      },
      {
        "text": "75%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "data for training and 25% for validation, achieving high predictive accuracy",
    "entities": [
      {
        "text": "25%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with R2 values exceeding 0.98 for most parameters. Results showed that E30",
    "entities": [
      {
        "text": "R2",
        "label": "CARDINAL"
      },
      {
        "text": "0.98",
        "label": "CARDINAL"
      },
      {
        "text": "E30",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improved combustion efficiency by 12.5% compared to E0 at 1500 RPM and reduced",
    "entities": [
      {
        "text": "12.5%",
        "label": "PERCENT"
      },
      {
        "text": "E0",
        "label": "PRODUCT"
      },
      {
        "text": "1500",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "BSFC by 22% in the 2000-2500 RPM range, while maximum cylinder pressure",
    "entities": [
      {
        "text": "22%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "increased with RPM but remained slightly lower for higher ethanol blends due to",
    "entities": [
      {
        "text": "RPM",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ethanol's cooling effect. By effectively predicting performance metrics across a",
    "entities": []
  },
  {
    "text": "broad RPM range (1500-3500), the ANN model reduces reliance on extensive",
    "entities": [
      {
        "text": "RPM",
        "label": "ORG"
      },
      {
        "text": "1500-3500",
        "label": "CARDINAL"
      },
      {
        "text": "ANN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "experimental testing and offers a scalable approach for optimizing fuel-blending",
    "entities": []
  },
  {
    "text": "strategies, thereby supporting the transition to cleaner, more efficient energy",
    "entities": []
  },
  {
    "text": "declare no competing interests.",
    "entities": []
  },
  {
    "text": "55. Eur Radiol. 2025 Jul 15. doi: 10.1007/s00330-025-11807-7. Online ahead of",
    "entities": [
      {
        "text": "55",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Motion artifacts and image quality in stroke MRI: associated factors and impact",
    "entities": []
  },
  {
    "text": "on AI and human diagnostic accuracy.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Radiology, University Hospital Copenhagen-Herlev and Gentofte,",
    "entities": [
      {
        "text": "Radiology, University Hospital Copenhagen-Herlev",
        "label": "ORG"
      },
      {
        "text": "Gentofte",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,",
    "entities": [
      {
        "text": "Health and Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Radiology, University Hospital Copenhagen-Herlev and Gentofte,",
    "entities": [
      {
        "text": "Radiology, University Hospital Copenhagen-Herlev",
        "label": "ORG"
      },
      {
        "text": "Gentofte",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(6)Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,",
    "entities": [
      {
        "text": "Health and Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Computer Science, University of Copenhagen, Copenhagen,",
    "entities": [
      {
        "text": "Computer Science, University of Copenhagen",
        "label": "ORG"
      },
      {
        "text": "Copenhagen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Department of Brain and Spinal Cord Injury, University Hospital",
    "entities": [
      {
        "text": "Brain",
        "label": "ORG"
      },
      {
        "text": "Spinal Cord Injury",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Neurology, University Hospital Copenhagen-Herlev and Gentofte,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "University Hospital Copenhagen-Herlev",
        "label": "ORG"
      },
      {
        "text": "Gentofte",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(10)Department of Radiology, University Hospital Copenhagen-Bispebjerg and",
    "entities": [
      {
        "text": "10)Department of Radiology",
        "label": "MONEY"
      },
      {
        "text": "University Hospital Copenhagen-Bispebjerg",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVES: To assess the prevalence of motion artifacts and the factors",
    "entities": [
      {
        "text": "OBJECTIVES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with them in a cohort of suspected stroke patients, and to determine",
    "entities": []
  },
  {
    "text": "their impact on diagnostic accuracy for both AI and radiologists.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: This retrospective cross-sectional study included brain",
    "entities": []
  },
  {
    "text": "MRI scans of consecutive adult suspected stroke patients from a",
    "entities": []
  },
  {
    "text": "non-comprehensive Danish stroke center between January and April 2020. An expert",
    "entities": [
      {
        "text": "Danish",
        "label": "NORP"
      },
      {
        "text": "between January and April 2020",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "neuroradiologist identified acute ischemic, hemorrhagic, and space-occupying",
    "entities": []
  },
  {
    "text": "lesions as references. Two blinded radiology residents rated MRI image quality",
    "entities": [
      {
        "text": "Two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and motion artifacts. The diagnostic accuracy of a CE-marked deep learning tool",
    "entities": []
  },
  {
    "text": "was compared to that of radiology reports. Multivariate analysis examined",
    "entities": []
  },
  {
    "text": "associations between patient characteristics and motion artifacts.",
    "entities": []
  },
  {
    "text": "RESULTS: 775 patients (68 years \u00b1 16, 420 female) were included. Acute ischemic,",
    "entities": [
      {
        "text": "775",
        "label": "CARDINAL"
      },
      {
        "text": "68 years",
        "label": "DATE"
      },
      {
        "text": "16",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "hemorrhagic, and space-occupying lesions were found in 216 (27.9%), 12 (1.5%),",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      },
      {
        "text": "216",
        "label": "CARDINAL"
      },
      {
        "text": "27.9%",
        "label": "PERCENT"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "1.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and 20 (2.6%). Motion artifacts were present in 57 (7.4%). Increasing age (OR",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "2.6%",
        "label": "PERCENT"
      },
      {
        "text": "57",
        "label": "DATE"
      },
      {
        "text": "7.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "2.36; 95% CI: 1.32, 4.20; p = 0.003) were independently associated with motion",
    "entities": [
      {
        "text": "2.36",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.32",
        "label": "CARDINAL"
      },
      {
        "text": "4.20",
        "label": "CARDINAL"
      },
      {
        "text": "0.003",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "artifacts in multivariate analysis. Motion artifacts significantly reduced the",
    "entities": []
  },
  {
    "text": "accuracy of detecting hemorrhage. This reduction was greater for the AI tool",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(from 88 to 67%; p < 0.001) than for radiology reports (from 100 to 93%;",
    "entities": [
      {
        "text": "88 to 67%",
        "label": "PERCENT"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "100 to 93%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "p < 0.001). Ischemic and space-occupying lesion detection was not significantly",
    "entities": [
      {
        "text": "p < 0.001",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "affected.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Motion artifacts are common in suspected stroke patients,",
    "entities": []
  },
  {
    "text": "particularly in the elderly and patients with motor symptoms, reducing accuracy",
    "entities": []
  },
  {
    "text": "for hemorrhage detection by both AI and radiologists.",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "KEY POINTS: Question Motion artifacts reduce the quality of MRI scans, but it is",
    "entities": [
      {
        "text": "Question Motion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "unclear which factors are associated with them and how they impact diagnostic",
    "entities": []
  },
  {
    "text": "accuracy. Findings Motion artifacts occurred in 7% of suspected stroke MRI",
    "entities": [
      {
        "text": "Findings Motion",
        "label": "ORG"
      },
      {
        "text": "7%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "scans, associated with higher patient age and motor symptoms, lowering",
    "entities": []
  },
  {
    "text": "hemorrhage detection by AI and radiologists. Clinical relevance Motion artifacts",
    "entities": [
      {
        "text": "AI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in stroke brain MRIs significantly reduce the diagnostic accuracy of human and",
    "entities": []
  },
  {
    "text": "AI detection of intracranial hemorrhages. Elderly patients and those with motor",
    "entities": []
  },
  {
    "text": "symptoms may benefit from a greater focus on motion artifact prevention and",
    "entities": []
  },
  {
    "text": "reduction.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00330-025-11807-7",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Compliance with ethical standards. Guarantor:",
    "entities": []
  },
  {
    "text": "The scientific guarantor of this publication is C.H.K. Conflict of interest:",
    "entities": []
  },
  {
    "text": "C.H.K.: Prior consultancy work for Cerebriu. Financial support from Innovation",
    "entities": [
      {
        "text": "C.H.K.",
        "label": "ORG"
      },
      {
        "text": "Cerebriu",
        "label": "PERSON"
      },
      {
        "text": "Innovation",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Fund Denmark. Affiliated with Radiology AI Testcenter (RAIT.dk). F.C.M.: None",
    "entities": [
      {
        "text": "Radiology AI Testcenter",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "related to this study. Prior consultancy work for Cerebriu. Prior consultancy",
    "entities": [
      {
        "text": "Cerebriu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "work for Siemens Healthineers and institutional research agreement with Siemens",
    "entities": [
      {
        "text": "Siemens Healthineers",
        "label": "ORG"
      },
      {
        "text": "Siemens",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Healthineers. Affiliated with Radiology AI Testcenter (RAIT.dk). K.L.G.: None",
    "entities": [
      {
        "text": "Radiology AI Testcenter",
        "label": "ORG"
      },
      {
        "text": "K.L.G.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relevant. M.B.A.: None related to this study. Prior speaker agreements with",
    "entities": []
  },
  {
    "text": "Siemens Healthineers, Philips Healthcare, GE Healthcare, Boehringer Ingelheim,",
    "entities": [
      {
        "text": "Siemens Healthineers",
        "label": "ORG"
      },
      {
        "text": "Philips Healthcare",
        "label": "ORG"
      },
      {
        "text": "GE Healthcare",
        "label": "ORG"
      },
      {
        "text": "Boehringer Ingelheim",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Roche. Institutional research agreement with Siemens Healthineers.",
    "entities": [
      {
        "text": "Roche",
        "label": "ORG"
      },
      {
        "text": "Siemens Healthineers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Affiliated with Radiology AI Testcenter (RAIT.dk). J.M.M.: None relevant.",
    "entities": [
      {
        "text": "Radiology AI Testcenter",
        "label": "ORG"
      },
      {
        "text": "J.M.M.",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "relevant. M.N.: Shareholder in Cerebriu A/S. C.K.: Local PI on studies from",
    "entities": [
      {
        "text": "M.N.",
        "label": "ORG"
      },
      {
        "text": "Cerebriu A/S. C.K.:",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Bayer A/S, and Coloplast, speakers fee from Lundbeck A/S all unrelated to the",
    "entities": [
      {
        "text": "Bayer A/S",
        "label": "ORG"
      },
      {
        "text": "Coloplast",
        "label": "ORG"
      },
      {
        "text": "Lundbeck A/S",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "current trial. Research fund from Innovation Fund Denmark for a collaborative",
    "entities": [
      {
        "text": "Innovation Fund Denmark",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "project with Cerebriu A/S. M.P.B.: None related to this study. Unrelated to this",
    "entities": [
      {
        "text": "Cerebriu A/S. M.P.B.:",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "study, M.B. has received speaker and consultancy fees from Novartis, Esaote, and",
    "entities": [
      {
        "text": "M.B.",
        "label": "GPE"
      },
      {
        "text": "Novartis, Esaote",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Image Analysis Group. Financial support from EUROSTAR, EIC-grant, Innovation",
    "entities": [
      {
        "text": "Image Analysis Group",
        "label": "ORG"
      },
      {
        "text": "EUROSTAR",
        "label": "ORG"
      },
      {
        "text": "EIC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fund Denmark, Agency for Digital Government and M.B. is an advisory board member",
    "entities": [
      {
        "text": "Fund Denmark",
        "label": "GPE"
      },
      {
        "text": "Digital Government",
        "label": "ORG"
      },
      {
        "text": "M.B.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "of Chondrometrics and Image Analysis group as shareholder of Image Analysis",
    "entities": [
      {
        "text": "Chondrometrics and Image Analysis",
        "label": "ORG"
      },
      {
        "text": "Image Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Group and Radiobotics. Affiliated with Radiology AI Testcenter (RAIT.dk).",
    "entities": [
      {
        "text": "Radiology AI Testcenter",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Statistics and biometry: F.C.M. and M.P.B. kindly provided statistical advice",
    "entities": [
      {
        "text": "F.C.M.",
        "label": "ORG"
      },
      {
        "text": "M.P.B.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for this manuscript. Informed consent: Written informed consent was waived by",
    "entities": []
  },
  {
    "text": "the Institutional Review Board. Ethical approval: Institutional Review Board",
    "entities": [
      {
        "text": "the Institutional Review Board",
        "label": "ORG"
      },
      {
        "text": "Institutional Review Board",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "approval was obtained. Study subjects or cohorts overlap: The patients without",
    "entities": []
  },
  {
    "text": "severe artifacts in this cohort (n = 767) were previously evaluated with a deep",
    "entities": [
      {
        "text": "767",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "learning tool in an external validation study (",
    "entities": []
  },
  {
    "text": "https://doi.org/10.1016/j.ejrad.2023.111126 ). Methodology: Retrospective",
    "entities": []
  },
  {
    "text": "Cross-sectional study Performed at one institution.",
    "entities": [
      {
        "text": "Performed",
        "label": "ORG"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Risk factors, clinical presentation, stroke subtype and short-term outcome",
    "entities": []
  },
  {
    "text": "following acute stroke in a multi-ethnic population: a 10-year study from Qatar.",
    "entities": [
      {
        "text": "10-year",
        "label": "DATE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Stroke Program, University of Alberta, 11350 83 Ave,",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Stroke Program",
        "label": "ORG"
      },
      {
        "text": "University of Alberta",
        "label": "ORG"
      },
      {
        "text": "11350 83",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(3)Department of Neuroscience, Hamad Medical Corporation, Doha, Qatar.",
    "entities": [
      {
        "text": "Neuroscience",
        "label": "ORG"
      },
      {
        "text": "Hamad Medical Corporation",
        "label": "ORG"
      },
      {
        "text": "Doha",
        "label": "GPE"
      },
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Stroke remains a leading global cause of disability and mortality",
    "entities": []
  },
  {
    "text": "with over 100 million patients affected worldwide. Its incidence has risen in",
    "entities": [
      {
        "text": "over 100 million",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "recent decades, especially in low- and middle-income countries (LMICs), due to",
    "entities": [
      {
        "text": "recent decades",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "limited education, healthcare, and effective prevention measures. This study",
    "entities": [
      {
        "text": "healthcare",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "investigates the association between ethnicity and outcomes of stroke in Qatar,",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "a country with a heterogeneous population.",
    "entities": []
  },
  {
    "text": "METHODS: Data from 18,174 stroke patients admitted to Hamad General Hospital",
    "entities": [
      {
        "text": "18,174",
        "label": "CARDINAL"
      },
      {
        "text": "Hamad General Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from 2014 to 2024 were analyzed. We assessed patient characteristics, stroke",
    "entities": [
      {
        "text": "2014 to 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "types, comorbidities, and outcomes using the NIH Stroke Scale and modified",
    "entities": [
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: There were significant ethnic differences in stroke presentation and",
    "entities": []
  },
  {
    "text": "outcomes. Middle Easterns were older (59.7 \u00b1 14.2) than South East Asian",
    "entities": [
      {
        "text": "59.7",
        "label": "CARDINAL"
      },
      {
        "text": "14.2",
        "label": "CARDINAL"
      },
      {
        "text": "South East",
        "label": "LOC"
      },
      {
        "text": "Asian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(50.1 \u00b1 11.7) and Far Eastern (47.5 \u00b1 9.85) patients; p < 0.001. Middle Eastern",
    "entities": [
      {
        "text": "50.1 \u00b1",
        "label": "QUANTITY"
      },
      {
        "text": "Far Eastern",
        "label": "ORG"
      },
      {
        "text": "47.5",
        "label": "CARDINAL"
      },
      {
        "text": "9.85",
        "label": "CARDINAL"
      },
      {
        "text": "p < 0.001",
        "label": "ORG"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "patients had a higher prevalence of stroke risk factors (diabetes, hypertension,",
    "entities": []
  },
  {
    "text": "obesity) and stroke mimics (39.8%) than Southeast Asian (21.7%) and Far Eastern",
    "entities": [
      {
        "text": "39.8%",
        "label": "PERCENT"
      },
      {
        "text": "Southeast Asian",
        "label": "NORP"
      },
      {
        "text": "21.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(27.7%) patients (p < 0.0001). Far Eastern patients demonstrated a higher",
    "entities": [
      {
        "text": "27.7%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "incidence (17.6%) of intracerebral hemorrhage compared to Middle Easterns (6.2%)",
    "entities": [
      {
        "text": "17.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Easterns",
        "label": "PERSON"
      },
      {
        "text": "6.2%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and East Asians (10.6%); p < 0.0001. However, ischemic stroke was more common",
    "entities": [
      {
        "text": "East Asians",
        "label": "NORP"
      },
      {
        "text": "10.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "among Southeast Asians (58.6%) than Middle Eastern (43.8%) and Far Eastern",
    "entities": [
      {
        "text": "Southeast Asians",
        "label": "NORP"
      },
      {
        "text": "58.6%",
        "label": "PERCENT"
      },
      {
        "text": "Middle Eastern",
        "label": "NORP"
      },
      {
        "text": "43.8%",
        "label": "PERCENT"
      },
      {
        "text": "Far Eastern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(44.4%) patients; p < 0.0001. Lastly, there were significant differences in",
    "entities": [
      {
        "text": "44.4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "outcomes as measured by mortality and the mRS.",
    "entities": []
  },
  {
    "text": "CONCLUSION: There are significant ethnic differences in stroke presentation,",
    "entities": []
  },
  {
    "text": "management, and outcomes in Qatar, some of which may reflect underlying",
    "entities": [
      {
        "text": "Qatar",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "disparities driven by social and structural inequities. While genetic",
    "entities": []
  },
  {
    "text": "differences play a role, early management of vascular risk factors is a crucial,",
    "entities": []
  },
  {
    "text": "preventable measure to reduce stroke burden in LMICs and improve health",
    "entities": []
  },
  {
    "text": "\u00a9 2025. Springer-Verlag GmbH Germany, part of Springer Nature.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Springer-Verlag GmbH Germany",
        "label": "ORG"
      },
      {
        "text": "Springer Nature",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "PMID: 40664805 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Declarations. Conflict of interest: On behalf of",
    "entities": []
  },
  {
    "text": "all authors, the corresponding author states that there is no conflict of",
    "entities": []
  },
  {
    "text": "interest. Ethical standards: For this type of study formal consent is not",
    "entities": []
  },
  {
    "text": "required.",
    "entities": []
  },
  {
    "text": "Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "self-controlled case series study.",
    "entities": []
  },
  {
    "text": "Pan Y(1)(2)(3), Han Y(4), Zhou C(5), Zhao L(6), Zheng J(2), Ye X(7)(8), He",
    "entities": [
      {
        "text": "Pan Y(1)(2)(3",
        "label": "PERSON"
      },
      {
        "text": "Han",
        "label": "NORP"
      },
      {
        "text": "Zhou C(5",
        "label": "PERSON"
      },
      {
        "text": "Zhao L(6",
        "label": "PERSON"
      },
      {
        "text": "Zheng J(2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Collaborators: Chute CG.",
    "entities": [
      {
        "text": "Chute CG",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Radiology, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Guizhou Province, China.",
    "entities": [
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Internal Medicine, Division of Nephrology, University of",
    "entities": [
      {
        "text": "Internal Medicine, Division of Nephrology, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Michigan, Medical School, Ann Arbor, MI, USA.",
    "entities": [
      {
        "text": "Michigan",
        "label": "GPE"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Radiology, University of Michigan, Medical School, Ann Arbor,",
    "entities": [
      {
        "text": "Radiology, University of Michigan,",
        "label": "ORG"
      },
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Preventive Medicine (Biostatistics Division), Northwestern",
    "entities": [
      {
        "text": "Preventive Medicine (Biostatistics Division",
        "label": "ORG"
      },
      {
        "text": "Northwestern\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Evanston, IL, USA.",
    "entities": [
      {
        "text": "Evanston",
        "label": "ORG"
      },
      {
        "text": "IL",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Guizhou University Medical College, Guiyang, Guizhou Province, China.",
    "entities": [
      {
        "text": "7)Guizhou University Medical College",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Respiratory and Critical Care Medicine and NHC Key Laboratory",
    "entities": [
      {
        "text": "Respiratory and Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "NHC Key Laboratory",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang,",
    "entities": [
      {
        "text": "Immunological Diseases",
        "label": "ORG"
      },
      {
        "text": "People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Guizhou Province, China. yxw1205@163.com.",
    "entities": [
      {
        "text": "Guizhou Province",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Unit for Laboratory Animal Medicine, University of Michigan Medical School,",
    "entities": [
      {
        "text": "Laboratory Animal Medicine,",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Learning Health Sciences, University of Michigan Medical",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Learning Health Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Michigan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Center for Computational Medicine and Bioinformatics, University of Michigan",
    "entities": [
      {
        "text": "11)Center",
        "label": "CARDINAL"
      },
      {
        "text": "Bioinformatics, University of Michigan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical School, Ann Arbor, MI, USA. yongqunh@med.umich.edu.",
    "entities": [
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Ann Arbor",
        "label": "GPE"
      },
      {
        "text": "MI",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "yongqunh@med.umich.edu",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "The safety of XBB.1.5-containing COVID-19 mRNA vaccines warrants investigation.",
    "entities": [
      {
        "text": "COVID-19",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "We assessed the relative risk of 15 adverse events following the XBB.1.5",
    "entities": [
      {
        "text": "15",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vaccination using a self-controlled case series study design with data from the",
    "entities": []
  },
  {
    "text": "National COVID Cohort Collaborative (N3C) from September 11, 2023, to June 1,",
    "entities": [
      {
        "text": "National COVID Cohort Collaborative",
        "label": "ORG"
      },
      {
        "text": "September 11, 2023",
        "label": "DATE"
      },
      {
        "text": "June 1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024 in the USA. Based on a baseline population of 244,494 patients, adverse",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "244,494",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "events included Guillain-Barr\u00e9 syndrome, seizure, non-hemorrhagic stroke and",
    "entities": []
  },
  {
    "text": "transient ischemic attack, hemorrhagic stroke, narcolepsy or cataplexy,",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "anaphylaxis, acute myocardial infarction, myo/pericarditis, coagulopathy,",
    "entities": []
  },
  {
    "text": "multisystem inflammatory syndrome, Bell's palsy, transverse myelitis,",
    "entities": [
      {
        "text": "Bell",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "appendicitis, pulmonary embolism, and encephalitis. We found an association",
    "entities": [
      {
        "text": "appendicitis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "between vaccination and anaphylaxis (IRR [95% CI]: day 0-17.35 [9.32-30.03], day",
    "entities": [
      {
        "text": "IRR",
        "label": "ORG"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0-17.35",
        "label": "CARDINAL"
      },
      {
        "text": "9.32",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1-9.35 [5.12-15.95], day 2-6.20 [3.40-10.57], <20 patients in each risk period).",
    "entities": [
      {
        "text": "1-9.35",
        "label": "PERCENT"
      },
      {
        "text": "5.12-15.95",
        "label": "CARDINAL"
      },
      {
        "text": "2-6.20",
        "label": "DATE"
      },
      {
        "text": "3.40",
        "label": "CARDINAL"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "No other outcomes showed significantly increased risk following vaccination. Our",
    "entities": []
  },
  {
    "text": "results contribute to the safety profile evaluation for XBB.1.5-containing",
    "entities": []
  },
  {
    "text": "DOI: 10.1038/s41467-025-61613-4",
    "entities": [
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664645 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664645",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "58. Microsyst Nanoeng. 2025 Jul 15;11(1):144. doi: 10.1038/s41378-025-00971-x.",
    "entities": [
      {
        "text": "58",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "Jul 15;11(1):144.",
        "label": "PERSON"
      },
      {
        "text": "10.1038",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Design method for out-of-plane motion rejecting structure in 2-DoF large stroke",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "This paper addresses a critical challenge in the design of MEMS actuators: the",
    "entities": [
      {
        "text": "MEMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rejection of out-of-plane motion, specifically along the Z-axis, which can",
    "entities": [
      {
        "text": "Z",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "severely impact the precision and performance of these micro-actuation systems.",
    "entities": []
  },
  {
    "text": "In many MEMS applications, unwanted out-of-plane displacement can lead to",
    "entities": [
      {
        "text": "MEMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced accuracy in tasks such as optical steering, micro-manipulation, and",
    "entities": []
  },
  {
    "text": "scanning applications. In response to these limitations, this paper proposes a",
    "entities": []
  },
  {
    "text": "novel design technique that effectively rejects Z-axis motion by transforming",
    "entities": []
  },
  {
    "text": "the motion of the micro stage along the Z-axis into equivalent displacements",
    "entities": [
      {
        "text": "Z",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "between pairs of points on cantilevers. These point pairs are founded exhibiting",
    "entities": []
  },
  {
    "text": "variable common-mode and differential-mode motion characteristics, depending on",
    "entities": []
  },
  {
    "text": "whether the stage is undergoing in-plane (X/Y) or out-of-plane (Z)",
    "entities": []
  },
  {
    "text": "displacements. By connecting these point pairs with rods, differential motion",
    "entities": []
  },
  {
    "text": "between the points in the pairs is suppressed, reducing unwanted out-of-plane",
    "entities": []
  },
  {
    "text": "motion significantly. We provide a detailed analysis of this design methodology",
    "entities": []
  },
  {
    "text": "and present a practical application in the form of an electromagnetic large",
    "entities": []
  },
  {
    "text": "design-simulation-manufacturing-testing cycle, where the effectiveness of the",
    "entities": []
  },
  {
    "text": "Z-axis motion rejection structure is systematically evaluated, and compared",
    "entities": []
  },
  {
    "text": "improvement in performance, with static and dynamic travel ranges reaching",
    "entities": []
  },
  {
    "text": "\u00b160 \u03bcm and \u00b1400 \u03bcm, respectively. Moreover, the Z-axis stiffness was enhanced by",
    "entities": [
      {
        "text": "Z",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "68.5%, which is more than five times the improvement observed in the X/Y axes'",
    "entities": [
      {
        "text": "68.5%",
        "label": "PERCENT"
      },
      {
        "text": "more than five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "stiffness. These results highlight the potential of the proposed method to",
    "entities": []
  },
  {
    "text": "provide a robust solution for out-of-plane motion suppression in MEMS actuators,",
    "entities": [
      {
        "text": "MEMS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "offering improved performance without compromising other critical parameters",
    "entities": []
  },
  {
    "text": "such as displacement and actuation speed.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Conflict of interest: The authors declare no",
    "entities": []
  },
  {
    "text": "10.1016/j.ejpn.2025.07.002. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Predicting a difficult journey: acute symptomatic seizures and post-stroke",
    "entities": []
  },
  {
    "text": "(1)Department for Paediatric and Adolescent Medicine, Johannes Kepler",
    "entities": [
      {
        "text": "Paediatric and Adolescent Medicine",
        "label": "ORG"
      },
      {
        "text": "Johannes Kepler",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Krankenhausstrasse 26-30, 4020, Linz, Austria. Electronic address:",
    "entities": [
      {
        "text": "Krankenhausstrasse",
        "label": "GPE"
      },
      {
        "text": "26-30",
        "label": "CARDINAL"
      },
      {
        "text": "4020",
        "label": "DATE"
      },
      {
        "text": "Linz",
        "label": "GPE"
      },
      {
        "text": "Austria",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Association between the levels of gamma-glutamyl transpeptidase and the risk of",
    "entities": []
  },
  {
    "text": "stroke: systematic review and meta-analysis.",
    "entities": []
  },
  {
    "text": "Stroke is influenced by numerous factors, both modifiable and non-modifiable.",
    "entities": []
  },
  {
    "text": "Among these, gamma-glutamyl transpeptidase (GGT) serves as a prognostic",
    "entities": []
  },
  {
    "text": "biomarker in cardiovascular diseases and, within this context, in neurological",
    "entities": []
  },
  {
    "text": "conditions like stroke.To determine whether an association exists between GGT",
    "entities": []
  },
  {
    "text": "and both ischemic and hemorrhagic strokes.A systematic and comprehensive",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "literature search was conducted across 5 databases, encompassing studies",
    "entities": [
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "published from their inception to January 28, 2024, following a population,",
    "entities": [
      {
        "text": "January 28, 2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "exposure, comparator, outcome, and study (PECOS) framework. Ten primary studies",
    "entities": [
      {
        "text": "Ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "meeting the eligibility criteria were selected.Our findings, based on a",
    "entities": []
  },
  {
    "text": "meta-analysis of the ten studies, indicate an increased risk of ischemic and",
    "entities": [
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hemorrhagic strokes in patients with elevated GGT levels, after excluding",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "outliers. The analysis demonstrated a significant association, with a relative",
    "entities": []
  },
  {
    "text": "risk of 1.42 (95%CI: 1.01-1.99; I2 = 19%) for hemorrhagic stroke and 1.22",
    "entities": [
      {
        "text": "1.42",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "I2",
        "label": "CARDINAL"
      },
      {
        "text": "19%",
        "label": "PERCENT"
      },
      {
        "text": "1.22",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(95%CI: 1.10-1.36; I2 = 49%) for ischemic stroke.Our study reveals an elevated",
    "entities": [
      {
        "text": "1.10-1.36",
        "label": "CARDINAL"
      },
      {
        "text": "I2",
        "label": "CARDINAL"
      },
      {
        "text": "49%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "risk of stroke in patients with high GGT levels, demonstrating a 42% higher",
    "entities": [
      {
        "text": "42%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "likelihood of hemorrhagic stroke and a 22% increased risk of ischemic stroke.",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      },
      {
        "text": "22%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "The Author(s). This is an open access article published by Thieme under the",
    "entities": [
      {
        "text": "Thieme",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "terms of the Creative Commons Attribution 4.0 International License, permitting",
    "entities": [
      {
        "text": "the Creative Commons Attribution 4.0 International License",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "copying and reproduction so long as the original work is given appropriate",
    "entities": []
  },
  {
    "text": "credit (https://creativecommons.org/licenses/by/4.0/).",
    "entities": [
      {
        "text": "https://creativecommons.org/licenses/by/4.0/",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "DOI: 10.1055/s-0045-1809936",
    "entities": [
      {
        "text": "10.1055",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664468 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664468",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There is no conflict of interest to declare.61. Arq Neuropsiquiatr. 2025 Jul;83(7):1-6. doi: 10.1055/s-0045-1809934. Epub",
    "entities": [
      {
        "text": "Arq Neuropsiquiatr",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1055",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Clinical characterization, natural history, and neuroimaging of cerebellar",
    "entities": []
  },
  {
    "text": "ataxia after abdominal surgery.",
    "entities": []
  },
  {
    "text": "The rates of complications after major abdominal surgeries remain high, despite",
    "entities": []
  },
  {
    "text": "the advances in pre- and postoperative care and surgical techniques. In these",
    "entities": []
  },
  {
    "text": "cases, neurological disorders mainly include stroke and delirium, with a high",
    "entities": []
  },
  {
    "text": "increase of morbidity. Ataxia is rarely a consequence of abdominal procedures",
    "entities": [
      {
        "text": "Ataxia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "like, more often being related to long-term complications of bariatric surgery",
    "entities": []
  },
  {
    "text": "due to chronic vitamin deficiency.To describe seven cases of ataxia following",
    "entities": [
      {
        "text": "seven",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "major abdominal surgeries and propose a prophylactic approach.A retrospective",
    "entities": []
  },
  {
    "text": "case series in which medical records of patients from the Ataxia Unit of",
    "entities": [
      {
        "text": "the Ataxia Unit",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Universidade Federal de S\u00e3o Paulo were evaluated from January 2007 to August",
    "entities": [
      {
        "text": "January 2007 to August",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2024. We identified seven patients who developed acute cerebellar ataxia after",
    "entities": [
      {
        "text": "2024",
        "label": "DATE"
      },
      {
        "text": "seven",
        "label": "CARDINAL"
      },
      {
        "text": "cerebellar ataxia",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "gastrointestinal surgery. Demographic, clinical, laboratory, neuroimaging, and",
    "entities": [
      {
        "text": "Demographic",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "treatment data were extracted. Descriptive statistics was used to summarize",
    "entities": []
  },
  {
    "text": "findings.There were two cases that evolved with neurological improvement, and",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "five remained with severe cerebellar ataxia. Brain imaging showed cerebellar",
    "entities": [
      {
        "text": "five",
        "label": "CARDINAL"
      },
      {
        "text": "cerebellar ataxia",
        "label": "PERSON"
      },
      {
        "text": "cerebellar\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "atrophy in three patients and signs of Wernicke encephalopathy in two.This case",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "Wernicke",
        "label": "PERSON"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "series describes an unusual form of acute ataxia with poor outcomes, possibly",
    "entities": []
  },
  {
    "text": "related to complications from major abdominal surgery. Early intervention and",
    "entities": []
  },
  {
    "text": "prophylactic supplementation with vitamins B1 and B12 in patients receiving TPN",
    "entities": [
      {
        "text": "B1",
        "label": "CARDINAL"
      },
      {
        "text": "B12",
        "label": "ORG"
      },
      {
        "text": "TPN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "should be considered to avoid such severe neurological complications.",
    "entities": []
  },
  {
    "text": "DOI: 10.1055/s-0045-1809934",
    "entities": [
      {
        "text": "10.1055",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40664467 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664467",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: There is no conflict of interest to declare.",
    "entities": []
  },
  {
    "text": "62. Semin Thromb Hemost. 2025 Jul 15. doi: 10.1055/a-2655-4120. Online ahead of",
    "entities": [
      {
        "text": "62",
        "label": "CARDINAL"
      },
      {
        "text": "Semin Thromb",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1055",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Current Understandings on Biological Characteristics of Thrombolytics in Acute",
    "entities": []
  },
  {
    "text": "(1)Pharmacology, Mahidol University Faculty of Pharmacy, Bangkok, Thailand.",
    "entities": [
      {
        "text": "Mahidol University Faculty of Pharmacy",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)N/A, Chulabhorn Royal Academy, Bangkok, Thailand.",
    "entities": [
      {
        "text": "2)N",
        "label": "CARDINAL"
      },
      {
        "text": "Chulabhorn Royal Academy",
        "label": "ORG"
      },
      {
        "text": "Bangkok",
        "label": "GPE"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Acute ischemic stroke leads to rapid and progressive neuronal losses. Early",
    "entities": []
  },
  {
    "text": "revascularization with thrombolytics and/or endovascular thrombectomy plays an",
    "entities": []
  },
  {
    "text": "important role in salvaging brain infarction. Currently, alteplase and",
    "entities": []
  },
  {
    "text": "tenecteplase are approved thrombolytics for the treatment of acute ischemic",
    "entities": []
  },
  {
    "text": "stroke, whereas favorable outcomes of reteplase have recently been reported in a",
    "entities": []
  },
  {
    "text": "phase 3 clinical trial. These thrombolytics share common and distinct",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "pharmacological characteristics, which contribute to their efficacy and safety",
    "entities": []
  },
  {
    "text": "in patients. In this review, biological profiles of alteplase, tenecteplase, and",
    "entities": []
  },
  {
    "text": "reteplase, including their advantages versus disadvantages in acute ischemic",
    "entities": []
  },
  {
    "text": "stroke, are discussed. Tenecteplase has high fibrin specificity, increased",
    "entities": []
  },
  {
    "text": "resistance to plasminogen activator inhibitor-1 (PAI-1), wider",
    "entities": [
      {
        "text": "PAI-1",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "concentration-response curve, and less off-target activities, which support its",
    "entities": []
  },
  {
    "text": "efficacy with low incidence of symptomatic intracranial hemorrhage (sICH).",
    "entities": []
  },
  {
    "text": "Reteplase greatly penetrates into the clot with prolonged retention, generating",
    "entities": []
  },
  {
    "text": "durable clot lysis. This activity might be associated with its excellent",
    "entities": []
  },
  {
    "text": "clinical outcomes in patients, although reteplase is sensitive to PAI-1.",
    "entities": [
      {
        "text": "PAI-1",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Notably, reteplase and alteplase produce off-target activities by inducing",
    "entities": []
  },
  {
    "text": "hypofibrinogenemia and hypoplasminogenemia, which may increase risk of",
    "entities": []
  },
  {
    "text": "hemorrhagic transformation. Moreover, orolingual angioedema is a",
    "entities": []
  },
  {
    "text": "life-threatening complication of all thrombolytics. Mechanistically, an increase",
    "entities": []
  },
  {
    "text": "in plasmin by thrombolytics leads to bradykinin generation. In addition, plasmin",
    "entities": []
  },
  {
    "text": "activates mast cell degranulation (e.g., histamine release). Together, these",
    "entities": []
  },
  {
    "text": "biopharmacological data of thrombolytics promote insights into their clinical",
    "entities": []
  },
  {
    "text": "outcomes, and might provide comprehensive bases for future research.",
    "entities": []
  },
  {
    "text": "Thieme. All rights reserved.",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: The authors declare that they have no conflict",
    "entities": []
  },
  {
    "text": "of interest.",
    "entities": []
  },
  {
    "text": "10.1136/jnis-2025-023620. Online ahead of print.",
    "entities": [
      {
        "text": "10.1136",
        "label": "CARDINAL"
      },
      {
        "text": "jnis-2025-023620",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Incidence, predictors, and outcomes of malignant cerebral edema after acute",
    "entities": []
  },
  {
    "text": "basilar artery occlusion thrombectomy.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurology, The First Affiliated Hospital of Wannan Medical",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "The First Affiliated Hospital of Wannan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Wuhu, Anhui, China.",
    "entities": [
      {
        "text": "Wuhu",
        "label": "GPE"
      },
      {
        "text": "Anhui",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Neurosurgery, and Radiology, Boston Medical Center,",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      },
      {
        "text": "Radiology, Boston Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Boston, Massachusetts, USA.",
    "entities": [
      {
        "text": "Boston",
        "label": "GPE"
      },
      {
        "text": "Massachusetts",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurology, No. 903 Hospital of PLA Joint Logistic Force,",
    "entities": []
  },
  {
    "text": "(4)Department of Neurology, Centre for Leading Medicine and Advanced",
    "entities": [
      {
        "text": "Neurology, Centre for Leading Medicine",
        "label": "ORG"
      },
      {
        "text": "Advanced",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life",
    "entities": [
      {
        "text": "The First Affiliated Hospital of USTC",
        "label": "ORG"
      },
      {
        "text": "Division of Life",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences and Medicine, University of Science and Technology of China, Hefei,",
    "entities": [
      {
        "text": "Medicine, University of Science and Technology of China",
        "label": "ORG"
      },
      {
        "text": "Hefei",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)NeuroMedical Center, The Affiliated Guangdong Second Provincial General",
    "entities": []
  },
  {
    "text": "Hospital of Jinan University, Guangzhou, Guangdong, China.",
    "entities": [
      {
        "text": "Jinan University",
        "label": "ORG"
      },
      {
        "text": "Guangzhou",
        "label": "GPE"
      },
      {
        "text": "Guangdong",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Neurology, The First Affiliated Hospital of Hainan Medical",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Hainan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Haikou, Hainan, China.",
    "entities": [
      {
        "text": "Haikou",
        "label": "GPE"
      },
      {
        "text": "Hainan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Stroke Center & Department of Neurology, The First Affiliated Hospital of",
    "entities": [
      {
        "text": "Center & Department of Neurology",
        "label": "ORG"
      },
      {
        "text": "The First Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "USTC, Division of Life Sciences and Medicine, University of Science and",
    "entities": [
      {
        "text": "USTC",
        "label": "ORG"
      },
      {
        "text": "Division of Life Sciences and Medicine, University of Science",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Technology of China, Hefei, Anhui, China.",
    "entities": [
      {
        "text": "Hefei",
        "label": "GPE"
      },
      {
        "text": "Anhui",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Neurosurgery, Xingguo People's Hospital, Xinguo Hospital of",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Xingguo People's Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Gannan Medical University, Ganzhou, Jiangxi, China.",
    "entities": [
      {
        "text": "Gannan Medical University",
        "label": "ORG"
      },
      {
        "text": "Ganzhou",
        "label": "GPE"
      },
      {
        "text": "Jiangxi",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Neurology, The First People's Hospital of Yongkang Affiliated",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "The First People's Hospital of Yongkang Affiliated",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Neurology, The First Affiliated Hospital of Wannan Medical",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "The First Affiliated Hospital of Wannan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College, Wuhu, Anhui, China doctorhuangxj@hotmail.com xuguoqiang1125@163.com.",
    "entities": [
      {
        "text": "Wuhu",
        "label": "GPE"
      },
      {
        "text": "Anhui",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Malignant cerebral edema (MCE) following basilar artery occlusion",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(BAO) thrombectomy is a critical, yet understudied, complication.",
    "entities": [
      {
        "text": "BAO",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To investigate the incidence, predictors, and clinical impact of MCE",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in patients with BAO after endovascular thrombectomy (EVT).",
    "entities": [
      {
        "text": "BAO",
        "label": "ORG"
      },
      {
        "text": "EVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: In this retrospective analysis of the national multicenter PERSIST",
    "entities": []
  },
  {
    "text": "Registry (2422 patients with BAO treated with EVT recruited from 65 Chinese",
    "entities": [
      {
        "text": "2422",
        "label": "DATE"
      },
      {
        "text": "BAO",
        "label": "ORG"
      },
      {
        "text": "EVT",
        "label": "ORG"
      },
      {
        "text": "65",
        "label": "CARDINAL"
      },
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "centers, 2015-2022), MCE was defined as Jauss score \u22654 on follow-up imaging.",
    "entities": [
      {
        "text": "2015-2022",
        "label": "DATE"
      },
      {
        "text": "MCE",
        "label": "ORG"
      },
      {
        "text": "Jauss",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Multivariable logistic regression identified predictors of MCE and its",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "association with 90-day outcomes. A favorable outcome was defined as achieving a",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "modified Rankin Scale score of 0-3 at 90 days.",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      },
      {
        "text": "0-3",
        "label": "CARDINAL"
      },
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 1883 patients who met the eligibility requirements were",
    "entities": [
      {
        "text": "1883",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "included. MCE occurred in 39.6% (746/1883) of patients. Independent predictors",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      },
      {
        "text": "39.6%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "included admission systolic blood pressure \u2265160 mm Hg (aOR=1.26, 95% CI 1.02 to",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.02",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.54), prolonged procedure time (aOR=1.01, 95% CI 1.01 to 1.01), BATMAN score \u22657",
    "entities": [
      {
        "text": "1.54",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "1.01",
        "label": "CARDINAL"
      },
      {
        "text": "BATMAN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(aOR=0.68, 95% CI 0.55 to 0.84), and vertebral V4 occlusion (vs proximal BA:",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.55 to 0.84",
        "label": "CARDINAL"
      },
      {
        "text": "V4",
        "label": "CARDINAL"
      },
      {
        "text": "BA",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "aOR=0.68, 95% CI 0.52 to 0.89). Successful reperfusion reduced MCE risk",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.52 to 0.89",
        "label": "CARDINAL"
      },
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(aOR=0.57, 95% CI 0.42 to 0.75). Diabetes mellitus exhibited an inverse",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.42",
        "label": "CARDINAL"
      },
      {
        "text": "0.75",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "association (aOR=0.78, 95% CI 0.61 to 0.99). MCE predicted lower odds of",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "0.61",
        "label": "CARDINAL"
      },
      {
        "text": "0.99",
        "label": "CARDINAL"
      },
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "favorable outcome (aOR=2.41, 95% CI 1.94 to 3.01; P<0.001) and higher mortality",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.94",
        "label": "CARDINAL"
      },
      {
        "text": "3.01",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(aOR=1.85, 95% CI 1.51 to 2.27; P<0.001) at 90 days.",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.51",
        "label": "CARDINAL"
      },
      {
        "text": "2.27",
        "label": "CARDINAL"
      },
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: MCE complicates 39.6% of patients with BAO after EVT and portends",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      },
      {
        "text": "39.6%",
        "label": "PERCENT"
      },
      {
        "text": "BAO",
        "label": "ORG"
      },
      {
        "text": "EVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "catastrophic outcomes despite successful recanalization. Shortening the",
    "entities": []
  },
  {
    "text": "procedure time, increasing the likelihood of first-pass success, and optimal",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "admission blood pressure management might be targets to decrease MCE for",
    "entities": [
      {
        "text": "MCE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with BAO undergoing EVT.",
    "entities": [
      {
        "text": "BAO",
        "label": "ORG"
      },
      {
        "text": "EVT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY-NC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "commercial re-use. See rights and permissions. Published by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: None declared.",
    "entities": []
  },
  {
    "text": "10.1136/jnis-2025-023658. Online ahead of print.",
    "entities": [
      {
        "text": "10.1136",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Electrical impedance spectroscopy signatures of red blood cells and platelets in",
    "entities": []
  },
  {
    "text": "acute ischemic stroke clots in the Clotbase International Registry: Significance",
    "entities": [
      {
        "text": "the Clotbase International Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "for etiology and first pass effect.",
    "entities": []
  },
  {
    "text": "(1)C\u00daRAM Research Ireland Centre for Medical Devices, University of Galway,",
    "entities": [
      {
        "text": "1)C\u00daRAM Research Ireland Centre for Medical Devices",
        "label": "ORG"
      },
      {
        "text": "University of Galway",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Galway, County Galway, Ireland.",
    "entities": [
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "County Galway",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Physiology, University of Galway, Galway, County Galway,",
    "entities": [
      {
        "text": "Physiology, University of Galway",
        "label": "ORG"
      },
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "County Galway",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Ireland.",
    "entities": [
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Sensome SAS, Massy, France.",
    "entities": [
      {
        "text": "3)Sensome",
        "label": "CARDINAL"
      },
      {
        "text": "SAS",
        "label": "ORG"
      },
      {
        "text": "Massy",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Diagnostic and Therapeutic Neuroradiology, CHU de Toulouse P\u00f4le",
    "entities": [
      {
        "text": "Diagnostic and Therapeutic Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "CHU de Toulouse P\u00f4le",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Neuroradiology, University Hospital of Purpan, Toulouse, France.",
    "entities": [
      {
        "text": "University Hospital of Purpan",
        "label": "ORG"
      },
      {
        "text": "Toulouse",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Toulouse 2 University, Toulouse, Occitanie, France.",
    "entities": [
      {
        "text": "Occitanie",
        "label": "PERSON"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Paris-Saclay University Faculty of Medicine, Le Kremlin-Bicetre, France.",
    "entities": [
      {
        "text": "9)Paris-Saclay University Faculty of Medicine",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)Department of Neurology, Hospital Germans Trias i Pujol, Badalona, Spain.",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Pujol",
        "label": "GPE"
      },
      {
        "text": "Badalona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Stroke Unit, Neurology, Hospital Vall d'Hebron, Barcelona, Spain.",
    "entities": [
      {
        "text": "11)Stroke",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Barcelona",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Department of Physiology, University of Galway, Galway, Ireland.",
    "entities": [
      {
        "text": "13)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Physiology, University of Galway",
        "label": "ORG"
      },
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Diagnostic and Therapeutic Neuroradiology, University Hospital",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Diagnostic and Therapeutic Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Toulouse, Toulouse, France.",
    "entities": [
      {
        "text": "Toulouse, Toulouse",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(15)Department of Neuroradiology, Klinicki centar Srbije, Beograd, Serbia.",
    "entities": [
      {
        "text": "15)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Klinicki",
        "label": "ORG"
      },
      {
        "text": "Beograd",
        "label": "PERSON"
      },
      {
        "text": "Serbia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Neurosurgery, Kobe City Medical Center General Hospital, Kobe-city, Hyogo,",
    "entities": [
      {
        "text": "16)Neurosurgery",
        "label": "DATE"
      },
      {
        "text": "Kobe City Medical Center General Hospital",
        "label": "ORG"
      },
      {
        "text": "Kobe-city",
        "label": "GPE"
      },
      {
        "text": "Hyogo",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Diagnostic and Therapeutic Neuroradiology, H\u00f4pital Purpan, Toulouse, France.",
    "entities": [
      {
        "text": "Therapeutic Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "H\u00f4pital Purpan",
        "label": "PERSON"
      },
      {
        "text": "Toulouse",
        "label": "PERSON"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)C\u00daRAM Research Ireland Centre for Medical Devices, University of Galway,",
    "entities": [
      {
        "text": "18)C\u00daRAM Research Ireland Centre for Medical Devices",
        "label": "ORG"
      },
      {
        "text": "University of Galway",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Galway, County Galway, Ireland karen.doyle@universityofgalway.ie.",
    "entities": [
      {
        "text": "Galway",
        "label": "GPE"
      },
      {
        "text": "County Galway",
        "label": "GPE"
      },
      {
        "text": "Ireland",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Clot composition plays a key role in the pathophysiology of Acute",
    "entities": [
      {
        "text": "Clot",
        "label": "ORG"
      },
      {
        "text": "Acute",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Ischemic Stroke (AIS) and impacts the effectiveness of treatments such as",
    "entities": [
      {
        "text": "Ischemic Stroke",
        "label": "ORG"
      },
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "thrombolysis and mechanical thrombectomy (MT). Developing an electrochemical",
    "entities": []
  },
  {
    "text": "impedance spectroscopy (EIS) based device to identify clot characteristics could",
    "entities": [
      {
        "text": "EIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "improve stroke treatment outcomes. This study aims to estimate the red blood",
    "entities": []
  },
  {
    "text": "cell (RBC) and platelet content in extracted AIS clots and explore EIS's",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "EIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "relevance to clinically important parameters, including stroke etiology and",
    "entities": []
  },
  {
    "text": "First Pass Effect (FPE).",
    "entities": [
      {
        "text": "First Pass Effect",
        "label": "ORG"
      },
      {
        "text": "FPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: A total of 508 clots from 426 MT patients at five stroke centers in",
    "entities": [
      {
        "text": "508",
        "label": "CARDINAL"
      },
      {
        "text": "426",
        "label": "CARDINAL"
      },
      {
        "text": "five",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "France, Japan, Serbia, and Spain (February 2021-2024) were analyzed in the",
    "entities": [
      {
        "text": "France",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "Serbia",
        "label": "GPE"
      },
      {
        "text": "Spain",
        "label": "GPE"
      },
      {
        "text": "February 2021-2024",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Clotbase International Registry. EIS was performed on retrieved clots, followed",
    "entities": [
      {
        "text": "Clotbase International Registry",
        "label": "ORG"
      },
      {
        "text": "EIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by Martius Scarlet Blue staining and CD42b immunohistochemistry. EIS based",
    "entities": [
      {
        "text": "Martius Scarlet Blue",
        "label": "ORG"
      },
      {
        "text": "CD42b",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "models to quantify RBCs and platelets were designed using a development dataset",
    "entities": []
  },
  {
    "text": "(n=309), validated on a blinded dataset (n=199), and combined in a full dataset",
    "entities": []
  },
  {
    "text": "(n=508). Components (median interquartile range (IQR)) were quantified,",
    "entities": [
      {
        "text": "IQR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "correlating RBC and platelet percentages with impedance and clinical parameters.",
    "entities": [
      {
        "text": "RBC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Correlations between content as determined by EIS and histology were",
    "entities": [
      {
        "text": "EIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "validated in a blind dataset for RBCs (r=0.7, P<0.0001) and platelets (r=0.5,",
    "entities": []
  },
  {
    "text": "P<0.0001). Similar correlations were observed in the full dataset. Large-artery",
    "entities": []
  },
  {
    "text": "atherosclerosis clots had significantly higher RBC (46.0% (25.7-67.7)) and lower",
    "entities": [
      {
        "text": "RBC",
        "label": "ORG"
      },
      {
        "text": "46.0%",
        "label": "PERCENT"
      },
      {
        "text": "25.7-67.7",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "platelet content (31.7% (22.4-42.7)) compared with cardioembolic (RBCs: 34.9%",
    "entities": [
      {
        "text": "31.7%",
        "label": "PERCENT"
      },
      {
        "text": "22.4-42.7",
        "label": "CARDINAL"
      },
      {
        "text": "34.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(14.0-56.2); platelets: 36.5% (26.7-51.0)) and cryptogenic (RBCs: 31.5%",
    "entities": [
      {
        "text": "14.0",
        "label": "CARDINAL"
      },
      {
        "text": "36.5%",
        "label": "PERCENT"
      },
      {
        "text": "26.7",
        "label": "CARDINAL"
      },
      {
        "text": "31.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(17.4-63.6); platelets: 37.8% (28.4-50.8)). FPE was associated with",
    "entities": [
      {
        "text": "17.4-63.6",
        "label": "DATE"
      },
      {
        "text": "37.8%",
        "label": "PERCENT"
      },
      {
        "text": "28.4-50.8",
        "label": "DATE"
      },
      {
        "text": "FPE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "significantly higher RBC (40.0% (25.6-55.4) vs non-FPE: 31.2% (6.6-50.2)) and",
    "entities": [
      {
        "text": "RBC",
        "label": "ORG"
      },
      {
        "text": "40.0%",
        "label": "PERCENT"
      },
      {
        "text": "25.6-55.4",
        "label": "CARDINAL"
      },
      {
        "text": "non-FPE",
        "label": "ORG"
      },
      {
        "text": "31.2%",
        "label": "PERCENT"
      },
      {
        "text": "6.6-50.2",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "lower platelet content (42.0% (32.0-54.0) vs non-FPE: 47.7% (30.6-65.0)),",
    "entities": [
      {
        "text": "42.0%",
        "label": "PERCENT"
      },
      {
        "text": "32.0",
        "label": "CARDINAL"
      },
      {
        "text": "non-FPE",
        "label": "ORG"
      },
      {
        "text": "47.7%",
        "label": "PERCENT"
      },
      {
        "text": "30.6-65.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "confirmed by histology.",
    "entities": []
  },
  {
    "text": "CONCLUSION: EIS of RBCs and platelets provide an accurate assessment of clot",
    "entities": []
  },
  {
    "text": "composition, correlating strongly with histology. EIS holds the potential to",
    "entities": [
      {
        "text": "EIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "deliver clinically relevant information on clot characteristics at the point of",
    "entities": []
  },
  {
    "text": "10.1136/jnis-2025-023697. Online ahead of print.",
    "entities": [
      {
        "text": "10.1136",
        "label": "CARDINAL"
      },
      {
        "text": "jnis-2025-023697",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Systolic blood pressure within 24 hours after successful reperfusion correlates",
    "entities": [
      {
        "text": "24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "with outcomes in acute ischemic stroke: a secondary analysis of the",
    "entities": []
  },
  {
    "text": "X(2), Ye X(4), Wen C(5), Zhong H(6)(7), Liu J(2); ENCHANTED2/MT Investigators.",
    "entities": [
      {
        "text": "Wen C(5",
        "label": "PERSON"
      },
      {
        "text": "Zhong",
        "label": "PERSON"
      },
      {
        "text": "Liu J(2",
        "label": "PERSON"
      },
      {
        "text": "ENCHANTED2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Collaborators: Song L, Chen X, Wang X, Liu J, Yang P, Zhang Y, Parsons CM,",
    "entities": [
      {
        "text": "Song L",
        "label": "PERSON"
      },
      {
        "text": "Chen X",
        "label": "PERSON"
      },
      {
        "text": "Wang X",
        "label": "PERSON"
      },
      {
        "text": "Liu J",
        "label": "PERSON"
      },
      {
        "text": "Yang P",
        "label": "PERSON"
      },
      {
        "text": "Zhang Y",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Butcher K, Robinson T, Campbell B, Goyal M, Majoie C, Roos Y, Dippel D, Wang L,",
    "entities": [
      {
        "text": "Robinson",
        "label": "PERSON"
      },
      {
        "text": "Campbell B",
        "label": "ORG"
      },
      {
        "text": "Goyal M",
        "label": "ORG"
      },
      {
        "text": "Majoie C",
        "label": "ORG"
      },
      {
        "text": "Roos Y",
        "label": "PERSON"
      },
      {
        "text": "Dippel D",
        "label": "PERSON"
      },
      {
        "text": "Wang L",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Neurology, Nanyang Central Hospital, Nanyang, Henan, China.",
    "entities": [
      {
        "text": "Neurology",
        "label": "GPE"
      },
      {
        "text": "Nanyang Central Hospital",
        "label": "ORG"
      },
      {
        "text": "Nanyang",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Neurovascular Center, Changhai Hospital, Shanghai, Shanghai, China.",
    "entities": [
      {
        "text": "Center",
        "label": "GPE"
      },
      {
        "text": "Changhai Hospital",
        "label": "PERSON"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou,",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Henan Provincial People's Hospital",
        "label": "ORG"
      },
      {
        "text": "Zhengzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Statistics, Naval Medical University, Shanghai, Shanghai,",
    "entities": [
      {
        "text": "Statistics, Naval Medical University",
        "label": "ORG"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      },
      {
        "text": "Shanghai",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Neurology, Nanyang Central Hospital, Nanyang, Henan, China",
    "entities": [
      {
        "text": "Neurology",
        "label": "GPE"
      },
      {
        "text": "Nanyang Central Hospital",
        "label": "ORG"
      },
      {
        "text": "Nanyang",
        "label": "GPE"
      },
      {
        "text": "Henan",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medical University, Beijing, Beijing, China.",
    "entities": [
      {
        "text": "Medical University",
        "label": "ORG"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "Beijing",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The optimal threshold or range for systolic blood pressure (SBP)",
    "entities": [
      {
        "text": "SBP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "control in patients with successful reperfusion after endovascular thrombectomy",
    "entities": []
  },
  {
    "text": "for acute ischemic stroke (AIS) remains undefined. This study investigated",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "whether SBP within the first 24 hours after successful reperfusion correlates",
    "entities": [
      {
        "text": "SBP",
        "label": "ORG"
      },
      {
        "text": "the first 24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "with functional outcomes in AIS.",
    "entities": [
      {
        "text": "AIS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: In this secondary analysis of the ENCHANTED2/MT trial, patients were",
    "entities": [
      {
        "text": "ENCHANTED2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "categorized into two groups (120-140 mm Hg and 140-180 mm Hg, respectively)",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      },
      {
        "text": "120-140",
        "label": "CARDINAL"
      },
      {
        "text": "140-180",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "based on achieved SBP within 24 hours after randomization. The primary outcome",
    "entities": [
      {
        "text": "SBP",
        "label": "ORG"
      },
      {
        "text": "24 hours",
        "label": "TIME"
      }
    ]
  },
  {
    "text": "was the modified Rankin Scale (mRS) score at 90 days. Secondary outcomes",
    "entities": [
      {
        "text": "Rankin Scale",
        "label": "PERSON"
      },
      {
        "text": "90 days",
        "label": "DATE"
      },
      {
        "text": "Secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "included neurological deterioration at 7 days, major disability (mRS score of",
    "entities": [
      {
        "text": "7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "3-5 at 90 days), hospitalization duration, and health-related quality of life",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "assessed by the three-level EuroQoL 5-Dimension Self-Report Questionnaire",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(EQ-5D-3L) at 90 days. Safety outcomes included early neurological decline",
    "entities": [
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(END), 90-day mortality, symptomatic intracranial hemorrhage (sICH), and any",
    "entities": [
      {
        "text": "END",
        "label": "ORG"
      },
      {
        "text": "90-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "intracranial hemorrhage (ICH). Treatment effects were expressed as ORs with 95%",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "confidence intervals (CIs).",
    "entities": []
  },
  {
    "text": "RESULTS: A total of 611 patients (363 in the 120-140 mm Hg group and 248 in the",
    "entities": [
      {
        "text": "611",
        "label": "CARDINAL"
      },
      {
        "text": "363",
        "label": "CARDINAL"
      },
      {
        "text": "120-140",
        "label": "QUANTITY"
      },
      {
        "text": "248",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "140-180 mm Hg group) were included. The mean (SD) age was 67 (12) years and",
    "entities": [
      {
        "text": "140",
        "label": "CARDINAL"
      },
      {
        "text": "67",
        "label": "DATE"
      },
      {
        "text": "12) years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "37.8% were female. After adjusting for confounders, the 120-140 mm Hg group was",
    "entities": [
      {
        "text": "37.8%",
        "label": "PERCENT"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly associated with better functional outcomes (mRS: 2 (IQR 1-4) vs 2",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(IQR 1-5); adjusted OR 1.54 (95% CI 1.10 to 2.17), P=0.013). Compared with the",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.10",
        "label": "CARDINAL"
      },
      {
        "text": "2.17",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "140-180 mm Hg group, the 120-140 mm Hg group had lower rates of neurological",
    "entities": [
      {
        "text": "140",
        "label": "CARDINAL"
      },
      {
        "text": "120",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "deterioration at 7 days (adjusted OR 0.68 (95% CI 0.47 to 0.98), P=0.037) and",
    "entities": [
      {
        "text": "7 days",
        "label": "DATE"
      },
      {
        "text": "0.68",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.47",
        "label": "CARDINAL"
      },
      {
        "text": "0.98",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "90-day mortality (47 (13.0%) vs 53 (21.4%); adjusted OR 0.48 (95% CI 0.27 to",
    "entities": [
      {
        "text": "90-day",
        "label": "DATE"
      },
      {
        "text": "13.0%",
        "label": "PERCENT"
      },
      {
        "text": "53",
        "label": "DATE"
      },
      {
        "text": "21.4%",
        "label": "PERCENT"
      },
      {
        "text": "0.48",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.27",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.86), P=0.013). There were no significant differences between groups in END,",
    "entities": [
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "END",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "major disability at 90 days, hospitalization duration, EQ-5D-3L score, sICH, or",
    "entities": [
      {
        "text": "90 days",
        "label": "DATE"
      },
      {
        "text": "EQ-5D-3L",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: In patients with successful reperfusion after endovascular",
    "entities": []
  },
  {
    "text": "thrombectomy, an average SBP within 24 hours of 120-140 mm Hg was associated",
    "entities": [
      {
        "text": "24 hours",
        "label": "TIME"
      },
      {
        "text": "120-140",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "with a greater likelihood of functional independence compared with 140-180 mm",
    "entities": [
      {
        "text": "140-180",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Heart failure with reduced ejection fraction polypill implementation strategy in",
    "entities": []
  },
  {
    "text": "Sri Lanka: design and protocol of a pilot type I hybrid randomised clinical",
    "entities": [
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Dhurjati R(5), Fernando C(4), Galappatthy G(6), Goss CW(3), Hively A(7),",
    "entities": [
      {
        "text": "Dhurjati",
        "label": "PERSON"
      },
      {
        "text": "Fernando C(4",
        "label": "PERSON"
      },
      {
        "text": "Galappatthy",
        "label": "PERSON"
      },
      {
        "text": "Goss",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Rodgers A(10), Roberts K(13), Salwa H(11), Huffman MD(7)(10), Salam A(5)(14).",
    "entities": [
      {
        "text": "Roberts K(13",
        "label": "PERSON"
      },
      {
        "text": "Salwa H(11",
        "label": "PERSON"
      },
      {
        "text": "Huffman",
        "label": "PERSON"
      },
      {
        "text": "Salam A(5)(14",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Division of Cardiology, Department of Medicine, Washington University in St",
    "entities": [
      {
        "text": "Cardiology, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Washington University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Louis School of Medicine, St Louis, Missouri, USA anubha@wustl.edu.",
    "entities": [
      {
        "text": "Louis School of Medicine",
        "label": "ORG"
      },
      {
        "text": "St Louis",
        "label": "GPE"
      },
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pharmacology, Faculty of Medicine, University of Kelaniya,",
    "entities": [
      {
        "text": "Pharmacology, Faculty of Medicine, University of Kelaniya",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Institute for Informatics, Data Science, and Biostatistics, Washington",
    "entities": [
      {
        "text": "Informatics",
        "label": "ORG"
      },
      {
        "text": "Biostatistics",
        "label": "GPE"
      },
      {
        "text": "Washington",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University in St Louis School of Medicine, St. Louis, Missouri, USA.",
    "entities": [
      {
        "text": "St Louis School of Medicine",
        "label": "ORG"
      },
      {
        "text": "St. Louis",
        "label": "GPE"
      },
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)The George Institute for Global Health India, Hyderabad, Telangana, India.",
    "entities": [
      {
        "text": "George Institute for Global Health India,",
        "label": "ORG"
      },
      {
        "text": "Hyderabad",
        "label": "GPE"
      },
      {
        "text": "Telangana",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)National Hospital of Sri Lanka, Colombo, Sri Lanka.",
    "entities": [
      {
        "text": "Sri Lanka",
        "label": "GPE"
      },
      {
        "text": "Colombo",
        "label": "GPE"
      },
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Division of Cardiology, Department of Medicine, Washington University in St",
    "entities": [
      {
        "text": "Cardiology, Department of Medicine",
        "label": "ORG"
      },
      {
        "text": "Washington University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Louis School of Medicine, St Louis, Missouri, USA.",
    "entities": [
      {
        "text": "Louis School of Medicine",
        "label": "ORG"
      },
      {
        "text": "St Louis",
        "label": "GPE"
      },
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(9)Department of Cardiology, Westfort Hi-Tech Hospital, Thrissur, Kerala, India.",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Thrissur",
        "label": "GPE"
      },
      {
        "text": "Kerala",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(10)The George Institute for Global Health, Sydney, New South Wales, Australia.",
    "entities": [
      {
        "text": "10)The George Institute for Global Health",
        "label": "ORG"
      },
      {
        "text": "Sydney",
        "label": "GPE"
      },
      {
        "text": "New South Wales",
        "label": "GPE"
      },
      {
        "text": "Australia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(11)Centre for Chronic Disease Control, New Delhi, Delhi, India.",
    "entities": [
      {
        "text": "11)Centre",
        "label": "CARDINAL"
      },
      {
        "text": "Chronic Disease Control",
        "label": "ORG"
      },
      {
        "text": "New Delhi",
        "label": "GPE"
      },
      {
        "text": "Delhi",
        "label": "GPE"
      },
      {
        "text": "India",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Colombo South Teaching Hospital, Dehiwala, Western Province, Sri Lanka.",
    "entities": [
      {
        "text": "Dehiwala",
        "label": "GPE"
      },
      {
        "text": "Western Province",
        "label": "GPE"
      },
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)George Medicines, London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Prasanna School of Public Health, Manipal Academy of Higher Education,",
    "entities": [
      {
        "text": "14)Prasanna School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Guideline-directed medical therapy (GDMT) for patients with heart",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "failure with reduced ejection fraction (HFrEF) reduces morbidity and mortality",
    "entities": []
  },
  {
    "text": "and remains widely underused. An HFrEF polypill containing all four pillars of",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "GDMT has been proposed as an implementation strategy to improve GDMT treatment",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      },
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rates and subsequent patient outcomes. We present the design and protocol for a",
    "entities": []
  },
  {
    "text": "proof-of-concept, pilot type I hybrid randomised clinical trial evaluating an",
    "entities": []
  },
  {
    "text": "HFrEF polypill compared with usual care among patients with HFrEF in Sri Lanka",
    "entities": [
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "to evaluate short-term feasibility.",
    "entities": []
  },
  {
    "text": "METHODS AND ANALYSIS: This multi-centre, open-label, pilot type I hybrid",
    "entities": []
  },
  {
    "text": "randomised clinical trial will recruit 40 adults with HFrEF from two public",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "hospital sites in Colombo, Sri Lanka. Participants will be randomised to an",
    "entities": [
      {
        "text": "Colombo",
        "label": "GPE"
      },
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "in three available strengths) or usual care and followed for 4 weeks. The",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "4 weeks",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "primary outcome is feasibility of recruitment measured by recruitment rate and",
    "entities": []
  },
  {
    "text": "adherence to study protocols measured by completion rate of study-related",
    "entities": []
  },
  {
    "text": "procedures. Other key outcomes include adherence to GDMT and assessment of",
    "entities": [
      {
        "text": "GDMT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "serious adverse events among other exploratory outcomes.",
    "entities": []
  },
  {
    "text": "ETHICS AND DISSEMINATION: The study has been approved by the ethics review",
    "entities": [
      {
        "text": "ETHICS",
        "label": "ORG"
      },
      {
        "text": "DISSEMINATION",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "committee at the Faculty of Medicine, University of Kelaniya (Sri Lanka), the",
    "entities": [
      {
        "text": "the Faculty of Medicine, University of Kelaniya",
        "label": "ORG"
      },
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "institutional review board at Washington University in St. Louis (United",
    "entities": [
      {
        "text": "institutional review board",
        "label": "ORG"
      },
      {
        "text": "Washington University",
        "label": "ORG"
      },
      {
        "text": "St. Louis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "States), and the National Medicines Regulatory Authority (Sri Lanka). The",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      },
      {
        "text": "the National Medicines Regulatory Authority",
        "label": "ORG"
      },
      {
        "text": "Sri Lanka",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "findings of this pilot trial will inform the design and implementation of a",
    "entities": []
  },
  {
    "text": "future large-scale type I hybrid trial to assess the efficacy and safety of an",
    "entities": []
  },
  {
    "text": "HFrEF polypill in improving clinical outcomes.",
    "entities": []
  },
  {
    "text": "TRIAL REGISTRATION NUMBERS: Sri Lanka Clinical Trials Registry (SLCTR/2024/003);",
    "entities": [
      {
        "text": "Sri Lanka Clinical Trials Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ClinicalTrials Registry (NCT06831864).",
    "entities": [
      {
        "text": "ClinicalTrials Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664424 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Conflict of interest statement: Competing interests: MDH has received travel",
    "entities": [
      {
        "text": "MDH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support from the American Heart Association and World Heart Federation and",
    "entities": [
      {
        "text": "the American Heart Association and World Heart Federation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consulting fees from PwC Switzerland. MDH, AS, AP and AR have an appointment at",
    "entities": [
      {
        "text": "Switzerland",
        "label": "GPE"
      },
      {
        "text": "MDH",
        "label": "ORG"
      },
      {
        "text": "AS",
        "label": "ORG"
      },
      {
        "text": "AP",
        "label": "ORG"
      },
      {
        "text": "AR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the George Institute for Global Health, which has a patent, license and has",
    "entities": [
      {
        "text": "the George Institute for Global Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "received investment funding with intent to commercialize fixed-dose combination",
    "entities": []
  },
  {
    "text": "therapy through its social enterprise business, George Medicines. AP is the",
    "entities": [
      {
        "text": "George Medicines",
        "label": "PERSON"
      },
      {
        "text": "AP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "non-remunerated Chair of George Medicines. MDH and AA have pending patents for",
    "entities": [
      {
        "text": "George Medicines",
        "label": "PERSON"
      },
      {
        "text": "MDH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "heart failure polypills. All other authors have no competing interests to",
    "entities": []
  },
  {
    "text": "Associations between Life's Essential 8 and stroke: findings from NHANES",
    "entities": [
      {
        "text": "NHANES",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.",
    "entities": [
      {
        "text": "Chinese Medical University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.",
    "entities": [
      {
        "text": "2)Tongde",
        "label": "CARDINAL"
      },
      {
        "text": "Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China",
    "entities": [
      {
        "text": "Hospital of Zhejiang Province",
        "label": "GPE"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Stroke poses a significant financial and medical burden as it is the",
    "entities": []
  },
  {
    "text": "primary cause of death and disability globally. The identification of modifiable",
    "entities": []
  },
  {
    "text": "risk factors is crucial in the prevention of stroke. Life's Essential 8 (LE8) is",
    "entities": []
  },
  {
    "text": "the most recent indicator of cardiovascular health, but its association with",
    "entities": []
  },
  {
    "text": "stroke is unclear.",
    "entities": []
  },
  {
    "text": "METHODS: Using information from the National Health and Nutrition Examination",
    "entities": [
      {
        "text": "the National Health and Nutrition Examination",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Survey conducted in 2005-2018, we evaluated the relationship between the LE8",
    "entities": [
      {
        "text": "2005-2018",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "score and the self-reported incidence of stroke in adult US citizens aged 20",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "20",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years or older on a cross-sectional basis. LE8 scores were classified as being",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "high, moderate or low according to American Heart Association guidelines. The",
    "entities": [
      {
        "text": "American Heart Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "stroke status was ascertained through self-reporting, and the analysis was",
    "entities": []
  },
  {
    "text": "adjusted for potential confounders. In addition, restricted cubic spline (RCS)",
    "entities": []
  },
  {
    "text": "analyses were used to further analyse the potential non-linear correlation",
    "entities": []
  },
  {
    "text": "between the LE8 score and the risk of stroke.",
    "entities": []
  },
  {
    "text": "RESULTS: In our study, a total of 24 851 study participants were included, with",
    "entities": [
      {
        "text": "24 851",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "943 strokes and a male prevalence of 48.21%. After adjusting for all covariates,",
    "entities": [
      {
        "text": "943",
        "label": "CARDINAL"
      },
      {
        "text": "48.21%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the odds of stroke were 2.17 (95% CI: 1.41 to 3.33) and 4.81 (95% CI: 3.07 to",
    "entities": [
      {
        "text": "2.17",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.41",
        "label": "CARDINAL"
      },
      {
        "text": "3.33",
        "label": "CARDINAL"
      },
      {
        "text": "4.81",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "3.07",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "7.56) in those with medium and low LE8 scores compared with those with a high",
    "entities": [
      {
        "text": "7.56",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "LE8 score, respectively. Both the health behaviour score and the health factor",
    "entities": []
  },
  {
    "text": "score exhibit a significant association with stroke risk. RCS further confirmed",
    "entities": []
  },
  {
    "text": "that the association was linear. Finally, subgroup analysis has further",
    "entities": []
  },
  {
    "text": "confirmed the robustness of the observed associations.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Our observation suggests an important independent negative",
    "entities": []
  },
  {
    "text": "association between LE8 score and stroke risk. This study demonstrates the",
    "entities": []
  },
  {
    "text": "utility of LE8 as a public health tool for stroke risk stratification and",
    "entities": []
  },
  {
    "text": "emphasises the importance of cardiovascular health in stroke prevention.",
    "entities": []
  },
  {
    "text": "PMID: 40664413 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664413",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Increased direct oral anticoagulant use and event rates in non-valvular atrial",
    "entities": []
  },
  {
    "text": "fibrillation: a nationwide retrospective registry study in Sweden.",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Department of Public Health and Clinical Medicine, Ume\u00e5 University, Ume\u00e5,",
    "entities": [
      {
        "text": "Public Health and Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "Ume\u00e5 University",
        "label": "ORG"
      },
      {
        "text": "Ume\u00e5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Public Health and Clinical Medicine, Ume\u00e5 University, Ume\u00e5,",
    "entities": [
      {
        "text": "Public Health and Clinical Medicine",
        "label": "ORG"
      },
      {
        "text": "Ume\u00e5 University",
        "label": "ORG"
      },
      {
        "text": "Ume\u00e5",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.",
    "entities": [
      {
        "text": "Clinical Research Center",
        "label": "ORG"
      },
      {
        "text": "Uppsala University",
        "label": "ORG"
      },
      {
        "text": "Uppsala",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Statistics, USBE, Ume\u00e5 University, Ume\u00e5, Sweden.",
    "entities": [
      {
        "text": "Statistics",
        "label": "GPE"
      },
      {
        "text": "Ume\u00e5 University",
        "label": "ORG"
      },
      {
        "text": "Ume\u00e5",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Clinical Sciences Lund, Neurology, Sk\u00e5ne University Hospital,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Clinical Sciences Lund,",
        "label": "ORG"
      },
      {
        "text": "Sk\u00e5ne University Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Lund University Hospital, Lund, Sweden.",
    "entities": [
      {
        "text": "Lund University Hospital",
        "label": "ORG"
      },
      {
        "text": "Lund",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "RATIONALE: The use of direct oral anticoagulants (DOACs) as stroke prophylaxis",
    "entities": [
      {
        "text": "RATIONALE",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "in patients with non-valvular atrial fibrillation (NVAF) has increased steadily",
    "entities": [
      {
        "text": "NVAF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "since the introduction in 2011. In Sweden today, more patients are treated with",
    "entities": [
      {
        "text": "2011",
        "label": "DATE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      },
      {
        "text": "today",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "DOACs than with warfarin. However, it is not shown that an increased proportion",
    "entities": []
  },
  {
    "text": "of DOAC prescriptions correlates to lower event rates of stroke and systemic",
    "entities": []
  },
  {
    "text": "OBJECTIVES: This study aims to investigate whether the increased prescription of",
    "entities": []
  },
  {
    "text": "DOACs in Sweden correlates with lower event rates for all-cause stroke, systemic",
    "entities": [
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "embolism and bleeding complications, using real-life data for the whole NVAF",
    "entities": [
      {
        "text": "NVAF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "DESIGN: Nationwide retrospective register study.",
    "entities": []
  },
  {
    "text": "SETTING: Data were obtained from the Swedish National Patient Registry, covering",
    "entities": [
      {
        "text": "the Swedish National Patient Registry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients aged 18 years or older with NVAF, between 1 January 2014, and 31",
    "entities": [
      {
        "text": "18 years",
        "label": "DATE"
      },
      {
        "text": "NVAF",
        "label": "ORG"
      },
      {
        "text": "between 1 January 2014",
        "label": "DATE"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "December 2017. Exposure to oral anticoagulants was determined based on",
    "entities": [
      {
        "text": "December 2017",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "pharmaceutical data, calculating treatment duration by the number of pills",
    "entities": []
  },
  {
    "text": "dispensed and the prescribed daily usage rate. Baseline characteristics and",
    "entities": []
  },
  {
    "text": "endpoints were collected from hospital administrative registers using",
    "entities": []
  },
  {
    "text": "International Classification of Diseases, 10th edition (ICD-10) codes.",
    "entities": [
      {
        "text": "International Classification of Diseases",
        "label": "ORG"
      },
      {
        "text": "10th",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "PARTICIPANTS: All patients with NVAF were identified using ICD-10 codes during",
    "entities": [
      {
        "text": "NVAF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the study period. Entry criteria included having a first recorded atrial",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "fibrillation diagnosis after 1 January 2014 or being previously diagnosed with",
    "entities": [
      {
        "text": "1 January 2014",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "atrial fibrillation before 2014 but still receiving care after this date.",
    "entities": [
      {
        "text": "2014",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "OUTCOME MEASURES: The outcomes were event rates (per 100 person-years) of",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "ischaemic stroke, systemic embolism, all-cause stroke, major bleeding and",
    "entities": []
  },
  {
    "text": "intracranial bleeding (including haemorrhagic stroke). Event rates were",
    "entities": []
  },
  {
    "text": "calculated and compared across the study period using Cox proportional hazard",
    "entities": [
      {
        "text": "Cox",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "RESULTS: In the total NVAF population, the proportional decrease in event rates",
    "entities": [
      {
        "text": "NVAF",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(per 100 treatment years) in 2017 compared with 2014 was ischaemic stroke 24%",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "2017",
        "label": "DATE"
      },
      {
        "text": "2014",
        "label": "DATE"
      },
      {
        "text": "24%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(1.70-1.30), all-cause mortality 4% (9.40-9.00), all-cause stroke 24%",
    "entities": [
      {
        "text": "1.70-1.30",
        "label": "CARDINAL"
      },
      {
        "text": "4%",
        "label": "PERCENT"
      },
      {
        "text": "9.40-9.00",
        "label": "CARDINAL"
      },
      {
        "text": "24%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "(2.10-1.60) and all-cause stroke and systemic embolism 23% (2.20-1.70). During",
    "entities": [
      {
        "text": "2.10-1.60",
        "label": "CARDINAL"
      },
      {
        "text": "23%",
        "label": "PERCENT"
      },
      {
        "text": "2.20-1.70",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the same time, the proportion of major bleeding and intracranial bleeding rates,",
    "entities": []
  },
  {
    "text": "including haemorrhagic stroke, also decreased: 5% (2.00-1.90), 6% (0.68-0.64)",
    "entities": [
      {
        "text": "5%",
        "label": "PERCENT"
      },
      {
        "text": "2.00-1.90",
        "label": "CARDINAL"
      },
      {
        "text": "6%",
        "label": "PERCENT"
      },
      {
        "text": "0.68-0.64",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and 17% (0.30-0.25), respectively. DOACs use increased from 4.1% to 28.3% in the",
    "entities": [
      {
        "text": "17%",
        "label": "PERCENT"
      },
      {
        "text": "0.30-0.25",
        "label": "CARDINAL"
      },
      {
        "text": "4.1%",
        "label": "PERCENT"
      },
      {
        "text": "28.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "total population and from 22.7% to 60.9% in newly diagnosed patients.",
    "entities": [
      {
        "text": "22.7%",
        "label": "PERCENT"
      },
      {
        "text": "60.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: In the initial years following the introduction when DOAC uptake in",
    "entities": [
      {
        "text": "the initial years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the population was high, an increasing proportion of Swedish NVAF patients",
    "entities": [
      {
        "text": "Swedish",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "receiving DOACs was accompanied by lower event rates of all-cause stroke and",
    "entities": []
  },
  {
    "text": "systemic embolism, ischaemic stroke and all-cause mortality, intracranial",
    "entities": []
  },
  {
    "text": "bleeding and major bleeding, highlighting the improved risk-benefit balance of",
    "entities": []
  },
  {
    "text": "DOACs in stroke prophylaxis.",
    "entities": []
  },
  {
    "text": "\u00a9 Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "CC BY",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "by BMJ Group.",
    "entities": [
      {
        "text": "BMJ Group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40664408 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40664408",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Competing interests: BN has received honoraria",
    "entities": []
  },
  {
    "text": "for Data Monitoring Safety Board work from Symbec-Orion. AS has received",
    "entities": [
      {
        "text": "Data Monitoring Safety Board",
        "label": "ORG"
      },
      {
        "text": "Symbec-Orion",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consultancy and lecture fees from Bayer, Boehringer-Ingelheim, Bristol-Myers",
    "entities": [
      {
        "text": "Bayer",
        "label": "ORG"
      },
      {
        "text": "Boehringer-Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Bristol-Myers",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Squibb, Portola and Pfizer. SS has received consultancy or lecture fees from",
    "entities": [
      {
        "text": "Squibb",
        "label": "ORG"
      },
      {
        "text": "Portola",
        "label": "PERSON"
      },
      {
        "text": "Pfizer",
        "label": "PERSON"
      },
      {
        "text": "SS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bristol Myers Squibb, Pfizer and Bayer. The other authors have declared that no",
    "entities": [
      {
        "text": "Bristol Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Bayer",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "competing interests exist.",
    "entities": []
  },
  {
    "text": "Effects of an individual and family self-management of fall prevention programme",
    "entities": []
  },
  {
    "text": "on balance ability and fall-related self-efficacy among Chinese poststroke",
    "entities": [
      {
        "text": "Chinese",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "individuals: a study protocol for a randomised controlled trial.",
    "entities": []
  },
  {
    "text": "(1)Chiang Mai University, Chiang Mai, Thailand.",
    "entities": [
      {
        "text": "Mai University",
        "label": "ORG"
      },
      {
        "text": "Chiang Mai,",
        "label": "PERSON"
      },
      {
        "text": "Thailand",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou,",
    "entities": [
      {
        "text": "Affiliated Hospital",
        "label": "ORG"
      },
      {
        "text": "Guizhou Medical University",
        "label": "ORG"
      },
      {
        "text": "Guiyang",
        "label": "GPE"
      },
      {
        "text": "Guizhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Chiang Mai University, Chiang Mai, Thailand jindarat.c@cmu.ac.th.",
    "entities": [
      {
        "text": "3)Chiang",
        "label": "CARDINAL"
      },
      {
        "text": "Mai University",
        "label": "ORG"
      },
      {
        "text": "Chiang Mai,",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "INTRODUCTION: Poststroke individuals have a high incidence of falls during the",
    "entities": []
  },
  {
    "text": "first months after discharge. The factors contributing to falls in poststroke",
    "entities": [
      {
        "text": "first months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patients are multifaceted, with balance deficits being the most prominent.",
    "entities": []
  },
  {
    "text": "Fall-related self-efficacy has also been identified as a key factor influencing",
    "entities": []
  },
  {
    "text": "the effectiveness of fall prevention interventions. Additionally, family members",
    "entities": []
  },
  {
    "text": "play a crucial role in fall prevention by providing support, supervision and",
    "entities": []
  },
  {
    "text": "assistance with mobility and daily activities. While previous studies support",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the potential benefits of a fall prevention programme for poststroke",
    "entities": []
  },
  {
    "text": "individuals, further evidence is needed to confirm their effectiveness. Building",
    "entities": []
  },
  {
    "text": "on the positive outcomes of self-management (SM) interventions in reducing falls",
    "entities": [
      {
        "text": "SM",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "across diverse populations, this study aims to evaluate the effects of an",
    "entities": []
  },
  {
    "text": "individual and family SM (IFSM) fall prevention programme on balance ability and",
    "entities": []
  },
  {
    "text": "fall-related self-efficacy among poststroke individuals.",
    "entities": []
  },
  {
    "text": "METHODS AND ANALYSIS: This study will be a two-arm, single-blind, pre-post test",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "randomised controlled trial. The target sample will consist of 60 poststroke",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "adults with moderate severity and their primary family members. The intervention",
    "entities": []
  },
  {
    "text": "group will receive the IFSM fall prevention programme, which consists of 10",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "weekly sessions. The main components of the programme are exercise, home",
    "entities": [
      {
        "text": "weekly",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "environment assessment, assistive technology, medication review and safety",
    "entities": []
  },
  {
    "text": "during daily activities. The control group will receive usual care but will not",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate in any specific intervention. Primary outcomes-balance ability and",
    "entities": []
  },
  {
    "text": "fall-related self-efficacy-will be assessed at baseline and week 8 after",
    "entities": [
      {
        "text": "week 8",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "discharge. Secondary outcomes will include the number of falls and fall-related",
    "entities": [
      {
        "text": "Secondary",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "ETHICS AND DISSEMINATION: Ethical approval was obtained from the Research Ethics",
    "entities": [
      {
        "text": "ETHICS",
        "label": "ORG"
      },
      {
        "text": "DISSEMINATION",
        "label": "PERSON"
      },
      {
        "text": "the Research Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committees of the Faculty of Nursing, Chiang Mai University and the Affiliated",
    "entities": [
      {
        "text": "the Faculty of Nursing",
        "label": "ORG"
      },
      {
        "text": "Chiang Mai University",
        "label": "ORG"
      },
      {
        "text": "Affiliated",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Hospital of Guizhou Medical University. The results will be disseminated to",
    "entities": [
      {
        "text": "Guizhou Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "poststroke individuals and their families through workshops; to healthcare",
    "entities": []
  },
  {
    "text": "professionals via professional training and meetings; and to researchers via",
    "entities": []
  },
  {
    "text": "conferences and publications.",
    "entities": []
  },
  {
    "text": "PMID: 40664404 [Indexed for MEDLINE]",
    "entities": []
  },
  {
    "text": "Online ahead of print.",
    "entities": []
  },
  {
    "text": "DNA methylation levels are independently associated with prevalence of",
    "entities": []
  },
  {
    "text": "(1)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": [
      {
        "text": "Dyslipidemias Clinic of the Montreal Clinical Research Institute",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Montr\u00e9al, Qu\u00e9bec, Canada; Department of Pediatrics, Division of Medical",
    "entities": [
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Pediatrics",
        "label": "ORG"
      },
      {
        "text": "Division of Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Genetics, Universit\u00e9 de Sherbrooke, Sherbrooke, Quebec, Canada; Centre de",
    "entities": [
      {
        "text": "Genetics",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "ORG"
      },
      {
        "text": "Sherbrooke, Quebec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Centre de\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "(3)Department of Biochemistry and Functional Genomics, Faculty of Medicine and",
    "entities": [
      {
        "text": "Biochemistry and Functional Genomics, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "ORG"
      },
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Biochemistry and Functional Genomics, Faculty of Medicine and",
    "entities": [
      {
        "text": "Biochemistry and Functional Genomics, Faculty of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Sciences, Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada; Centre de",
    "entities": [
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "ORG"
      },
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Centre de\n",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada; Department of Biochemistry",
    "entities": [
      {
        "text": "Universit\u00e9 de Sherbrooke",
        "label": "PERSON"
      },
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Biochemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Functional Genomics, Faculty of Medicine and Health Sciences, Universit\u00e9 de",
    "entities": [
      {
        "text": "Functional Genomics, Faculty of Medicine and Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Universit\u00e9 de\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada; Centre de recherche et d'innovation,",
    "entities": [
      {
        "text": "Sherbrooke, Qu\u00e9bec,",
        "label": "ORG"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Centre de recherche et d'innovation",
        "label": "FAC"
      }
    ]
  },
  {
    "text": "Saguenay-Lac-Saint-Jean, Saguenay, Qu\u00e9bec, Canada; Clinical Department of",
    "entities": [
      {
        "text": "Saguenay-Lac-Saint-Jean",
        "label": "GPE"
      },
      {
        "text": "Saguenay",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Clinical Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "(7)Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute,",
    "entities": []
  },
  {
    "text": "Montr\u00e9al, Qu\u00e9bec, Canada; Department of Medicine, Divisions of Experimental",
    "entities": [
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      },
      {
        "text": "Department of Medicine, Divisions of Experimental",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine and Medical Biochemistry, McGill University, Montr\u00e9al, Qu\u00e9bec, Canada.",
    "entities": [
      {
        "text": "McGill University",
        "label": "ORG"
      },
      {
        "text": "Montr\u00e9al",
        "label": "GPE"
      },
      {
        "text": "Qu\u00e9bec",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Multifactorial chylomicronemia syndrome (MCS) is a form of severe",
    "entities": []
  },
  {
    "text": "hypertriglyceridemia (sHTG) associated with increased risk of acute pancreatitis",
    "entities": []
  },
  {
    "text": "and atherosclerotic cardiovascular disease (ASCVD). We recently reported",
    "entities": []
  },
  {
    "text": "suggestive evidence that DNA methylation (DNAm) contribute to the sHTG phenotype",
    "entities": []
  },
  {
    "text": "in MCS. While few predictors of acute pancreatitis were previously identified in",
    "entities": []
  },
  {
    "text": "MCS, predictors of ASCVD in MCS remain mostly unknown.",
    "entities": [
      {
        "text": "ASCVD",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To study the factors associated with previous history of ASCVD in MCS",
    "entities": []
  },
  {
    "text": "METHODS: A total of 114 patients with MCS were included in this retrospective",
    "entities": [
      {
        "text": "114",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "study. Prevalence of ASCVD was determined at the baseline visit and defined as",
    "entities": []
  },
  {
    "text": "any atherosclerotic event: angina, myocardial infarction, coronary angioplasty,",
    "entities": [
      {
        "text": "coronary angioplasty",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "coronary bypass surgery, claudication, peripheral angioplasty, peripheral",
    "entities": []
  },
  {
    "text": "arterial surgery, transient ischemic attack, stroke, carotid endarterectomy, and",
    "entities": []
  },
  {
    "text": "artery stenosis (>50 %). DNAm level at ABCG1 (cg06500161), CPT1A (cg00574958),",
    "entities": [
      {
        "text": "50 %",
        "label": "PERCENT"
      },
      {
        "text": "ABCG1 (cg06500161",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and SREBF1 (cg11024682) candidate gene loci was quantified using pyrosequencing",
    "entities": [
      {
        "text": "SREBF1",
        "label": "PERSON"
      },
      {
        "text": "gene loci",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "of bisulfite-treated DNA.",
    "entities": []
  },
  {
    "text": "RESULTS: Univariate analysis showed that age, ABCG1 and SREBF1 DNAm level, and",
    "entities": [
      {
        "text": "ABCG1",
        "label": "PERSON"
      },
      {
        "text": "SREBF1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the presence of obesity, hypertension, diabetes, and maximal TG",
    "entities": []
  },
  {
    "text": "level > 40 mmol/L were associated with previous history of ASCVD. Multivariate",
    "entities": [
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis showed that age (OR 1.11 [1.04-1.18], p = 0.0006), SREBF1 DNAm levels",
    "entities": [
      {
        "text": "1.11",
        "label": "CARDINAL"
      },
      {
        "text": "1.04",
        "label": "CARDINAL"
      },
      {
        "text": "0.0006",
        "label": "CARDINAL"
      },
      {
        "text": "SREBF1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(OR 1.12 [1.03-1.24], p = 0.01), the presence of a maximal TG level > 40 mmol/L",
    "entities": [
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "1.03-1.24",
        "label": "CARDINAL"
      },
      {
        "text": "0.01",
        "label": "CARDINAL"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(OR 0.13 [0.02-0.90], p = 0.04), and obesity (OR 3.32 [1.00-11.19, p = 0.05]",
    "entities": [
      {
        "text": "0.13",
        "label": "CARDINAL"
      },
      {
        "text": "0.02",
        "label": "CARDINAL"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "3.32",
        "label": "CARDINAL"
      },
      {
        "text": "1.00",
        "label": "CARDINAL"
      },
      {
        "text": "0.05",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "were independently associated with history of ASCVD and explained 44.8 % of the",
    "entities": [
      {
        "text": "44.8 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "variability in the prevalence of ASCVD (p < 0.0001).",
    "entities": [
      {
        "text": "ASCVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: This study shows that SREBF1 DNAm levels are independently",
    "entities": [
      {
        "text": "SREBF1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with prevalence of ASCVD in MCS patients. It suggests that further",
    "entities": []
  },
  {
    "text": "studies of epivariations may contribute to better understand the clinical",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025. Published by Elsevier Inc.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Elsevier Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of Competing Interest The authors",
    "entities": []
  },
  {
    "text": "declare the following financial interests/personal relationships which may be",
    "entities": []
  },
  {
    "text": "considered as potential competing interests: AB received research grants from",
    "entities": []
  },
  {
    "text": "Akcea, Amgen, Astra Zeneca, Fondation Leducq, Fondation Yvan Morin, Merck",
    "entities": [
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Fondation Leducq",
        "label": "PERSON"
      },
      {
        "text": "Yvan Morin",
        "label": "PERSON"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Frosst, and Sanofi. He has participated in clinical research protocols from",
    "entities": [
      {
        "text": "Frosst",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Acasti Pharma Inc., Akcea, Amgen, Arrowhead Pharmaceuticals, Astra Zeneca, Ionis",
    "entities": [
      {
        "text": "Acasti Pharma Inc.",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Arrowhead Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "Astra Zeneca",
        "label": "PERSON"
      },
      {
        "text": "Ionis",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Pharmaceuticals, Inc., ISIS Pharmaceuticals, The Medicines Company, Merck",
    "entities": [
      {
        "text": "Pharmaceuticals, Inc.",
        "label": "ORG"
      },
      {
        "text": "ISIS Pharmaceuticals",
        "label": "ORG"
      },
      {
        "text": "The Medicines Company",
        "label": "ORG"
      },
      {
        "text": "Merck",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Frosst, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi. He has",
    "entities": [
      {
        "text": "Frosst",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      },
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Regeneron Pharmaceuticals Inc.",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "served on advisory boards and received honoraria for symposia from Akcea, Amgen,",
    "entities": [
      {
        "text": "symposia",
        "label": "GPE"
      },
      {
        "text": "Akcea",
        "label": "GPE"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Sanofi. SBreceived research grants from Akcea, Fondation Leducq, and",
    "entities": [
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Fondation Leducq",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Fondation Yvan Morin. She has participated in clinical research protocols from",
    "entities": [
      {
        "text": "Yvan Morin",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Akcea, Amgen, Ionis Pharmaceuticals, Inc., The Medicines Company, Novartis,",
    "entities": [
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Ionis Pharmaceuticals, Inc.",
        "label": "ORG"
      },
      {
        "text": "The Medicines Company",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pfizer, and Sanofi. She has served on advisory boards for Akcea, Amgen, HLS",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "Akcea",
        "label": "ORG"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therapeutics, Novartis, Novo Nordisk, and Sanofi, and received honoraria for",
    "entities": [
      {
        "text": "Novartis",
        "label": "GPE"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "symposia from Akcea, Amgen, Novo Nordisk, and Sanofi. SPG has served on advisory",
    "entities": [
      {
        "text": "symposia",
        "label": "GPE"
      },
      {
        "text": "Akcea",
        "label": "GPE"
      },
      {
        "text": "Amgen",
        "label": "ORG"
      },
      {
        "text": "Novo Nordisk",
        "label": "PERSON"
      },
      {
        "text": "Sanofi",
        "label": "ORG"
      },
      {
        "text": "SPG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "boards for Ultragenyx. MP, LB, LG, VD and AT have nothing to declare.",
    "entities": [
      {
        "text": "Ultragenyx",
        "label": "GPE"
      },
      {
        "text": "LB",
        "label": "ORG"
      },
      {
        "text": "LG",
        "label": "GPE"
      },
      {
        "text": "VD",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Identifying homogenous patient subgroups using transformer based hierarchical",
    "entities": []
  },
  {
    "text": "clustering of heterogeneous Mixed-Modality medical data.",
    "entities": [
      {
        "text": "Mixed-Modality",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baskett W(1), Black B(2), Qureshi AI(3), Shyu CR(4).",
    "entities": [
      {
        "text": "Qureshi AI(3",
        "label": "ORG"
      },
      {
        "text": "Shyu CR(4",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(1)Institute for Data Science and Informatics, University of Missouri, MO 65211",
    "entities": [
      {
        "text": "Data Science and Informatics, University",
        "label": "ORG"
      },
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "MO 65211",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Pediatrics, School of Medicine, University of Missouri, MO",
    "entities": [
      {
        "text": "Pediatrics, School of Medicine, University of Missouri",
        "label": "ORG"
      },
      {
        "text": "MO",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "65211 USA; Thompson Center for Autism & Neurodevelopment, University of",
    "entities": [
      {
        "text": "65211",
        "label": "CARDINAL"
      },
      {
        "text": "Thompson Center for Autism & Neurodevelopment",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Medicine, School of Medicine, University of Missouri, MO 65211",
    "entities": [
      {
        "text": "Medicine, School of Medicine, University of Missouri",
        "label": "ORG"
      },
      {
        "text": "MO 65211",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "USA; Zeenat Qureshi Stroke Institute and Department of Neurology, University of",
    "entities": [
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "Zeenat Qureshi Stroke Institute and Department of Neurology",
        "label": "ORG"
      },
      {
        "text": "University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Institute for Data Science and Informatics, University of Missouri, MO 65211",
    "entities": [
      {
        "text": "Data Science and Informatics, University of Missouri",
        "label": "ORG"
      },
      {
        "text": "MO 65211",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "USA; Department of Electrical Engineering and Computer Science, University of",
    "entities": [
      {
        "text": "USA",
        "label": "GPE"
      },
      {
        "text": "Department of Electrical Engineering and Computer Science, University of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Missouri, MO 65211 USA; Department of Medicine, School of Medicine, University",
    "entities": [
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "MO 65211 USA",
        "label": "ORG"
      },
      {
        "text": "Department of Medicine, School of Medicine, University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Missouri, MO 65211 USA. Electronic address: shyuc@missouri.edu.",
    "entities": [
      {
        "text": "Missouri",
        "label": "GPE"
      },
      {
        "text": "MO 65211 USA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "OBJECTIVE: Patients are highly heterogeneous, with varying needs and responses",
    "entities": []
  },
  {
    "text": "to treatment. Identifying clinically homogenous patient subgroups is critical to",
    "entities": []
  },
  {
    "text": "improve personalized care. Patient records are often heterogeneous, may include",
    "entities": []
  },
  {
    "text": "multiple modalities which conventionally require separate data processing",
    "entities": []
  },
  {
    "text": "considerations, and are often incomplete, leading to difficulties in identifying",
    "entities": []
  },
  {
    "text": "meaningful clusters of patients.",
    "entities": []
  },
  {
    "text": "METHODS: We introduce a Med-ROAR, a transformer-based Random Order",
    "entities": [
      {
        "text": "Med-ROAR",
        "label": "ORG"
      },
      {
        "text": "Random Order",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AutoRegressive (ROAR) embedding model for medical data. Med-ROAR hierarchically",
    "entities": [
      {
        "text": "AutoRegressive",
        "label": "ORG"
      },
      {
        "text": "ROAR",
        "label": "ORG"
      },
      {
        "text": "Med-ROAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clusters data by encoding it into hierarchical discrete embeddings using a",
    "entities": []
  },
  {
    "text": "modified self-attention operation to facilitate random order mixed modality",
    "entities": []
  },
  {
    "text": "autoregressive modeling. This allows the model to accept arbitrary mixes of",
    "entities": []
  },
  {
    "text": "record types without special considerations. We compare our method's clustering",
    "entities": []
  },
  {
    "text": "effectiveness to standard agglomerative clustering using 147,469 individuals",
    "entities": [
      {
        "text": "147,469",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "diagnosed with Autism Spectrum Disorder (ASD). We also evaluate its use on data",
    "entities": [
      {
        "text": "Autism Spectrum Disorder (ASD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with mixed modalities and its resilience to missing information using 50,458",
    "entities": [
      {
        "text": "50,458",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "clinical records from Intensive Care Unit (ICU) patients which include both",
    "entities": [
      {
        "text": "Intensive Care Unit",
        "label": "ORG"
      },
      {
        "text": "ICU",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "tabular and time-series components.",
    "entities": []
  },
  {
    "text": "RESULTS: We demonstrate that Med-ROAR is more likely to discover more cohesive",
    "entities": [
      {
        "text": "Med-ROAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "high-level clusters than distance-based methods like agglomerative clustering.",
    "entities": []
  },
  {
    "text": "Our exploratory analysis of the autism data identifies clinically meaningful",
    "entities": []
  },
  {
    "text": "patterns of phenotypes within ASD. We identify homogenous, but atypical, patient",
    "entities": [
      {
        "text": "ASD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subgroups within the ASD population. We also demonstrate Med-ROAR's",
    "entities": [
      {
        "text": "ASD",
        "label": "ORG"
      },
      {
        "text": "Med-ROAR's",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "effectiveness in clustering patients using mixes of both tabular and time series",
    "entities": []
  },
  {
    "text": "clinical records from ICU patients. We demonstrate that Med-ROAR can predict",
    "entities": [
      {
        "text": "ICU",
        "label": "ORG"
      },
      {
        "text": "Med-ROAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patient subgroups even using incomplete, preliminary information collected",
    "entities": []
  },
  {
    "text": "shortly after admission.",
    "entities": []
  },
  {
    "text": "CONCLUSION: Med-ROAR is a flexible hierarchical clustering technique which",
    "entities": [
      {
        "text": "Med-ROAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "learns to cluster patients based on learned high-level semantic similarities",
    "entities": []
  },
  {
    "text": "rather than rule-based metrics. It can accept whatever patient data may be",
    "entities": []
  },
  {
    "text": "available without modification to the underlying model architecture. The data",
    "entities": []
  },
  {
    "text": "modalities which Med-ROAR can accept are primarily constrained by computational",
    "entities": [
      {
        "text": "Med-ROAR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "resources, rather than architectural limitations.",
    "entities": []
  },
  {
    "text": "10.1016/j.amjcard.2025.07.009. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Long-term Outcomes Following Transcatheter Aortic Valve Replacement in Patients",
    "entities": [
      {
        "text": "Outcomes Following Transcatheter Aortic Valve Replacement",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with Severe Aortic Atheroma.",
    "entities": []
  },
  {
    "text": "(1)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Hospital, Strasbourg, France; UR 3074 Translational Cardiovascular",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      },
      {
        "text": "UR 3074 Translational Cardiovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, CRBS, University of Strasbourg, France. Electronic address:",
    "entities": [
      {
        "text": "University of Strasbourg",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medicine, CRBS, University of Strasbourg, France.",
    "entities": [
      {
        "text": "University of Strasbourg",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Hospital, Strasbourg, France.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Hospital, Strasbourg, France; Vietnam National cardiovascular",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      },
      {
        "text": "France",
        "label": "GPE"
      },
      {
        "text": "Vietnam National",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "institute, Hano\u00ef, Vietnam; Hano\u00ef Medical University, Vietnam.",
    "entities": [
      {
        "text": "Hano\u00ef",
        "label": "GPE"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      },
      {
        "text": "Hano\u00ef Medical University",
        "label": "ORG"
      },
      {
        "text": "Vietnam",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medicine, CRBS, University of Strasbourg, France; Division of Cardiology,",
    "entities": [
      {
        "text": "University of Strasbourg",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      },
      {
        "text": "Division of Cardiology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Yokohama City University Medical Center, Yokohama, Japan.",
    "entities": [
      {
        "text": "Yokohama City University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Yokohama",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Division of Cardiology, Yokohama City University Medical Center, Yokohama,",
    "entities": [
      {
        "text": "Cardiology",
        "label": "ORG"
      },
      {
        "text": "Yokohama City University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Yokohama",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Japan; Department of Cardiology, Yokohama City University Graduate School of",
    "entities": [
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "Department of Cardiology",
        "label": "ORG"
      },
      {
        "text": "Yokohama City University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Cardiology, Hospital of Haguenau, France.",
    "entities": [
      {
        "text": "Cardiology, Hospital of Haguenau",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Department of Cardiovascular Medicine, Nouvel H\u00f4pital Civil, Strasbourg",
    "entities": [
      {
        "text": "Cardiovascular Medicine",
        "label": "ORG"
      },
      {
        "text": "Strasbourg",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Medicine, CRBS, University of Strasbourg, France; Hano\u00ef Medical University,",
    "entities": [
      {
        "text": "University of Strasbourg",
        "label": "ORG"
      },
      {
        "text": "France",
        "label": "GPE"
      },
      {
        "text": "Hano\u00ef Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Although aorta atheroma morphology is associated with acute outcomes",
    "entities": []
  },
  {
    "text": "post-transcatheter aortic valve replacement (TAVR), its association with",
    "entities": []
  },
  {
    "text": "long-term outcomes post-TAVR remains unknown. This study evaluates the impact of",
    "entities": []
  },
  {
    "text": "severe aortic atheroma on long-term outcomes following TAVR.",
    "entities": [
      {
        "text": "TAVR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: We enrolled 977 patients who underwent TAVR between February 2010 and",
    "entities": [
      {
        "text": "977",
        "label": "CARDINAL"
      },
      {
        "text": "February 2010",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "May 2019, with available contrast-enhanced computed tomography data. Severe",
    "entities": [
      {
        "text": "May 2019",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "aortic atheroma was defined as protruding atheroma of \u22653mm thickness with",
    "entities": [
      {
        "text": "mm",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "protruding components, ulcerated atheroma with ulcer-like intimal disruption,",
    "entities": []
  },
  {
    "text": "and atheroma of \u22655mm thickness. The primary endpoint was 2-year major adverse",
    "entities": [
      {
        "text": "2-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "cardiac and cerebrovascular event (MACCE), defined as a composite of",
    "entities": []
  },
  {
    "text": "cardiovascular death, myocardial infarction, ischemic stroke, and heart failure,",
    "entities": []
  },
  {
    "text": "events classified as periprocedural (\u226430 days), early (30 days to 1 year), and",
    "entities": [
      {
        "text": "early (30 days to 1 year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "late (>1-year post-TAVR).",
    "entities": [
      {
        "text": "1-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "RESULTS: Patients with severe aortic atheroma (n=274, 28%) had a higher",
    "entities": [
      {
        "text": "28%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "cumulative incidence of 2-year MACCE than those without (40.6% vs. 28.9%,",
    "entities": [
      {
        "text": "2-year",
        "label": "DATE"
      },
      {
        "text": "40.6%",
        "label": "PERCENT"
      },
      {
        "text": "28.9%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "log-rank p=0.0002), which was attributed to increased risks of ischemic stroke",
    "entities": [
      {
        "text": "log-rank p=0.0002",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(13.8% vs. 6.8%, log-rank p=0.0012) and cardiovascular death (18.6% vs. 10.8%,",
    "entities": [
      {
        "text": "13.8%",
        "label": "PERCENT"
      },
      {
        "text": "6.8%",
        "label": "PERCENT"
      },
      {
        "text": "18.6%",
        "label": "PERCENT"
      },
      {
        "text": "10.8%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "log-rank p=0.0009). Severe aortic atheroma was an independent risk factors for",
    "entities": [
      {
        "text": "log-rank",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "2-year MACCE (adjusted hazard ratio [aHR], 1.49, 95% CI, 1.16-1.90). In the",
    "entities": [
      {
        "text": "2-year",
        "label": "DATE"
      },
      {
        "text": "1.49",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.16-1.90",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "landmark analysis, severe aortic atheroma was independently associated with",
    "entities": [
      {
        "text": "landmark analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "periprocedural ischemic stroke and cardiovascular death (aHR, 2.12, 95% CI,",
    "entities": [
      {
        "text": "2.12",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.15-3.90 and aHR, 3.29, 95% CI, 1.70-6.37, respectively), and late ischemic",
    "entities": [
      {
        "text": "1.15",
        "label": "CARDINAL"
      },
      {
        "text": "3.29",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.70-6.37",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: Patients with severe aortic atheroma have an increased risk of",
    "entities": []
  },
  {
    "text": "2-year MACCE post-TAVR.",
    "entities": [
      {
        "text": "2-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "considered as potential competing interests:",
    "entities": []
  },
  {
    "text": "73. J Neural Eng. 2025 Jul 15. doi: 10.1088/1741-2552/adf010. Online ahead of",
    "entities": [
      {
        "text": "73",
        "label": "CARDINAL"
      },
      {
        "text": "J Neural Eng",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1088/1741-2552",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Detection of movement-related cortical potentials associated with upper and low",
    "entities": []
  },
  {
    "text": "limb movements in patients with multiple sclerosis for brain-computer",
    "entities": []
  },
  {
    "text": "interfacing.",
    "entities": []
  },
  {
    "text": "(1)Department of Health Science and Technology, Aalborg University, Selma",
    "entities": [
      {
        "text": "Health Science and Technology",
        "label": "ORG"
      },
      {
        "text": "Aalborg University",
        "label": "ORG"
      },
      {
        "text": "Selma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "&#xD;Brain-computer interface (BCI) training has been shown to be effective for",
    "entities": [
      {
        "text": "xD;Brain",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "inducing neural plasticity and for improving motor function in stroke patients.",
    "entities": []
  },
  {
    "text": "BCI training could potentially have a positive effect on people with multiple",
    "entities": []
  },
  {
    "text": "sclerosis (MS) as well by pairing movement-related brain activity with congruent",
    "entities": []
  },
  {
    "text": "afferent feedback from e.g. functional electrical stimulation. In the current",
    "entities": []
  },
  {
    "text": "study, the aim was to detect movement-related cortical potentials (MRCPs) from",
    "entities": []
  },
  {
    "text": "single-trial EEG in people with MS across two separate days using different",
    "entities": [
      {
        "text": "EEG",
        "label": "ORG"
      },
      {
        "text": "MS",
        "label": "ORG"
      },
      {
        "text": "two separate days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "classifier calibration schemes to estimate the performance of a BCI that can be",
    "entities": []
  },
  {
    "text": "used for neurorehabilitation.&#xD;Approach:&#xD;Fifteen individuals with MS",
    "entities": [
      {
        "text": "MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "performed 100 wrist movements and 100 ankle movements while continuous EEG was",
    "entities": [
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "EEG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "recorded. Also, idle brain activity was recorded. This was repeated on a",
    "entities": []
  },
  {
    "text": "separate day. The data were filtered and divided into epochs containing data",
    "entities": [
      {
        "text": "separate day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "prior to the movement onset. Temporal, spectral and template-matching features",
    "entities": []
  },
  {
    "text": "were extracted and classified with a random forest classifier using different",
    "entities": []
  },
  {
    "text": "calibration schemes to estimate the performance when training the classifier on",
    "entities": []
  },
  {
    "text": "data from the same day and same participant, different day but same participant,",
    "entities": [
      {
        "text": "the same day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "and across different participants.&#xD;Main results:&#xD;Clear MRCPs were",
    "entities": []
  },
  {
    "text": "elicited across both recording days, and it was possible to discriminate between",
    "entities": []
  },
  {
    "text": "idle activity and movement-related brain activity with accuracies between",
    "entities": []
  },
  {
    "text": "~80-90% when training and testing the classifier on data from the same day and",
    "entities": [
      {
        "text": "~80-90%",
        "label": "ORG"
      },
      {
        "text": "the same day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participant. The performance decreased when using data from a separate day but",
    "entities": []
  },
  {
    "text": "training the classifier.&#xD;Significance:&#xD;The results showed that it is",
    "entities": []
  },
  {
    "text": "feasible for people with MS to use a BCI for inducing neural plasticity.&#xD.",
    "entities": [
      {
        "text": "MS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Creative Commons Attribution license.",
    "entities": []
  },
  {
    "text": "Crucial nursing role in performing the appropriate bed positioning during the",
    "entities": []
  },
  {
    "text": "acute flaccid phase of cerebrovascular accidents (CVAs).",
    "entities": []
  },
  {
    "text": "(1)Nursing medical surgical critical care department, Minia University, Minia,",
    "entities": [
      {
        "text": "Minia University",
        "label": "ORG"
      },
      {
        "text": "Minia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Physiotherapy Department, DR.Erfan and Bagedo General Hospital, Jeddah,Saudi",
    "entities": [
      {
        "text": "2)Physiotherapy",
        "label": "CARDINAL"
      },
      {
        "text": "Bagedo General Hospital",
        "label": "ORG"
      },
      {
        "text": "Jeddah",
        "label": "GPE"
      },
      {
        "text": "Saudi",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(3)Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of",
    "entities": [
      {
        "text": "Physical Medicine, Rheumatology and Rehabilitation, Faculty",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medicine, Mansoura University, Mansoura 35516, Egypt. Electronic address:",
    "entities": [
      {
        "text": "35516",
        "label": "DATE"
      },
      {
        "text": "Egypt",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "To create educational program for the nursing team regarding appropriate bed",
    "entities": []
  },
  {
    "text": "positioning during the flaccid stage of cerebrovascular accidents (CVAs)",
    "entities": []
  },
  {
    "text": "METHODS: The chief nursing instructor and rehabilitation department initiated an",
    "entities": []
  },
  {
    "text": "educational teaching program that involved ten senior nurses who were given",
    "entities": [
      {
        "text": "ten",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "learning assignments for clinical practice. The ultimate goal was to maintain",
    "entities": []
  },
  {
    "text": "joint range of motion to avoid flexion deformity or extension lag in acute",
    "entities": []
  },
  {
    "text": "flaccid stage of CVAs. At day 0, day 14, and day 30, the Action Research Arm",
    "entities": [
      {
        "text": "0, day 14",
        "label": "DATE"
      },
      {
        "text": "day 30",
        "label": "DATE"
      },
      {
        "text": "the Action Research Arm\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Test (ARAT) was utilized to measure the functional outcome RESULTS: The mean",
    "entities": []
  },
  {
    "text": "ARAT score was 8.83\u00b14.094 at inclusion, 22.87\u00b16.015 at day 14, and 44.64\u00b13.268",
    "entities": [
      {
        "text": "22.87\u00b16.015",
        "label": "DATE"
      },
      {
        "text": "day 14",
        "label": "DATE"
      },
      {
        "text": "44.64\u00b13.268",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "at day 30, (p < 0.001). Patients showed no flexion deformity or extension lag at",
    "entities": [
      {
        "text": "day 30",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "the end of the study period CONCLUSION: For CVAs patients, the nursing staff's",
    "entities": []
  },
  {
    "text": "daily implementation of proper bed posture was essential for enhancing the",
    "entities": [
      {
        "text": "daily",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "rehabilitation program and optimum functional recovery.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declaration of competing interest None.",
    "entities": []
  },
  {
    "text": "Letter to the Editor: Serum creatinine-to-albumin ratio as a predictor of 28-day",
    "entities": [
      {
        "text": "28-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "mortality in critically ill patients with ischemic stroke: A retrospective",
    "entities": []
  },
  {
    "text": "cohort study.",
    "entities": []
  },
  {
    "text": "(1)Department of Critical Care Medicine, The First People's Hospital of Xiaoshan",
    "entities": [
      {
        "text": "Critical Care Medicine",
        "label": "ORG"
      },
      {
        "text": "The First People's Hospital of Xiaoshan\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou",
    "entities": [
      {
        "text": "Wenzhou Medical University",
        "label": "ORG"
      },
      {
        "text": "Hangzhou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "311200 Zhejiang, China. Electronic address: luosongsong110@wmu.edu.cn.",
    "entities": [
      {
        "text": "311200",
        "label": "CARDINAL"
      },
      {
        "text": "Zhejiang",
        "label": "GPE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "10.1016/j.clineuro.2025.109057. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Author reply to the letter regarding: \"Transition from alteplase to tenecteplase",
    "entities": [
      {
        "text": "Author",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for treatment of acute ischemic stroke in a rural stroke network of the Midwest:",
    "entities": [
      {
        "text": "Midwest",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Planning, execution, safety, and outcomes\".",
    "entities": []
  },
  {
    "text": "(1)Brain and Spine Institute, Southern Illinois Healthcare, Carbondale, IL,",
    "entities": [
      {
        "text": "Spine Institute",
        "label": "ORG"
      },
      {
        "text": "Southern Illinois Healthcare",
        "label": "ORG"
      },
      {
        "text": "Carbondale",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States; Southern Illinois University School of Medicine, Carbondale, IL,",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      },
      {
        "text": "Southern Illinois University School of Medicine",
        "label": "ORG"
      },
      {
        "text": "Carbondale",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States. Electronic address: andrea.loggini@sih.net.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Brain and Spine Institute, Southern Illinois Healthcare, Carbondale, IL,",
    "entities": [
      {
        "text": "2)Brain",
        "label": "CARDINAL"
      },
      {
        "text": "Spine Institute",
        "label": "ORG"
      },
      {
        "text": "Southern Illinois Healthcare",
        "label": "ORG"
      },
      {
        "text": "Carbondale",
        "label": "GPE"
      },
      {
        "text": "IL",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "United States.",
    "entities": [
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "10.1016/j.clineuro.2025.109054. Online ahead of print.",
    "entities": [
      {
        "text": "10.1016",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Triglyceride-glucose index and its association with collaterals in acute",
    "entities": []
  },
  {
    "text": "ischemic stroke: A cross-sectional study.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurology, University of Kansas Medical Center, Kansas City,",
    "entities": [
      {
        "text": "Neurology, University of Kansas Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "KS, United States.",
    "entities": [
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Radiology, University of Kansas Medical Center, Kansas City,",
    "entities": [
      {
        "text": "Radiology, University of Kansas Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurology, University of Kansas Medical Center, Kansas City,",
    "entities": [
      {
        "text": "Neurology, University of Kansas Medical Center",
        "label": "ORG"
      },
      {
        "text": "Kansas City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "KS, United States. Electronic address: peswaradass@kumc.edu.",
    "entities": [
      {
        "text": "KS",
        "label": "GPE"
      },
      {
        "text": "United States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Division of Neurology, University of Alberta Hospital, Edmonton, AB, United",
    "entities": [
      {
        "text": "Neurology, University of Alberta Hospital",
        "label": "ORG"
      },
      {
        "text": "Edmonton",
        "label": "PERSON"
      },
      {
        "text": "AB",
        "label": "GPE"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "States.",
    "entities": [
      {
        "text": "States",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "for patients with Acute ischemic stroke (AIS). Insulin resistance (IR) is",
    "entities": [
      {
        "text": "Acute",
        "label": "NORP"
      },
      {
        "text": "AIS",
        "label": "ORG"
      },
      {
        "text": "IR",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "associated with cardiovascular disease, but its impact on stroke outcomes is",
    "entities": []
  },
  {
    "text": "less clear. The triglyceride-glucose (TyG) index is a novel, accessible",
    "entities": [
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "biomarker for IR. This study aims to evaluate the association between TyG index",
    "entities": [
      {
        "text": "IR",
        "label": "ORG"
      },
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and LMCs.",
    "entities": []
  },
  {
    "text": "METHODS: In this cross-sectional study, we included patients with internal",
    "entities": []
  },
  {
    "text": "carotid artery or middle cerebral artery occlusion and having CTA within 24 h of",
    "entities": [
      {
        "text": "CTA",
        "label": "ORG"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "symptoms onset. TyG index formula was: ln [triglyceride (mg/dl) \u00d7 glucose",
    "entities": [
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(mg/dl)]/2. CTA collaterals were classified into symmetrical, malignant, and",
    "entities": [
      {
        "text": "CTA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "other. Hypoperfusion Intensity Ratio (HIR) calculated from CT perfusion (CTP)",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      },
      {
        "text": "CTP",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was used as secondary marker. We did a multivariate ordinal logistic regression",
    "entities": []
  },
  {
    "text": "analysis for collaterals and multi linear regression analysis for HIR.",
    "entities": []
  },
  {
    "text": "RESULTS: Of 265 patients, 54.1 % were males, and 45.9 % were females, with a",
    "entities": [
      {
        "text": "265",
        "label": "CARDINAL"
      },
      {
        "text": "54.1 %",
        "label": "PERCENT"
      },
      {
        "text": "45.9 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "mean BMI of 28. A total of 219 (82 %) patients received reperfusion therapy,",
    "entities": [
      {
        "text": "BMI",
        "label": "ORG"
      },
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "219",
        "label": "CARDINAL"
      },
      {
        "text": "82 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "with 40 % and 74 % patients receiving tPA and EVT, respectively. 39.2 % and",
    "entities": [
      {
        "text": "40 % and",
        "label": "PERCENT"
      },
      {
        "text": "74 %",
        "label": "PERCENT"
      },
      {
        "text": "EVT",
        "label": "ORG"
      },
      {
        "text": "39.2 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "27.2 % of patients had symmetrical and malignant CTA collateral scores,",
    "entities": [
      {
        "text": "27.2 %",
        "label": "PERCENT"
      },
      {
        "text": "CTA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respectively. TyG index was a significant predictor of malignant CTA collaterals",
    "entities": [
      {
        "text": "TyG",
        "label": "ORG"
      },
      {
        "text": "CTA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(\u03b2 = 2.2, 95 % CI: 1.7 - 2.7) and CTP HIR (\u03b2 = 0.1, 95 % CI: 0.03-0.14). TyG",
    "entities": [
      {
        "text": "2.2",
        "label": "CARDINAL"
      },
      {
        "text": "95 %",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.7 - 2.7",
        "label": "CARDINAL"
      },
      {
        "text": "CTP",
        "label": "ORG"
      },
      {
        "text": "0.1",
        "label": "CARDINAL"
      },
      {
        "text": "95 %",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.03-0.14",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "> 8.7 had diagnostic accuracy of 0.76 for malignant CTA collaterals.",
    "entities": [
      {
        "text": "8.7",
        "label": "CARDINAL"
      },
      {
        "text": "0.76",
        "label": "CARDINAL"
      },
      {
        "text": "CTA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: IR, as measured by TyG index, is predictive of worse LMCs. TyG is a",
    "entities": [
      {
        "text": "IR",
        "label": "ORG"
      },
      {
        "text": "TyG",
        "label": "ORG"
      },
      {
        "text": "TyG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "promising biomarker with a potential value in predicting stroke outcomes after",
    "entities": []
  },
  {
    "text": "reperfusion therapy.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 The Authors. Published by Elsevier B.V. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "declares that they have no relevant or material financial interests that relate",
    "entities": []
  },
  {
    "text": "to the research described in this paper.",
    "entities": []
  },
  {
    "text": "Efficacy and limitations of 180-day subcutaneous heparin therapy for",
    "entities": [
      {
        "text": "180-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "cancer-associated ischemic stroke.",
    "entities": []
  },
  {
    "text": "251-8550, Japan. Electronic address: gyama31.8796@gmail.com.",
    "entities": [
      {
        "text": "251",
        "label": "CARDINAL"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Neurology, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Fujisawa City Hospital",
        "label": "ORG"
      },
      {
        "text": "2-6",
        "label": "CARDINAL"
      },
      {
        "text": "Fujisawa",
        "label": "ORG"
      },
      {
        "text": "Fujisawa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "251-8550, Japan; Department of Neurology and Stroke Medicine, Yokohama City",
    "entities": [
      {
        "text": "251",
        "label": "CARDINAL"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "Department of Neurology",
        "label": "ORG"
      },
      {
        "text": "Yokohama City",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama",
    "entities": [
      {
        "text": "University Graduate School of Medicine",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "Kanazawa-ku",
        "label": "PERSON"
      },
      {
        "text": "Yokohama\n",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "251-8550, Japan; Department of Neurology, Yokohama Municipal Citizen's Hospital,",
    "entities": [
      {
        "text": "251",
        "label": "CARDINAL"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "Department of Neurology",
        "label": "ORG"
      },
      {
        "text": "Yokohama Municipal Citizen's Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Neurology and Stroke Medicine, Yokohama City University",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Yokohama City University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Neurology, Saiseikai Yokohamashi Nanbu Hospital, 3-2-10",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Saiseikai Yokohamashi Nanbu Hospital",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(6)Department of Neurology, Yokohama Minami Kyousai Hospital, 1-21-1",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Yokohama Minami Kyousai Hospital",
        "label": "PERSON"
      },
      {
        "text": "1-21-1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(7)Department of Neurology, Yokohama City University Medical Center, 4-57",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Yokohama City University Medical Center",
        "label": "ORG"
      },
      {
        "text": "4",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(8)Department of Neurology and Stroke Medicine, Yokohama Sakae Kyosai Hospital,",
    "entities": [
      {
        "text": "Yokohama Sakae Kyosai Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(9)Department of Neurology, Yokohama Municipal Citizen's Hospital, 1-1",
    "entities": [
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Yokohama Municipal Citizen's Hospital",
        "label": "ORG"
      },
      {
        "text": "1-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(10)Department of Neurology, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "ORG"
      },
      {
        "text": "Fujisawa City Hospital",
        "label": "ORG"
      },
      {
        "text": "2-6",
        "label": "CARDINAL"
      },
      {
        "text": "Fujisawa",
        "label": "ORG"
      },
      {
        "text": "Fujisawa",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Neurology and Stroke Medicine, Yokohama City University",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Yokohama City University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Cancer-associated ischemic stroke has a high recurrence rate.",
    "entities": []
  },
  {
    "text": "Subcutaneous (SC) heparin therapy is used to prevent this recurrence, but its",
    "entities": [
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "long-term efficacy remains unclear. This study evaluated the 180-day effects,",
    "entities": [
      {
        "text": "180-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "safety, and sustainability of SC heparin treatment in patients with",
    "entities": [
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Patients with cancer-associated ischemic stroke who were treated with",
    "entities": []
  },
  {
    "text": "unfractionated heparin were retrospectively investigated. Clinical data, such as",
    "entities": []
  },
  {
    "text": "D-dimer levels, heparin dosing, and cancer-related information, were collected.",
    "entities": []
  },
  {
    "text": "Outcomes assessed over 180 days included recurrent cancer-associated thrombosis",
    "entities": [
      {
        "text": "180 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(CAT), mortality, adverse events, and treatment discontinuation.",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Five of 100 patients treated with SC heparin experienced recurrence of",
    "entities": [
      {
        "text": "Five",
        "label": "CARDINAL"
      },
      {
        "text": "100",
        "label": "CARDINAL"
      },
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CAT (ischemic stroke, four patients; pulmonary embolism, one patient). The",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      },
      {
        "text": "four",
        "label": "CARDINAL"
      },
      {
        "text": "one",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cumulative recurrence rates of CAT were 2.4 % at 30 days and 7.7 % at 90 days,",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      },
      {
        "text": "2.4 %",
        "label": "PERCENT"
      },
      {
        "text": "30 days",
        "label": "DATE"
      },
      {
        "text": "7.7 %",
        "label": "PERCENT"
      },
      {
        "text": "90 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with no recurrence observed thereafter. At 180 days of follow-up, 19 patients",
    "entities": [
      {
        "text": "180 days",
        "label": "DATE"
      },
      {
        "text": "19",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "survived without CAT recurrence and one patient was completely cured of cancer",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "through surgery, while 29 patients died of cancer without recurrence of CAT.",
    "entities": [
      {
        "text": "29",
        "label": "CARDINAL"
      },
      {
        "text": "CAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "This finding suggested that approximately half of the patients benefited from SC",
    "entities": [
      {
        "text": "approximately half",
        "label": "CARDINAL"
      },
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "heparin therapy. Adverse events such as major bleeding were observed in 16",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients, leading to the discontinuation of treatment. Additionally, treatment",
    "entities": []
  },
  {
    "text": "was discontinued for various reasons such as psychological distress in 30",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "patients. D-dimer levels at the time of the initial cancer-associated ischemic",
    "entities": []
  },
  {
    "text": "stroke tended to be higher in patients with recurrence than in those without",
    "entities": []
  },
  {
    "text": "recurrence, but this was not significant. No recurrence of CAT was observed in",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "patients with pancreatic cancer, likely due to early cancer-related mortality.",
    "entities": []
  },
  {
    "text": "CAT recurrence and adverse event rates were not significantly different by",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cancer stage (stage IV vs. other stages) or between the fixed dose and adjusted",
    "entities": [
      {
        "text": "IV",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: SC heparin therapy effectively maintained a low recurrence rate of",
    "entities": []
  },
  {
    "text": "CAT for 180 days, and may have contributed to preserving functionality and",
    "entities": [
      {
        "text": "CAT",
        "label": "ORG"
      },
      {
        "text": "180 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "quality of life of the patients. Recurrence and adverse events were primarily",
    "entities": []
  },
  {
    "text": "observed within the first 90 days. However, challenges related to long-term SC",
    "entities": [
      {
        "text": "the first 90 days",
        "label": "DATE"
      },
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "heparin therapy remain. To improve treatment sustainability, comprehensive",
    "entities": []
  },
  {
    "text": "palliative care that addresses physical discomfort and psychological distress is",
    "entities": []
  },
  {
    "text": "essential. This study suggests the potential long-term benefits and limitations",
    "entities": []
  },
  {
    "text": "of SC heparin therapy and highlights the need for future long-term prospective",
    "entities": [
      {
        "text": "SC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "studies comparing this therapy with alternative anticoagulation strategies.",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Elsevier Ltd. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "79. IEEE Trans Biomed Eng. 2025 Jul 15;PP. doi: 10.1109/TBME.2025.3588902. Online",
    "entities": [
      {
        "text": "79",
        "label": "CARDINAL"
      },
      {
        "text": "Trans Biomed Eng",
        "label": "ORG"
      },
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "10.1109",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Design, Modeling and Evaluation of Lattice Structure Pneumatic Actuators (LSPAs)",
    "entities": []
  },
  {
    "text": "for Soft Wrist Rehabilitation Robot.",
    "entities": [
      {
        "text": "Soft Wrist Rehabilitation Robot",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Soft robots have gained recognition as promising solutions in rehabilitation",
    "entities": []
  },
  {
    "text": "robotics due to their intrinsic flexibility and safety features. However, they",
    "entities": []
  },
  {
    "text": "often encounter challenges related to output efficiency and portability. This",
    "entities": []
  },
  {
    "text": "paper presents the design, modeling, and evaluation of an innovative wrist",
    "entities": []
  },
  {
    "text": "rehabilitation robot that employs two double-layer lattice structure pneumatic",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "actuators (DLSPAs) to enhance efficiency. Key parameters of these DLSPAs are",
    "entities": []
  },
  {
    "text": "optimized through a mathematical model, with calibration experiments indicating",
    "entities": []
  },
  {
    "text": "that the discrepancy between actual and predicted values remains within 4% of",
    "entities": [
      {
        "text": "4%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "the DLSPAs' maximum output force, thereby validating the model's accuracy.",
    "entities": []
  },
  {
    "text": "Furthermore, the DLSPAs achieve an end output force of 27.02 N, marking a 156%",
    "entities": [
      {
        "text": "27.02",
        "label": "CARDINAL"
      },
      {
        "text": "156%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "increase compared to single-layer lattice structure pneumatic actuators (SLSPAs)",
    "entities": []
  },
  {
    "text": "and underscoring the structural advantages of the design. To evaluate the",
    "entities": []
  },
  {
    "text": "clinical efficacy of the wrist rehabilitation robot, trials were conducted with",
    "entities": []
  },
  {
    "text": "8 individuals post-stroke. Results demonstrate that, with robotic assistance,",
    "entities": [
      {
        "text": "8",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "participants' lifting force reached 4.85 N and 5.11 N in dorsal extension and",
    "entities": [
      {
        "text": "4.85",
        "label": "CARDINAL"
      },
      {
        "text": "5.11",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "palmar flexion, respectively, with corresponding angular movements of",
    "entities": [
      {
        "text": "palmar",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "36.40${}^{\\circ }$ and 38.36${}^{\\circ }$. These findings suggest that the",
    "entities": [
      {
        "text": "36.40${}^{\\circ }$",
        "label": "MONEY"
      },
      {
        "text": "38.36${}^{\\circ }$",
        "label": "MONEY"
      }
    ]
  },
  {
    "text": "lattice-structured soft wrist rehabilitation robot offers substantial potential",
    "entities": []
  },
  {
    "text": "for effective assisted rehabilitation training.",
    "entities": []
  },
  {
    "text": "DOI: 10.1109/TBME.2025.3588902",
    "entities": [
      {
        "text": "10.1109",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1080/17483107.2025.2532701. Online ahead of print.",
    "entities": []
  },
  {
    "text": "Co-design and evaluation of an information and communication technology-based",
    "entities": []
  },
  {
    "text": "solution to support mild stroke - an experience-based co-design study.",
    "entities": []
  },
  {
    "text": "(1)Centre for Innovative Medical Technology, Department of Clinical Research,",
    "entities": [
      {
        "text": "Innovative Medical Technology",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Southern Denmark, Odense, Denmark.",
    "entities": [
      {
        "text": "University of Southern Denmark, Odense, Denmark",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Health Sciences Research Centre, UCL University College, Odense, Denmark.",
    "entities": [
      {
        "text": "2)Health Sciences Research Centre",
        "label": "ORG"
      },
      {
        "text": "UCL University College,",
        "label": "ORG"
      },
      {
        "text": "Odense",
        "label": "GPE"
      },
      {
        "text": "Denmark",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurobiology, Care Sciences and Society, Division of",
    "entities": [
      {
        "text": "Neurobiology, Care Sciences",
        "label": "ORG"
      },
      {
        "text": "Society, Division of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Women's Health and Allied Health Professionals Theme, Medical Unit Allied",
    "entities": [
      {
        "text": "Health and Allied Health Professionals Theme, Medical Unit Allied\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Health Professionals, Karolinska University Hospital, Stockholm, Sweden.",
    "entities": [
      {
        "text": "Health Professionals",
        "label": "ORG"
      },
      {
        "text": "Karolinska University Hospital",
        "label": "ORG"
      },
      {
        "text": "Stockholm",
        "label": "GPE"
      },
      {
        "text": "Sweden",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Geriatric Research Unit, Department of Clinical Research, University of",
    "entities": [
      {
        "text": "Research Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Approximately 60-70% of people with stroke experience a mild incident. However,",
    "entities": [
      {
        "text": "60-70%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "mild stroke can significantly impact daily life for these individuals and their",
    "entities": []
  },
  {
    "text": "significant others. Reviews suggest that the use of information and",
    "entities": []
  },
  {
    "text": "communication technology (ICT) can add value to the existing stroke",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "rehabilitation. The purpose of the current study was to co-design and evaluate",
    "entities": []
  },
  {
    "text": "an ICT-based solution with and for people with mild stroke and their significant",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "others to support them through the stroke trajectory. Inspired by",
    "entities": []
  },
  {
    "text": "experience-based co-design, the study focused on developing an ICT-based",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "solution in a co-design workshop, testing the prototype in co-design teams, and",
    "entities": []
  },
  {
    "text": "pilot testing and evaluating the intervention through interviews with",
    "entities": []
  },
  {
    "text": "individuals with mild stroke and their significant others. Through the co-design",
    "entities": []
  },
  {
    "text": "process, a prototype was developed and tested. The developed ICT-based solution",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "offers targeted information and tips for managing mild stroke consequences, such",
    "entities": []
  },
  {
    "text": "as concentration issues and fatigue. The evaluation led to the identified four",
    "entities": [
      {
        "text": "four",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "categories: Diverse ways of using the ICT-based solution, Significant others'",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      },
      {
        "text": "Significant",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "use of information tailored for people with mild strokes and vice versa,",
    "entities": []
  },
  {
    "text": "Essential elements related to the usability of the ICT-based solution, and",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Suggestions for further development and implementation. The evaluation showed",
    "entities": []
  },
  {
    "text": "that the app provided useful information to both participants with stroke and",
    "entities": []
  },
  {
    "text": "their significant others, which may have supported their stroke trajectory and",
    "entities": []
  },
  {
    "text": "coping abilities. Introducing the app during the hospital stay was beneficial.",
    "entities": []
  },
  {
    "text": "Over time, participants valued the app's information as they adapted to living",
    "entities": []
  },
  {
    "text": "with mild stroke.",
    "entities": []
  },
  {
    "text": "Plain Language Summary: Integrating ICT-based tools, such as the co-designed",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "app, early in the stroke trajectory is important to support individuals with",
    "entities": []
  },
  {
    "text": "mild stroke and their significant others throughout the stroke trajectory.Usable",
    "entities": []
  },
  {
    "text": "and relevant ICT solutions can enhance coping abilities, promoting long-term",
    "entities": [
      {
        "text": "ICT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support beyond the clinical setting.",
    "entities": []
  },
  {
    "text": "81. Brain. 2025 Jul 15:awaf262. doi: 10.1093/brain/awaf262. Online ahead of",
    "entities": [
      {
        "text": "81",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1093",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Occludin modulates HIV and ischaemic stroke response via mitochondrial antiviral",
    "entities": []
  },
  {
    "text": "Torices S(1), Moreno T(2), Osborne OM(1), Ramaswamy S(1), Naranjo O(1), Teglas",
    "entities": [
      {
        "text": "Moreno T(2",
        "label": "ORG"
      },
      {
        "text": "Osborne OM(1",
        "label": "PERSON"
      },
      {
        "text": "Naranjo",
        "label": "PERSON"
      },
      {
        "text": "Teglas",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "(1)University of Miami Miller School of Medicine, Department of Biochemistry and",
    "entities": [
      {
        "text": "1)University",
        "label": "CARDINAL"
      },
      {
        "text": "Miami Miller School of Medicine, Department of Biochemistry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Radiation Oncology, UCSF, San Francisco, CA 94143, USA.",
    "entities": [
      {
        "text": "Radiation Oncology",
        "label": "ORG"
      },
      {
        "text": "UCSF",
        "label": "ORG"
      },
      {
        "text": "San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA 94143",
        "label": "FAC"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Specific cell types of the blood-brain barrier (BBB), such as pericytes, can be",
    "entities": [
      {
        "text": "BBB",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "infected by HIV-1. Importantly, alterations of the expression of tight junction",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "protein occludin have been linked to regulation of HIV-1 infection. In the",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "present study, we hypothesized that occludin can influence HIV-1 infection via",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "modulating innate immunity responses. Unbiased transcriptome analysis was",
    "entities": []
  },
  {
    "text": "conducted on wild type and occludin-silenced primary human blood-brain barrier",
    "entities": []
  },
  {
    "text": "pericytes. The role of differentially expressed innate-immunity pathways was",
    "entities": []
  },
  {
    "text": "then evaluated in the context of mitochondrial dysfunction and HIV-1 infection.",
    "entities": [
      {
        "text": "HIV-1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Using a model of ischemic stroke and occludin-deficient mice, we elucidated the",
    "entities": []
  },
  {
    "text": "functional role of occludin in cerebrovascular health in the presence of HIV-1",
    "entities": [
      {
        "text": "HIV-1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "infection. Occludin silencing resulted in alterations of the gene expression",
    "entities": []
  },
  {
    "text": "signatures of IFN-stimulated genes and the antiviral retinoic acid-inducible",
    "entities": [
      {
        "text": "IFN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "gene-1 pathway, which functions as a regulator of the cytoplasmic sensors",
    "entities": []
  },
  {
    "text": "upstream of the mitochondrial antiviral signaling protein. Indeed, we observed",
    "entities": []
  },
  {
    "text": "dysfunctional mitochondrial bioenergetics, dynamics, and autophagy following",
    "entities": [
      {
        "text": "dysfunctional mitochondrial bioenergetics",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "occludin silencing. Alterations of mitochondrial bioenergetics and innate immune",
    "entities": []
  },
  {
    "text": "protection translated into worsened ischemic stroke outcomes in EcoHIV-infected",
    "entities": []
  },
  {
    "text": "occludin-deficient mice. Animal studies also confirmed that occludin-/- mice had",
    "entities": []
  },
  {
    "text": "higher EcoHIV load in plasma, spleen, and brain. Our results allow for a better",
    "entities": [
      {
        "text": "plasma",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "understanding of the molecular mechanisms of viral infection in the brain and",
    "entities": []
  },
  {
    "text": "describe a previously unrecognized role of occludin as a key factor in the",
    "entities": []
  },
  {
    "text": "control of innate immune responses and mitochondrial dynamics at the blood-brain",
    "entities": []
  },
  {
    "text": "barrier level, which influence cerebral vascular disease outcomes such as",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of the",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guarantors of Brain.",
    "entities": [
      {
        "text": "Brain",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical",
    "entities": [
      {
        "text": "Safety of Edoxaban",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bioprosthetic Valve Replacement: A Randomized Clinical Trial.",
    "entities": []
  },
  {
    "text": "Investigators.",
    "entities": []
  },
  {
    "text": "(1)Department of Heart Failure and Transplantation (C.I., M.A.), National",
    "entities": [
      {
        "text": "Transplantation",
        "label": "PERSON"
      },
      {
        "text": "C.I.",
        "label": "GPE"
      },
      {
        "text": "M.A.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Biostatistics (Y.Y.), National Cerebral and Cardiovascular",
    "entities": [
      {
        "text": "2)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Biostatistics",
        "label": "GPE"
      },
      {
        "text": "Y.Y.",
        "label": "GPE"
      },
      {
        "text": "National Cerebral and Cardiovascular",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Cardiovascular Surgery (S.F.), National Cerebral and",
    "entities": [
      {
        "text": "National Cerebral",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Department of Cardiovascular Surgery, Kyoto Prefectural University of",
    "entities": [
      {
        "text": "Cardiovascular Surgery",
        "label": "ORG"
      },
      {
        "text": "Kyoto Prefectural University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Cardiovascular Surgery, Hakujyuji Hospital, Fukuoka, Japan",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Hakujyuji Hospital",
        "label": "PERSON"
      },
      {
        "text": "Fukuoka",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Cardiovascular Surgery, Hyogo Medical University, Nishinomiya,",
    "entities": [
      {
        "text": "Hyogo Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Department of Cardiovascular Surgery, Kokura Memorial Hospital, Kitakyushu,",
    "entities": [
      {
        "text": "Kokura Memorial Hospital",
        "label": "PERSON"
      },
      {
        "text": "Kitakyushu",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(8)Department of Cardiovascular Surgery, Sakakibara Heart Institute of Okayama,",
    "entities": [
      {
        "text": "Sakakibara Heart Institute of Okayama",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Department of Cardiovascular Surgery, Kobe University Graduate School of",
    "entities": [
      {
        "text": "Kobe University Graduate School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(10)Department of Cardiovascular Surgery, Tohoku University Graduate School of",
    "entities": [
      {
        "text": "10)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Tohoku University Graduate School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(11)Department of Cardiovascular Surgery, Nagasaki University Graduate School of",
    "entities": [
      {
        "text": "11)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Nagasaki University Graduate School of\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Biomedical Sciences, Japan (T.M.).",
    "entities": [
      {
        "text": "Biomedical Sciences",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "T.M.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(12)Department of Cardiac Surgery, Kurashiki Central Hospital, Japan (T.K.).",
    "entities": [
      {
        "text": "12)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Cardiac Surgery",
        "label": "ORG"
      },
      {
        "text": "Kurashiki Central Hospital",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "T.K.",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)and Department of Data Science (M.M., H. Yamamoto, K. Omae), National",
    "entities": [
      {
        "text": "13)and Department of Data Science",
        "label": "ORG"
      },
      {
        "text": "H. Yamamoto",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "BACKGROUND: Anticoagulant therapy with vitamin K antagonists is recommended in",
    "entities": [
      {
        "text": "K",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the current guidelines for 3 to 6 months following bioprosthetic valve",
    "entities": [
      {
        "text": "3 to 6 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "replacement. However, in the era of direct oral anticoagulants, there is a",
    "entities": []
  },
  {
    "text": "paucity of evidence regarding the efficacy and safety of direct oral",
    "entities": []
  },
  {
    "text": "anticoagulants in this patient group.",
    "entities": []
  },
  {
    "text": "METHODS: The ENBALV trial (Edoxaban in Anticoagulant Therapy After Surgical",
    "entities": [
      {
        "text": "Edoxaban",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Bioprosthetic Valve Replacement) was an investigator-initiated, phase 3,",
    "entities": [
      {
        "text": "Bioprosthetic Valve Replacement",
        "label": "ORG"
      },
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "randomized, open-label, multicenter study that aimed to evaluate the efficacy",
    "entities": []
  },
  {
    "text": "and safety of edoxaban compared with warfarin within 3 months following",
    "entities": [
      {
        "text": "3 months",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "bioprosthetic valve replacement at the aortic or mitral position or both. The",
    "entities": []
  },
  {
    "text": "primary outcome was stroke or systemic embolism. The secondary outcomes included",
    "entities": []
  },
  {
    "text": "major bleeding, intracardiac thrombus, and a composite of stroke, systemic",
    "entities": []
  },
  {
    "text": "embolism, or major bleeding. Given the limited study period and the low event",
    "entities": []
  },
  {
    "text": "rate of the primary outcome, this study assessed the difference in the point",
    "entities": []
  },
  {
    "text": "estimates of the event rate.",
    "entities": []
  },
  {
    "text": "RESULTS: Of the 410 enrolled patients, 389 were included in the final analysis",
    "entities": [
      {
        "text": "410",
        "label": "CARDINAL"
      },
      {
        "text": "389",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(73\u00b16 years, 56.8% male, 79.4% sinus rhythm; edoxaban group: n=195, warfarin",
    "entities": [
      {
        "text": "73\u00b16 years",
        "label": "DATE"
      },
      {
        "text": "56.8%",
        "label": "PERCENT"
      },
      {
        "text": "79.4%",
        "label": "PERCENT"
      },
      {
        "text": "edoxaban group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "group: n=194). The primary outcome occurred in 0.5% (n=1) in the edoxaban group,",
    "entities": [
      {
        "text": "0.5%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "whereas in 1.5% (n=3) in the warfarin group (risk difference, -1.03% [95% CI,",
    "entities": [
      {
        "text": "1.5%",
        "label": "PERCENT"
      },
      {
        "text": "-1.03%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "-4.34 to 1.95%]). Major bleeding occurred in 4.1% (n=8) in the edoxaban group",
    "entities": [
      {
        "text": "1.95%",
        "label": "PERCENT"
      },
      {
        "text": "4.1%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "and in 1.0% (n=2) in the warfarin group (risk difference, 3.07% [95% CI, -0.67",
    "entities": [
      {
        "text": "1.0%",
        "label": "PERCENT"
      },
      {
        "text": "3.07%",
        "label": "PERCENT"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to 7.27%]). No fatal bleeding or intracranial hemorrhage was observed in",
    "entities": [
      {
        "text": "7.27%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "patients treated with edoxaban, whereas 1 fatal intracranial hemorrhage occurred",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "in the warfarin group. Intracardiac thrombus did not occur in any of the",
    "entities": []
  },
  {
    "text": "patients in the edoxaban group, but did occur in 1.0% (n=2) in the warfarin",
    "entities": [
      {
        "text": "1.0%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "group.",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Edoxaban is a potential alternative anticoagulant therapy early",
    "entities": [
      {
        "text": "Edoxaban",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "after bioprosthetic valve replacement.",
    "entities": []
  },
  {
    "text": "PMID: 40663622 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663622",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Dr Izumi has received speaker honoraria from",
    "entities": [
      {
        "text": "Dr Izumi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Daiichi Sankyo Co, Ltd, Nippon Boehringer Ingelheim, and Novartis and research",
    "entities": [
      {
        "text": "Daiichi Sankyo Co, Ltd",
        "label": "ORG"
      },
      {
        "text": "Nippon Boehringer Ingelheim",
        "label": "ORG"
      },
      {
        "text": "Novartis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "funding from Pfizer, LSI Medience Co, PPD-SNBL K.K., Abbott Medical Japan,",
    "entities": [
      {
        "text": "Pfizer",
        "label": "ORG"
      },
      {
        "text": "LSI Medience Co",
        "label": "ORG"
      },
      {
        "text": "Abbott Medical",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Bristol-Myers Squibb, and Eli Lilly and Company. Dr Sakaguchi has received",
    "entities": [
      {
        "text": "Bristol-Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "Eli Lilly and Company",
        "label": "ORG"
      },
      {
        "text": "Dr Sakaguchi",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "speaker honoraria from Abbott Medical Japan and Medtronic Japan. The other",
    "entities": [
      {
        "text": "honoraria",
        "label": "PERSON"
      },
      {
        "text": "Abbott Medical",
        "label": "ORG"
      },
      {
        "text": "Japan",
        "label": "GPE"
      },
      {
        "text": "Medtronic Japan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "authors report no conflicts.",
    "entities": []
  },
  {
    "text": "83. Toxicol Pathol. 2025 Jul 15:1926233251349767. doi: 10.1177/01926233251349767.",
    "entities": [
      {
        "text": "83",
        "label": "CARDINAL"
      },
      {
        "text": "Pathol",
        "label": "PERSON"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "10.1177/01926233251349767",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Evaluation of Biomarkers to Detect Early Prothrombotic Imbalance in Rat Models",
    "entities": [
      {
        "text": "Rat Models",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "of Hypercoagulability Induced by Thromboplastin Infusion and Hypofibrinolysis",
    "entities": [
      {
        "text": "Thromboplastin Infusion and Hypofibrinolysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Induced by Tranexamic Acid.",
    "entities": []
  },
  {
    "text": "(1)Cornell University, Ithaca, NY, USA.",
    "entities": [
      {
        "text": "University",
        "label": "GPE"
      },
      {
        "text": "Ithaca",
        "label": "GPE"
      },
      {
        "text": "NY",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Bristol Myers Squibb, New Brunswick, NJ, USA.",
    "entities": [
      {
        "text": "3)Bristol",
        "label": "CARDINAL"
      },
      {
        "text": "Myers Squibb",
        "label": "ORG"
      },
      {
        "text": "New Brunswick",
        "label": "GPE"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Health and Environmental Sciences Institute, Washington, DC, USA.",
    "entities": [
      {
        "text": "Environmental Sciences Institute",
        "label": "ORG"
      },
      {
        "text": "Washington, DC",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Charles River Laboratories, Senneville, QC, Canada.",
    "entities": [
      {
        "text": "River Laboratories",
        "label": "ORG"
      },
      {
        "text": "Senneville",
        "label": "GPE"
      },
      {
        "text": "QC",
        "label": "GPE"
      },
      {
        "text": "Canada",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Cytokinetics, South San Francisco, CA, USA.",
    "entities": [
      {
        "text": "South San Francisco",
        "label": "GPE"
      },
      {
        "text": "CA",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Bristol Myers Squibb, Princeton, NJ, USA.",
    "entities": [
      {
        "text": "Myers Squibb",
        "label": "PERSON"
      },
      {
        "text": "Princeton",
        "label": "PERSON"
      },
      {
        "text": "NJ",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Lilly Research Laboratories, Indianapolis, IN, USA.",
    "entities": [
      {
        "text": "Research Laboratories",
        "label": "ORG"
      },
      {
        "text": "Indianapolis",
        "label": "GPE"
      },
      {
        "text": "IN",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Thrombotic complications including myocardial infarction, stroke, venous",
    "entities": []
  },
  {
    "text": "thrombosis and pulmonary thromboembolism are common causes of drug attrition",
    "entities": []
  },
  {
    "text": "often discovered at late stages of drug development. Current nonclinical safety",
    "entities": []
  },
  {
    "text": "assessments include screening tests that detect hemorrhagic complications but do",
    "entities": []
  },
  {
    "text": "not identify conditions signaling a risk of thrombosis. Our study aimed to",
    "entities": []
  },
  {
    "text": "identify sensitive tests for detecting prothrombotic imbalance, without overt",
    "entities": []
  },
  {
    "text": "thrombosis, for use in early nonclinical drug safety assessments in rodents.",
    "entities": []
  },
  {
    "text": "Sprague Dawley rats were administered different doses of thromboplastin or",
    "entities": [
      {
        "text": "Sprague Dawley",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "tranexamic acid to induce variable intensity hypercoagulable or hypofibrinolytic",
    "entities": []
  },
  {
    "text": "states, respectively. A panel of functional and quantitative assays measuring",
    "entities": []
  },
  {
    "text": "hemostatic proteins and pathways were evaluated, in concert with traditional",
    "entities": []
  },
  {
    "text": "coagulation screening tests and blood cell counts. Profound changes were",
    "entities": []
  },
  {
    "text": "observed with different patterns of test abnormalities for the different",
    "entities": []
  },
  {
    "text": "stimuli. Measurements of D-dimer and thrombin antithrombin complex",
    "entities": []
  },
  {
    "text": "concentrations, plasminogen activator inhibitor-1 and Factor VIIa activity were",
    "entities": [
      {
        "text": "Factor",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "among the most sensitive tests of hypercoagulability. In contrast,",
    "entities": []
  },
  {
    "text": "hypofibrinolysis was best characterized in a kinetic, turbidimetric assay.",
    "entities": []
  },
  {
    "text": "Traditional coagulation screening tests were relatively insensitive, and no",
    "entities": []
  },
  {
    "text": "single test defined the cause of prothrombotic imbalance. Our results",
    "entities": []
  },
  {
    "text": "demonstrate that customized biomarker panels can detect early drug-induced",
    "entities": []
  },
  {
    "text": "prothrombotic states in rats arising from distinct mechanisms.",
    "entities": []
  },
  {
    "text": "B\u00e1lint Syndrome From Posterior Cerebral Artery Infarctions Case Report.",
    "entities": []
  },
  {
    "text": "Leidy L(1), Dickinson A.",
    "entities": [
      {
        "text": "Leidy L(1",
        "label": "LAW"
      },
      {
        "text": "Dickinson A.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Eastern Virginia Medical School, Norfolk, VA.",
    "entities": [
      {
        "text": "Virginia Medical School",
        "label": "ORG"
      },
      {
        "text": "Norfolk",
        "label": "GPE"
      },
      {
        "text": "VA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "OBJECTIVES: B\u00e1lint syndrome is a debilitating, rare neurological condition that",
    "entities": []
  },
  {
    "text": "is characterized by a triad of visuospatial distortions: simultanagnosia, optic",
    "entities": [
      {
        "text": "simultanagnosia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "ataxia, and oculomotor apraxia. We highlight the pathways involved with",
    "entities": []
  },
  {
    "text": "infarction of the posterior cerebral artery (PCA), which may be an important",
    "entities": []
  },
  {
    "text": "underlying factor leading to the development of clinical presentations found in",
    "entities": []
  },
  {
    "text": "METHODS: We present a case of a middle-aged patient who presents with B\u00e1lint",
    "entities": [
      {
        "text": "B\u00e1lint",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "syndrome following a PCA infarction.",
    "entities": []
  },
  {
    "text": "RESULTS: A 49-year-old male bus driver with a recent PCA infarction presented",
    "entities": [
      {
        "text": "49-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "with all 3 components of B\u00e1lint syndrome. His clinical course was notable for",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "B\u00e1lint",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "simultanagnosia, optic ataxia, oculomotor apraxia, and a right greater than left",
    "entities": [
      {
        "text": "simultanagnosia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "lower visual field deficit. Neuroimaging revealed infarctions in the P1 and",
    "entities": [
      {
        "text": "P1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "bilateral P2 segments of the posterior cerebral arteries, affecting the",
    "entities": [
      {
        "text": "P2",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "workup helped exclude opportunistic and systemic causes, supporting a",
    "entities": []
  },
  {
    "text": "CONCLUSIONS: Posterior cerebral artery infarctions may be responsible for the",
    "entities": []
  },
  {
    "text": "clinical presentation of B\u00e1lint syndrome; however, further investigation into",
    "entities": [
      {
        "text": "B\u00e1lint",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "vascular and neuronal networks underlying the clinical signs and symptoms of",
    "entities": []
  },
  {
    "text": "Copyright \u00a9 2025 Wolters Kluwer Health, Inc. All rights reserved.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Wolters Kluwer Health, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Conflicts of Interest and Source of Funding: The",
    "entities": []
  },
  {
    "text": "authors have no conflicts of interest to declare.",
    "entities": []
  },
  {
    "text": "Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With",
    "entities": []
  },
  {
    "text": "Diabetes and Obesity.",
    "entities": []
  },
  {
    "text": "(1)Department of Anesthesiology, Chang Gung Memorial Hospital at Linkou,",
    "entities": [
      {
        "text": "Anesthesiology",
        "label": "ORG"
      },
      {
        "text": "Chang Gung Memorial Hospital",
        "label": "PERSON"
      },
      {
        "text": "Linkou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)College of Medicine, Chang Gung University, Taoyuan, Taiwan.",
    "entities": [
      {
        "text": "2)College",
        "label": "CARDINAL"
      },
      {
        "text": "Chang Gung University",
        "label": "PERSON"
      },
      {
        "text": "Taoyuan",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Neuroscience Research Center, Chang Gung Memorial Hospital at Linkou,",
    "entities": [
      {
        "text": "Chang Gung Memorial Hospital",
        "label": "PERSON"
      },
      {
        "text": "Linkou",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.",
    "entities": [
      {
        "text": "Chung Shan Medical University",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Center for Health Data Science, Department of Medical Research, Chung Shan",
    "entities": [
      {
        "text": "Health Data Science, Department of Medical Research",
        "label": "ORG"
      },
      {
        "text": "Chung Shan\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Medical University Hospital, Taichung, Taiwan.",
    "entities": [
      {
        "text": "Medical University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Allergy, Immunology and Rheumatology, Chung Shan Medical",
    "entities": [
      {
        "text": "Allergy, Immunology and Rheumatology",
        "label": "ORG"
      },
      {
        "text": "Chung Shan Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Hospital, Taichung, Taiwan.",
    "entities": [
      {
        "text": "University Hospital",
        "label": "ORG"
      },
      {
        "text": "Taichung",
        "label": "GPE"
      },
      {
        "text": "Taiwan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Graduate Institute of Integrated Medicine, China Medical University,",
    "entities": [
      {
        "text": "Institute of Integrated Medicine",
        "label": "ORG"
      },
      {
        "text": "China Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(8)Institute of Medicine, Department of Nursing, Chung Shan Medical University,",
    "entities": [
      {
        "text": "Medicine, Department of Nursing",
        "label": "ORG"
      },
      {
        "text": "Chung Shan Medical University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "IMPORTANCE: Glucagon-like peptide 1 receptor agonists (GLP-1RAs), such as",
    "entities": [
      {
        "text": "Glucagon",
        "label": "GPE"
      },
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "GLP-1RAs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "semaglutide and tirzepatide, provide cardiometabolic benefits to patients with",
    "entities": []
  },
  {
    "text": "type 2 diabetes and obesity, but their potential benefits in mitigating",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "OBJECTIVE: To evaluate the association of semaglutide and tirzepatide with the",
    "entities": []
  },
  {
    "text": "incidence of dementia, Parkinson disease, ischemic stroke, intracerebral",
    "entities": []
  },
  {
    "text": "hemorrhage, and all-cause mortality compared with other antidiabetic drugs in",
    "entities": []
  },
  {
    "text": "adults with type 2 diabetes and obesity.",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study analyzed",
    "entities": []
  },
  {
    "text": "electronic health record-based data from the TriNetX US network (December 1,",
    "entities": [
      {
        "text": "US",
        "label": "GPE"
      },
      {
        "text": "December 1",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "2017, to June 30, 2024) in adults aged 40 years or older with type 2 diabetes",
    "entities": [
      {
        "text": "2017",
        "label": "DATE"
      },
      {
        "text": "June 30, 2024",
        "label": "DATE"
      },
      {
        "text": "aged 40 years or",
        "label": "DATE"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "and obesity initiating semaglutide, tirzepatide, or other antidiabetic drugs,",
    "entities": []
  },
  {
    "text": "excluding those with prior neurodegenerative or cerebrovascular diseases.",
    "entities": []
  },
  {
    "text": "Propensity score matching was used to balance the baseline characteristics.",
    "entities": []
  },
  {
    "text": "EXPOSURES: Patients treated with antidiabetic drugs were categorized as GLP-1RA",
    "entities": []
  },
  {
    "text": "(semaglutide or tirzepatide) or other antidiabetic drug (biguanides,",
    "entities": []
  },
  {
    "text": "inhibitors, thiazolidinediones, and \u03b1-glucosidase inhibitors) users.",
    "entities": []
  },
  {
    "text": "MAIN OUTCOMES AND MEASURES: The primary outcomes were the incidence of",
    "entities": [
      {
        "text": "MAIN",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "neurodegenerative diseases (dementia, Parkinson disease, and mild cognitive",
    "entities": []
  },
  {
    "text": "impairment) and cerebrovascular (stroke and intracerebral hemorrhage) diseases,",
    "entities": []
  },
  {
    "text": "while the secondary outcome was all-cause mortality. Cox proportional hazard",
    "entities": []
  },
  {
    "text": "models were used to estimate hazard ratios (HRs) with 95% CIs.",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "RESULTS: A total of 60 860 adults with type 2 diabetes and obesity were",
    "entities": [
      {
        "text": "60",
        "label": "CARDINAL"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "included, with 30 430 each in the GLP-1RA group (mean [SD] age, 57.9 [9.9]",
    "entities": [
      {
        "text": "30 430",
        "label": "CARDINAL"
      },
      {
        "text": "GLP-1RA",
        "label": "NORP"
      },
      {
        "text": "57.9",
        "label": "CARDINAL"
      },
      {
        "text": "9.9",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "years; 50.2% female) and the other antidiabetic drug group (mean [SD] age, 58.0",
    "entities": [
      {
        "text": "years",
        "label": "DATE"
      },
      {
        "text": "50.2%",
        "label": "PERCENT"
      },
      {
        "text": "58.0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[10.8] years; 51.4% female) after propensity score matching. During a 7-year",
    "entities": [
      {
        "text": "10.8] years",
        "label": "DATE"
      },
      {
        "text": "51.4%",
        "label": "PERCENT"
      },
      {
        "text": "7-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "follow-up, GLP-1RA users had a lower risk of dementia (HR, 0.63; 95% CI,",
    "entities": [
      {
        "text": "GLP-1RA",
        "label": "GPE"
      },
      {
        "text": "0.63",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.50-0.81), stroke (HR, 0.81; 95% CI, 0.70-0.93), and all-cause mortality (HR,",
    "entities": [
      {
        "text": "0.50-0.81",
        "label": "CARDINAL"
      },
      {
        "text": "0.81",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.70-0.93",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.70; 95% CI, 0.63-0.78), with no significant differences in the risk of",
    "entities": [
      {
        "text": "0.70",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.63-0.78",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "Parkinson disease or intracerebral hemorrhage. Subgroup analyses revealed",
    "entities": []
  },
  {
    "text": "greater benefits in patients aged 60 years or older, women, and patients with a",
    "entities": [
      {
        "text": "60 years or older",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "body mass index of 30 to 40.",
    "entities": [
      {
        "text": "30 to 40",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSIONS AND RELEVANCE: In this cohort study, the use of GLP-1RAs semaglutide",
    "entities": [
      {
        "text": "CONCLUSIONS",
        "label": "ORG"
      },
      {
        "text": "RELEVANCE",
        "label": "PERSON"
      },
      {
        "text": "GLP-1RAs",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "and tirzepatide was associated with a lower risk of dementia, stroke, and",
    "entities": []
  },
  {
    "text": "all-cause mortality in adults with type 2 diabetes and obesity. These findings",
    "entities": [
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "suggest potential neuroprotective and cerebrovascular benefits of GLP-1RAs",
    "entities": [
      {
        "text": "GLP-1RAs",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "beyond glycemic control, warranting further trials to confirm these outcomes.",
    "entities": []
  },
  {
    "text": "PMID: 40663350 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663350",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Regulatory effects of head acupuncture on the GABAergic system and",
    "entities": [
      {
        "text": "GABAergic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Wnt7a/\u03b2-catenin pathway in post-stroke spasticity rats.",
    "entities": [
      {
        "text": "Wnt7a",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Graduate School, Heilongjiang University of Chinese Medicine, Harbin, 150040,",
    "entities": [
      {
        "text": "School, Heilongjiang University of Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Harbin",
        "label": "GPE"
      },
      {
        "text": "150040",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "(2)Seventh Ward of Acupuncture and Moxibustion Department, The Second Affiliated",
    "entities": [
      {
        "text": "2)Seventh",
        "label": "CARDINAL"
      },
      {
        "text": "Ward of Acupuncture and Moxibustion Department",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150001, China.",
    "entities": [
      {
        "text": "Harbin",
        "label": "GPE"
      },
      {
        "text": "150001",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)The Second Department of Geriatrics, The Second Affiliated Hospital of",
    "entities": [
      {
        "text": "Second Department of Geriatrics",
        "label": "ORG"
      },
      {
        "text": "The Second Affiliated Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Heilongjiang University of Chinese Medicine, Harbin, 150001, China.",
    "entities": [
      {
        "text": "Heilongjiang University of Chinese Medicine",
        "label": "ORG"
      },
      {
        "text": "Harbin",
        "label": "GPE"
      },
      {
        "text": "150001",
        "label": "DATE"
      },
      {
        "text": "China",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "To investigate the regulation of the GABAergic system and Wnt/\u03b2-catenin",
    "entities": [
      {
        "text": "GABAergic",
        "label": "NORP"
      },
      {
        "text": "Wnt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "signaling pathway in rats with limb spasticity after stroke by Head Acupuncture",
    "entities": []
  },
  {
    "text": "therapy and its potential mechanism. A middle cerebral artery occlusion (MCAO)",
    "entities": []
  },
  {
    "text": "model was established by the thread bolus method, and randomly grouped into a",
    "entities": []
  },
  {
    "text": "blank group, a model group, and a needling group, the latter of which received",
    "entities": [
      {
        "text": "blank group",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the intervention of needling at the points of \"Hundred Houses\" and \"Rate Valley\"",
    "entities": [
      {
        "text": "\"Hundred Houses",
        "label": "WORK_OF_ART"
      },
      {
        "text": "Rate Valley",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "for 30 min a day for 7 consecutive days. The neurological deficits and muscle",
    "entities": [
      {
        "text": "30",
        "label": "CARDINAL"
      },
      {
        "text": "7 consecutive days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "tone of rats were assessed by Zeo Longa score and modified Ashworth score, and",
    "entities": [
      {
        "text": "Zeo Longa",
        "label": "PERSON"
      },
      {
        "text": "Ashworth",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "the expression levels of key proteins of the GABAergic system (GAD65, GAD67,",
    "entities": [
      {
        "text": "GABAergic",
        "label": "NORP"
      },
      {
        "text": "GAD67",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "GABA-T, GAT-3, NKCC1) and Wnt/\u03b2-catenin signaling pathway were detected by",
    "entities": [
      {
        "text": "GABA",
        "label": "ORG"
      },
      {
        "text": "GAT-3",
        "label": "ORG"
      },
      {
        "text": "NKCC1",
        "label": "ORG"
      },
      {
        "text": "Wnt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "immunohistochemistry, real-time fluorescence quantitative PCR and Western blot",
    "entities": [
      {
        "text": "PCR",
        "label": "ORG"
      },
      {
        "text": "Western",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "and Wnt/\u03b2-catenin signaling pathway key protein expression levels. Head",
    "entities": [
      {
        "text": "Wnt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Acupuncture significantly improved the neurological deficit score and muscle",
    "entities": []
  },
  {
    "text": "tone of rats in the model group, decreased the mRNA and protein expression",
    "entities": []
  },
  {
    "text": "levels of GABA-T and NKCC1, and significantly up-regulated the expression of",
    "entities": [
      {
        "text": "GABA",
        "label": "ORG"
      },
      {
        "text": "NKCC1",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "GAD65, GAD67, and GAT-3. In addition, acupuncture promoted the expression of",
    "entities": [
      {
        "text": "GAD67",
        "label": "PERSON"
      },
      {
        "text": "GAT-3",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Wnt7a and \u03b2-catenin, and the effect of 7 days of treatment was better than that",
    "entities": [
      {
        "text": "Wnt7a",
        "label": "PERSON"
      },
      {
        "text": "7 days",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "of 1 day. Head Acupuncture therapy may exert a therapeutic effect on limb",
    "entities": [
      {
        "text": "1 day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "spasticity after stroke by regulating the balance of the GABAergic system and",
    "entities": [
      {
        "text": "GABAergic",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "activating the Wnt/\u03b2-catenin signaling pathway. This provides a new experimental",
    "entities": [
      {
        "text": "Wnt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "basis for the application of acupuncture in post-stroke sequelae.Clinical trial",
    "entities": []
  },
  {
    "text": "PMID: 40663208 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663208",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "participate: Not applicable. Consent for publication: All authors consent to",
    "entities": []
  },
  {
    "text": "publish. Competing interests: The authors declare no competing interests.",
    "entities": []
  },
  {
    "text": "10.1007/s00701-025-06586-5.",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "The NeVa Net stent-retriever - initial report of 20 cases from two high volume",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Bhogal P(1), Mancuso-Marcello M(1), Fairhead R(1), Shah N(2), Lee KS(3)(4),",
    "entities": [
      {
        "text": "Mancuso-Marcello",
        "label": "PERSON"
      },
      {
        "text": "Lee KS(3)(4",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Interventional Neuroradiology, The Royal London Hospital,",
    "entities": [
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "The Royal London Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Whitechapel Road, London, E1 1BB, UK.",
    "entities": [
      {
        "text": "Whitechapel Road",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "E1 1BB",
        "label": "DATE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)The London School of Medicine and Dentistry, Queen Mary University, Turner",
    "entities": [
      {
        "text": "2)The",
        "label": "CARDINAL"
      },
      {
        "text": "London School of Medicine and Dentistry",
        "label": "ORG"
      },
      {
        "text": "Queen Mary University",
        "label": "ORG"
      },
      {
        "text": "Turner",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Street, London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Basic and Clinical Neurosciences, Maurice Wohl Clinical",
    "entities": [
      {
        "text": "Basic and Clinical Neurosciences",
        "label": "ORG"
      },
      {
        "text": "Maurice Wohl Clinical",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience",
    "entities": [
      {
        "text": "Neuroscience Institute",
        "label": "ORG"
      },
      {
        "text": "Institute of Psychiatry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(IoPPN), King's College London, London, UK. kengsiang.lee1@nhs.net.",
    "entities": [
      {
        "text": "IoPPN",
        "label": "ORG"
      },
      {
        "text": "King's College London",
        "label": "ORG"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery, National Neuroscience Institute, Singapore,",
    "entities": [
      {
        "text": "Neurosurgery, National Neuroscience Institute",
        "label": "ORG"
      },
      {
        "text": "Singapore",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Stroke, The Royal London Hospital, Whitechapel Road, London,",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Stroke, The Royal London Hospital",
        "label": "ORG"
      },
      {
        "text": "Whitechapel Road",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Interventional Neuroradiology, UHC Sisters of Mercy, Zagreb,",
    "entities": [
      {
        "text": "Interventional Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "UHC Sisters of Mercy,",
        "label": "ORG"
      },
      {
        "text": "Zagreb",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: Various different technologies have been developed to optimise the",
    "entities": []
  },
  {
    "text": "mechanical thrombectomy procedure and first pass recanalisation. We report our",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "initial experience with the NeVa NET - a novel stent-retriever with built in",
    "entities": [
      {
        "text": "the NeVa NET - a",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "MATERIALS AND METHODS: We performed a retrospective review of our prospectively",
    "entities": []
  },
  {
    "text": "maintained databases to identify all patients treated with the NeVa NET",
    "entities": []
  },
  {
    "text": "4 \u00d7 30 mm device. We recorded the baseline demographics, NIHSS, ASPECT score and",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "ASPECT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "clot characteristics, first pass and final eTICI scores, complications and",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "RESULTS: We identified 20 patients (50% male), average age 67.9 \u00b1 16.2 yrs, and",
    "entities": [
      {
        "text": "20",
        "label": "CARDINAL"
      },
      {
        "text": "50%",
        "label": "PERCENT"
      },
      {
        "text": "age 67.9",
        "label": "DATE"
      },
      {
        "text": "16.2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "median NIHSS 18 (range 6-29). 30% of patients received tPA. Average clot length",
    "entities": [
      {
        "text": "NIHSS",
        "label": "ORG"
      },
      {
        "text": "6-29",
        "label": "CARDINAL"
      },
      {
        "text": "30%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "was 21.6 \u00b1 8.9 mm and median ASPECT score 9 (range 5-10). In 18 cases the NeVa",
    "entities": [
      {
        "text": "21.6 \u00b1",
        "label": "QUANTITY"
      },
      {
        "text": "8.9 mm",
        "label": "QUANTITY"
      },
      {
        "text": "9",
        "label": "CARDINAL"
      },
      {
        "text": "5",
        "label": "CARDINAL"
      },
      {
        "text": "18",
        "label": "CARDINAL"
      },
      {
        "text": "NeVa",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "NET could be tracked into position, however, in 2 cases it could not be tracked",
    "entities": [
      {
        "text": "NET",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "into position within the 0,021inch microcatheter. First pass recanalization",
    "entities": [
      {
        "text": "0,021inch",
        "label": "CARDINAL"
      },
      {
        "text": "First",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "(eTICI \u2265 2c) was seen in 94% (n = 17) and the average number of NeVa NET passes",
    "entities": [
      {
        "text": "\u2265 2c",
        "label": "FAC"
      },
      {
        "text": "94%",
        "label": "PERCENT"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "NeVa NET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "was 1. A final eTICI score of \u2265 2c was achieved in 17 patients (94%). There were",
    "entities": [
      {
        "text": "1",
        "label": "CARDINAL"
      },
      {
        "text": "\u2265",
        "label": "PERSON"
      },
      {
        "text": "2c",
        "label": "CARDINAL"
      },
      {
        "text": "17",
        "label": "CARDINAL"
      },
      {
        "text": "94%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "no emboli to new territories. No cases of vessel rupture or dissections occured",
    "entities": []
  },
  {
    "text": "due to the NeVa NET. 50% of patients achieved mRS 0-2. SAH was seen in 31.3% and",
    "entities": [
      {
        "text": "the NeVa NET",
        "label": "ORG"
      },
      {
        "text": "50%",
        "label": "PERCENT"
      },
      {
        "text": "0",
        "label": "CARDINAL"
      },
      {
        "text": "SAH",
        "label": "ORG"
      },
      {
        "text": "31.3%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "SICH in 6.3% of the 16 patients for whom a 24 h CT head was available.",
    "entities": [
      {
        "text": "6.3%",
        "label": "PERCENT"
      },
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "24",
        "label": "CARDINAL"
      },
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: The NeVa Net stent-retriever is uniquely designed to prevent distal",
    "entities": []
  },
  {
    "text": "embolisation and our initial experience demonstrates a very high FPE and mFPE.",
    "entities": [
      {
        "text": "FPE",
        "label": "ORG"
      },
      {
        "text": "mFPE",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "We believe this is the first publication on the use of this novel technology and",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "larger studies are warranted.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00701-025-06586-5",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40663179 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40663179",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Human ethics and consent to",
    "entities": []
  },
  {
    "text": "participate: Informed consent was obtained from all patients involved in this",
    "entities": []
  },
  {
    "text": "study. This study was conducted in accordance with the principles outlined in",
    "entities": []
  },
  {
    "text": "the Declaration of Helsinki and was approved by the East London Research Ethics",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      },
      {
        "text": "the East London Research Ethics",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Committee. Competing interests: PB - consulting agreements, JnJ MedTech Balt,",
    "entities": [
      {
        "text": "JnJ MedTech Balt",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Brainomix, Perfuze, PockIt Diagnostics, Vesalio, Penumbra. LM \u2013 consulting",
    "entities": [
      {
        "text": "Brainomix",
        "label": "ORG"
      },
      {
        "text": "Perfuze, PockIt Diagnostics, Vesalio, Penumbra",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "agreements Cerenovus, Balt, Perfuze, Microvention, Penumbra, Neuroventures. The",
    "entities": [
      {
        "text": "Cerenovus, Balt",
        "label": "ORG"
      },
      {
        "text": "Perfuze",
        "label": "PERSON"
      },
      {
        "text": "Neuroventures",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "remaining authors declare no Conflict of interests.",
    "entities": []
  },
  {
    "text": "88. Neuroradiology. 2025 Jul 15. doi: 10.1007/s00234-025-03702-1. Online ahead of",
    "entities": [
      {
        "text": "88",
        "label": "CARDINAL"
      },
      {
        "text": "2025",
        "label": "CARDINAL"
      },
      {
        "text": "15",
        "label": "CARDINAL"
      },
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Evaluation of radiogenomics for risk stratification of intracranial aneurysms: a",
    "entities": []
  },
  {
    "text": "(1)Department of Pathology and Anatomical Sciences, University at Buffalo, State",
    "entities": [
      {
        "text": "Pathology and Anatomical Sciences",
        "label": "ORG"
      },
      {
        "text": "University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of New York, Buffalo, USA.",
    "entities": [
      {
        "text": "University of New York,",
        "label": "ORG"
      },
      {
        "text": "Buffalo",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Canon Stroke and Vascular Research Center, University at Buffalo, State",
    "entities": [
      {
        "text": "2)Canon",
        "label": "CARDINAL"
      },
      {
        "text": "Stroke and Vascular Research Center, University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Neurosurgery, University at Buffalo, State University of New",
    "entities": [
      {
        "text": "Neurosurgery, University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State University of New\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "York, Buffalo, USA.",
    "entities": [
      {
        "text": "York, Buffalo, USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Pathology and Anatomical Sciences, University at Buffalo, State",
    "entities": [
      {
        "text": "Pathology and Anatomical Sciences",
        "label": "ORG"
      },
      {
        "text": "University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of New York, Buffalo, USA. vincentt@buffalo.edu.",
    "entities": [
      {
        "text": "University of New York,",
        "label": "ORG"
      },
      {
        "text": "Buffalo",
        "label": "GPE"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Canon Stroke and Vascular Research Center, University at Buffalo, State",
    "entities": [
      {
        "text": "Stroke and Vascular Research Center, University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Department of Neurosurgery, University at Buffalo, State University of New",
    "entities": [
      {
        "text": "Neurosurgery, University at Buffalo",
        "label": "ORG"
      },
      {
        "text": "State University of New\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "York, Buffalo, USA. vincentt@buffalo.edu.",
    "entities": [
      {
        "text": "York, Buffalo, USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE: Aneurysm wall enhancement (AWE) is an imaging biomarker that could aid",
    "entities": [
      {
        "text": "PURPOSE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "in risk stratification of intracranial aneurysms (IAs) In this pilot study, we",
    "entities": []
  },
  {
    "text": "explored the potential of a radiogenomics approach by combining blood-based",
    "entities": []
  },
  {
    "text": "biomarkers and AWE for better risk stratification of IAs.",
    "entities": [
      {
        "text": "AWE",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: Patient specific vessel wall imaging scans and whole blood samples were",
    "entities": []
  },
  {
    "text": "obtained, and IAs were classified as high-risk or low-risk using two different",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "metrics: symptomatic status (3 symptomatic vs. 13 asymptomatic) and PHASES score",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(4 with a high score vs. 12 with a low score). Radiomics features (RFs) were",
    "entities": [
      {
        "text": "4",
        "label": "CARDINAL"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "extracted from the pre- and post-contrast MRI for all IA sac walls, and",
    "entities": [
      {
        "text": "IA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "significantly different RFs were identified through univariate analysis. RNA",
    "entities": [
      {
        "text": "RNA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "sequencing from whole blood samples for these patients was also performed to",
    "entities": []
  },
  {
    "text": "identify differentially expressed genes (DEGs) between high and low-risk IA",
    "entities": [
      {
        "text": "IA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "groups. Principal component analysis (PCA) and clustering analysis were applied,",
    "entities": []
  },
  {
    "text": "using both risk metrics, to evaluate discriminatory power. Lastly, ontological",
    "entities": []
  },
  {
    "text": "and correlation analyses were carried out to investigate biological mechanisms",
    "entities": []
  },
  {
    "text": "associated with the DEGs.",
    "entities": []
  },
  {
    "text": "RESULTS: Our analysis of 16 IAs identified 12 RFs and 97 genes that were",
    "entities": [
      {
        "text": "16",
        "label": "CARDINAL"
      },
      {
        "text": "12",
        "label": "CARDINAL"
      },
      {
        "text": "97",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "significantly different between symptomatic and asymptomatic IAs (RF:",
    "entities": []
  },
  {
    "text": "p-value < 0.05; DEG: fold-change > 2, p-value < 0.01). Examining risk with",
    "entities": [
      {
        "text": "0.05",
        "label": "CARDINAL"
      },
      {
        "text": "DEG",
        "label": "ORG"
      },
      {
        "text": "2",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "respect to PHASES score, we identified 6 significant radiomics features and 38",
    "entities": [
      {
        "text": "6",
        "label": "CARDINAL"
      },
      {
        "text": "38",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "differentially expressed genes. Through principal component analysis and",
    "entities": []
  },
  {
    "text": "clustering analysis, we found that DEGs only and radiogenomics features produced",
    "entities": []
  },
  {
    "text": "a better separation between high- and low-risk than RFs alone for both risk",
    "entities": []
  },
  {
    "text": "metrics. Furthermore, we found a significant correlation between 7 unique RFs",
    "entities": []
  },
  {
    "text": "and 38 DEGs.",
    "entities": [
      {
        "text": "38",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "CONCLUSION: We demonstrated that a radiogenomics approach can help in better",
    "entities": []
  },
  {
    "text": "risk stratification of IAs.",
    "entities": []
  },
  {
    "text": "DOI: 10.1007/s00234-025-03702-1",
    "entities": [
      {
        "text": "10.1007",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: Declarations. Competing interests: NKP and VJ:",
    "entities": [
      {
        "text": "NKP",
        "label": "ORG"
      },
      {
        "text": "VJ",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "None. KEP: Financial interest/investor/stock options/ownership: Neurovascular",
    "entities": [
      {
        "text": "Neurovascular",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diagnostics, Inc. Principal investigator: NIH NINDS award R44NS115314.EIL: Board",
    "entities": [
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Membership: Stryker, NeXtGen Biologics, MedX Health, Cog-nition Medical,",
    "entities": [
      {
        "text": "NeXtGen Biologics",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "EndoStream; Consultancy: Claret Medical, GLG Consulting, Guidepoint, Imperative",
    "entities": [
      {
        "text": "EndoStream",
        "label": "ORG"
      },
      {
        "text": "Consultancy",
        "label": "ORG"
      },
      {
        "text": "Claret Medical",
        "label": "ORG"
      },
      {
        "text": "GLG Consulting",
        "label": "ORG"
      },
      {
        "text": "Guidepoint",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Care, Medtronic, Rebound Therapeutics, StimMed; Employment: University at",
    "entities": [
      {
        "text": "Medtronic",
        "label": "ORG"
      },
      {
        "text": "StimMed",
        "label": "ORG"
      },
      {
        "text": "Employment: University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Buffalo Neurosurgery Inc; Expert Testimony: renders medical/legal opinions as an",
    "entities": [
      {
        "text": "Buffalo Neurosurgery Inc",
        "label": "ORG"
      },
      {
        "text": "Expert Testimony",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "expert witness; Stock/Stock Options: NeXtGen Biologics, Cognition Medical,",
    "entities": [
      {
        "text": "Stock/Stock Options",
        "label": "ORG"
      },
      {
        "text": "NeXtGen Biologics",
        "label": "PERSON"
      },
      {
        "text": "Cognition Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RapidMedical, Claret Medical, Imperative Care, Rebound Therapeutics, StimMed.",
    "entities": [
      {
        "text": "RapidMedical",
        "label": "ORG"
      },
      {
        "text": "Claret Medical",
        "label": "ORG"
      },
      {
        "text": "StimMed",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "AHS: Financial interest/investor/stock options/ownership: Adona Medical, Inc.,",
    "entities": [
      {
        "text": "AHS",
        "label": "ORG"
      },
      {
        "text": "Adona Medical, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Amnis Therapeutics, BlinkTBI, Inc., Boston Scientific Corp. (for purchase of",
    "entities": [
      {
        "text": "Amnis Therapeutics",
        "label": "ORG"
      },
      {
        "text": "BlinkTBI, Inc.",
        "label": "ORG"
      },
      {
        "text": "Boston Scientific Corp.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Claret Medical), BuffaloTechnology Partners, Inc., Cardinal Consultants, LLC,",
    "entities": [
      {
        "text": "Claret Medical",
        "label": "ORG"
      },
      {
        "text": "BuffaloTechnology Partners",
        "label": "ORG"
      },
      {
        "text": "Cardinal Consultants",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CerebrotechMedical Systems, Inc., Cognition Medical, Endostream Medical, Ltd,",
    "entities": [
      {
        "text": "CerebrotechMedical Systems",
        "label": "ORG"
      },
      {
        "text": "Cognition Medical",
        "label": "ORG"
      },
      {
        "text": "Endostream Medical, Ltd",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Imperative Care, Inc., International Medical Distribution Partners,",
    "entities": [
      {
        "text": "Imperative Care, Inc.",
        "label": "ORG"
      },
      {
        "text": "International Medical Distribution Partners",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Technologies, Inc., Rebound Therapeutics Corp. (purchased2019 by Integra",
    "entities": [
      {
        "text": "Technologies, Inc.",
        "label": "ORG"
      },
      {
        "text": "Rebound Therapeutics Corp.",
        "label": "ORG"
      },
      {
        "text": "purchased2019",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Lifesciences, Corp.), Rist Neurovascular, Inc., SenseDiagnostics, Inc., Serenity",
    "entities": [
      {
        "text": "Lifesciences, Corp.",
        "label": "ORG"
      },
      {
        "text": "Rist Neurovascular, Inc.",
        "label": "ORG"
      },
      {
        "text": "SenseDiagnostics, Inc.",
        "label": "ORG"
      },
      {
        "text": "Serenity",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medical, Inc., Silk Road Medical, Spinnaker Medical, Inc., StimMed, Synchron,",
    "entities": [
      {
        "text": "Medical, Inc.",
        "label": "ORG"
      },
      {
        "text": "Silk Road Medical",
        "label": "ORG"
      },
      {
        "text": "Spinnaker Medical, Inc.",
        "label": "ORG"
      },
      {
        "text": "StimMed",
        "label": "ORG"
      },
      {
        "text": "Synchron",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Three Rivers Medical, Inc.,Vastrax, LLC, VICIS, Inc., Viseon, Inc.;",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "Rivers Medical, Inc.",
        "label": "ORG"
      },
      {
        "text": "LLC",
        "label": "ORG"
      },
      {
        "text": "Viseon, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "consultant/advisory board: Amnis Therapeutics, Boston Scientific, Canon Medical",
    "entities": [
      {
        "text": "Amnis Therapeutics",
        "label": "ORG"
      },
      {
        "text": "Boston Scientific",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Systems USA, Inc., Cerebrotech Medical Systems, Inc., Cerenovus, Corindus,",
    "entities": [
      {
        "text": "Systems USA, Inc.",
        "label": "ORG"
      },
      {
        "text": "Cerebrotech Medical Systems, Inc.",
        "label": "ORG"
      },
      {
        "text": "Cerenovus, Corindus",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Inc.,Endostream Medical, Ltd, Imperative Care, Inc., Integra LifeSciencesCorp.,",
    "entities": [
      {
        "text": "Medical, Ltd",
        "label": "ORG"
      },
      {
        "text": "Imperative Care, Inc.",
        "label": "ORG"
      },
      {
        "text": "Integra LifeSciencesCorp.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Medtronic, MicroVention, Minnetronix Neuro, Inc., North-west University\u2014DSMB",
    "entities": [
      {
        "text": "Medtronic",
        "label": "ORG"
      },
      {
        "text": "MicroVention",
        "label": "ORG"
      },
      {
        "text": "North-west University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Chair for HEAT Trial, Penumbra, Q\u2019ApelMedical, Inc., Rapid Medical, Rebound",
    "entities": [
      {
        "text": "Q\u2019ApelMedical, Inc.",
        "label": "ORG"
      },
      {
        "text": "Rapid Medical",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Therapeutics Corp., SerenityMedical, Inc., Silk Road Medical, StimMed, Stryker,",
    "entities": [
      {
        "text": "Therapeutics Corp.",
        "label": "ORG"
      },
      {
        "text": "SerenityMedical, Inc.",
        "label": "ORG"
      },
      {
        "text": "Silk Road Medical",
        "label": "ORG"
      },
      {
        "text": "StimMed",
        "label": "ORG"
      },
      {
        "text": "Stryker",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Three RiversMedical, Inc., VasSol, W.L. Gore & Associates; national",
    "entities": [
      {
        "text": "Three",
        "label": "CARDINAL"
      },
      {
        "text": "VasSol",
        "label": "ORG"
      },
      {
        "text": "W.L. Gore & Associates",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PI/steeringcommittees: Cerenovus LARGE trial and ARISE II trial, MedtronicSWIFT",
    "entities": [
      {
        "text": "PI",
        "label": "ORG"
      },
      {
        "text": "Cerenovus LARGE",
        "label": "PERSON"
      },
      {
        "text": "ARISE II",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PRIME and SWIFT DIRECT trials, MicroVention FRED Trialand CONFIDENCE study, MUSC",
    "entities": [
      {
        "text": "MUSC",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "research grants: co-investigator, NIH/NINDS 1R01NS091075 Virtual Intervention of",
    "entities": [
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "R21NS109575-01 Optimizing Approaches to Endovascular Therapy of Acute Ischemic",
    "entities": [
      {
        "text": "R21NS109575-01",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "StrokeVMT: Financial interest/investor/stock options/ownership: Neurovascular",
    "entities": [
      {
        "text": "Neurovascular",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Diagnostics, Inc., QAS.AI, Inc.; Consultant/advisory board: Canon Medical",
    "entities": [
      {
        "text": "Diagnostics, Inc.",
        "label": "ORG"
      },
      {
        "text": "QAS.AI, Inc.",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Systems USA; Research grants: Principal investigator, National Science",
    "entities": [
      {
        "text": "Research",
        "label": "ORG"
      },
      {
        "text": "National Science\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Foundation Award No.1746694 and NIH NINDS award R43 NS115314-0; awardee of a",
    "entities": [
      {
        "text": "Award No.1746694",
        "label": "PERSON"
      },
      {
        "text": "NIH",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Brain Aneurysm Foundation grant, a Center for Advanced Technology grant, and a",
    "entities": [
      {
        "text": "Brain Aneurysm Foundation",
        "label": "ORG"
      },
      {
        "text": "Center for Advanced Technology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cummings Foundation grant. Ethical approval: This study was conducted in",
    "entities": [
      {
        "text": "Cummings Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "accordance with the Declaration of Helsinki and was approved by the",
    "entities": [
      {
        "text": "the Declaration of Helsinki",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "Institutional review board of the University at Buffalo (STUDY030474433). All",
    "entities": [
      {
        "text": "the University at Buffalo",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "participating subjects provided informed consent.",
    "entities": []
  },
  {
    "text": "Life Support in Hemodialysis Emergencies - Treatment standard.",
    "entities": []
  },
  {
    "text": "Aoun M(1)(2), Combe C(3)(4), Jadoul M(5).",
    "entities": [
      {
        "text": "Aoun",
        "label": "PERSON"
      },
      {
        "text": "Combe",
        "label": "PERSON"
      },
      {
        "text": "Jadoul",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Faculty of Medicine, Saint-Joseph University of Beirut, Lebanon.",
    "entities": [
      {
        "text": "Medicine, Saint-Joseph University of Beirut",
        "label": "ORG"
      },
      {
        "text": "Lebanon",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Hemodialysis removes uremic toxins and excess water and sodium from the blood of",
    "entities": []
  },
  {
    "text": "patients with kidney failure. For the last 60 years, this technique has been",
    "entities": [
      {
        "text": "the last 60 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "extensively improved in order to optimize patient survival and mimimize adverse",
    "entities": []
  },
  {
    "text": "events. Indeed, life-threatening complications related to hemodialysis have",
    "entities": []
  },
  {
    "text": "become very rare with the use of modern machines and equipment. These",
    "entities": []
  },
  {
    "text": "hemodialysis-related serious events that became less frequent include hemolysis,",
    "entities": []
  },
  {
    "text": "air embolism, dialyzer reactions and dialysis disequilibrium syndrome. On the",
    "entities": []
  },
  {
    "text": "other hand, other medical emergencies are regularly encountered in hemodialysis",
    "entities": []
  },
  {
    "text": "units such as arrhythmia, acute coronary syndrome, stroke, epilepsy, trauma,",
    "entities": []
  },
  {
    "text": "sepsis, allergic reactions, or bleeding related or not to vascular access.",
    "entities": []
  },
  {
    "text": "Cardiac arrest can also occur suddenly or as a result of the severity of medical",
    "entities": [
      {
        "text": "Cardiac",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "events or delay in their management. In fact, patients on hemodialysis have",
    "entities": []
  },
  {
    "text": "multiple comorbidities and are subject to common complications that need to be",
    "entities": []
  },
  {
    "text": "promptly recognized and timely managed by the dialysis staff. Nephrologists",
    "entities": []
  },
  {
    "text": "taking care of these high-risk patients need a practical, efficient approach to",
    "entities": []
  },
  {
    "text": "provide care and save lives. Based on the European Resuscitation Council",
    "entities": [
      {
        "text": "the European Resuscitation Council",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Guidelines, the Resuscitation Council UK, the American Heart Association, and",
    "entities": [
      {
        "text": "the Resuscitation Council",
        "label": "ORG"
      },
      {
        "text": "UK",
        "label": "GPE"
      },
      {
        "text": "the American Heart Association",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "the Advanced Trauma Life Support, we review here the current standards of life",
    "entities": [
      {
        "text": "the Advanced Trauma Life Support",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "support and propose a systematic approach to be used in the hemodialysis",
    "entities": []
  },
  {
    "text": "setting, that helps healthcare providers in their assessment and management of",
    "entities": []
  },
  {
    "text": "\u00a9 The Author(s) 2025. Published by Oxford University Press on behalf of the ERA.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "Oxford University Press",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "All rights reserved. For commercial re-use, please contact reprints@oup.com for",
    "entities": []
  },
  {
    "text": "reprints and translation rights for reprints. All other permissions can be",
    "entities": []
  },
  {
    "text": "obtained through our RightsLink service via the Permissions link on the article",
    "entities": [
      {
        "text": "Permissions",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "page on our site-for further information please contact",
    "entities": []
  },
  {
    "text": "A Systematic Review and Meta-Analysis on Long-Term Exposure to Particulate",
    "entities": [
      {
        "text": "Meta-Analysis",
        "label": "ORG"
      },
      {
        "text": "Particulate",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Matter and All-Cause and Cause-Specific Mortality in the Asia-Pacific States.",
    "entities": [
      {
        "text": "the Asia-Pacific States",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "Oh J(#)(1)(2)(3), Hevia-Ramos G(#)(4), Ha E(1)(2)(5), Hong YC(3)(6), Kim",
    "entities": [
      {
        "text": "Hevia-Ramos",
        "label": "PERSON"
      },
      {
        "text": "Hong YC(3)(6",
        "label": "GPE"
      },
      {
        "text": "Kim\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Environmental Medicine, College of Medicine, Ewha Womans",
    "entities": [
      {
        "text": "Environmental Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Seoul, Korea.",
    "entities": [
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Institute of Ewha-SCL for Environmental Health (IESEH), College of Medicine,",
    "entities": [
      {
        "text": "2)Institute",
        "label": "CARDINAL"
      },
      {
        "text": "Ewha-SCL for Environmental Health",
        "label": "ORG"
      },
      {
        "text": "IESEH",
        "label": "ORG"
      },
      {
        "text": "College of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ewha Womans University, Seoul, Korea.",
    "entities": [
      {
        "text": "Ewha Womans University",
        "label": "ORG"
      },
      {
        "text": "Seoul",
        "label": "GPE"
      },
      {
        "text": "Korea",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Human Systems Medicine, College of Medicine, Seoul National",
    "entities": [
      {
        "text": "Human Systems Medicine, College of Medicine, Seoul National",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(4)Section of Environmental Health, Department of Public Health, University of",
    "entities": [
      {
        "text": "Environmental Health",
        "label": "ORG"
      },
      {
        "text": "Department of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)System Health & Engineering Major in Graduate School (BK21 Plus Program),",
    "entities": [
      {
        "text": "Health & Engineering Major",
        "label": "ORG"
      },
      {
        "text": "Graduate School",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(6)Institute of Environmental Medicine, Medical Research Center, Seoul National",
    "entities": [
      {
        "text": "Environmental Medicine",
        "label": "ORG"
      },
      {
        "text": "Medical Research Center",
        "label": "ORG"
      },
      {
        "text": "Seoul National",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(7)Division of Environmental Health Sciences, School of Public Health,",
    "entities": [
      {
        "text": "Environmental Health Sciences",
        "label": "ORG"
      },
      {
        "text": "School of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University of Minnesota, Minneapolis, MN, USA.",
    "entities": [
      {
        "text": "University of Minnesota",
        "label": "ORG"
      },
      {
        "text": "Minneapolis",
        "label": "GPE"
      },
      {
        "text": "MN,",
        "label": "ORG"
      },
      {
        "text": "USA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(8)Section of Environmental Health, Department of Public Health, University of",
    "entities": [
      {
        "text": "Environmental Health",
        "label": "ORG"
      },
      {
        "text": "Department of Public Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BACKGROUND: Global Burden of Disease (GBD) studies have proposed integrated",
    "entities": [
      {
        "text": "Global Burden",
        "label": "PERSON"
      },
      {
        "text": "GBD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "exposure-response models primarily based on North American and European data,",
    "entities": [
      {
        "text": "North American",
        "label": "NORP"
      },
      {
        "text": "European",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "which may not be directly applicable to the Asia-Pacific region. Through a",
    "entities": []
  },
  {
    "text": "systematic review and meta-analysis, we aimed to explore the association between",
    "entities": []
  },
  {
    "text": "long-term exposure to ambient particulate matter (PM) and mortality in the",
    "entities": []
  },
  {
    "text": "METHODS: We searched 3 databases (PubMed [n = 8,326], Embase [n = 4,709], and",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      },
      {
        "text": "PubMed",
        "label": "ORG"
      },
      {
        "text": "8,326",
        "label": "CARDINAL"
      },
      {
        "text": "Embase",
        "label": "PERSON"
      },
      {
        "text": "4,709",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Cochrane Library [n = 357]) between 1st January 1990 and 31st July 2023. Our",
    "entities": [
      {
        "text": "Cochrane Library",
        "label": "PERSON"
      },
      {
        "text": "357",
        "label": "CARDINAL"
      },
      {
        "text": "between 1st January 1990 and 31st July 2023",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "search focused on studies examining the associations between long-term exposure",
    "entities": []
  },
  {
    "text": "to PM with an aerodynamic diameter < 2.5 \u03bcm (PM2.5) and 10 \u03bcm (PM\u2081\u2080) and",
    "entities": [
      {
        "text": "10 \u03bcm",
        "label": "QUANTITY"
      }
    ]
  },
  {
    "text": "all-cause (or non-accidental) and cause-specific mortality, including",
    "entities": []
  },
  {
    "text": "cardiovascular disease (CVD), ischemic heart disease (IHD), stroke, acute lower",
    "entities": [
      {
        "text": "IHD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "respiratory infection, chronic obstructive pulmonary disease, and lung cancer",
    "entities": []
  },
  {
    "text": "deaths in the Asia-Pacific states. We conducted a meta-analysis to pool the",
    "entities": [
      {
        "text": "the Asia-Pacific states",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "estimates in the studies.",
    "entities": []
  },
  {
    "text": "RESULTS: We identified 71 articles investigating the association between",
    "entities": [
      {
        "text": "71",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "long-term exposure to PM and all-cause and cause-specific mortality. For a 10",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u03bcg/m\u00b3 increase in PM2.5, the pooled relative risk (RR) with 95% confidence",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "intervals (CI) for all-cause mortality was 1.11 (95% CI, 1.05-1.17), 1.13 (95%",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.11",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.05",
        "label": "CARDINAL"
      },
      {
        "text": "1.13",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI, 1.06-1.21) for CVD, 1.13 (95% CI, 1.02-1.25) for IHD, 1.12 (95% CI,",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.06-1.21",
        "label": "DATE"
      },
      {
        "text": "CVD",
        "label": "ORG"
      },
      {
        "text": "1.13",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.02-1.25",
        "label": "CARDINAL"
      },
      {
        "text": "IHD",
        "label": "ORG"
      },
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.02-1.24) for stroke, and 1.12 (95% CI, 1.08-1.16) for lung cancer. For a 10",
    "entities": [
      {
        "text": "1.02",
        "label": "CARDINAL"
      },
      {
        "text": "1.12",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.08",
        "label": "CARDINAL"
      },
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "\u03bcg/m\u00b3 increase in PM\u2081\u2080, the pooled RR for all-cause mortality was 1.12 (95% CI,",
    "entities": [
      {
        "text": "1.12",
        "label": "DATE"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "1.00-1.24) and 1.33 (95% CI, 1.28-1.38) for IHD.",
    "entities": [
      {
        "text": "1.00",
        "label": "CARDINAL"
      },
      {
        "text": "1.33",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "1.28-1.38",
        "label": "CARDINAL"
      },
      {
        "text": "IHD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSION: Our analysis revealed positive associations between long-term",
    "entities": []
  },
  {
    "text": "exposure to PM and all-cause and cause-specific mortality for CVD, IHD, stroke,",
    "entities": [
      {
        "text": "CVD",
        "label": "ORG"
      },
      {
        "text": "IHD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and lung cancer in the Asia-Pacific states.",
    "entities": [
      {
        "text": "the Asia-Pacific states",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "TRIAL REGISTRATION: PROSPERO Identifier: CRD42023441916.",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Korean Academy of Medical Sciences.",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "The Korean Academy of Medical Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40662655 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662655",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Conflict of interest statement: All meta-analyses described in this study can be",
    "entities": []
  },
  {
    "text": "obtained from the corresponding author upon request, including the data and",
    "entities": []
  },
  {
    "text": "analytic code used in the analyses.",
    "entities": []
  },
  {
    "text": "91. Rozhl Chir. 2025;104(6):262-266. doi: 10.48095/ccrvch2025262.",
    "entities": [
      {
        "text": "91",
        "label": "CARDINAL"
      },
      {
        "text": "Rozhl Chir",
        "label": "PERSON"
      },
      {
        "text": "2025;104(6):262-266",
        "label": "CARDINAL"
      },
      {
        "text": "10.48095/ccrvch2025262",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Carotid web - a rare cause of ischemic stroke.",
    "entities": []
  },
  {
    "text": "[Article in English]",
    "entities": [
      {
        "text": "English",
        "label": "LANGUAGE"
      }
    ]
  },
  {
    "text": "INTRODUCTION: A carotid web is a rare but clinically important cause of",
    "entities": []
  },
  {
    "text": "cryptogenic ischemic stroke. It is an atypical form of fibromuscular dysplasia",
    "entities": []
  },
  {
    "text": "localized at the carotid bulb. The aim of this paper is to present this",
    "entities": []
  },
  {
    "text": "less-known cause of ischemic stroke based on a case study.",
    "entities": []
  },
  {
    "text": "CASE REPORT: In a 55-year-old female patient with acute ischemic strok in the",
    "entities": [
      {
        "text": "55-year-old",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "left carotid territory, a carotid web was diagnosed on CT angiography. Other",
    "entities": [
      {
        "text": "CT",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "extracranial or intracranial cerebral arteries showed no stenoses or occlusions.",
    "entities": []
  },
  {
    "text": "The patient was initially treated effectively with intravenous thrombolysis. A",
    "entities": []
  },
  {
    "text": "follow-up brain MRI revealed a small cortical ischemia and a detailed",
    "entities": []
  },
  {
    "text": "cardiological evaluation excluded the cardioembolic etiology of the stroke. As",
    "entities": []
  },
  {
    "text": "part of the secondary stroke prevention, the patient was managed with",
    "entities": []
  },
  {
    "text": "antiplatelet therapy and underwent an uncomplicated carotid endarterectomy.",
    "entities": []
  },
  {
    "text": "During a 10-month follow-up period, there was no recurrence of cerebral",
    "entities": [
      {
        "text": "10-month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: Carotid endarterectomy represents a safe and effective method for",
    "entities": []
  },
  {
    "text": "treating symptomatic carotid web.",
    "entities": []
  },
  {
    "text": "DOI: 10.48095/ccrvch2025262",
    "entities": [
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662438 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662438",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "92. Rozhl Chir. 2025;104(6):252-256. doi: 10.48095/ccrvch2025252.",
    "entities": [
      {
        "text": "92",
        "label": "CARDINAL"
      },
      {
        "text": "Rozhl Chir",
        "label": "PERSON"
      },
      {
        "text": "2025;104(6):252-256",
        "label": "CARDINAL"
      },
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "View of current vascular surgery on asymptomatic carotid stenosis.",
    "entities": []
  },
  {
    "text": "In recent years, the significant progress in the outcomes of conservative",
    "entities": [
      {
        "text": "recent years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "treatment for patients with asymptomatic carotid stenosis has sparked",
    "entities": []
  },
  {
    "text": "discussions about the most effective invasive treatment. The necessity of such",
    "entities": []
  },
  {
    "text": "treatment is still being debated in certain cases. Several studies have already",
    "entities": []
  },
  {
    "text": "been conducted to find the most appropriate approach for asymptomatic patients",
    "entities": []
  },
  {
    "text": "with carotid stenosis, while others are still randomizing and awaiting results.",
    "entities": []
  },
  {
    "text": "A major unanswered question is whether revascularization is more beneficial than",
    "entities": []
  },
  {
    "text": "intensive conservative treatment, particularly in view of the lower stroke rates",
    "entities": []
  },
  {
    "text": "achieved in recent years without conventional or endovascular intervention. The",
    "entities": [
      {
        "text": "recent years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "long-term goal should be to identify a subset of patients who would benefit from",
    "entities": []
  },
  {
    "text": "conservative treatment. In this text, we summarize the issue in the context of",
    "entities": []
  },
  {
    "text": "the results of two recently completed pivotal studies.",
    "entities": [
      {
        "text": "two",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "DOI: 10.48095/ccrvch2025252",
    "entities": [
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662436 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662436",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "93. Rozhl Chir. 2025;104(6):247-251. doi: 10.48095/ccrvch2025247.",
    "entities": [
      {
        "text": "93",
        "label": "CARDINAL"
      },
      {
        "text": "Rozhl Chir",
        "label": "PERSON"
      },
      {
        "text": "2025;104(6):247-251",
        "label": "CARDINAL"
      },
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "of neurosurgical treatment for cerebrovascular diseases. The indications are",
    "entities": []
  },
  {
    "text": "moyamoya dis-ease, steno-occlusive atherosclerotic disease of the internal",
    "entities": []
  },
  {
    "text": "carotid artery, acute ischemic stroke, and, more rarely, complex intracranial",
    "entities": []
  },
  {
    "text": "aneurysms and skull base tumors. Although historical studies have yielded mixed",
    "entities": []
  },
  {
    "text": "results and limited its use, modern diagnostic and surgical techniques are",
    "entities": []
  },
  {
    "text": "reopening the path for selective application of bypass in high-risk patients. A",
    "entities": []
  },
  {
    "text": "clear indication is the rare moyamoya disease, where bypass is a proven method",
    "entities": []
  },
  {
    "text": "for preventing ischemic or hemorrhagic strokes. In patients with symptomatic",
    "entities": [
      {
        "text": "hemorrhagic",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "chronic internal carotid artery occlusion and exhausted cerebrovascular reserve,",
    "entities": []
  },
  {
    "text": "bypass may serve as a potential treatment modality, provided it is carefully",
    "entities": []
  },
  {
    "text": "indicated -through comprehensive specialized evaluation. Emergent bypass should",
    "entities": []
  },
  {
    "text": "be considered for a narrow group of patients with acute ischemic stroke when",
    "entities": []
  },
  {
    "text": "standard treatment fails or is not feasible. Despite ongoing debate,",
    "entities": []
  },
  {
    "text": "extra-intracranial bypass remains an essential part of cerebrovascular surgery.",
    "entities": []
  },
  {
    "text": "The key to success lies in the proper selection of patients and precise",
    "entities": []
  },
  {
    "text": "microsurgical execution. Modern approaches and technologies help reduce the risk",
    "entities": []
  },
  {
    "text": "of complications and enhance the effectiveness of this intervention, offering",
    "entities": []
  },
  {
    "text": "hope to patients with otherwise limited treatment options.",
    "entities": []
  },
  {
    "text": "DOI: 10.48095/ccrvch2025247",
    "entities": [
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662435 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662435",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "94. Rozhl Chir. 2025;104(6):235-237. doi: 10.48095/ccrvch2025235.",
    "entities": [
      {
        "text": "94",
        "label": "CARDINAL"
      },
      {
        "text": "Rozhl Chir",
        "label": "PERSON"
      },
      {
        "text": "2025;104(6):235-237",
        "label": "CARDINAL"
      },
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "A brief history of carotid artery disease and carotid endarterectomy.",
    "entities": []
  },
  {
    "text": "INTRODUCTION: The authors discuss the history of carotid disease and injuries",
    "entities": []
  },
  {
    "text": "and focus on historical milestones of carotid endarterectomy worldwide and in",
    "entities": []
  },
  {
    "text": "RESULTS: The first part discusses the carotid artery and ischemic stroke,",
    "entities": [
      {
        "text": "first",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "beginning with Hippocrates' description of apoplexy. It then highlights Willis's",
    "entities": [
      {
        "text": "Hippocrates",
        "label": "NORP"
      },
      {
        "text": "Willis",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "discovery of the collateral circulation, followed by the 19th-century",
    "entities": [
      {
        "text": "19th-century",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "thromboembolic theory of ischemic stroke caused by carotid artery occlusion,",
    "entities": []
  },
  {
    "text": "which is associated with the work of Wirchow and Chiari. Then, in the 1950s, C.",
    "entities": [
      {
        "text": "Wirchow",
        "label": "ORG"
      },
      {
        "text": "Chiari",
        "label": "PERSON"
      },
      {
        "text": "the 1950s",
        "label": "DATE"
      },
      {
        "text": "C.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "M. Fisher visionarily pointed out the possible surgical management of carotid",
    "entities": [
      {
        "text": "M. Fisher",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "stenosis in the prevention of stroke. In the second part, carotid ligature,",
    "entities": [
      {
        "text": "second",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "treatments for arterial injuries are mentioned, starting with A. Par\u00e9 in 1552,",
    "entities": [
      {
        "text": "A. Par\u00e9",
        "label": "PERSON"
      },
      {
        "text": "1552",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "to ligature of the extracranial carotid artery for intracranial aneurysm by V.",
    "entities": [
      {
        "text": "V.\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Horsley in 1885. The third part describes the history of reconstructive carotid",
    "entities": [
      {
        "text": "Horsley",
        "label": "ORG"
      },
      {
        "text": "1885",
        "label": "DATE"
      },
      {
        "text": "third",
        "label": "ORDINAL"
      }
    ]
  },
  {
    "text": "surgery, especially carotid endarterectomy worldwide, with the priorities of",
    "entities": []
  },
  {
    "text": "Carrea, Eastcott and DeBakey in the early 1950s. The priority in Bohemia belongs",
    "entities": [
      {
        "text": "Carrea",
        "label": "ORG"
      },
      {
        "text": "Eastcott",
        "label": "PERSON"
      },
      {
        "text": "DeBakey",
        "label": "PERSON"
      },
      {
        "text": "the early 1950s",
        "label": "DATE"
      },
      {
        "text": "Bohemia",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "to Jaroslav Lhotka, who published his results in 1962.",
    "entities": [
      {
        "text": "Jaroslav Lhotka",
        "label": "PERSON"
      },
      {
        "text": "1962",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "CONCLUSION: The authors summarize the history of carotid disease, especially",
    "entities": []
  },
  {
    "text": "carotid endarterectomy, worldwide and in Bohemia.",
    "entities": [
      {
        "text": "Bohemia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "DOI: 10.48095/ccrvch2025235",
    "entities": [
      {
        "text": "10.48095",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "PMID: 40662432 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662432",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Targeting hemostatic enzymes: from mechanistic insights to therapeutic",
    "entities": []
  },
  {
    "text": "frontiers.",
    "entities": []
  },
  {
    "text": "Zakar R(1), Neal MD(1), Shea SM(1)(2).",
    "entities": [
      {
        "text": "Zakar R(1)",
        "label": "PERSON"
      },
      {
        "text": "Neal MD(1",
        "label": "PERSON"
      },
      {
        "text": "Shea SM(1)(2",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Trauma and Transfusion Medicine Research Center, Department of Surgery.",
    "entities": [
      {
        "text": "Transfusion Medicine Research Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Department of Bioengineering, University of Pittsburgh, Pittsburgh,",
    "entities": [
      {
        "text": "Bioengineering, University of Pittsburgh",
        "label": "ORG"
      },
      {
        "text": "Pittsburgh",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "PURPOSE OF REVIEW: This review examines the enzymatic regulation of coagulation",
    "entities": [
      {
        "text": "PURPOSE OF REVIEW",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and fibrinolysis, focusing on key players such as thrombin, plasmin, and",
    "entities": []
  },
  {
    "text": "ADAMTS13. We highlight how dysregulation of these enzymes contributes to",
    "entities": []
  },
  {
    "text": "thrombotic and hemorrhagic disorders and review emerging diagnostic biomarkers",
    "entities": []
  },
  {
    "text": "and therapeutic strategies.",
    "entities": []
  },
  {
    "text": "RECENT FINDINGS: Recent studies demonstrate the prognostic utility of biomarkers",
    "entities": []
  },
  {
    "text": "such as thrombin-antithrombin (TAT) and plasmin-\u03b12-antiplasmin (PAP) complexes",
    "entities": [
      {
        "text": "TAT",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "across critical illnesses including trauma, sepsis, and stroke. Advances in",
    "entities": []
  },
  {
    "text": "plasmin and thrombin generation assays, enzyme-specific assays, and",
    "entities": []
  },
  {
    "text": "enzyme-modulating therapies (e.g., factor XI inhibitors and recombinant",
    "entities": [
      {
        "text": "XI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "ADAMTS13) are reshaping approaches to hemostatic balance.",
    "entities": []
  },
  {
    "text": "SUMMARY: Understanding hemostatic enzymatic regulation offers new avenues for",
    "entities": []
  },
  {
    "text": "risk stratification, diagnosis, and treatment of coagulation disorders. Although",
    "entities": []
  },
  {
    "text": "significant progress has been made, challenges remain in translating laboratory",
    "entities": []
  },
  {
    "text": "findings to clinical practice, necessitating further large-scale validation.",
    "entities": []
  },
  {
    "text": "Precision-guided enzymatic therapies hold promise for improving outcomes in",
    "entities": []
  },
  {
    "text": "Outcomes of External Ventricular Drainage, and Lumbar Drainage in Aneurysmal",
    "entities": [
      {
        "text": "Outcomes of External Ventricular Drainage",
        "label": "ORG"
      },
      {
        "text": "Lumbar Drainage",
        "label": "ORG"
      },
      {
        "text": "Aneurysmal\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Subarachnoid Hemorrhage: A Systematic Review, and Meta-Analysis.",
    "entities": [
      {
        "text": "Subarachnoid",
        "label": "PERSON"
      },
      {
        "text": "Meta-Analysis",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Morcos J(5), Rosenwasser RH(1), Jabbour P(1).",
    "entities": [
      {
        "text": "Rosenwasser RH(1",
        "label": "ORG"
      },
      {
        "text": "Jabbour P(1",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(1)Department of Neurological Surgery, Thomas Jefferson University Hospital,",
    "entities": [
      {
        "text": "Thomas Jefferson University Hospital",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "(2)Department of Neuroradiology, MD Anderson Medical Center, Houston, TX, United",
    "entities": [
      {
        "text": "Neuroradiology",
        "label": "ORG"
      },
      {
        "text": "MD Anderson Medical Center",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      },
      {
        "text": "United",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Radiology and Neurosurgery, Louisiana State University Health",
    "entities": [
      {
        "text": "Neurosurgery",
        "label": "GPE"
      },
      {
        "text": "Louisiana State University Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Science Center, Shreveport, LA.",
    "entities": [
      {
        "text": "Shreveport",
        "label": "GPE"
      },
      {
        "text": "LA",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Neurosurgery, UT Health Sciences Center at Houston, McGovern",
    "entities": [
      {
        "text": "Neurosurgery, UT Health Sciences Center",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "McGovern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "Medical School, Houston, TX.",
    "entities": [
      {
        "text": "Medical School",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "TX",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Department of Neurosurgery, UT Health Sciences Center at Houston, McGovern",
    "entities": [
      {
        "text": "5)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurosurgery, UT Health Sciences Center",
        "label": "ORG"
      },
      {
        "text": "Houston",
        "label": "GPE"
      },
      {
        "text": "McGovern",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "used in patients with aneurysmal subarachnoid hemorrhage (aSAH) for",
    "entities": []
  },
  {
    "text": "cerebrospinal fluid diversion and blood clearance. While both have potential",
    "entities": []
  },
  {
    "text": "benefits, the relative efficacy and safety of LD versus EVD remain unclear,",
    "entities": []
  },
  {
    "text": "particularly given their use in differing clinical contexts. This study aims to",
    "entities": []
  },
  {
    "text": "provide a crude comparison of LD and EVD in the context of aSAH using the most",
    "entities": [
      {
        "text": "LD",
        "label": "GPE"
      },
      {
        "text": "EVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "updated and comprehensive meta-analysis.",
    "entities": []
  },
  {
    "text": "METHODS: Following PRISMA guidelines, we performed a systematic review and",
    "entities": []
  },
  {
    "text": "pair-wise meta-analyses of 28 studies (4390 patients). Cohorts were analyzed",
    "entities": [
      {
        "text": "28",
        "label": "CARDINAL"
      },
      {
        "text": "4390",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "across three contrasts-LD vs non-LD, EVD vs non-EVD, and LD vs EVD-using",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "non-LD",
        "label": "NORP"
      },
      {
        "text": "EVD",
        "label": "ORG"
      },
      {
        "text": "LD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "random-effects models. Outcomes included rebleeding, clinical vasospasm, delayed",
    "entities": []
  },
  {
    "text": "ischemic neurological deficit (DIND)/ischemic stroke, functional status (mRS 0-2",
    "entities": [
      {
        "text": "0",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "early and late; GOS \u2264 2), mortality, infection, and shunt dependency.",
    "entities": [
      {
        "text": "GOS",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "RESULTS: Compared with non-LD, LD lowered the odds of vasospasm (OR 0.51, 95 %",
    "entities": [
      {
        "text": "non-LD",
        "label": "NORP"
      },
      {
        "text": "LD",
        "label": "GPE"
      },
      {
        "text": "95 %",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "CI 0.33 to 0.78), DIND/ischemic stroke (OR 0.55, 0.37 to 0.83), severe",
    "entities": [
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.33",
        "label": "CARDINAL"
      },
      {
        "text": "0.78",
        "label": "CARDINAL"
      },
      {
        "text": "0.55",
        "label": "CARDINAL"
      },
      {
        "text": "0.37",
        "label": "CARDINAL"
      },
      {
        "text": "0.83",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "disability/vegetative state (GOS \u2264 2) (OR 0.28, 0.17 to 0.46), and mortality (OR",
    "entities": [
      {
        "text": "GOS",
        "label": "ORG"
      },
      {
        "text": "0.28",
        "label": "CARDINAL"
      },
      {
        "text": "0.17",
        "label": "CARDINAL"
      },
      {
        "text": "0.46",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "0.59, 0.41 to 0.85) without affecting rebleeding rates. Versus non-EVD, EVD",
    "entities": [
      {
        "text": "0.59",
        "label": "CARDINAL"
      },
      {
        "text": "0.41",
        "label": "CARDINAL"
      },
      {
        "text": "0.85",
        "label": "CARDINAL"
      },
      {
        "text": "Versus non-EVD",
        "label": "PERSON"
      },
      {
        "text": "EVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "reduced ischemic complications (OR 0.39, 0.16 to 0.96) but increased infection",
    "entities": [
      {
        "text": "0.39",
        "label": "CARDINAL"
      },
      {
        "text": "0.16",
        "label": "CARDINAL"
      },
      {
        "text": "0.96",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "risk (OR 11.58, 1.45 to 92.71); vasospasm and rebleeding were similar. Direct",
    "entities": [
      {
        "text": "11.58",
        "label": "CARDINAL"
      },
      {
        "text": "1.45",
        "label": "CARDINAL"
      },
      {
        "text": "92.71",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "comparison showed LD superior to EVD for early functional independence (OR 1.92,",
    "entities": [
      {
        "text": "LD",
        "label": "NORP"
      },
      {
        "text": "EVD",
        "label": "ORG"
      },
      {
        "text": "1.92",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "1.06 to 3.50) and mortality (OR 0.49, 0.30 to 0.81), while rebleeding,",
    "entities": [
      {
        "text": "1.06",
        "label": "CARDINAL"
      },
      {
        "text": "3.50",
        "label": "CARDINAL"
      },
      {
        "text": "0.49",
        "label": "CARDINAL"
      },
      {
        "text": "0.30",
        "label": "CARDINAL"
      },
      {
        "text": "0.81",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "vasospasm, infections, and shunt dependency were similar.",
    "entities": []
  },
  {
    "text": "CONCLUSION: LD was associated with lower rates of vasospasm, ischemic",
    "entities": [
      {
        "text": "LD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "complications, severe disability, and mortality compared to non-LD, without",
    "entities": [
      {
        "text": "non-LD",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "increasing rebleeding risk. EVD reduced ischemic complications but was linked to",
    "entities": [
      {
        "text": "EVD",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "higher infection rates. When directly compared, LD was favored for early",
    "entities": [
      {
        "text": "LD",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "functional recovery and survival. These findings should be interpreted in light",
    "entities": []
  },
  {
    "text": "of differing clinical indications and baseline severity. Further studies are",
    "entities": []
  },
  {
    "text": "Neuroinflammation in long-term cognitive impairment after aneurysmal",
    "entities": []
  },
  {
    "text": "subarachnoid hemorrhage.",
    "entities": []
  },
  {
    "text": "(1)Department of Neurology and Neurosurgery, UMC Utrecht Brain Center,",
    "entities": [
      {
        "text": "Neurology",
        "label": "PERSON"
      },
      {
        "text": "Neurosurgery",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "University Medical Centre Utrecht",
        "label": "ORG"
      },
      {
        "text": "Utrecht University",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(2)Department of Radiology and Nuclear Medicine, University Medical Center",
    "entities": [
      {
        "text": "Radiology and Nuclear Medicine, University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Utrecht, Utrecht University, Utrecht, the Netherlands.",
    "entities": [
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Utrecht University",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VU",
    "entities": [
      {
        "text": "Radiology and Nuclear Medicine",
        "label": "ORG"
      },
      {
        "text": "Amsterdam UMC",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "University Medical Center, Amsterdam, the Netherlands.",
    "entities": [
      {
        "text": "University Medical Center",
        "label": "ORG"
      },
      {
        "text": "Amsterdam",
        "label": "GPE"
      },
      {
        "text": "Netherlands",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Radiology and Nuclear Medicine, University Medical Center",
    "entities": [
      {
        "text": "Radiology and Nuclear Medicine, University Medical Center",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(5)Center of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Center,",
    "entities": [
      {
        "text": "Excellence for Rehabilitation Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht, the",
    "entities": [
      {
        "text": "University Medical Center Utrecht",
        "label": "ORG"
      },
      {
        "text": "De Hoogstraat Rehabilitation",
        "label": "ORG"
      },
      {
        "text": "Utrecht",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(6)Department of Translational Neuroscience, UMC Utrecht Brain Centre,",
    "entities": [
      {
        "text": "Translational Neuroscience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BackgroundSurvivors of aneurysmal subarachnoid hemorrhage (aSAH) often have",
    "entities": []
  },
  {
    "text": "cognitive impairment, which may be caused by long-term inflammation. We aimed to",
    "entities": []
  },
  {
    "text": "determine whether long-term neuroinflammation or microstructural brain damage is",
    "entities": []
  },
  {
    "text": "associated with cognitive impairment after aSAH.MethodsIn this prospective",
    "entities": []
  },
  {
    "text": "cohort study, we included patients >3 years after aSAH between 2020 and 2022.",
    "entities": [
      {
        "text": "3 years",
        "label": "DATE"
      },
      {
        "text": "between 2020 and 2022",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "Patients underwent neuropsychological evaluation, translocator protein 18 kDA",
    "entities": [
      {
        "text": "18",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "(TSPO) positron emission tomography (PET) imaging using [18F]DPA-714 to",
    "entities": [
      {
        "text": "PET",
        "label": "ORG"
      },
      {
        "text": "18F]DPA-714",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "determine microstructural damage. We compared TSPO PET binding potential, mean",
    "entities": [
      {
        "text": "PET",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(RA) between groups and determined which metric was correlated with individual",
    "entities": [
      {
        "text": "RA",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "cognitive tests.ResultsWe included 27 patients with aSAH; 14 with and 13 without",
    "entities": [
      {
        "text": "27",
        "label": "CARDINAL"
      },
      {
        "text": "14",
        "label": "CARDINAL"
      },
      {
        "text": "13",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "cognitive impairment. Whole brain TSPO binding potential was similar between",
    "entities": []
  },
  {
    "text": "groups (Mean BPND -0.046 [95% CI -0.105; 0.013] vs -0.047 [95% CI -0.108;",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.013",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.014], p = 0.98) and there were no regional differences. Those with cognitive",
    "entities": [
      {
        "text": "0.014",
        "label": "CARDINAL"
      },
      {
        "text": "0.98",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "impairment had a lower whole brain MK (mean MK 0.70 [95% CI 0.69-0.72] vs 0.73",
    "entities": [
      {
        "text": "MK",
        "label": "PERSON"
      },
      {
        "text": "MK",
        "label": "ORG"
      },
      {
        "text": "0.70",
        "label": "CARDINAL"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.69-0.72",
        "label": "CARDINAL"
      },
      {
        "text": "0.73",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "[95% CI 0.72-0.74], p = 0.03) and whole brain AK (mean AK 0.81 [95% CI",
    "entities": [
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      },
      {
        "text": "0.72",
        "label": "CARDINAL"
      },
      {
        "text": "0.03",
        "label": "CARDINAL"
      },
      {
        "text": "AK",
        "label": "ORG"
      },
      {
        "text": "AK 0.81",
        "label": "PERSON"
      },
      {
        "text": "95%",
        "label": "PERCENT"
      },
      {
        "text": "CI",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "0.78-0.83] vs 0.86 [0.84-0.87], p = 0.04). Left thalamic MK and AK were",
    "entities": [
      {
        "text": "0.78-0.83",
        "label": "CARDINAL"
      },
      {
        "text": "0.86",
        "label": "CARDINAL"
      },
      {
        "text": "0.84",
        "label": "CARDINAL"
      },
      {
        "text": "0.04",
        "label": "CARDINAL"
      },
      {
        "text": "MK",
        "label": "ORG"
      },
      {
        "text": "AK",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "correlated with tests of verbal memory (r = 0.60-0.67, p < 0.01), while other",
    "entities": [
      {
        "text": "0.60-0.67",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "correlation tests were non-significant.ConclusionsOur results do not support the",
    "entities": [
      {
        "text": "ConclusionsOur",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "hypothesis that long-term cognitive impairment after aSAH is caused by long-term",
    "entities": []
  },
  {
    "text": "neuroinflammation. Instead, microstructural damage may play a role.",
    "entities": []
  },
  {
    "text": "Commentary on \"Sodium-Glucose Cotransporter-2 Inhibitors and Stroke Risk in",
    "entities": []
  },
  {
    "text": "Patients With Atrial Fibrillation\".",
    "entities": []
  },
  {
    "text": "(1)Clinical Research Development Unit, Rouhani Hospital, Babol University of",
    "entities": [
      {
        "text": "Research Development Unit",
        "label": "ORG"
      },
      {
        "text": "Rouhani Hospital",
        "label": "ORG"
      },
      {
        "text": "Babol University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Student Research Committee, Department of Pharmacology, School of Medicine,",
    "entities": [
      {
        "text": "Research Committee",
        "label": "ORG"
      },
      {
        "text": "Department of Pharmacology, School of Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Infectious Diseases and Tropical Medicine Research Center, Health Research",
    "entities": [
      {
        "text": "Diseases and Tropical Medicine Research Center",
        "label": "ORG"
      },
      {
        "text": "Health Research",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Institute, Babol University of Medical Sciences, Babol, Iran.",
    "entities": [
      {
        "text": "Babol University of Medical Sciences",
        "label": "ORG"
      },
      {
        "text": "Babol",
        "label": "GPE"
      },
      {
        "text": "Iran",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Effects of GBA1 Variants in Patients With Parkinson's Disease and",
    "entities": []
  },
  {
    "text": "\"Real-World\" Study. The EPIC Study.",
    "entities": [
      {
        "text": "Real-World\" Study",
        "label": "WORK_OF_ART"
      }
    ]
  },
  {
    "text": "(1)Parkinson and Movement Disorders Unit, Department of Clinical Neurosciences,",
    "entities": [
      {
        "text": "1)Parkinson",
        "label": "ORG"
      },
      {
        "text": "Movement Disorders Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical Neurosciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(3)Department of Neuroscience and Rehabilitation, University of Ferrara,",
    "entities": [
      {
        "text": "Neuroscience and Rehabilitation, University of Ferrara",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ferrara, Italy.",
    "entities": [
      {
        "text": "Ferrara",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Matteo, Pavia, Italy.",
    "entities": [
      {
        "text": "Matteo",
        "label": "GPE"
      },
      {
        "text": "Pavia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Parkinson's Centre of Excellence, At King's College Hospital and King's",
    "entities": [
      {
        "text": "Centre of Excellence",
        "label": "ORG"
      },
      {
        "text": "King's College Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "College London, London, UK.",
    "entities": [
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "London",
        "label": "GPE"
      },
      {
        "text": "UK",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "Lanusei, Italy.",
    "entities": [
      {
        "text": "Lanusei",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(7)Department of Neuroscience \"Rita Levi Montalcini\", University of Torino,",
    "entities": [
      {
        "text": "University of Torino",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(9)Parkinson and Movement Disorders Unit, Department of Neuroscience, University",
    "entities": [
      {
        "text": "Movement Disorders Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Neuroscience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(12)Department of Biomedical and NeuroMotor Sciences, Alma Mater Studiorum,",
    "entities": [
      {
        "text": "Biomedical",
        "label": "ORG"
      },
      {
        "text": "NeuroMotor Sciences",
        "label": "ORG"
      },
      {
        "text": "Alma Mater Studiorum",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University of Bologna, Bologna, Italy.",
    "entities": [
      {
        "text": "University of Bologna",
        "label": "ORG"
      },
      {
        "text": "Bologna",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(13)Parkinson's Disease Unit, University Hospital of Rome \"Tor Vergata\", Rome,",
    "entities": [
      {
        "text": "13)Parkinson",
        "label": "CARDINAL"
      },
      {
        "text": "Disease Unit",
        "label": "ORG"
      },
      {
        "text": "University Hospital of Rome",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(14)Department of Advanced Medical and Surgical Sciences, University of Campania",
    "entities": [
      {
        "text": "14)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Advanced Medical and Surgical Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Campania\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(15)Section of Neurology, Department of Neurosciences, Biomedicine, and Movement",
    "entities": [
      {
        "text": "Neurology, Department of Neurosciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, University of Verona, Verona, Italy.",
    "entities": [
      {
        "text": "University of Verona",
        "label": "ORG"
      },
      {
        "text": "Verona",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(16)Department of Translational Medicine, Movement Disorders Centre, Neurology",
    "entities": [
      {
        "text": "16)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Translational Medicine",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Unit, University of Piemonte Orientale, Novara, Italy.",
    "entities": [
      {
        "text": "University of Piemonte Orientale",
        "label": "ORG"
      },
      {
        "text": "Novara",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(17)Parkinson and Movement Disorders Unit, IRCCS Neuromed, Pozzilli, Italy.",
    "entities": [
      {
        "text": "17)Parkinson",
        "label": "CARDINAL"
      },
      {
        "text": "IRCCS Neuromed",
        "label": "PERSON"
      },
      {
        "text": "Pozzilli",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(18)Neurology Unit, University Hospital of Cagliari, Cagliari, Italy.",
    "entities": [
      {
        "text": "18)Neurology Unit",
        "label": "ORG"
      },
      {
        "text": "University Hospital of Cagliari",
        "label": "ORG"
      },
      {
        "text": "Cagliari",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(19)Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\",",
    "entities": [
      {
        "text": "Medica Salernitana",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Center for Neurodegenerative Diseases (CEMAND), University of Salerno,",
    "entities": [
      {
        "text": "CEMAND",
        "label": "ORG"
      },
      {
        "text": "University of Salerno",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Baronissi, Italy.",
    "entities": [
      {
        "text": "Baronissi",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(20)Neurology Service and Stroke Unit, Department of Neuroscience, AO Brotzu,",
    "entities": [
      {
        "text": "Stroke Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Neuroscience",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(21)Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Department",
    "entities": [
      {
        "text": "Neurology, Neurophysiology, Neurobiology and Psychiatry",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Medicine and Surgery, Universit\u00e0 Campus Bio-Medico di Roma, Rome, Italy.",
    "entities": [
      {
        "text": "Universit\u00e0 Campus Bio-Medico",
        "label": "PERSON"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(23)Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.",
    "entities": [
      {
        "text": "23)Department of Human Neurosciences",
        "label": "MONEY"
      },
      {
        "text": "Sapienza University of Rome",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(24)IRCCS Santa Lucia Foundation, Rome, Italy.",
    "entities": [
      {
        "text": "24)IRCCS",
        "label": "CARDINAL"
      },
      {
        "text": "Santa Lucia Foundation",
        "label": "ORG"
      },
      {
        "text": "Rome",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(26)Neurology Unit, Department of Clinical and Experimental Sciences, University",
    "entities": [
      {
        "text": "26)Neurology Unit",
        "label": "ORG"
      },
      {
        "text": "Department of Clinical",
        "label": "ORG"
      },
      {
        "text": "Experimental Sciences",
        "label": "ORG"
      },
      {
        "text": "University",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "of Brescia, Brescia, Italy.",
    "entities": [
      {
        "text": "Brescia",
        "label": "GPE"
      },
      {
        "text": "Brescia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(27)Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation,",
    "entities": [
      {
        "text": "27)Parkinson",
        "label": "CARDINAL"
      },
      {
        "text": "Disease and Movement Disorders Unit",
        "label": "ORG"
      },
      {
        "text": "IRCCS Mondino Foundation",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Pavia, Italy.",
    "entities": [
      {
        "text": "Pavia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(28)Department of Brain and Behavioral Sciences, University of Pavia, Pavia,",
    "entities": [
      {
        "text": "28)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Brain",
        "label": "ORG"
      },
      {
        "text": "Behavioral Sciences",
        "label": "ORG"
      },
      {
        "text": "University of Pavia",
        "label": "ORG"
      },
      {
        "text": "Pavia",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(29)IRCCS Centro Neurolesi \"Bonino-Pulejo\", Messina, Italy.",
    "entities": [
      {
        "text": "29)IRCCS",
        "label": "CARDINAL"
      },
      {
        "text": "Messina",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(32)Department of Medical, Surgical Sciences and Advanced Technologies \"GF",
    "entities": [
      {
        "text": "32)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Surgical Sciences",
        "label": "ORG"
      },
      {
        "text": "Advanced Technologies",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Ingrassia\", University of Catania, Catania, Italy.",
    "entities": [
      {
        "text": "University of Catania,",
        "label": "ORG"
      },
      {
        "text": "Catania",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(33)Neurological Unit, AOU Sassari, University of Sassari, Sassari, Italy.",
    "entities": [
      {
        "text": "33)Neurological Unit",
        "label": "ORG"
      },
      {
        "text": "Sassari",
        "label": "PERSON"
      },
      {
        "text": "University of Sassari",
        "label": "ORG"
      },
      {
        "text": "Sassari",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(34)Department of Neurology, Santa Chiara Hospital, Trento, Italy.",
    "entities": [
      {
        "text": "34)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Neurology",
        "label": "GPE"
      },
      {
        "text": "Santa Chiara Hospital",
        "label": "ORG"
      },
      {
        "text": "Trento",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(35)Department of Neurological Rehabilitation, Parkinson's Disease and Movement",
    "entities": [
      {
        "text": "Disease and Movement",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Fonti, Italy.",
    "entities": [
      {
        "text": "Fonti",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(37)Neurology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.",
    "entities": [
      {
        "text": "37)Neurology Unit",
        "label": "ORG"
      },
      {
        "text": "ASST Papa Giovanni XXIII",
        "label": "ORG"
      },
      {
        "text": "Bergamo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(38)Neurology Unit, ASO Santa Croce, Cuneo, Italy.",
    "entities": [
      {
        "text": "38)Neurology Unit",
        "label": "ORG"
      },
      {
        "text": "ASO",
        "label": "ORG"
      },
      {
        "text": "Santa Croce",
        "label": "GPE"
      },
      {
        "text": "Cuneo",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(39)Department of Health Sciences, \"Aldo Ravelli\" Center, University of Milan",
    "entities": [
      {
        "text": "39)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Aldo Ravelli\"",
        "label": "PERSON"
      },
      {
        "text": "University of Milan",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Neurogenetics, Milan, Italy.",
    "entities": [
      {
        "text": "Neurogenetics",
        "label": "ORG"
      },
      {
        "text": "Milan",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(42)Neurology Unit, Department of Medical, Surgical and Health Sciences,",
    "entities": [
      {
        "text": "42)Neurology Unit,",
        "label": "ORG"
      },
      {
        "text": "Department of Medical, Surgical and Health Sciences",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Cattinara University Hospital, ASUGI, University of Trieste, Trieste, Italy.",
    "entities": [
      {
        "text": "Cattinara University Hospital",
        "label": "ORG"
      },
      {
        "text": "ASUGI",
        "label": "ORG"
      },
      {
        "text": "University of Trieste, Trieste",
        "label": "ORG"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(43)Department of Molecular Medicine, University of Pavia, Pavia, Italy.",
    "entities": [
      {
        "text": "43)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Molecular Medicine",
        "label": "ORG"
      },
      {
        "text": "University of Pavia",
        "label": "ORG"
      },
      {
        "text": "Pavia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(44)Neurogenetic Unit, IRCCS Mondino Foundation, Pavia, Italy.",
    "entities": [
      {
        "text": "44)Neurogenetic Unit",
        "label": "ORG"
      },
      {
        "text": "IRCCS Mondino Foundation",
        "label": "ORG"
      },
      {
        "text": "Pavia",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(45)Department of Neuroscience, Mental Health and Sensory Organs, Sapienza",
    "entities": [
      {
        "text": "45)Department",
        "label": "CARDINAL"
      },
      {
        "text": "Sapienza\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "University of Rome, Roma, Italy.",
    "entities": [
      {
        "text": "University of Rome,",
        "label": "ORG"
      },
      {
        "text": "Roma",
        "label": "GPE"
      },
      {
        "text": "Italy",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "BACKGROUND: The outcome of levodopa/carbidopa intestinal gel (LCIG) in",
    "entities": []
  },
  {
    "text": "Parkinson's disease carriers of GBA1 mutations (GBA-PD) remains uncertain.",
    "entities": []
  },
  {
    "text": "OBJECTIVE: To evaluate the safety and efficacy of LCIG in a large PD cohort,",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      },
      {
        "text": "PD",
        "label": "LOC"
      }
    ]
  },
  {
    "text": "focusing on GBA1 variants.",
    "entities": [
      {
        "text": "GBA1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "METHODS: This multicenter, retrospective, longitudinal \"real-world\" study",
    "entities": []
  },
  {
    "text": "included consecutive patients with advanced PD treated with LCIG at 31 Italian",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      },
      {
        "text": "31",
        "label": "CARDINAL"
      },
      {
        "text": "Italian",
        "label": "NORP"
      }
    ]
  },
  {
    "text": "centers; data were collected at baseline, 1-, 5-year, and last-available",
    "entities": [
      {
        "text": "5-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "follow-up.",
    "entities": []
  },
  {
    "text": "RESULTS: Data from 512 PD patients (59% male, mean age and disease duration at",
    "entities": [
      {
        "text": "512",
        "label": "CARDINAL"
      },
      {
        "text": "59%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "LCIG initiation 67.0 \u00b1 8.0 and 12.9 \u00b1 5.0 years, respectively) were analyzed.",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      },
      {
        "text": "67.0",
        "label": "CARDINAL"
      },
      {
        "text": "8.0",
        "label": "CARDINAL"
      },
      {
        "text": "12.9",
        "label": "CARDINAL"
      },
      {
        "text": "5.0 years",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "GBA1 genotyping was available for 306 patients (60%), of whom 40 (13%) had GBA1",
    "entities": [
      {
        "text": "GBA1",
        "label": "ORG"
      },
      {
        "text": "306",
        "label": "CARDINAL"
      },
      {
        "text": "60%",
        "label": "PERCENT"
      },
      {
        "text": "40",
        "label": "CARDINAL"
      },
      {
        "text": "13%",
        "label": "PERCENT"
      }
    ]
  },
  {
    "text": "mutations or risk variants. Mean follow-up on LCIG was 3.9 \u00b1 2.9 years; 5-year",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      },
      {
        "text": "3.9",
        "label": "DATE"
      },
      {
        "text": "2.9 years",
        "label": "DATE"
      },
      {
        "text": "5-year",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "follow-up data were available for 159 subjects. At baseline, GBA-PD had a",
    "entities": [
      {
        "text": "159",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "younger age, shorter PD duration, worse cognition, and more hallucinations than",
    "entities": []
  },
  {
    "text": "noncarriers. At 1- and 5-year follow-up, LCIG improved motor and non-motor",
    "entities": [
      {
        "text": "5-year",
        "label": "DATE"
      },
      {
        "text": "LCIG",
        "label": "ORG"
      },
      {
        "text": "non-motor",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "symptoms, OFF-time, and dyskinesias in the entire population. In GBA-PD,",
    "entities": []
  },
  {
    "text": "MDS-UPDRS parts I, II, and III scores did not change, while part IV score",
    "entities": [
      {
        "text": "III",
        "label": "ORG"
      },
      {
        "text": "IV",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "improved significantly less than in noncarriers; cognition and orthostatic",
    "entities": []
  },
  {
    "text": "hypotension symptoms worsened more rapidly. Multivariate analysis of predictors",
    "entities": []
  },
  {
    "text": "for adverse events and LCIG discontinuation found no significant contribution",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "from GBA1 mutation status.",
    "entities": [
      {
        "text": "GBA1",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "CONCLUSIONS: GBA1 status does not increase the risk of adverse events or LCIG",
    "entities": [
      {
        "text": "GBA1",
        "label": "ORG"
      },
      {
        "text": "LCIG\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "discontinuation. LCIG is a safe option for advanced GBA-PD, even in patients",
    "entities": [
      {
        "text": "LCIG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "with cognitive impairment at baseline. However, GBA-PD experiences lower",
    "entities": []
  },
  {
    "text": "efficacy on motor disability and complications and faster cognitive decline than",
    "entities": []
  },
  {
    "text": "\u00a9 2025 The Author(s). European Journal of Neurology published by John Wiley &",
    "entities": [
      {
        "text": "2025",
        "label": "DATE"
      },
      {
        "text": "European Journal of Neurology",
        "label": "ORG"
      },
      {
        "text": "John Wiley &\n",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "Sons Ltd on behalf of European Academy of Neurology.",
    "entities": [
      {
        "text": "Sons Ltd",
        "label": "ORG"
      },
      {
        "text": "European Academy of Neurology",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "PMID: 40662275 [Indexed for MEDLINE]",
    "entities": [
      {
        "text": "40662275",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "10.1177/09226028251358166. Online ahead of print.",
    "entities": [
      {
        "text": "10.1177/09226028251358166",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "Relationship Between Descending Neural Drives from the Non-Injured Hemisphere",
    "entities": [
      {
        "text": "the Non-Injured Hemisphere\n",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "and Lower Limb Motor Function and Gait Ability in Patients Following Severe",
    "entities": [
      {
        "text": "Lower Limb Motor Function",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(1)Department of Therapy, Takarazuka Rehabilitation Hospital, Medical",
    "entities": [
      {
        "text": "Therapy, Takarazuka Rehabilitation Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "(2)Neurorehabilitation Research Center, Kio University, Kitakatsuragi-gun,",
    "entities": [
      {
        "text": "2)Neurorehabilitation Research Center",
        "label": "ORG"
      },
      {
        "text": "Kio University",
        "label": "ORG"
      },
      {
        "text": "Kitakatsuragi",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(3)Department of Neurorehabilitation Laboratory, Graduate School of Health",
    "entities": [
      {
        "text": "Neurorehabilitation Laboratory",
        "label": "ORG"
      },
      {
        "text": "Graduate School of Health",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "Sciences, Kio University, Kitakatsuragi-gun, Japan.",
    "entities": [
      {
        "text": "Kio University",
        "label": "ORG"
      },
      {
        "text": "Kitakatsuragi",
        "label": "GPE"
      },
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(4)Department of Rehabilitation, Faculty of Health Sciences, Nihon Fukushi",
    "entities": [
      {
        "text": "Rehabilitation, Faculty of Health Sciences",
        "label": "ORG"
      },
      {
        "text": "Nihon Fukushi",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "University, Handa-shi, Japan.",
    "entities": [
      {
        "text": "Japan",
        "label": "GPE"
      }
    ]
  },
  {
    "text": "(5)Department of Medical, Takarazuka Rehabilitation Hospital, Medical",
    "entities": [
      {
        "text": "Takarazuka Rehabilitation Hospital",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "BackgroundThe relationship between the functional recovery of patients in the",
    "entities": [
      {
        "text": "BackgroundThe",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "subacute phase of stroke and descending neural drives from the non-injured",
    "entities": []
  },
  {
    "text": "hemisphere to the paretic lower limb muscles during movement remains unclear. We",
    "entities": []
  },
  {
    "text": "investigated this relationship in patients with severe",
    "entities": []
  },
  {
    "text": "paralysis.MethodsTwenty-nine patients with stroke were recruited and categorized",
    "entities": [
      {
        "text": "MethodsTwenty-nine",
        "label": "PRODUCT"
      }
    ]
  },
  {
    "text": "into three groups based on paralysis severity. Within 1 month of admission, each",
    "entities": [
      {
        "text": "three",
        "label": "CARDINAL"
      },
      {
        "text": "1 month",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "patient received 10 min of anodal tDCS applied to the cortical motor areas of",
    "entities": [
      {
        "text": "10",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "the injured or non-injured hemispheres. Each stimulation condition was performed",
    "entities": []
  },
  {
    "text": "in a random order, one day at a time, with a 7-day washout period. Before and",
    "entities": [
      {
        "text": "one day",
        "label": "DATE"
      },
      {
        "text": "7-day",
        "label": "DATE"
      }
    ]
  },
  {
    "text": "after each stimulation, patients performed multiple voluntary knee extensions on",
    "entities": []
  },
  {
    "text": "the paretic side 20% of their maximal strength, sustained for 6 s. Coherence",
    "entities": [
      {
        "text": "20%",
        "label": "PERCENT"
      },
      {
        "text": "6",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "analysis of EMG signals from proximal and distal segments of the vastus medialis",
    "entities": [
      {
        "text": "EMG",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "muscle was conducted to quantify common neural drive from each cortical",
    "entities": []
  },
  {
    "text": "motor-related area based on coherence variations before and post stimulation in",
    "entities": []
  },
  {
    "text": "each condition. We investigated the relationship between the excitability of the",
    "entities": []
  },
  {
    "text": "descending neural pathway from the non-injured hemisphere in the initial phase",
    "entities": []
  },
  {
    "text": "and motor function recovery at 3 months.ResultsNo significant differences",
    "entities": [
      {
        "text": "3 months",
        "label": "DATE"
      },
      {
        "text": "ResultsNo",
        "label": "PERSON"
      }
    ]
  },
  {
    "text": "emerged across groups in the change in coherence values when the non-injured",
    "entities": []
  },
  {
    "text": "hemisphere stimulated. However, within the severe group, an increase in \u03b2-band",
    "entities": []
  },
  {
    "text": "coherence following non-injured hemisphere stimulation correlated with greater",
    "entities": []
  },
  {
    "text": "recovery of paretic-side muscle strength and trunk function at 3",
    "entities": [
      {
        "text": "3",
        "label": "CARDINAL"
      }
    ]
  },
  {
    "text": "months.ConclusionOur findings deepen understanding of paralysis pathophysiology",
    "entities": [
      {
        "text": "months",
        "label": "DATE"
      },
      {
        "text": "ConclusionOur",
        "label": "ORG"
      }
    ]
  },
  {
    "text": "based on severity level and may support the development of targeted",
    "entities": []
  },
  {
    "text": "neuromodulation strategies to enhance motor recovery.",
    "entities": []
  }
]